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3Abstract
Human life expectancy is increasing globally. This has major socioeconomic implications,
but also raises scientific questions about the biological bases of ageing and longevity. Re-
search on appropriate model organisms, such as the nematode worm Caenorhabditis ele-
gans, is a key component of answering these questions. Ageing is a complex phenomenon,
with both environmental and genetic influences. Metabolomics, the analysis of all small
molecules within a biological system, offers the ability to integrate these complex factors
to help understand the role of metabolism in ageing.
This thesis addresses the current lack of methods for C. elegans metabolite analysis, with
a particular focus on combining analytical and computational approaches.
As a first essential step, C. elegans metabolite extraction protocols for NMR, GC-MS and
LC-MS based analysis were optimized. Several methods to improve the coverage, auto-
matic annotation and data analysis steps of NMR and GC-MS are proposed.
Next, stable isotope labelling was explored as a tool for C. elegans metabolomics. An
automated stable isotope based workflow was developed, which identifies all biological,
non-redundant features within a LC-MS acquisition and annotates them with molecular
compositions. This demonstrated that the vast majority (> 99.5%) of detected features
inside LC-MS metabolomics experiments are not of biological origin or redundant.
This stable isotope workflow was then used to compare the metabolism of 24 different
C. elegans mutant strains from different pathways (e.g. insulin signalling, TOR path-
way, neuronal signalling), with differing levels of lifespan extension compared to wild-type
worms. The biologically relevant features (metabolites) were detected and annotated, and
compared across the mutants. Some metabolites were correlated with longevity across the
mutant set, in particular, glycerophospholipids. This led to the formulation of a hypothesis,
that lifespan extension in C. elegans requires increased activity of common downstream
longevity effector mechanisms (autophagy, and mitochondrial biogenesis), that also in-
volve subcellular compartmentation and hence membrane formation. This results in the
alterations in lipid metabolism detected here.
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Metabolomics versus Metabonomics
This work is mainly based on global metabolic profiling, also referred to as
”metabonomics” [444] or ”metabolomics” [455, 171]. However, ”In practice, the terms are
often used interchangeably, and the analytical and modelling procedures are the same”.
Furthermore, ”The distinction is mainly philosophical, rather than technical.” [443]
In order to be consistent, across this thesis, the term metabolomics will be used.
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I.. Introduction
I.1. Ageing and longevity
Even though life expectancy has steadily risen over the last thousands of years, the rapid
increase during the last century was nothing like before (Figure I.1).
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Figure I.1.: Changing demography:
Life expectancy displayed a steep increase over the past century. X5 and X10
in figure (a) indicate the ages at which 5 and 10 years life expectancy remain,
respectively, and their increase over time. Figure (b) shows the drastic
increase in centenarians - people over 100 years. (The figures were adapted
from [594])
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Thirty years of additional life expectancy or more were gained in several countries through-
out the last century [97]. Currently life expectancy increases with a pace of 2.5 years per
decade, or 6 hours a day in wealthy countries [593]. If this trend continues, then most
children born in these countries since 2000 will turn 100 [97]. These demographic changes
will have a far reaching economic impact, not only for federal social security system, but
also insurance companies. Inevitably, rising expenses for pensions and healthcare will need
to be faced, being exacerbated by a world-wide decrease of birth rate in western countries
[219]. Interestingly, the constant offset between 5 and 10 year life expectancy in figure I.1a
suggests that senescence is postponed, rather than decelerated [594].
The causes of senescence, i.e. biological ageing, are still unknown, but many theories have
been proposed. In general one has to differentiate between mechanistic and evolutionary
explanations [325, 263]. Important mechanistic theories include the somatic mutation,
telomere loss, mitohermesis, free radical [230] and protein waste accumulation, theories.
Established evolutionary explanations include the mutation accumulation [407] and the
antagonistic pleiotropy theory [627]. However, a recent point of view is to acknowledge
that none of the theories can be seen as sufficient [326]. They need to be interlinked and
complement each other, which leads to the definition of network theories of ageing [327].
Genetics has a limited influence on an individual’s life-span. In their natural habitats,
most animals will not reach their maximum possible age. This is due to challenging envi-
ronmental conditions, such as availability of nutrition, succumbing to predators, a harsh
climate, or other reasons. In a laboratory setting, however, under controlled and optimal
environmental conditions, maximum life-span is mainly limited by genetic predisposition
[287, 124]. The very same trend has been observed for humans. Demographic studies in
twin cohorts showed, that only 25 % of the variance of life expectancy can be explained
by genetic disposition [401, 240]. This value though, may slightly increase at higher age
[595]. For the oldest of a population, however, genetics seems to be the primary driver
of life-expectancy [475]. This explains the prior mentioned, drastic increase in population
life-span: Throughout the last century, we have tamed our environmental conditions by
medical progress, understanding of hygiene, balanced and secure food supply and imple-
menting social security systems. Thus, more people survive to an age where genetic dis-
position governs the remaining lifespan. This shows that an understanding of the genetics
behind ageing becomes increasingly important. However, the fact that overall lifespan still
26 I.. Introduction
increases with such a pace, also demonstrates that many life-expectancy influencing envi-
ronmental factors still remain to be elucidated or to be improved.
Apart from demographic studies, such as above, humans themselves are rarely subject to
ageing research, in order to understand those factors and general limits of longevity. Apart
from ethical issues, this is because of their long absolute life expectancy and the impact
of non-controllable, confounding factors, such as nutrition, medication and other lifestyle
choices. For those reasons, model systems, in controlled environments, are used [309].
They range from simple systems such as bacteria [659], fungi (yeast) [290], cultured cells,
over multicellular invertebrates [307, 308, 465] like fruit flies [208], nematode worms [183],
up to fish [191] and even mammals such as mice [573] or dogs [611].
The model system used in this thesis is the nematode worm Caenorhabditis elegans.
I.2. C. elegans as model organism
Caenorhabditis elegans, shown in figure I.2 is a soil inhabiting nematode of approximately 1
mm length, feeding on bacteria. Being a nematode, it is a multicellular animal, containing
around one thousand cells. In fact, the hermaphrodite has exactly 959 and the male 1031
cells.
Figure I.2.: Adult C. elegans:
3.5 days after hatching (at 20 ℃), a hermaphrodite C. elegans reaches
adulthood and measures 1.1 mm in length and 30µm in radius.
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It was first established as a model organism by Sydney Brenner in 1974 [60]. It was soon
adopted by many research labs around the globe, [149], making it one of the best un-
derstood organisms. It was the first multicellular animal to have its 97 million base pair
genome completely sequenced [79]. Over 35 % of its genes have homologues in humans,
with whom it shares many conserved pathways [99, 522]. Thus, C. elegans research may
have direct implications for human biology.
C. elegans is also convenient to handle. It can be grown on agar plates, feeding on an
E. coli lawn, with one plate supporting up to ten thousand individuals. It can be frozen,
stored, and thawed when needed. As it is transparent, its cellular development can be
observed by light microscopy. In fact, each of its cell’s fates can be traced and has been
mapped in detail, making it an important model for developmental biology [150]. As
hermaphrodites can reproduce asexually, their offspring are genetic clones. This and the
ease of silencing specific genes, using RNA interference (RNAi) [223] through feeding of
siRNA expressing bacteria [294], also made it an indispensable system for genetics. A
full genome RNAi library is available [293] and thousands of genetically modified mutant
strains can readily be ordered from the CGC (Caenorhabditis Genetics Center) [239]. The
”worm community” also provides a plethora of other resources, such as the WormBook
(wormbook.org), a peer reviewed collection of C. elegans biology, methods and protocols
and Wormbase (wormbase.org), which is a large bioinformatics repository [654].
One reason which made C. elegans an indispensable model for development and ageing is
its short, but precisely timed lifecycle [78], which is summarised in figure I.3. Depending
on the temperature, which may be varied between 15°C and 25°C, a worm’s lifecycle from
hatching to egg laying takes between 3 and 5 days. As they have an exoskeleton (cuticle),
composed of cross-linked collagen, they undergo molting. Four phases of linear growth,
with subsequent moulting [331], define C. elegans’s larval stages, from L1 to L4. After
the final molt, the young adult stage, spermatogenesis is complete and oogensis begins.
Once completed, they are considered adults, which starts at the onset of egg laying. A
self-fertilising hermaphrodite can lay up to 300 eggs, but if fertilised by a male, this may
increase to well over 1000 eggs [244]. Even though fertility ceases after a few days, the
(wild type) worm may live on up to two more weeks.
As seen in figure I.3, a worm may also take a different lifecycle. The morphologically
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L1
L2
L3
L4
young
Adult
Eggs
Adult
Dauer
~0.25 mm
~0.37 mm
~0.5 mm
~0.64 mm
~0.9 mm
~1.1 mm
~12h
~14h
~8h~10h
~12h
~10h
up to 4 months
2 weeks
~0.4 mm
Figure I.3.: C. elegans lifecycle:
Different developmental stages of C. elegans, including their approximate
timing at 20°C and the worm’s length. Numbers are taken from Byerly et
al.[78]
distinct dauer larval stage is an arrested stage which L2 larva may enter if environmental
conditions become unfavourable [492]. Such conditions are high temperatures (> 25°C),
scarce availability of food, and high population density, sensed by the increased concentra-
tion of small molecules, the dauer pheromones [203]. Dauer larvae have altered metabolism
[72] and reduced locomotion, and may survive up to several months and develop directly
into L4 larvae once environmental conditions improve. Despite having a normal lifespan
after escaping the dauer stage, it was shown that during the dauer stage, worms actually
age [254] and can even die, i.e. are not able to recover to L4, if conditions do not allow
lifecycle progression.
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Not only the dauer stage makes C. elegans an interesting model for ageing and longevity,
but also the presence of long-lived mutant strains. In 1988, the first mutation which in-
creases lifespan was found; it affects the gene age-1, which encodes for a catalytic subunit of
the PI3K orthologue [182]. In 1992, a mutation that doubles life-span by reducing insulin
like signalling (ILS) was discovered by Kenyon and coworkers [310]. Since then, C. ele-
gans has become one of the most important model organisms for ageing. Using large scale
RNAi screens, many more genes have been discovered that when deleted or over-expressed
extend lifespan [224, 227, 351, 439, 415]. These genes act over many different pathways.
An extensive review of all those pathways, can be found in the introduction of Chapter V.,
in which the metabolic profiles of several life extending mutations are compared.
Most of these life-span enhancing mutants have been extensively studied from a a genetic
control [311] and transcriptomic point of view [377]. However, little research has been done
on the role of metabolism itself. This is surprising, considering that in addition to genetic
factors, there are also a number of small molecules and physicochemical conditions [456],
that can significantly increase C. elegans lifespan. Those small molecules include valproic
acid [155], resveratrol [34], spermidine [424], oxalacetate [626], glycolysis inhibitors [518],
antidepressants [478], antidiabetics [80], or different carbohydrates [249], such as trehalose.
Also, life expectancy is determined by the food source, such as by the choice of bacterial
strains [382, 488] or whether they were alive or killed before feeding [601, 162].
Thus, analyses which focus on metabolic changes, such as metabolomics, may provide in-
teresting insights.
I.3. Systems biology and metabolomics
Over the past century molecular biology and biochemistry have enabled scientists to un-
derstand many fundamental processes and principles, which when combined, make up an
organism. Both disciplines usually work by reductionism. This means that they try to
isolate and abstract a mechanism as much as possible, in order to understand its function.
Therefore, those disciplines may be viewed as bottom-up approaches. Even though such
simplified systems are an effective way of studying underlying mechanisms, they may fail
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to capture integrated biological regulation. In any organism, even as simple as a single cell,
those systems are all interconnected, regulating and impacting each other in a regulated
but often non-linear manner [359, 91].
More recently, enabled by the rapid increase of available computing power, progress in
database curation, modern chemical analysis and sequencing technology, science has be-
gun to use top-down approaches to understand this complex interplay [621], and ultimately
reach a more holistic picture of a biological system. The emerging field of systems biology
aims to pool methods and knowledge from various classical disciplines of science, such
as biology, chemistry, physics, mathematics and informatics, to build large network-based
models, connecting the individual mechanisms. Sub-disciplines of systems biology are usu-
ally referred to as ”-omics”. [269, 328]
H3C-C-OH
H
H3C-C
H
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transcription
translation
catalysis
H
Figure I.4.: System biology’s OMICS
Many different (or at least proposed) omics disciplines exist. The most common, however,
are centred around Francis Crick’s central dogma of molecular biology [119], as shown
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in figure I.4. Genomics uses high throughput sequencing technology with bioinformatic
annotation to determine the DNA sequence and proposed gene functions of an organism
[272]. Transcriptomics aims at identifying and quantifying all expressed transcripts inside
a system. Unlike genomics, transcriptomics at least partially reflects an organismÕs en-
vironment, as only transcripts currently being expressed are measured. Transcriptomics
was typically performed by expression microarray analysis, but next generation sequenc-
ing based RNA-seq has become the gold standard [612]. Proteomics aims at determining
and quantifying all expressed proteins [583]. Proteomics is even more specific than tran-
scriptomics, as post-translational modifications, such as phosphorylation, ubiquitination
or glycosylation, may also be assessd. Methods may range from gel electrophoresis with
subsequent antibody detection, to sophisticated mass spectrometry based assays.
Metabolomics, the untargeted profiling of metabolites [122, 444, 171, 204], is the most
downstream of system biology’s omics approaches. It aims to quantify and identify low
molecular weight compounds (e.g. below 1 kDa), such as organic acids, carbohydrates or
lipids, inside a biological matrix. As metabolites are an endpoint of the biological system,
metabolomics gives an integrated phenotype, reflecting the effects of environmental fac-
tors [204]. Thus, it provides an ideal tool to study complex phenomena like ageing, which
are the result of genetic predisposition impacted by environmental conditions and various
stimuli.
Figure I.5.: Workflow of a typical LC-MS experiment
Indeed, many different sample types have been analysed, using different analytical tools,
modelling and analysis approaches in order to answer questions from very different fields of
science [246, 553]. The typical workflow of a metabolomics experiment is outlined in figure
I.5. It starts with sample collection, with the most common sample types being animal and
plant tissues and biofluids, such as urine or blood plasma. Sample preparation may range
from minimal intervention, to sophisticated extraction and derivatisation procedures. The
32 I.. Introduction
most commonly used analytical platforms are nuclear magnetic resonance spectroscopy
(NMR) [442], and gas or liquid chromatography, coupled to mass spectrometry (GC-MS,
LC-MS) [135, 614]. Data processing may range from quantification of a targeted set of
metabolites up to complex dataset deconvolution and alignment procedures. Analysis
may also range from classic biomarker discovery, using multivariate pattern recognition
[579], time series analysis [477, 11, 329, 148], up to quantitative pathway based models
[457, 279, 175, 167].
All elements of this workflow, from the basic science, over instrumentation up to exper-
iment execution with subsequent processing and statistics are discussed in detail in the
theory and methods chapter (VI.4), which was moved to the appendix.
The combination of advanced analytical approaches and sophisticated data processing and
analysis tools is key to metabolomics experiments. Thus, analytical and computational
method development are a main aspect of this thesis.
I.4. Metabolomics of ageing and C. celegans
Metabolomics has also been employed for ageing research [417]. It has been used to find
biomarkers of ageing and longevity, for several model organisms, such as yeast [655], fruit
flies [514], mice [256, 128, 625, 573] and even dogs [611], up to human cohort studies
[213, 657]. A large proportion of all reported significant molecules are lipids, analysed by
reversed phase chromatography.
C. elegans ageing has also been subject to metabolomic analyses. Fuchs et al.[183] charac-
terized a ”metabolic signature of long life in Caenorhabditis elegans” by applying a 1H-NMR
metabolomics approach to IIS longevity mutants and worms of different ages. They found
branched chain amino acids (BCAA) were a key set of metabolites. Martin et al.[392]
independently reported very similar findings, using the same or related mutant strains. An
et al. used multidimensional NMR to also show the involvement of BCAA in sirtuin based
life-span extension [15]. Butler et al. showed that long-lived mitochondrial mutants use
a novel type of mitochondrial metabolism [77] with the involvement of alpha-ketoacids [75].
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Most of these findings were published only after the start of this degree. Furthermore, the
majority of long-lived mutant strains have not yet been examined by metabolomics. A key
shortcoming of current published studies is that they focus on single pathways of lifespan
extension, without comparing between them. Hence, analysis of additional long-lived mu-
tant strains and making comparisons between them will be the main application for the
methods developed in this thesis. This is described in a large scale longevity mutant screen
in chapter V..
Next to ageing, other aspects of C. elegans biology have been examined using metabolomics.
Those include cell growth [556], fat metabolism [23, 86, 85], heavy metal and pesticide
toxicology [264, 288] and reactive oxygen species [660]1 and acute anoxia [76] responses,
respectively. Reinke et al.[488, 558] showed that the choice of E. coli strain affects the
C. elegans baseline metabolome. Davies et al.[125] also showed that the mitosis inhibitor
fluorodeoxyuridine (FUdR), which is often used to maintain synchronous populations of
C. elegans during longevity-assays, heavily impacts the metabolic phenotype.
Blaise et al.[51] also developed a protocol for whole worm metabolite profiling by magic
angle spinning NMR. However, apart from these last three studies, there has been surpris-
ingly little method development, considering the rapid growth of C. elegans metabolomics
research. This gap in the literature will be addressed by this thesis, in which analytical and
computational methods for C. elegans metabolite analysis will be developed, with an em-
phasis on increasing metabolite coverage by the use of multiple analytical platforms. Many
of the methods will also be applicable to other model organisms, and also the broader field
of metabolomics.
I.5. Aims and structure of this thesis
The aim of this thesis is to address the lack of advanced methods for C. elegans metabo-
lite analysis; with conjoint analytical and computational approaches in particular. Those
methods will be used to understand the metabolic basis of factors that drive ageing and
longevity in C. elegans.
1This work was published in collaboration with Stephen Stuerzenbaum and Sukaina Zeitoun-Ghandour
from Kings College, London; Metabolite profiling and data analysis was performed by Florian Geier.
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Explore the C. elegans "baseline metabolome"
Find "best" protocol for NMR, GC-MS and LC-MS proling
Explore prospects and limitations of NMR, GC-MS and LC-MS for C. elegans, metabolomics 
Increase sensitivity for HSQC experiments and perform automatic annotation
Increase NMR coverage through a chromatographic separation step
Develop a workow to analyse GC-MS data without a priori metabolite information
Investigate necessary atom-count constraint for unambiguous formula generation
Develop an automated workow for stable isotope labelling based data reduction and formula generation
Test the developed algorithm on dierent LC-MS datasets
Find and annotate C. elegans, metabolites using the workow from last chapter 
Match C. elegans, metabolites to longevity-mutant proling experiment
Find a common metabolic signature of longevity
Figure I.6.: Overview of thesis structure
Figure I.6 outlines the general structures of this thesis and the specific objectives of the
individual chapters.
The thesis has four results chapters, of which the first three are primarily concerned with
method development, the last one, with the application of some of those methods.
In the first results chapter (II.), C. elegans metabolite extraction protocols will be bench-
marked for subsequent GC-MS, NMR and LC-MS based untargeted profiling.
The second chapter (III.) is a compound chapter, containing three mini-projects, to in-
crease metabolite coverage and annotation for NMR and GC-MS. The first project (III.2),
uses 13C to enhance the sensitivity of 2-D NMR spectra (HSQC) and perform automatic
database annotation of those. In the second project (III.3), a LC-NMR ion-pairing strategy
was used to separate the anionic constituents of the NMR visible C. elegans metabolome;
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a NMR-silent, fully deuterated ion-pair reagent was evaluated. The third project (III.4)
proposes an alternative to the standard GC-MS analysis workflow from chapter one. The
workflow dynamically aligns and overlays the total ion chromatograms (TIC) of different
sample groups for a quick, visual analysis. This method will be applied to the analysis
dataset of mitochondrial mutants, which make C. elegans either long- or short-lived.
The third results chapter (IV.) is concerned with developing a method, which reduces LC-
MS data to biological, non-redundant features only, which a subsequently annotated with
their molecular composition. This method relies on the increase of molecular weight, when
a metabolite incorporates stable isotopes. First, a simulation explores the feasibility of this
approach, then protocols for triple (carbon, nitrogen, sulphur) stable isotope labelling of
E. coli and C. elegans samples and a software algorithm to extract this information from
LC-MS data, is developed. Finally the method is tested with E. coli samples, acquired by
different chromatographic and electrospray modes.
In the final experimental chapter (V.), a panel of 24 different long-lived C. elegans mutant
strains is analysed, to find a common metabolite pattern, associated with longevity. This
is done in a ”targeted untargeted” fashion. First, the stable isotope based data reduction
and annotation method is used, to annotate a C. elegans extract. Then, the annotated
biological features are integrated within the mutant dataset. The resulting data matrix is
then subject to a variety of multivariate and univariate modelling approaches, also consid-
ering the annotated molecular compositions.
In a final discussion chapter (VI.), results will be summarised and put into the context of
current issues faced in metabolomics and (C. elegans) ageing research. Also, two methods,
which were already published as a proof of concept, and promise to solve key problems in
C. elegans ageing research, will be presented.
In the appendix (A), a comprehensive discussion on the theory of the methodology used
can be found. This chapter also gives an introduction to the algorithms, including their
parameters, used for data-processing. Thus, it may serve as a general source of reference.
Next to the supplementary tables and figures (B), the appendix contains wet-lab protocols,
for procedures, which are applied frequently throughout the thesis (C).
II.. Evaluation of C. elegans metabolite
extraction strategies for untargeted
cross-platform profiling
Aims and Objectives:
• Explore the C. elegans ”baseline metabolome”
• Find the ”best” protocol for NMR, GC-MS and LC-MS profiling
• Explore prospects and limitations of NMR, GC-MS and LC-MS for C.
elegans metabolomics
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II.1. Introduction
The ultimate goal of metabolomics is to measure the concentration of each metabolite
contained inside a matrix. Endogenous metabolites have a high diversity of physicochem-
ical properties compared to other biomolecules, such as RNA or DNA. Thus, one sample
simultaneously contains small, highly polar compounds from central carbon metabolism,
amphiphilic amino acids, and high molecular weight, hydrophobic lipids. This has two
major implications. Firstly, as discussed in A2.4, a combination of analytical methods is
required to provide the most comprehensive coverage of metabolite classes. Secondly, sam-
ple preparation, including the choice of solvents, which themselves bias particular metabo-
lite classes, is crucial. Whereas sample preparation for biofluids, such as urine [616] or
blood [615, 141], is often minimal, with typical steps such as sample dilution or protein
precipitation, preparation of tissue samples is more complex. Tissues must be disrupted
to allow the metabolites to be accessed by the extraction solvents.
C. elegans are both tough and small, with an adult size of 1.2 mm × 60 µm, and an
external collagenous cuticle. As a result, tissue extraction protocols [613] developed for
eukaryotic cells or tissue samples from larger organisms are unlikely to be suitable for C.
elegans, with tissue disruption being a particular concern. There are many extraction pro-
tocols in the metabolomics literature, but little has been done with regards to C. elegans.
Bhaskaran et al.[47] showed that a Balch homogeniser delivers good results for protein
and DNA extractions. However, their device operates on a ”one sample per batch” basis
and would therefore not be suitable for high throughput experiments. To find the best
metabolite extraction method for C. elegans, this chapter benchmarks six different tissue
disruption methods.
Following tissue disruption, metabolites must be solubilised by the extraction solvents.
Equally important, the extraction solvents must effectively halt all metabolic activity,
to enable a reproducible, accurate snapshot of the metabolome: aqueous extractions are
generally not suitable, and may lead to significant degradation of many metabolites within
seconds after disruption [364]. Thus, for most metabolomics applications a mixture of
aqueous and miscible organic solvents is used. Most commonly, those are either mono-
phasic or bi-phasic. Bi-phasic systems, however, lead to metabolite partitioning, such
as separation between hydrophilic and hydrophobic compounds, between the two phases.
[349, 394, 364, 367, 613].
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II.2. Design of Experiment
This chapter aims to evaluate C. elegans extraction strategies for subsequent untargeted
profiling using NMR, GC-MS and LC-MS, focusing on tissue disruption techniques, which,
in contrast to solvent systems, have received little attention throughout the literature.
The success of a solvent - disruption pair was assessed by three criteria.
Similarity What is the common or unique metabolite coverage
Reproducibility How does within-replicate variation compare
Yield Which method extracts ”the most” of a certain metabolite
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Figure II.1.: Design of experiment:
300 agar plates of C. elegans were pooled and aliquoted into 60 fractions for
5 replicates of six extraction methods and two solvent systems. After
extraction with either 80 % methanol or methanol:chloroform:water, each
extract was aliquoted for GC-MS, LC-MS and NMR in a ratio of 1:1:8.
The full-factorial design of the experiment is outlined in figure II.1. 300 plates of mixed N2
wild type worms were pooled and aliquoted, and then extracted using 2 solvent systems
and 6 tissue disruption methods, with 5 replicates each.
A mono-phasic 80 % methanol-water (M80) mixture and a classic bi-phasic Bligh &
Dyer [52] methanol-chloroform-water (MCW) approach were selected as extraction sol-
vents. Both of those have successfully been used to extract metabolites from C. ele-
gans[556, 183, 125, 23, 86], but their performance has not been compared yet. For the
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MCW extraction, only the polar aqueous fraction was tested, as specific protocols for
C. elegans lipid analysis already exist [396]. For tissue disintegration six methods were
compared, with four different pieces of equipments, one tested with three different milling
agents:
(1) Manual grinding with mortar and pestle, (2) bead-beating in a planetary bead-beater,
as widely used for DNA/RNA/Protein extractions, (3) homogenisation by a blender, (4) a
grinding shape optimised metal spheroid inside a reciprocating ball mill, (5) silicon beads
inside a reciprocating ball mill, and (6) grinding at cryogenic temperatures using a metal
ball bearing inside vessels, operated inside a reciprocating ball mill.
All samples were then analysed by GC-MS, LC-MS and NMR.
40
II.. Evaluation of C. elegans metabolite extraction strategies for untargeted
cross-platform profiling
II.3. Materials and Methods
II.3.1. Sampling and extraction
300 plates of N2 Bristol wild type worms were grown to a mixed age population. Each plate
was washed with 5 ml of sterile M9 buffer and the worm suspension pooled inside a large
beaker. After the worms had settled, the volume was reduced to 25 ml and dispensed into
60 (+ 2 backup) 0.5 ml aliquots under constant shaking to ensure homogeneity. Aliquots
were snap frozen immediately and stored at -80°C, until extraction.
As extraction solvents a mono-phasic 80 % methanol (M80) and a bi-phasic Bligh & Dyer
[52] 2:1:1 methanol:chloroform:water (MCW) extraction were chosen. Six tissue disruption
methods were compared: (1) manual grinding, using a liquid nitrogen chilled ( = 10 cm)
mortar and pestle, (2) homogenisation by an electric homogeniser, (3) bead-beating, and
finally beating in a reciprocating ball mill (Qiagen Tissue-Lyser (Qiagen, Crawley, UK))
used with (4) metal spheroids, (5) SiO2 beads, or (6) metal ball bearings at cryogenic
temperatures. The exact procedures on how these were operated are outlined below.
In all cases a two-step extraction was used to improve recovery: first, a direct extraction of
the worm pellet, and second, another aliquot of solvent was used for rinsing (mortar and
pestle, homogenizer, ball bearing) or re-extraction of the pellet (bead beater, spheroids,
glass beads). For the M80 extraction, 2 ml of methanol were added to the 0.4 ml aque-
ous worm pellet, so that a 80 % methanol composition was reached. For the second step
(rinsing/re-extraction) 1 ml of 80 % methanol was used. In the first step of the MCW
extraction, 1.2 ml of 2:1 v/v methanol:chloroform were added to the 0.4 ml pellet, to give
a 2:1:1 methanol:chloroform: water mixture. For the second step, 0.8 ml of 1:1 chloro-
form:water were used.
Generally, extraction times and intensities were chosen based on manufacturersÕ recom-
mendations, existing protocols from other sample types, and also, that with the amount
of possible cooling, the sample temperature never exceeded 0°C. Exact procedures are as
follows.
The...
Mortar & pestle were cleaned with ultra-pure water, following a 0.1 M HNO3 acid wash
between each sample. Using liquid nitrogen, they were pre-chilled before grinding
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the worm pellet to a fine powder (ca. 10 min). Extraction solvents were directly
added to the mortar and recovered after dissolving the frozen powder, using a glass
pipette.
Homogeniser was a T25 ultrathurax (Janke & Kunkel, Staufen, Germany), operated for
3 min at 24 × 103 rpm inside a 10 ml glass vial. To ensure that the homogeniser’s
blades were immersed inside the extraction solvents at all times, the solvent vol-
umes had to be increased. This also required a change in solvent ratios to yield the
same final solvent composition as in the other methods, when considering the 0.4
ml aqueous worm pellet. For the 80% methanol extraction, 3.6 ml 90% were used
for the first and 2 ml 80% MeOH for the second step. For the MCW extraction,
volumes were increased to 3.6 ml of 2:1:0.4 methanol:chloroform:water and 2 ml of
1:1 chloroform:water in the first and second step, respectively.
Bead-beater was a FastPrep 12 (MP Biomedicals, Cambridge, UK), operated at 6.5×103
rpm for 2 times 30 s and a 60 s cooling step in-between. The frozen pellet was split
into two 2 ml tubes (StarLabs, Milton Keynes, UK), after filling those with ca. 100
µl of 0.1 mm glass beads(VWR). The cold extraction solvents were added and the
extraction started before the pellet could thaw.
Metal oblate spheroids of ca. 3 mm diameter have superior grinding performance com-
pared to spherical balls, according to the manufacturer (Retsch, Leeds, UK). One
spheroid was placed inside a 2 ml microcentrifuge tube, before the worm pellet was
added. Again, the frozen pellet was split into two tubes before addition of the cold
solvents. The ball mill was operated at 25 Hz for eight min.
Glass beads were identical to those, used inside the bead-beater. The extraction proce-
dure was the same as for the metal spheroids, just with the beads instead of the
spheroids.
Ball bearing with a diameter of 7 mm were put inside 5 ml stainless steel vessels (Retsch)
(one per vessel), before submerging the vessel into liquid nitrogen for 20 min. The
sample was loaded and the ball mill operated as for the metal spheroids and glass
beads. The ground powder was then extracted directly.
After extraction, all extracts were combined (where split) and centrifuged (5 min, at 16×103
g, 4°C) to precipitate residual protein. The supernatants were pooled inside a centrifuge
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tube and - if necessary, topped up to a defined volume (2 ml and 6 ml for the homogeniser
extracts) to allow precise aliquoting. After aliquoting for GC-MS, LC-MS, and NMR in
a ratio of 1:1:8, the samples were dried overnight in a vacuum sample concentrator (Ep-
pendorf, Hamburg, Germany) at room temperature. All samples were kept at -80°C until
analysis. Aliquots designated for GC-MS analysis were dried directly inside silanised GC-
MS glass vials (Agilent).
Only the aqueous fractions of the MCW extraction were analysed in this study, as targeted
lipidomic protocols for C. elegans are available [396].
II.3.2. Analytics
II.3.2.1. NMR
Sample preparation, was performed according to the standard procedures, described in the
appendix B3.
Spectra were acquired on a Bruker Avance III spectrometer with a 14.1 T magnet (Bruker
Biospin; Rheinstetten, Germany), operating at 600.13 MHz 1H observation frequency, and
using a cryogenically-cooled inverse 5 mm probe; the spectrometer was controlled using
Bruker TopSpin 2.1.
Acquisitions were based on a standard 1H NOESY [RD-90◦-t1- 90-tm-90◦-acquire] sequence.
The recycle delay (RD) was 3.5 s, with a mixing time (tm) of 0.1 and acquisition time of
1.3 s. The 90◦ was determined for each experiment but usually was between 8− 14µs. 128
free induction decay (FID) transients were collected and summed over a 20 ppm sweep
width from -5 to 15 ppm, with a time domain resolution of 32k data points. The water
signal was suppressed by pre-saturation during the RD.
For peak assignment, coupling constant resolved (J-Res), 1H -1H correlation spectroscopy
(H,H-COSY) and heteronuclear 1H -13C single quantum bond correlation (HSQC) spectra
were acquired.
Furthermore, 32 assigned metabolites were quantified using a computer-assisted manual
fitting approach [617]. To this end, the commercial software package Chenomx NMR Suite
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6 (Chenomx, Alberta Canada) was used as described in detail by Tredwell et al.[578].
II.3.2.2. GC-MS
Derivisation, acquisition and processing were performed according to the standard proce-
dures described in chapter B4 and A2.1.3. To monitor runtime and machine variation,
quality control samples (QC) [511] were injected every ten samples and five consecutive
times in the middle of the run, respectively. Those QC samples were aliquots from the QC
samples prepared for LC-MS analysis (See next section).
II.3.2.3. LC-MS
Dried extracts were solubilised by 120 µl of water by using an ultrasonic bath for 5 min
and vortexing. After centrifugation (5 min, at 16× 103 g, 4°C), 100 µl of the supernatant
was transferred into a 96 well autosampler plate. The remaining volumes were pooled,
centrifuged and used as quality control (QC) sample. 10 µl were injected onto a 2.1× 100
mm Acquity BEH C18 column (1.7µm) (Waters Corporation, Milford, USA) by a Waters
Acquity ultra-pressure liquid-chromatography (UPLC) system (Waters Ltd. Elstree, UK).
Analytes were eluted on a linear 25 min gradient from 100% water (+ 0.1 % formic acid)
to 100% acetonitrile (+ 0.1 % formic acid) with a flow rate of 0.5 ml per min and a column
temperature of 40°C.
The LC was coupled online to a LCT Premier mass spectrometer (Waters MS Technolo-
gies, Ltd., Manchester, UK). Spectra were acquired in negative electrospray ionisation
mode (ESI-), with a capillary and sampling cone voltage of 2.4 kV and 35 V, respectively.
Desolvation temperature was set to 350°C, source temperature to 120°C and desolvation
gas flow (N2) to 900 litres per hour. The instrument was operated in v-mode optics, for
maximum sensitivity. Data were acquired at a scanning frequency of 10 Hz, with a 10 ms
inter-scan delay over a scan range of 50 - 1000 u in centroid mode. For high mass accuracy,
a 200 pg/µl leucine-enkephaline (m/z = 556.2771) was infused as lock-spray at 3µl per
min and 3 lock-mass scans averaged every 15 s.
The whole LC-MS system was controlled using Water’s MassLynx software suite.
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In the beginning of the run, 5 QC samples were injected to condition the column. All
samples were run in randomised order and QC samples were injected every 10 samples to
assess runtime variation. In the middle of the run, 5 consecutive QC injections were made
to quantify pure machine variation.
After acquisition, raw data were converted into netCDF using MassLynx. The free soft-
ware package xcms [531] was used to detect metabolite features and align them across data
files. For peak detection the continuous wavelet transform based algorithm ”centWave”
[566] was used with recommended UPLC parameters (peak width between 3 and 15 s and
maximum retention time deviation of ± 2 s). During the lock-mass scans, no signal is
recorded for the sample, resulting in gaps throughout the acquisition. Therefore, an al-
gorithm developed by Benton et al.[43] was used to ”stitch” these gaps in order to avoid
distortion of the reproducibility and yield metrics.
After obtaining the final sample × feature intensity matrix, all further statistical analysis
was carried out in the statistical software suite R.
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II.4. Results
II.4.1. Contribution of bacterial biomass to total signal
As C. elegans feeds on an E. coli lawn, there might be a bacterial contribution to the overall
signal. Standard C. elegans cleaning procedures such as sucrose gradient centrifugation
or even simple consecutive buffer washes could prevent this [181, 337, 159] - but will also
alter worm physiology and thus impact the metabolic profile. The severity of washing-
stress may well depend on the experiment and would therefore need to be assessed in
each case. To get around this, the validity of the sampling protocol was tested prior to
the extraction evaluation. This was done by measuring the amount of possible ”bacterial
contamination” of an unwashed C. elegans pellet. After the harvested worms had settled
to form a pellet (ca. 5 min), 0.4 ml of buffer - directly above the pellet were sampled and
processed in the same way as the pellet itself (bead-beater extraction as described in II.3.1).
Thus, the pellet would at most have as many suspended bacteria as the supernatant. 1H
spectroscopy was used to quantitatively compare the signal of the supernatant to the pellet
extract signal. Results displayed in figure II.2 confirm that the bacterial contribution to
metabolite concentrations is minimal.
II.4.2. Assigned metabolites
Before differences between the different extraction methods were assessed, an attempt was
made to assign as many metabolites as possible. Table C1.1 shows a list of metabolites as-
signed by NMR and GC-MS, with their corresponding PubChem identifier and functional
class.
For the 32 NMR based compound assignments, 1D and 2D (H,C-HSQC, H,H-COSY) in-
house recorded spectra, as well as spectra from the the Biological Magnetic Resonance
Data Bank (BMRB) [585] and the Human Metabolome Database (HMDB) [630] were
used. GC-MS metabolites were initially assigned by AMDIS and the ”Fiehn Library”.
In cases where the automatic retention time and fragmentation pattern based assignment
was not unambiguous, the Golm database (GMD) [335] was also consulted. Authentic
standards for most of the database-assigned metabolites were run for final confirmation.
Some metabolites (partially) decay into other compounds during derivatisation or analysis
- which is usually not documented in databases. However, this must be considered for
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Figure II.2.: Bacterial ”contamination” of C. elegans pellet:
Contribution of bacterial biomass to a C. elegans extract spectrum, as
determined by 600 MHz 1H spectroscopy. An equal volume of supernatant
above an unwashed worm-pellet (blue) was sampled and compared to the
pellet itself (black); n = 3 for both. The aromatic region (A) is magnified by
a factor of 5, relative to the aliphatic (B).
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Name PubChem Key GC-MS NMR Class
Betaine 247 x Biogenic amine
Choline 305 x Biogenic amine
O-phosphocolamine 1015 x Biogenic amine
Phosphocholine 1014 x Biogenic amine
Putrescine 1045 x Biogenic amine
3-aminoisobutyric acid 64956 x Amino acid
Alanine 602 x Amino acid
Arginine 232 x∗ x Amino acid
Asparagine 236 x Amino acid
Aspartate 424 x Amino acid
Glutamate 611 x∗ x Amino acid
Glutamine 738 x Amino acid
Glycine 750 x x Amino acid
Isoleucine 791 x x Amino acid
Leucine 857 x Amino acid
Lysine 866 x Amino acid
Methionine 876 x Amino acid
Phenylalanine 994 x x Amino acid
Proline 614 x Amino acid
Serine 617 x x Amino acid
Threonine 205 x Amino acid
Threonine 205 x Amino acid
Tyrosine 1153 x Amino acid
Valine 1182 x x Amino acid
Beta - alanine 239 x Amino acid Derivative/Precursor
Cystathionine 834 x Amino acid Derivative/Precursor
D-Ala-D-Ala 601 x Amino acid Derivative/Precursor
Homoserine 779 x Amino acid Derivative/Precursor
Hydroxy-proline 5810 x Amino acid Derivative/Precursor
Ornithine 389 x Amino acid Derivative/Precursor
D-(+)-Trehalose 1143 x x Carbohydrate
Glucose 5793 x Carbohydrate
3-Glycerophosphate 754 x Carbohydrate Derivative/Precursor
3-Phosphoglycerate 724 x Carbohydrate Derivative/Precursor
D-glucose-6-phosphate 5958 x Carbohydrate Derivative/Precursor
Gluconic acid 604 x Carbohydrate Derivative/Precursor
Glycerol 753 x x Carbohydrate Derivative/Precursor
myo-Inositol 892 x Carbohydrate Derivative/Precursor
sn-Glycero-3-phosphocholine 71920 x Carbohydrate Derivative/Precursor
Sucrose 5988 x Carbohydrate Derivative/Precursor
Acetate 175 x Carboxylic acid
Citramalic acid 1081 x Carboxylic acid
Citric acid 311 x Carboxylic acid
Formate 283 x Carboxylic acid
Fumarate 723 x x Carboxylic acid
Lactate 612 x x Carboxylic acid
Malate 525 x Carboxylic acid
Phosphoenolpyruvic acid 1005 x Carboxylic acid
Phosphoglycolic acid 529 x Carboxylic acid
Propionate 1032 x Carboxylic acid
Succinate 1110 x x Carboxylic acid
Heptadecanoic acid 10456 x Fatty acid
Linoleic acid 3931 x Fatty acid
Palmitic acid 985 x Fatty acid
Stearic acid 5281 x Fatty acid
Adenosine 191 x Nucleoside
Guanosine 765 x Nucleoside
Xanthosine 1189 x Nucleoside
Adenine 190 x Nucleoside base
Thymine 1135 x Nucleoside base
Uracil 1174 x Nucleoside base
Xanthine 1188 x Nucleoside base
AMP 224 x x Nucleotide
ATP 238 x Nucleotide
GTP 762 x Nucleotide
Inosine 5-monophosphate 8582 x Nucleotide
UMP 6030 x Nucleotide
Pyrophosphate 1023 x Phospate
Nicotinic acid 938 x Vitamin or derivative
Pantothenic acid 988 x Vitamin or derivative
Cholesterol 304 x Steroid
Methoxytryptamine 1833 x Biogenic amine
Phenylethanolamine 1000 x Biogenic amine
Table II.1.: Putative C. elegans metabolites detected by GC-MS and NMR:
Pubchem identifier and compound class is also given. Compounds noted with
x∗ show an instability during derivatisation and are therefore only of limited
interpretational value.
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interpretation. Such incompatibilities are also documented in table C1.1.
For LC-MS, 4905 features were detected in the 80% methanol and 3595 features in the
methanol-chloroform-water extracts, totalling 5141 across all extraction methods and sol-
vents. Due to these high numbers and the stringent criteria the metabolomics community
has set for LC-MS assignments [551, 428], no attempt was made to assign any of the fea-
tures. However, the R-based CAMERA package [338] is designed to estimate the number
of ”real metabolites”, by annotating redundant features, such as fragments, adducts and
isotopes. Out of the 5141 features, CAMERA assigned 760 as isotopes and 1667 as adducts,
fragments or multimers. This leaves 2713 features (53 %) as metabolite candidates.
II.4.3. Distribution of LC-MS features
As no LC-MS features were assigned, methods were compared with regards to their num-
ber of features only. Figure II.3a shows that between 50 % and 70 % of all LC-MS peaks
could be detected in either none (0/0) or all (5/5) replicates of each individual method.
Remarkably, features detected in only one, two, three or four replicates of a method often
had a coefficient of variation similar to peaks detected in all (five) replicates of a method.
However, when inspecting the corresponding extracted ion chromatograms, in most of these
cases a feature was present, but failed to meet the minimum default peak detection criteria
of the xcms ”centWave” peak picker (intensity≥ 100, SN ≥ 10). Low intensity metabolite
features often deteriorate overall reproducibility of LC-MS data [197, 512, 199, 572]. For
this reason, classic analytical chemistry sets the limit of quantification (LOQ) to a multiple
of the limit of detection (LOD), which itself is a certain number of standard deviations (e.g.
three) above zero. As a research technique, metabolomics does not necessarily require such
arbitrary limits. However, defining thresholds to ensure high data quality is still perfectly
justifiable. Here, for all further analyses, it was decided to include only features detected in
all five replicates of at least one method (5/5). This is a conservative approach, and means
that while there will undoubtedly be some false negatives, we can be confident that the
between-method comparisons are based on robust data. Even with this stringent criterion,
1000 to 1366 features per disruption method could be detected (figure II.3b).
Figure II.3b displays the number of shared, reproducible features between any two meth-
ods. In terms of common reproducible features, the mortar and pestle, spheroid, beads
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Figure II.3.: Distribution of LC-MS metabolite features:
II.3a: Detection of metabolic features across a method’s replicates: The
colour scale indicates the percentage of features, detected in a certain
number of replicates of a method. For most extraction methods, most peaks
are detected either in no replicate (0/5), or all of the replicates (5/5).
II.3b: The colour scale indicates the number of reproducible (5 out of 5
replicates) features, shared by two methods; with the diagonal representing
the number of reproducible features of a method itself.
II.3c: The colour scale indicates the overlap between reproducible (5/5) and
not detected features (0/5) between all methods, i.e. the number of features
that are present in all replicates of one method, but not in any replicate of
another method.
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Figure II.4.: LC-MS BIP chromatograms of M80 and MCW extraction:
LC-MS base ion peak chromatograms for a representative M80 (figure II.4a)
and MCW (figure II.4b) extraction. Whereas the chromatogram appears to
be identical up to a retention time of 700 s, between 800 to 1000 fewer
features are visible in the MCW sample. The periodic vertical lines are
missing scans due to lock mass scans, which were corrected by using the gap
filling algorithm from Benton et al.[43].
(TissueLyser) and bead beater (Fastprep) extraction methods showed the highest overlap
within and across solvent systems, with the exception of the bead beater in conjunction
with MCW. The ball-bearing and homogeniser extractions, however, were relative outliers,
with the smallest overlap with any of the other methods. It is also interesting to ask which
features were exclusive to a single method, i.e. the intersection of features detected in
all (5/5) and no (0/5) replicates of a method. This comparison, displayed in figure II.3c,
clearly shows that there are very few features unique to specific tissue disruption meth-
ods, but there are clear differences between the two solvents: M80 extraction resulted in
about 100 to 300 additional reproducible features across all methods compared to MCW
extraction. These are from lipids that are solubilised by methanol, but partition into the
non-polar chloroform phase during MCW extraction. This is clearly demonstrated by the
LC chromatograms, displayed in figure II.4.
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II.4.4. Multivariate clustering and similarity
After a first exploration of the C. elegans baseline metabolome, it must be assessed how
the different extraction methods compare. Before this is done in detail with respect to
reproducibility and yield, multivariate clustering can be used to visualise broad similarities
and differences between the methods. Scores of the principal component analysis of the
log-scaled, mean centred data are displayed in figure II.5.
For both GC-MS (figure II.5a) and LC-MS (figure II.5b), runtime and (repeated injection)
machine variance quality control samples clustered tightly. This indicates a robust analyti-
cal performance that allows further quantitative analysis of the data [511, 199, 197, 198, 44].
It is immediately apparent that for both mass spectrometric methods, samples separated
with regards to solvent, but not tissue disruption method. In contrast, for the NMR data,
neither the PCA of the aligned full resolution spectra (not shown), nor the PCA of the 32
fitted metabolite concentrations showed a clear solvent effect. However, the homogeniser
used in conjunction with methanol-chloroform-water was clearly distinct from the rest of
the other disruption/solvent pairs. Indeed, if the raw spectra of the homogeniser MCW
method are compared to the other methods, some metabolites, e.g. trehalose, are com-
pletely missing, and others, like acetate, are highly increased. The homogeniser method
was different from the other methods in two aspects. It used a larger solvent volume and
the disruption process of the pellet did not start at a frozen state. As care was taken
to reach the same final solvent ratio as the other methods, the most likely explanation is
that these samples thawed slightly before extraction. Indeed, Liebeke et al.[364] reported
that sample degradation may lead to drastic changes in metabolite concentrations within
seconds, if enzymatic activity cannot be quenched.
II.4.5. Reproducibility
The multivariate analyses above already gave a first estimation of replicate to replicate
variability of different methods. However, classically, the reproducibility of an analytical
method is assessed using univariate methods.
Reproducibility itself is divided into accuracy and precision (see appendix figure A2.1).
Precision is the deviation of results from their arithmetic mean, usually expressed as stan-
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Figure II.5.: Principal component analysis of extracted metabolite features:
PCA scores plots of the metabolites or metabolite features for GC-MS
(II.5a), LC-MS (II.5b) and NMR (II.5c), including the R2 for each principal
component. For the LC-MS data, only one principal component was fitted,
as PC 2 only explained 6 % of the variance, and did not provide any
interpretational value.
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dard deviation or coefficient of variation of the measured values. Accuracy, however, is
the deviation of the measured from its ”true” value. Whereas accuracy is relatively easy
to assess for synthetic mixtures, such as drugs in pharmaceutical preparations, it is more
difficult or even impossible for complex biological mixtures as the ”true” concentration is
unknown. For this reason, only precision, expressed as coefficient of variation (CV), was
used to analyse reproducibility.
Figure II.6 displays the CV box plots of each method for the metabolites quantified by
GC-MS (figure II.6a) and the ones fitted in the NMR spectra (figure II.6b). For LC-MS,
only features detected (SN ≥ 10) in all (5/5) replicates were used for this comparison.
Hence, each method ends up with a different number of features. This could bias interpre-
tation of the box plots, as illustrated by the following hypothetical example. Imagine two
methods were to yield the same features with same CV, but one of them had additional
features, with an average CV, worse than the average CV of the shared subset. In this
case, this method would have its CV distribution skewed towards a higher value and thus
be classified as less reproducible. However, it is as reproducible for the shared subset, but
only has a higher coverage (for which it would be punished). For this reason, a ranked CV
representation was used for method comparison in preference to boxplots, as displayed in
figure II.6c.
Both GC-MS and LC-MS had a median repeated injection (RI) and quality control sample
(QC) variability of 5 % and 10 %, respectively. No published data on the CV distribution
of repeated injection (instrument) variation could be found for GC-MS. The mean techni-
cal reproducibility of GC-MS QC samples, including derivatisation induced variance, was
shown to have an average CV of 8 %[171]. The reported median CV of instrument vari-
ation for LC-MS, however, is higher [661, 118]. This is most likely due to the fact that
I employed a stringent minimum quantification criterion (feature detected in 5 out of 5
replicates). The median CV for the QC agrees well with previously published results for
both GC-MS and LC-MS [531, 197, 394]. The CVs of the LC column conditioning QCs
were nearly identical to the runtime QC samples. This could be taken to imply that our
matrix may not require column conditioning, but it is still recommended to ensure stable
chromatography and reproducible retention times. It is also noteworthy that the QC sam-
ples yielded 50 % more features on average than any of the methods. This could either be
due to concentration effects in the QC sample, or that each method extracted a slightly
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Figure II.6.: Precision of extracted metabolite features:
The coefficient of variation (CV) is used to assess the precision for the
metabolite features of each extraction method for GC-MS (II.6a), NMR
(II.6b) and LC-MS (II.6c). For GC-MS and NMR features the CV
distribution is presented as box plots, whereas for a LC-MS the CV is
ranked in ascending order. The box spans between the 25th and 75th
percentile, with a line at median height and a dot representing the mean.
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different subset of features, which were combined in the QC. Most likely, a combination
of those two phenomena might be the case. The most interesting observation, however,
is how the individual types of variation partition and correlate, especially for the LC-MS
experiment. Repeated injection and QC sample CVs rise with the same slope, but with
a small and constant offset. This offset, the difference between throughout run variation
(QC) and machine variation (repeated injection), equals the pure runtime variation (2 -
3%). The fact this offset is constant suggests that, in a well-performed LC-MS experiment
(i.e. no intensity drift due to source contamination), runtime variation is constant for each
feature. The pure technical reproducibility, however, seems to depend on the feature, as
its CV rises with the number of features. Thus, in this experiment, the CV of a feature
only depends on its ionisation efficiency, which seems to be constant throughout the run.
Generally, nearly all methods yielded a median CV of 15% - 30% across the three plat-
forms. This is in good agreement with values published for several GC-MS and LC-MS
extraction benchmarks [615, 572, 394]. For NMR however, the median CV was higher than
the ones reported in literature [349, 314, 35]. Usually though, the NMR-derived instrument
variation is much less than the variation between two biological replicates [71], even taking
metabolite fitting errors into account. Therefore the high amount of variation must reflect
the substantial amount of process variation.
Some individual method/solvent/platform combinations (e.g. spheroid/MCW extraction
for GC-MS; homogeniser/M80 for LC-MS; and homogeniser/MCW for NMR) had a CV
distribution clearly skewed towards a poor performance. Similar unexplainable method
bias for the same extraction protocol on different platform was previously described by
t’Kind et al.[572]. The spheroid/MCW results are particularly intriguing. For NMR, the
median CV lies well within the other methodsÕ; for GC-MS, it clearly performed worse
than the other methods; whereas judging by the LC-MS data, this method had the lowest
CVs throughout.
II.4.6. Yield
Nearly all extraction comparisons discuss coverage and reproducibility. However, yield,
the total amount of extracted metabolites, is rarely considered, but should be equally as
important. This is clearly the case for the current study, which has a tough matrix with
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different cell types, and it is unclear which disruption method does the best job at reaching
all compartments. The problem is the lack of clear metrics. Recovery, i.e. what percentage
of a solubilised metabolite is recovered by the solvent, can be assessed by stable-isotope
labelled metabolite spike-in [414]. The total amount amount inside the matrix, however,
is unknown, which makes absolute yield difficult to assess. Therefore, a relative metric
was adopted. For each metabolite feature, the most intense feature across all methods was
set as maximum yield (100 %). The other methods intensities of this feature were scaled
proportionally. The distribution of relative yields can then be plotted, as shown in figure
II.7.
For GC-MS (figure II.7a), the median yield ranged from 50 % to 90 %. For LC-MS (figure
II.7b) yield was between 50 % and 75 % and for NMR (figure II.7c) it ranged from 65 %
to 95 %. Only LC-MS showed a solvent effect, with lower yields in the MCW samples.
This goes in hand with the observation that M80 yielded 150 - 300 more peaks than their
MCW counterparts. LC-MS had the highest within-method variance, but GC-MS and
NMR had the highest between-method variance. Ball-bearing and homogeniser had the
lowest overall yield. This might either be due to incomplete tissue disruption or, more
likely, the difficulty of complete recovery from these devices, especially as those were the
only methods that did not contain the sample in microcentrifuge/bead-beater tubes.
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Figure II.7.: Yield of extracted metabolite features:
Yield for GC-MS (II.7a), LC-MS (II.7b) and NMR (II.7c) is assessed on a
relative scale. The yield of any metabolite feature is expressed as a
percentage of the highest signal intensity found by any of the extraction
methods for this feature. The box represents the 25th and 75th percentiles,
with a line at median height and a dot representing the mean.
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II.5. Discussion
II.5.1. Necessity of a washing step during sampling
In the first step of the extraction optimisation, the C. elegans sampling protocol was put
under scrutiny. The amount of bacterial contamination, stemming from E. coli as the
worm’s food source, was evaluated. This was done to assess whether an additional wash-
ing step of the worm pellet was required prior to extraction. Compared to the NMR signal
of the extracted worm pellet, the same volume of ”used” buffer, with suspended bacteria,
showed no appreciable contribution of bacterial biomass. Close inspection revealed there
were a few low-intensity peaks. However, these were negligible compared to the wealth
of peaks in the worm spectrum. Furthermore it must be noted that only large (L4 or
adult) worms had settled after 5 min. As this experiment was performed using a mixed
population, there is a fair chance that some of the bacterial signal was partially due to the
presence of smaller worms in the volume above the pellet. The negligible impact of bacteria
is not surprising. Worms are usually sampled shortly before exhaustion of the bacterial
lawn, which also firmly ”sticks” to the plate throughout the harvesting process. Based
on this result, future experiments, including the extraction comparison, were conducted
without a pellet washing step.
II.5.2. What is the ”best” method
Some methods were best on on a particular platform, even though under-performing when
analysed using a different analytical platform. Thus, definition of the apparent ”best”
method depends in part on which analytical platform is used for evaluation. In fact, sev-
eral disruption methods, such mortar and pestle, bead-beating, and grinding with beads in
a reciprocating mill, performed consistently well. However, it was decided to select a single
optimal extraction method for subsequent studies. Bead-beating performed consistently
well with respect to the total number of metabolites (or metabolite features) detected,
precision, and yield. It also can be used for high-throughput (≤ 24 samples per 3 min)
applications. Most importantly, however, compared to grinding with a mortar and pestle,
it is independent of the operator and therefore results should be reproducible across labs.
Overall, tissue disruption methods had a lower impact on the result than solvent systems
- at least for GC-MS and LC-MS. 80 % methanol rather than chloroform/methanol was
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chosen as the best solvent system. It is simpler than the chloroform/methanol protocol
that requires phase separation, metabolite partitioning, and accessing a single phase later.,
and so it is likely to be more robust for high-throughput studies in particular. Also, it is
able to extract a variety of lipids, which can be analysed via LC-MS and reduce the need
for a separate, lipidomic approach.
The final sampling and extraction protocol, using 80 % methanol and bead-beating, which
will be used for all other experiments of this thesis, is outlined in the appendix (B2).
II.5.3. Observed metabolites - In comparison to previously published
studies
When this study was initiated, only Blaise et al.[50] and Atherton et al.[23] had published
C. elegans metabolite annotations for NMR and GC-MS, respectively. All metabolites
assigned by this study using NMR and GC-MS have been confirmed in the meantime, by
other publications [51, 299, 392, 86, 288, 76, 15, 75, 85]. However, this is hardly surprising,
as those are all abundant and frequently observed metabolites from central carbon and
energy metabolism, including amino acids, small organic acids, (sugar) nucleotides and
sugars.
Nevertheless, [50, 23] are comparable with regards to sample generation and analytical
platforms, also reported more uncommon metabolites that were not observed in this study.
These include trimethylamine-N-oxide (TMAO) (both Atherton et al. and Blaise et al.);
4-hydroxyphenylacetic acid, α-ketoglutarate, β-alanine, phenylacetylglycine, indoxyl sul-
phate, fructose, and malonate (Atherton et al.); and β-hydroxyvalerate, penicillamine,
saccharopine, 2-keto-3-methylvalerate, N-acetylglutamate, isovalerate, homocysteine, ho-
mocarnosine, 5-methoxytryptamine, dihydroxyacetone, folate, galactose, indole, pheny-
lacetate, β-phenylpyruvate, anserine, and picolinate (Blaiseet al.). Several of those are
common mammalian urinary metabolites, unlikely to be found in tissues (TMAO, pheny-
lacetylglutamate, phenylacetylglycine, phenylpyruvate). Some are not likely to be present
in NMR-detectable concentrations (e.g. indole, folate, 5-methoxytryptamine, saccharopine,
dihydroxyacetone, picolinate). Penicillamine, as a penicillin metabolite, is very unlikely to
be present. Others are not implausible (β-hydroxyvalerate, 2-keto-3-methylvalerate, N-
acetylglutamate, isovalerate, homocysteine, homocarnosine, galactose, anserine), but have
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not been observed in this or subsequent studies [660] (others in preparation). It appears
that many previously reported C. elegans metabolites are likely to be misassignments.
There are still several resonances and peaks that remain unassigned in the NMR and GC
spectra, respectively. This shows the need for improved metabolite assignment tools, as
well as the potential strength of untargeted approaches.
II.5.4. What is limiting the coverage and assignment?
Metabolomics, as an untargeted profiling approach, heavily relies on two parameters.
Firstly, ”as wide as possible” metabolite coverage, and secondly, the ability to annotate
biomarker candidates. To this end, this chapter benchmarked extraction methods and
established standard profiling workflows for NMR, GC-MS and LC-MS. The coverage and
ease of annotation was highly dependent on the analytical detection method. Therefore it
is important to understand limitations of the three profiling platforms used.
NMR spectroscopy yielded the least number of metabolites. However, those were readily
assigned. Assignment for common metabolites at least is straightforward, as informative
2-D experiments (COSY, HSQC, J-Res) can be run. HSQC spectra are particularly helpful
as they connect protons (1 ppm to 9 ppm) to the much wider spectral range of carbon (10
ppm to >200 ppm). The reason why not more than 32 compounds could be annotated
with confidence was because of the low inherent sensitivity of HSQC spectra. This is due
to its four times lower gyromagnetic ratio, but more importantly due to the low natural 13C
abundance of only 1.1 %. Another problem, especially in the 1H domain, is the significant
overlap of spectral resonances, as no prior separation is used. Particularly in the region
between 2.5 ppm and 4.5 ppm it is not always apparent whether the signal represents a
complex spin system, a spin system overlap or a combination thereof. It is very likely that
some low-intensity metabolites are not detected because of peak overlap problems, even
though they would be above absolute detection limits in pure solutions.
GC-MS coverage and annotation complexity falls somewhere between NMR and LC-
MS. A retention-time-locked spectral database yields quick annotation success. However,
even the best fragment matching systems cannot outperform experienced spectrometrists
[140, 25, 434]. Therefore it is vital to confirm database hits to reduce the number of false
positives, i.e. falsely annotated peaks. Done carefully, this is a very robust workflow [38].
The workflow implementation used in this study, however, has a major drawback, never-
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theless. It is not truly untargeted. For the used software package (GaVin) to integrate
a metabolite, this metabolite must be present in the database, and therefore a high false
negative rate, can be expected. More uncommon, or even unknown and therefore especially
interesting, metabolites are likely to be missed. This is even more likely to be the case with
C. elegans , as there is fewer metabolome resources available compared with e.g. humans.
Indeed, under close inspection, the total ion chromatogram (TIC) displays an abundance
of peaks currently not annotated and therefore not considered by the employed workflow.
LC-MS unarguably has the highest coverage, but annotation is difficult. Even though
electrospray ionisation (ESI) mass spectrometry based metabolite databases have been
growing substantially over the last few years [530, 630, 251], they are still very far from
being comprehensive [320, 321]. However, before a database may be queried, it must be
decided whether the candidate mass is the charged metabolite itself or an adduct or even
an isotope. To some degree this can be done by rule and correlation based methods, such
as the CAMERA software package [338]. Once the exact M+/− is known, but no database
entry exists, there are plenty of possible molecular formulae, albeit the ever improving
mass accuracy of modern high resolution mass spectrometers (≈ 1 ppm). Furthermore,
there is also growing evidence that a vast majority of the peaks observed in LC-MS are not
of biological origin, but rather contaminants from the sampling, processing, consumables
or analytical platform [31, 194]. Altogether, these problems severely affect the advantages
gained from the broad LC-MS coverage.
The following chapter (III.) tries to address the discussed limitations for NMR and GC-
MS. Analytical and processing approaches more advanced than the standard workflow will
be developed. Chapter IV. addresses the mentioned problems with LC-MS data. First,
by in-silico experiments and algorithm development, but with a wet-lab based proof-of-
concept following. The improved methods are then used for the final and major biological
experiment - the longevity mutant screen in chapter V..
III.. Methods to increase the
metabolite coverage and
annotation on NMR and GC-MS
based profiling platforms
Aims and Ojectives:
• Increase sensitivity for HSQC experiments and perform automatic an-
notation
• Increase NMR coverage through a chromatographic separation step
• Develop a workflow to analyse GC-MS data without a priori metabolite
information
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III.1. Introduction
In the last chapter, in section II.5.4, I discussed limitations for the three different profiling
platforms. This chapter proposes solutions for some of the constraints with application
to C. elegans samples. Section III.2 will investigate the feasibility of automatic database-
assisted metabolite assignment of an isotope-enriched C. elegans sample, acquired using a
2D HSQC pulse sequence that has not previously been used for metabolomics. Section III.3
will explore the advantage of using fully deuterated ion pair chromatography, to separate
a high concentration C. elegans extract for online (LC-NMR) and oﬄine NMR detection.
Section III.4 will analyse a dataset of long-lived and short-lived C. elegans mitochondrial
respiratory chain mutations by a workflow based on TICs following retention time align-
ment.
The focus of this chapter is not to exhaustively test methods or perform in-depth biological
characterisation, but rather to show that many of the constraints of the analytical platforms
can be addressed by simple means.
All of the projects in this chapters were performed in a collaborative effort.
The isotope enriched sample of section III.2 was prepared and acquired together with Yev-
geniy Izraelit from Cornell University (Ithaca, NY, USA). The high concentration sample
of experiment III.3 was also prepared by Yevgeniy Izraelit at the lab of Frank Schroeder
at Cornell University. Section III.4 is based on a collaboration with the lab of Aleksan-
dra Trifunovic at the University of Cologne (Germany). Worm pellets were generated by
Marija Sumakovic at the University of Cologne.
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III.2. HSQC sensitivity improvement by universal 13C
labelling
III.2.1. Background and introduction
Since introduced by Bodenhausen and Ruben in 1980 [55], heteronuclear single quantum co-
herence (HSQC) NMR experiments have become indispensable for structural assignments
and elucidation, and in particular 13C - 1H HSQC experiments [643]. However, its major
drawback is its low inherent sensitivity and thus long acquisition time and poor signal to
noise ratio. Therefore it mostly yields information on high abundance metabolites; which
often are well known already. Interesting, but less intense peaks remain difficult to assign.
The low sensitivity is due to two factors. One is the four times lower gyromagnetic ratio
and thus excited energy level of the 13C nuclei, compared to 1H at the same magnetic field
strength; but the main factor is the low natural abundance of only 1.1 % 13C. In order to
follow a protein’s peptide bond backbone, NMR-based structural biology routinely has to
use three dimensional 1H-13C-15N sequences. With a 0.37 % 15N natural abundance, 13C
to 15N magnetisation transfers become rare events. In order to avoid week long acquisition
times, the structural biology field has developed several strategies.
A simple and often applied strategy to increase low natural abundance is artificial isotope
enrichment [184]. Indeed, as many protein expression system, such as E. coli can be grown
on minimal media this is readily possible; with 13C glucose as sole carbon and 15N ammo-
nium salts as sole nitrogen source [218].
With full 13C abundance, carbon - carbon couplings, which at natural abundance are rare
events, become an issue. Classic broadband decoupling techniques used to suppress 1H-
13C satellites do not work for 13C-13C coupling at full 13C incorporation [605], and would
lead to unacceptable sample heating. To this end, the structural NMR community has
developed pulse sequences that circumvent C-C couplings. In particular, the constant time
HSQC (ct-HSQC), proposed in 1992 by Vuister and Bax [605], is a pulse sequence that is
often used for fully labelled multidimensional protein NMR spectroscopy [391]. A ct-HSQC
pulse sequence is very similar to a standard HSQC sequence. However, instead of the usual
variable 13C evolution period t1, a constant time is used. Also during this interval, an ad-
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ditional 180◦ pulse refocuses 13C-13C coupling constants. Therefore couplings will not split
but appear as cross-peaks along the F1 domain and (ideally) not interfere with the rest of
the spectrum.
So far only a few studies have used stable isotope labelling to improve HSQC sensitiv-
ity for small molecules. In 2004 Kikuchi et al.[316] were the first to 13C and 15N label
Arabidopsis thaliana plants to probe ethanol stress response and nitrogen fluxes during
germination, respectively; both with HSQC pulse sequences. In 2008 Chikayama et al.[94]
built an online-database of > 1000 13C-1H HSQC chemical shifts they had assigned to
142 metabolites from Arabidopsis thaliana and silkmoth larvae (Bombyx mori). In 2010
they went on to refine their approach by implementing an algorithm that automatically
considers multiple HSQC resonances and assigns plausible metabolites. This assignment
is based on a statistical likelihood value [93]. Gowda et al.[206] extended the use of stable
isotopes in conjunction with HSQC sequences to matrices that cannot readily be isotope
enriched. By derivatising blood plasma samples with 13C formate and 15N ethanolamine
they were able to show a significant improvement in HSQC sensitivity. However, this ap-
proach only covers part of the metabolome, is only useful for identification when chemical
standards are available and does not help with de-novo assignments. In 2012, when this
study was already completed, An et al.[15] demonstrated the feasibility of HSQC profiling
with 13C enriched C. elegans samples. However, none of these studies used a constant time
HSQC pulse sequence, even though this would be the structural biology community’s gold
standard approach for isotope enriched samples.
Therefore, this experiment aims to evaluate, whether 13C labelling and the use of a ct-
HSQC pulse sequence is a valuable approach to improve annotation of C. elegans HSQC
visible metabolites.
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III.2.2. Materials and Methods
III.2.2.1. Sample generation
An unlabelled control sample was prepared by growing wild-type N2 worms according to
standard procedures, outlined in the appendix (B1.1). To generate the 13C enriched C.
elegans samples, a protocol developed in chapter IV. was used. Agar plates were prepared
without bacterial nutrient (peptone). Instead, the pellet of a 25 ml overnight culture of the
E. coli K-12 wild type strain NCM3722 was spread onto the agar plates. NCM3722 was
grown in a minimal medium, with 13C-glucose and 14N-ammonium chloride as sole carbon
and nitrogen source, respectively. To allow full isotope enrichment, worms were grown over
two generations on the isotope medium. For detail on this method, please refer to section
IV.2.1.4.
All worm cultures (isotope enriched and unlabeled) were age synchronised by the method
described in B1.2. Worms were harvested as young adults and extracted by bead-beating
in 80% methanol, according to a consensus protocol based on the extraction comparison
in chapter II.. For experimental detail, please refer to B2.
In both cases, the biomass of three plates of worms were pooled to yield one biological
replicate, in order to improve the signal to noise ratio.
III.2.2.2. Acquisition and processing
For NMR spectroscopy, the samples were prepared according to the general procedure de-
scribed in B3.1. Acquisition was performed at 300◦ K on Bruker Avance II spectrometer
at 800 MHz 1H observation frequency. A cryogenically cooled triple-axis inverse probe was
used. The system was controlled by Bruker TopSpin 2.1. For the regular HSQC spectra
a Bruker gradient HSQC sequence with pre-saturation and sensitivity enhancement was
used. The constant time sequence (ct-HSQC) used the Bruker ”hsqcctetgpsp” sequence,
adapted from Isaacson et al.[273] and originally based on Vuister and Bax [605]. The con-
stant t1 evolution time needs to be optimised, to target the coupling constant that needs
to be ”removed” during the 180◦ refocusing pulse. As most metabolites of a complex mix-
ture have at least some resonances in the aliphatic region, it was decided to target those.
Aliphatic C-C couplings are usually around 32-40 Hz. Therefore the constant time (d23)
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was set to (2T = 1/J = 1/38.5Hz = 26.6ms ). The pulses in the carbon domain were
adiabatic, shaped pulses [564]. For both the HSQC and ct-HSQC the 90◦ pulse p1 was set
to 14 ms. After 32 dummy scans, 64 time domain transients with 2048 increments in the
F2 domain and 512 increments in the F1 domain were acquired. The spectral sweep width
spanned 10 ppm in the proton and 90 ppm in the carbon domain, centred at 4.70 and 90
ppm, respectively.
For processing inside TopSpin 3.1, the FID was multiplied by a Gaussian window function
in the F2 and a shifted sine-bell squared function in the F1 dimension. The time domain
spectrum was then Fourier transformed into a 1k by 1k data point frequency spectrum.
Phase correction was performed by optimising the phase angle of 1D projections of selected
peaks across the whole spectrum.
III.2.2.3. Spectral deconvolution and automatic database matching
For automatic assignment, the processed spectra were loaded into rNMR [361]. The signal-
to-noise threshold was manually adjusted so that peaks had defined contours and no ran-
dom noise was visible in spectral regions that are unlikely to contain peaks, i.e. the
high proton, low carbon range. Peaks were detected using the default algorithm, without
prior signal smoothing. In the constant time HSQC spectra, peaks stemming from the F1
artefact were manually removed. For assignment, the HSQC reference spectra from HMDB
were used. To this end all available spectra (n = 669) were downloaded (on the 21.11.2012)
as XML files and read into R. Spectra were filtered by meta-information and only spectra
recorded in similar experimental condition were kept (aqueous buffer with pH ≈ 7)
As the reference spectra were recorded in a similar but not identical setup, ppm values can
slightly deviate. This deviation might be composed of a systemic and an individual peak-
by-peak component. In this experiment it was attempted to minimise both. The systemic
shift was estimated by comparing ppm shifts of 15 peaks from different metabolites across
the spectrum, that were assigned in chapter II., with the ppm values of the corresponding
reference peaks.
Peak to peak deviations are more difficult to deal with. When matching the spectra against
a reference, the acceptable error must be large enough to allow for the peak to peak de-
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viation. However, when the allowed error margin is too large, one peak may match other
neighbouring peaks, making the match ambiguous and therefore reducing the power of
the query. Therefore, it is important to adapt the error tolerance for each dataset, when
an automatic search algorithm is used [93]. The best way to find this value would be to
annotate most metabolites in the mixture and determine their (median) distance from the
reference. However, this tedious approach is contradictory to the intention behind auto-
matic assignment, which the goal of this experiment. A Monte-Carlo simulation was used
to optimize these parameters for both proton and carbon shifts.
The selected cross peaks and the HMDB HSQC reference peaks were matched three thou-
sand times. Each time, the allowed ppm error was randomly chosen within a window of
1 to 0.001 ppm and 2 to 0.005 ppm in the proton and carbon domain, respectively. After
each iteration, it was counted (a) which fraction of metabolites from the HMDB reference
spectra did not receive at least one match from a HSQC spectral peak. (b) how many
HMDB metabolites were completely matched (each cross peak of the reference matched a
cross peak of the spectrum). The convolution of (a) and (b) (a ∗ b) was then calculated to
determine the best trade off between the minimum (a) and maximum (b) matching window
size, necessary to minimise false negatives and false positives, respectively. The maximum
(best tradeoff) of the spectrum that resulted from the convolution determined the error
margin for the final matching of HSQC peaks and HMDB reference spectra.
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III.2.3. Results and Discussion
III.2.3.1. 13C enrichment can achieve a drastic increase in sensitivity
The first step in evaluating whether 13C enriched samples acquired by ct-HSQC pulse
sequences for C. elegans metabolite assignment are valuable, is to compare a fully 13C
labelled versus an unlabelled sample. To this end, wild type worms were either fed with E.
coli grown on U-13C-glucose or unlabelled glucose minimal medium. D2O reconstituted
80 % MeOH extracts of three pooled plates were then compared using ct-HSQC sequences.
To make the spectra comparable, the signal-to-noise cut-off of both spectra was scaled such
that the 1H resonances at 5.20 ppm ( from the anomeric protons of trehalose) matched
each other’s intensity. Results are shown in figure III.1.
As expected and documented in literature [316, 94], an increase in signal intensity obtained
from isotope enrichment of the matrix is immediately obvious. Not only do cross peaks
that are already visible in the 12C extract (figure III.1a) become more intense, a plethora of
new resonances appear above the detection limit (figure III.1b), especially in the otherwise
sparse aromatic region; the aliphatic region also increases in resonance density. Resonances
around F2 = 4 ppm become crowded and overlap even in two dimensions. However, at
a higher zoom level, displayed in figure III.2b, individual cross-peaks can still be well re-
solved. Increasing the number of increments in the F2 domain would also be a readily
implemented solution to reduce signal overlap.
III.2.3.2. The constant time version outperforms the regular HSQC pulse sequence
for 13C enriched sample types.
As mentioned in the introduction, all HSQC spectra of 13C enriched metabolite mixtures
that have been reported in the literature were acquired with a standard HSQC pulse
sequence, even though constant time HSQC sequences are more commonly used in struc-
tural biology. Therefore, both sequences were compared for their performance with small
molecules (metabolomics).
If the full spectra from the constant time (figure III.1b) and regular HSQC (figure III.1c)
sequences are compared, there are not as many striking differences as between the acqui-
sition of 12C and 13C samples. However, the ct-HSQC artefact parallel to the F2 domain
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Figure III.1.: Effects of 13C enrichment on (ct)-HSQC spectra:
ct-HSQC spectrum of a natural abundance (III.1a) and 13C enriched
(III.1b) extract. Figure III.1c shows a regular HSQC sequence of the 13C
sample.
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Figure III.2.: Difference between HSQC and ct-HSQC:
Magnification of the aliphatic resonances
(10 < ppm(13C) < 80 - 0.5 < ppm(1H) < 5) of the 13C sample, acquired
with the regular HSQC sequence (III.2a) and the constant time HSQC
sequence (III.2b).
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at half F1 shift range (90 ppm) is immediately obvious. Those are the C-C couplings, pro-
jected into this plane by the 180◦ refocusing pulse at the end of the constant time period.
Luckily this artefact affects a region of the spectrum containing little or no information. At
a higher magnification of the aliphatic region, the benefits of the constant time sequence
become apparent. Compared to the cross peaks of the regular sequence (figure III.2a),
the ct-HSQC’s (figure III.2b) have an improved peak shape. There are many examples
where carbon splitting patterns collapse into a single cross peak. Figure III.3 illustrates
this phenomenon with two examples.
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Figure III.3.: Effect of the constant time HSQC sequence on C-C couplings:
Figure III.3a and III.3b show two cross peaks acquired by a regular HSQC
pulse sequence. Figure III.3c and III.3d display the same cross peaks, but
acquired with a constant time HSQC sequence. The magenta line below is
the 1D projection of the 2D spectrum.
By removing C-C coupling, two doublets (figure III.3a) and one high-order multiplet (figure
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III.3b) are collapsed into two (figure III.3c) and one (figure III.3d) singlets, respectively.
Even though C-C coupling patterns may be of diagnostic use in the same way as H-H
couplings are for one dimensional 1H NMR spectroscopy, they might also lead to mis-
interpretation. It is not immediately apparent that the two example peaks acquired by
the regular HSQC pulse sequence belong to the same carbon, rather than to several car-
bons inside similar chemical environments. Furthermore, the increased sensitivity, arising
from the avoidance of C-C splitting, gives higher confidence for low intensity peaks - the
ones HSQC spectroscopy usually struggles with and for which this project was initiated.
Without a doubt, these properties of the ct-HSQC pulse sequence will ease HSQC based
metabolite assignment, and may also improve automated assignment.
III.2.3.3. 13C enriched ct-HSQC spectra are ideal for automatic compound
annotation
Usually 1H NMR metabolomics annotations are performed manually, using published as-
signment lists [442, 160] or more recently online databases, such as the human metabolome
database [630]. Fully automated assignment would be highly desirable, considering the
large number of metabolites present in complex mixtures and the resulting effort for an
exhaustive compound annotation. However, automatic 1H spectrum assignments are am-
biguous, due to the small shift range and the use of only one dimension. Multi-dimensional
spectra, such as HSQC spectra should allow for automatic annotation. Indeed, Chikayama
et al.[94, 93] have built a database (SpinAssign) for automatic assignment of (13C enriched)
HSQC spectra.
The observed advantages of the constant time HSQC over the regular sequence, the sim-
plification of the spectra by collapse of splitting patterns and the increased intensity of the
resulting cross peaks, should improve automatic database-assisted compound annotation
readily. As Chikayama et al.’s SpinAssign only contains ca. 250 metabolites and the qual-
ity of the reference spectra cannot be checked, it was decided to build a workflow using
HMDB’s HSQC reference spectra (n = 669). However, before any database query, the
spectra had to be subject to a peak detection algorithm. Figure III.4 shows excerpts of
the three spectra (12C HSQC, 13C HSQC, 13C ct-HSQC) after peak detection with the R
based software package rNMR [361].
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Figure III.4.: Peaks detected in the 12C and 13C (constant time) HSQC spectra:
Spectral excerpts after peak detection with rNMR. Red crosses symbolise
detected peaks in the 12C (figure III.4a), 13C HSQC (figure III.4b) and 13C
ct-HSQC (figure III.4c) spectra.
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As expected, the 12C HSQC showed the least number (n = 69) of detected peaks (figure
III.4a). In the regular HSQC acquisition (figure III.4b) many more peaks (n = 1242) were
detected than in the constant time version (n = 340) (figure III.4c). Checking which cross
peaks were detected as apparent peaks showed a surprisingly good performance of the algo-
rithm for the ct-HSQC spectrum. Each cross peak was detected once and only once. Even
coinciding cross peaks was recognised by the algorithm, which then flagged all apices of a
clustered peak group correctly. Conversely, for the regular 13C HSQC acquisition, multiple
apices were detected for a single cross peak, rendering the peak list completely useless.
Close inspection revealed that the algorithm identified the local maxima of the C-C split-
ting patterns as individual peaks. Tweaking parameters, e.g. using smoothing filters, did
not lead to noticeable improvement. Even though other software packages may perform
slightly better, a ct-HSQC-like performance is unlikely, as differentiating between overlap-
ping cross peaks and the maxima of complex splitting patterns is extremely challenging.
Therefore, these result confirm the hypothesis that the constant time HSQC experiment
is better suited for automatic assignment. For this reason it was decided to only compare
the automatic annotation of the unlabelled and 13C sample, acquired with the constant
time HSQC pulse sequence.
In order to achieve the best database matching results, the HSQC spectra need to be
aligned with the reference spectra as much as possible, by removing both systematic and
random offsets. A constant chemical shift offset of 0.02 ppm in the proton and 0.228 ppm
in the carbon domain could be removed. On average, this lowered the root mean square
matching error between reference and acquired resonances by 3 fold in the proton domain
and 0.5 fold in the carbon domain. A Monte-Carlo simulation was then used to determine
the best error window for the HSQC - reference spectra matching. Results of this simula-
tion are displayed in figure III.5.
The simulation results display the empirical relationship between the allowed error in the
C and H domain and (a) the fraction of database metabolites yet completely unmatched
by any HSQC cross peak (figure III.5a) and (b) the fraction of fully matched database
metabolites, i.e. each cross peak of a reference metabolite is matched to a cross peak from
the HSQC spectrum (figure III.5b). Interestingly, both functions’ slopes were aligned diag-
onally, which means that to achieve the same number of matches, the error tolerance in the
proton domain can be increased, if the error tolerance in the carbon domain is increased
76
III.. Methods to increase the metabolite coverage and annotation on NMR
and GC-MS based profiling platforms
(a) (b)
(c)
Figure III.5.: Monte Carlo simulation to find the ideal matching error window:
HSQC peak - reference spectrum peak matching quality indicators in
response to varied proton and carbon matching error. Figure III.5a shows
the fraction of reference metabolites that were not yet matched with at
least one HSQC cross peak. In figure III.5b the fraction of reference
metabolites that were fully matched, i.e. each cross peak of the metabolite
is matched to a cross peak in the HSQC spectra, is shown. Figure III.5c is
the convolution of spectrum III.5a and III.5b. The ”X” denotes the
maximum of the convolution and therefore the best matching error window.
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(and vice versa). In order to determine the best tradeoff between the danger of missing
out on metabolites (a) and the risk of ”over-assignment” (b), the optimum between those
two functions was determined by convolution (a ∗ b = c). The resulting spectrum (c),
displayed in figure III.5c shows the recommended error ranges. It was decided to choose
log10 = −1.25 =ˆ± 0.056 ppm and log10 = −0.25 =ˆ± 0.56 ppm as matching tolerance in the
proton and carbon domain, respectively.
(a) (b)
Figure III.6.: HSQC cross peaks matched to HMDB metabolites:
Peaks detected in the 12C (III.6a) and 13C (III.6b) ct-HSQC spectrum, that
could be matched (red) or left unexplained (black) by cross peaks of the
HMDB metabolite reference spectra using the prior determined matching
error threshold.
Figure III.6 shows which peaks of the constant time HSQC spectrum of the 12C (figure
III.6a) and 13C (figure III.6b) sample could be explained by HMDB metabolite cross peaks,
using the determined error threshold. Even though most HSQC cross peaks were assigned
to metabolites, a few still remained unassigned, particularly in the 13C sample. This could
be due to a too small error window, or more likely metabolites that are not recorded in
the HMDB. C. elegans is known to produce a plethora of exotic NMR visible secondary
metabolites, such as ascarosides [74, 536, 484].
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The list of metabolites that were automatically assigned, in both the 12C and 13C ct-HSQC
spectra, can be found in the appendix, in table C2.1. As expected, either more metabolites
were detected in the 13C sample, or detected with a higher confidence (more individual
peaks of a metabolite matched). The number of metabolites for which all (100 %) peaks
were matched to a peak in the reference HSQC spectrum increased by more than 7 fold with
isotopic enrichment. If examined for their biochemical plausibility, almost all top (100 %)
metabolite candidates appear to be reasonable suggestions for a cell extract. Suggestions
with a lower confidence become more exotic, but completely implausible hits, for example
drugs like metoprolol (No. 261) or theophylline (287), rank at the very bottom of the list.
Furthermore, most of the metabolites manually assigned in chapter II. are recovered at the
top of the list, indicating the robustness of this approach. However, there are also minor
problems to be pointed out: the technique cannot differentiate between stereo descriptors.
If enantiomeric pairs are listed in the database, those will be duplicated in the final list,
as is the case for is the case for L/D - Glutamine (27/31) Ð although this could also be
seen as more of a failure of database curation. Another potential pitfall is demonstrated by
the assignment of citicoline (2). As an intermediate in the phosphatidylcholine biosynthe-
sis pathway, it will generally be found in tissue extracts, but often below NMR detection
limits. As it is made up of CDP and a choline subgroup, it is possible that the algorithm
matched cross peaks to both individual compounds. To this end, all results will need to
be manually validated.
However, as a first effort at assigning the metabolome of a new matrix, isotope enrichment,
acquisition by a ct-HSQC sequence and database matching with optimised parameters,
appears to be a valuable workflow. In chapter II., it would have saved a considerable effort
and maybe led to the assignment of less commonly assigned metabolites - which was the
major motivation for this chapter.
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III.3. Online and oﬄine LC-NMR separation of C. elegans
extracts
III.3.1. Background and introduction
As discussed in chapter II., signal overlap poses a severe problem during the NMR anal-
ysis of complex mixtures, such as biofluids or tissue extracts. This is because NMR, in
contrast to mass spectrometry, usually has no prior chromatographic analyte separation
step. Particularly in a metabolite profiling experiment, where several samples need to be
compared (semi-) quantitatively, LC with online-coupled NMR detection is of little use.
Firstly, as NMR is an insensitive technique, it requires multiple experiments (scans) to be
averaged to yield an acceptable S/N ratio. Secondly, NMR’s strength in metabolomics is
its fully quantitative nature and reproducibility. These would be compromised for on-flow
LC-NMR. Higher costs, by an elevated demand for deuterated solvents and increased anal-
ysis times, are other prohibitive factors.
Nonetheless, LC-NMR is routinely used with complex mixtures for the purpose of com-
pound characterization, most frequently in drug metabolism and natural product chem-
istry. However, the ability to exhaustively characterise a complex matrix by ”pulling it
apart” in a separation stage, is also useful for metabolomics. Biomarker candidates result-
ing from a metabolomics experiment or metabolites that are to be fitted for quantitative
analyses, require assignment. Signal overlap in complex mixtures impedes assignment in
two ways. Firstly, it is not always clear which resonances stem from the same compound
and secondly, some similar compounds are not fully differentiable by proton NMR, e.g.
. ADP and ATP. The first problem may partially be addressed using covariance based
bioinformatic approaches, such as STOCSY [106, 510] or CLASSY [498]. However, those
techniques require many samples with varying concentrations and little overlap of the sig-
nals of interest. In order to address the second problem and to distinguish similar, but
not 1H NMR visible moieties, NMR spectroscopy of other NMR active nuclei, such as 13C,
15N and 31P could be performed. However, this is not straightforward. It often requires
isotope enrichment, appropriate NMR probes, expert knowledge and sometimes even spe-
cial sample preparation [379, 380]. Therefore LC-NMR remains a viable option for the
characterisation of new matrices and compounds.
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LC-NMR is classically based on reversed phase chromatography. However, most NMR-
visible metabolites of polar matrices, such as urine or cell extracts do not retain well
on reversed phase [133, 525, 201]. To this end, other, more ”polar friendly” types of
chromatography have been evaluated for LC-NMR. Those range from hydrophobic inter-
action (HILIC) [201], to ion exchange [133, 207] up to ion pairing [525] chromatography.
Even though all of them show superior performance for highly polar metabolites, ion pair
chromatography can be advantageous as it does not require specialised chromatography
columns like HILIC or ion exchange [87]. It only requires a reversed phase system, to
which an ion pair reagent is added. Ion pairs consist of a positive or negative charge that
are linked to a hydrophobic moiety. The charge will interact with oppositely charged com-
pounds and the hydrophobic moiety will retain on the phase, until eluting with organic
solvents. Most contemporary ion pairing methods have been developed with tertiary and
quaternary butyl amines, as those retain a plethora of central carbon metabolism metabo-
lites [525, 378, 375, 68].
The method for LC-NMR developed by Simpson et al.[525] uses a tetrabutylammonium
salt. They report an effective separation of the polar constituents of complex environ-
mental samples. However, they also noted that the ion pair’s butyl resonances impedes
interpretation of several aliphatic regions and requires heavy signal suppression of the af-
fected ppm regions.
For this reason, this experiment’s purpose is to evaluate the utility of a fully deuterated ion
pair, such as d27-tributylamine, that only requires standard solvent suppression. It could
be a valuable complement to online and oﬄine NMR detected reversed phase separation
for the characterisation of small, polar molecules in a C. elegans tissue extract.
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III.3.2. Materials and Methods
III.3.2.1. Sample generation
The C. elegans wild type sample was prepared by Yevgeniy Izraelit at Frank Schroeder’s
lab at Cornell University, Ithaca, NY.
To obtain a highly concentrated extract, worms were grown in liquid culture, rather than
agar plates, as this method is the most appropriate for the generation of high amounts
of biomass. Culturing was performed according to a standard procedure described in the
wormbook [544]. The culture of approximately 1 million worms (100 plate equivalents)
was frozen and freeze dried before posting the sample to Imperial College London.
The sample was extracted using the 80 % methanol bead-beater protocol, described in
the appendix’s protocol section (B2). Two consecutive extractions of 5 ml solvent were
performed. Three aliquots of equal volume were made up, dried and stored at -80° until
analysis.
III.3.2.2. Instrumentation and acquisition
For liquid chromatography an Agilent 1100 HPLC system (Waldbronn, Germany) system
with a quaternary pump, Agilent sample manager, Agilent VWD UV detector set to mea-
sure at 254 nm, and a vacuum degasser was used. Separation was performed on a ACE 5
C18-HL column. This 150 mm by 4.6 mm C18 column with 5 µm particle size has a higher
loading capacity than conventional C18 columns. Thus, it allows injection of concentrated
samples. Hystar software (Bruker Daltonik, Bremen, Germany) was used to control the
whole LC system. The gradient for reversed and ion pairing chromatography can be seen
in table III.1 and III.2, respectively.
Whereas the reversed phase method is a linear gradient, the ion pairing method mainly uses
isocratic elution profiles at different organic content. The later is based on Luo et al.[378],
as they optimised their method on the same LC system as the one used for this study. For
both methods, solvent A was deuterium oxide (Sigma) and solvent B acetonitrile, both
with 1 % acetic acid added as modifier. In the ion pairing chromatography 10 mM tributy-
lamine was added and dissolved by sonication for 15 minutes. For the deuterated online
and oﬄine chromatography, d3 - acetonitrile (Fisher), d4 - acetic acid (Sigma) and d27 -
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Time A[%] B[%]
0.00 97.0 3.0
5.00 97.0 3.0
40.00 0 100
50.00 0 100
Table III.1.: Reversed phase gradient
Time A[%] B[%]
0.00 97.0 3.0
15.00 97.0 3.0
25.00 80.0 20.0
55.00 80.0 20.0
60.00 65.0 35.0
65.00 65.0 35.0
70.00 40.0 60.0
75.00 40.0 60.0
75.10 10.0 90.0
85.00 10.0 90.0
Table III.2.: Ion pairing gradient
tributylamine (Qmx isotopes, Thaxted, UK) were used. The system was equilibrated for
at least 15 minutes, before injecting 50 µl into a solvent flow rate of 0.2 ml per minute.
For the online separation the LC eluent was directly coupled to a 60 µl Bruker flow cell
probe. This flow cell probe was inside a Bruker Avance III DRX600 spectrometer, with a
14.1 T magnet, operating at 600.13 Mhz 1H observation frequency and controlled by Top-
Spin 3.1. Bruker’s ”lc2grdonflow” pulse sequence was used and set up with the provided
GUI. This sequence is based on a standard NOESY sequence, with an intermediate prepa-
ration scan prior to the acquisition scans to adjust receiver gain and solvent suppression.
Solvent suppression was performed by a shaped pulse WET sequence [451, 529], which
was followed by 13C broadband decoupling prior to the acquisition. During the acquisi-
tion, eight time domain transients were collected over a sweep with of 14 ppm and with
a FID resolution of 8k and then added, to yield one spectrum every ≈ 10 seconds. The
90°pulse width was determined by manually introducing an aliquot of the sample, diluted
in a solvent mixture reflecting starting conditions, into the flow probe. During processing
in TopSpin 3.1, the individual time-domain spectra were multiplied with a 1 Hz sine bell
window function with a sine bell shift (SSB) of 2.5, prior to Fourier transform. After phase
correction at multiple retention times, the 1H domain was calibrated to the anomeric pro-
ton of trehalose at 5.20 ppm.
The off-flow acquisition was performed in two steps. First, manual collection of one minute
LC eluent fractions with subsequent solvent evaporation. In the second step, the fractions
were prepared (see B3.1) and analysed by conventional tube NMR [37]. Spectra were
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acquired on a Bruker Avance II spectrometer with a 14.1 T magnet (Bruker Biospin; Rhe-
instetten, Germany) operating at 600.13 MHz 1H observation frequency. Due to the high
number of samples a BACS automatic sample changer (Bruker) was used. After intro-
duction into the magnet, sample temperature was allowed to settle to the 300°K of the
probe. Automatic shimming and receiver gain adjustment was then performed prior to
acquisition with a 1H NOESYpresat sequence. 128 free induction decay (FID) transients
were collected and summed over a 20 ppm sweep width from -5 to +15 ppm, with a time
domain resolution of 32k data points.
After acquisition, spectra were imported into the iNMR (Nucleomatica, Molfetta, Italy)
software package for further processing. Before Fourier transform, time domain spectra
were zero filled to 64 k data points and multiplied with a 1 Hz exponentially decaying line
broadening function. Using iNMR’s batch processing, spectra were automatically phased,
baseline corrected and referenced to TSP.
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III.3.3. Results and Discussion
An aliquot of the highly concentrated extract from wild type C. elegans, grown by liquid
culture, produced a very signal rich NMR spectrum (displayed in figure III.7a), when
acquired with the tube-NMR based method. The signal overlap in the aliphatic region
reveals the problem of complex mixture NMR and highlights the usefulness of a prior
separation step for an in-depth metabolome characterisation.
III.3.3.1. The ion pair reagent needs to be deuterated
Before any experiments were performed, it was tested whether the ion pair reagent (trib-
utylamine) needs to be deuterated, when used with the C. elegans matrix. To this end, a
separation was performed using non-deuterated modifiers and ion pair reagent. The first
minute of the eluent (after void volume) was collected, dried and analysed by tube NMR
(figure III.7b). Even though the signal of the first LC fraction is usually by far the most
intense, the resonances of the ion pair’s butyl moieties and acetic acid singlet occupy a
considerable share of the chemical shift range. Comparing the neat spectrum with the
first fraction, it can be seen that the separation worked as several peaks are missing and
therefore must be retained. However, it also becomes apparent that the additive’s reso-
nances overlap or even completely mask several metabolite peaks, as the 10 mM of the
ion pair is in a typical concentration range of NMR visible metabolites [578]. For this
reason, Simpson et al.[525], who used tetrabutylammonium ion pairing to separate natural
organic matter, primarily interpreted the aromatic region of their acquisition. Even worse,
subsequent fractions will contain less total metabolite signal. Therefore the metabolite to
additive signal intensity ratio is bound to decrease, but the amplifier gain will still be set
to the height of the additives. As the amplifier resolution is limited, this could negatively
affect the S/N for lesser intense metabolites; the reason for which solvent suppression is
generally used. Simpson et al. also used a WET (water suppression enhanced through
T1 effects) [451, 529] water suppression sequence adapted to selectively suppress the ion
pair’s resonances. However, not only is this adding complexity, but it still fails to solve the
problem of signal overlap - in fact, it will even attenuate signals close to the suppressed
resonances.
For those reasons, fully deuterated chemicals, i.e. d27-tributylamine, d4-acetic acid, D2O
and d3-Acetonitrile, were used for all subsequent experiments.
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Figure III.7.: Spectral overlap between C. elegans extract and ion pair reagent:
Figure III.7a displays the complexity of the C. elegans wild-type extract
used in this study. The first minute fraction (proceeding the void volume)
from a LC separation, with non-deuterated ion pair (red) and acetic acid
(orange) is shown in figure III.7b.
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III.3.3.2. Online LC-NMR sensitivity is too low for the C. elegans extract
As a first test for the complementary application of ion pair and reversed phase chromatog-
raphy, online LC-NMR was performed. The eluent of the LC was directly coupled to the
60 µl flow cell probe inside a 600 MHz spectrometer. For reversed phase, a generic, linear
45 minute gradient with initial and final 5 minute hold and for ion pairing an optimised
tributylamine gradient according to Luo et al.[378] was used. Results are displayed in
figure III.8. The deuterated chemicals behaved as anticipated, compared to acquisition
with protonated additives (figure III.8c). Despite a small residual artefact from the water
suppression, solvent suppression was very effective for the ion pairing run (figure III.8b)
and most of the reversed phase method (figure III.8a). The artefact at the end of the RP
method is most likely due to absence of D2O and therefore the failing of the frequency lock.
Thus, the software struggles to automatically find and adjust the suppression frequency.
In the reversed phase run, every visible resonance, except for an unidentified doublet and
potential artifact at 9 minutes and 2.7 ppm, eluted with the void volume. One singlet, at
38.7 minutes and 2.63 ppm was the only visibly retained compound for the ion pair method.
This singlet was identified as succinic acid, that was shifted from its usual position at 2.41.
This is due to two reasons. Firstly, the ppm scale is usually referenced (locked) to wa-
ter (D2O). However, the chemical shift of a solvent peak inside another solvent depends
on their ratio [205, 305]. If now the ratio and thus resonance changes (throughout the
gradient), but the water resonance is kept fixed at the centre of the spectrum, analyte
resonances will shift (as can be seen with the non deuterated ion pair in figure III.8c). A
second and probably more important reason for this ppm shift, is that due to the acetate
buffered solvent, one of succinic acid’s carboxylic acid sites will be deprotonated and there-
fore unshielded, compared to an acquisition using a pH 7 phosphate buffer.
As in the neat spectrum succinic acid was the second most intense peak, it is obvious that
the ion pairing separation worked, but the subsequent NMR detection did not provide
enough sensitivity to detect other compounds from this sample - the number one problem
of on-flow LC-NMR [6, 535, 606]. To address this, Spraul et al.[535] demonstrated that by
operating the detector at cryogenic temperatures, up to a four fold improvement in S/N
can be achieved. Even though this was not possible for this study, it remains as a possible
future option. Furthermore, another LC-NMR weakness became apparent: the full width
half maximum of succinic acid increased from 1 to 6 Hz, when comparing tube based and
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Figure III.8.: On-flow LC-NMR experiments:
Figure III.8a and III.8b show an online LC-NMR reversed phase and a
tributylamine based ion-pairing separation, respectively. In both cases,
solvents, modifier (acetic acid) and the ion pair were fully deuterated. In
contrast, figure III.8c displays an ion pair separation, in which ion pair and
modifier were not deuterated.
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online spectrum. The deterioration of the shims is caused by two phenomena that cannot
be addressed readily: The mix of different excitation states in the flow probe as ”fresh”
nuclei are continuously introduced [6] and a constantly changing field homogeneity by the
changing ratios of the two solvents.
As using deuterated ion pair chromatography seemed to work in principle, and more com-
pounds than just succinic acid were retained when the neat extract and the first fraction
are compared, it was decided to continue, but change to an oﬄine method. By fraction-
ating the whole run and using conventional tube based NMR to analyse the individual
fractions, each sample can be prepared with the same pH and solvent composition, indi-
vidually shimmed and acquired using a desired number of scans.
III.3.3.3. Oﬄine ion pair chromatography compliments reversed phase
The eluent of both the reversed phase and ion pair chromatography was collected in one
minute fractions, dried and analysed by conventional tube NMR. The individual and par-
tially assigned spectra can be seen in figure III.9. As assumed, the bulk of NMR visible
material elutes within the first two fractions after the void volume. However, particularly
in the aromatic region the ion pairing method appears to retain a fair share of resonances.
All retained resonances were assigned as far as possible, using the assignments of the previ-
ous chapters, shift databases, computer assisted fitting software and retention times from
the publications that characterised the ion pairing method [378, 375].
In the reversed phase spectra (figure III.9a), resonances characteristic for a steroid back-
bone [324, 36] can be seen at around 20 minutes. Even though this is exciting, as several C.
elegans specific steroid based signalling molecules have been discovered and also shown to
have a role in ageing [427, 192, 355], those molecules are most likely to be found at a much
lower concentration. Although more detailed NMR studies would be necessary for confir-
mation, this compound is most likely cholesterol, as C. elegans needs to be supplemented
with cholesterol at 1 mg per litre medium, due to its impaired sterol biosynthesis [339].
Furthermore, at an even higher organic solvent ratio, several constituents of lipids, such
as alkyl-moities (σ ≈ 0.8 ppm) and alkenes (σ ≈ 2.1 ppm), most likely from unsaturated
fatty acids, eluted.
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Figure III.9.: Fractions from oﬄine LC-NMR experiments:
1 minute LC fractions were collected oﬄine and analysed by conventional
tube-based NMR after solvent evaporation and resolubilisation in D2O
buffer. The separation was performed using reversed phase (figure III.9a)
and ion pairing (figure III.9b) chromatography. Resonances of an
annotation are in the same colour as their respective label.
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Compared to reversed phase, in the ion pair separation (figure III.9b) several specific
metabolites were assigned. As expected, most of those were molecules attributed to the
central carbon metabolism, such as amino acids, small organic acids, nucleotides or redox
equivalents. All of those can be observed in 1D 1H, without separation. However, many
metabolites with aromatic resonances cannot routinely be assigned with high confidence
by 1D or even 2D NMR. Differentiating between different levels of phosphorylation of the
energy or redox equivalents, such as AMP, ADP and ATP and NAD and NADP posses a
regular assignment challenge. This is because their diagnostic ribose protons, which are
the closest to the differentiating moieties, the phosphoric acid groups, are usually masked
by other sugars, due to their relatively low relative abundance. Furthermore, the ppm
shift effect of different phosphorylation levels on these protons is not very pronounced and
is easily impacted by small pH variation. However, as can be seen in the chromatogram,
their retention times vary vastly. For example the 47 minute retention of AMP is extended
to 69 minutes by addition of just another phosphoric acid group (ADP).
It must be noted, that there are several other retained metabolites, which could be elu-
cidated readily, if one of their resonances were to be found as biomarker. Particularly, as
NMR tube samples can be conveniently stored long term for future analysis. Therefore
oﬄine acquired ion pair chromatography fractions with deuterated additives are a helpful
addition to the spectroscopist’s toolset for characterising unknown matrices.
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III.4. Workflow for GC-MS TIC alignment for easy visual
interpretation and application to longevity mutants
.
III.4.1. Background and introduction
As discussed in chapter II.5.4, the current GC-MS workflow, which is explained in the
theory and methods chapter (A3.1.4), has a major disadvantage: as it only considers
compounds from the Fiehn retention time and fragmentation library [323], it is not truly
untargeted and therefore not in the ”true” metabolomics spirit [204]. The post-processing
step using the GaVin software package [38] requires some manual input, and so can be time
consuming and is not well suited for a quick, initial overview. Furthermore, the workflow
does not yet include a retention time correction. Even with the small deviations of GC,
this may cause problems if two closely eluting compounds share the same quantification ion.
Just like in NMR, full deconvolution and integration of all compounds may not be neces-
sary for an initial assessment of the data. In NMR, spectral overlays, e.g. . as used for the
off-line fractions of the ion pair separation in the last chapter (see figure III.9), provide a
quick, untargetted, and powerful shortcut to identify differentially abundant metabolites.
Analytes can then be subsequently identified and deconvoluted, by a manual [578] or au-
tomatic [617, 229] spectral fitting approach, to yield quantitative data.
However, NMR spectra are often aligned before spectral overlay, to remove small frequency
shifts due to pH deviations [598]. Many alignment procedures have also been reported for
chromatographic/mass spectral data [332]. Two non-linear algorithms of particular interest
are the LOESS regression of xcms (discussed in A3.1.3.1), and the open-source software
package ”FlagMe” [499]. Even though it may have been initially intended for GCMS align-
ment, xcms (x = G/L) has not been widely used for this purpose. Despite its otherwise
excellent performance for high resolution data, it is not able to make use of (unit mass)
GC-EI-MS fragmentation patterns. In contrast, FlagMe tries to align AMDIS [539] com-
ponents (A3.1.4), i.e. collected fragmentation patterns, across samples without identifying
them first, based solely on their spectral similarity (dot product) [540]. This is done by
pairwise comparison of all samples using an algorithm, similar to the ones used in multiple
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(gene) sequence alignment [499]. However, it was found that this often introduces abrupt
retention time shifts, rather then the ”smooth” LOESS alignment models generated by
xcms.
Therefore this chapter tries to combine both alignment approaches, by using AMDIS com-
ponents to LOESS align total ion chromatograms (TIC) of GC-MS files. The developed
workflow will then be used to analyse a dataset comparing metabolic differences of C. el-
egans mutant strains.
Strain Gene(Allele) Complex Extension [%] Literature
N2 wildtype - - - -
MQ1333 nuo-6 (qm200) I 70 [649]
MQ989 isp-1;ctb-1 III 60 [169]
CW152 gas-1 (fc21) I -33 [303]
TK1 mev-1 (kn1) II -35 [274]
Table III.3.: C. elegans strains used to test the GC-MS TIC alignment:
This table includes the strain name, the knocked down allele and the
respiratory chain complex number of the to be analysed mutant strains.
Furthermore, the observed life-span extension (compared to N2 wild type)
according to literature is given.
All four mutant strains have mutations in subunits of mitochondrial electron transport
chain complexes, as outlined in table III.3. Even though all mutations impair mitochon-
drial function, two of them are short-lived and two long-lived. The molecular links between
mitochondrial function and ageing is a long and ongoing scientific debate [26]. However,
metabolomics may generate new hypotheses.
For a detailed discussion of mutations, which increase lifespan in C. elegans, please refer
to chapter V. and in particular section V.1.3.6.
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III.4.2. Materials and Methods
III.4.2.1. Sample generation, extraction and acquisition
Worm culture was performed by Dr. Marija Sumakovic, at the lab of Dr. Aleksandra
Trifunovic, at the University of Cologne, Germany.
The following number of replicates (plates) per strain were prepared: wild type n = 11,
MQ989 n = 13, CW152 n = 15, TK1 n = 14 and MQ1333 n = 14.
All worms were grown according to standard procedures (see protocol in the appendix B1).
Synchronised worms were harvested at young adult stage, before the onset of egg laying.
They were snap frozen and transported to Imperial College London, in a frozen state.
Samples were extracted using 80 % methanol and a bead-beater, according to the standard
protocol, outlined in the appendix (B2). A QC sample was prepared by pooling 10 % of
each sample. The remainder was partitioned into three technical replicates, the solvent
removed by a vacuum concentrator and samples stored at -80°C, until analysis.
One of the three technical replicates of the samples was analysed using GC-MS. The two
step methoximation with subsequent silylation derivatisation procedure, according to the
standard protocol (B4), was performed. For more information, please also refer to the
appropriate section in the theory and methods chapter A2.3.3.2.
Samples were prepared and run in a single batch. The samples were run in replicate blocks
(i.e. replicate one of all samples, replicate two...). QC samples were injected in between
to monitor runtime performance. A blank was used at the beginning of the acquisition to
assess system contamination. Acquisition parameters were set according to the the Fiehn
method [323].
III.4.2.2. Data processing
Data files were converted to the CDF format within Chemstation (Agilent, UK).
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III.4.2.2.1. Retention time alignment (for TIC overlay) .
Inside AMDIS, a representative QC file was used to build a ”model component” library,
consisting of unique, empirical fragmentation spectra, with retention indices locked to d27-
myristic acid. This library was then selected as the target library, for the deconvolution
of all sample set files. The AMDIS output (FIN files) were parsed into R, to yield a
”model component” by sample matrix (C×S) of the retention times (with the dimensions
c = 1, 2, ..., 259 and s = 1, 2, ..., 67). For each component, its median retention time was
calculated, yielding the 259 elements long median retention time vector rˆ. Correction is
performed sample by sample. Each sample’s component retention time vector rs will be
aligned to rˆ, and values in-between interpolated. To this end, the deviation of rs and rˆ is
calculated, according to equation III.1.
∆rs = rˆ − rs (III.1)
The retention time deviation (from the median retention time) ∆rs is only known at
c = 259 retention times. However, it must be interpolated for each datapoint across the
chromatogram. Thus, for each sample s, a LOESS regression model Ms is fitted according
to equation III.2; with ∆rs and rˆ as independent and dependant variable, respectively. The
LOESS regression model used first order polynomials and a smoothing parameter (”span”)
of 0.6.
Ms = loess(∆rs ∼ rˆ) (III.2)
Ms can then be used to predict a sample’s retention time deviation (from the median
retention time) at each scantime xs.
∆xs = Ms(xs) (III.3)
According to equation III.3, this yields the scan time deviation vector ∆xs, which gives
xs’s deviation from the median scan time vector xˆ.
x′s = xs + xˆ (III.4)
As shown in equation III.4, the new, aligned scan time vector x′s, can easily be computed
by summing xs and xˆ. This procedure is used to compute x′s for all s samples.
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After this, (CDF) sample files, with x′s as the new scan time vector, were created and a
second iteration of the retention time alignment workflow was performed. Finally, TICs
were overlaid, by using x′′s as a common x-axis for all samples.
III.4.2.2.2. Standard GC-MS processing workflow .
Next to the the TIC alignment approach, the regular GC-MS workflow according to the
Fiehn method (see A2.3.3.2) was used (with a database version from 07/2008). As usual,
post processing was performed in GaVin. The integrated intensity matrix was subject to
probabilistic quotient normalisation. The normalisation factors were also applied to the
aligned TIC spectra and the differential features, not detected by the standard workflow.
III.4.2.2.3. Processing of differential features, not found by the standard workflow
.
Some peaks were identified as potentially different between the mutant strains on the basis
of the TIC overlay, but were not identified using the standard workflow. These were fol-
lowed up in more detail. A combination of running authentic standards, and querying the
Golm and NIST databases were used for (putative) identification, prior to quantification.
Three additional metabolites could be identified: fructose-6-phosphate, 2-aminoadipic acid
and 2-hydroxyglutaric acid. Intensity integration of these was performed by xcms in a tar-
geted manner, using the original, unaligned data files.
To this end, quantitation ions for those three compounds were chosen to be unique, com-
pared to closely eluting components. (6 TMS)-fructose-6-phosphate (F6P) and (6 TMS)-
glucose-6-phosphate (G6P) do not have differential ions that could be used for their in-
tegration (315 m/z, 357 m/z, 387 m/z,). However, the GC method allows for sufficient
separation of the two; F6P elutes at 21.33 minutes, whereas G6P does so at 21.44 minutes.
(3 TMS)-2-aminoadipic acid elutes at 15.35 minutes and has unique quantitation ions at
260 m/z, 217 m/z and 128 m/z. (3 TMS)-2-hydroxyglutaric acid (2HG) elutes at 13.76
minutes and coincides with (2 TMS + 1 MeOx)-a-ketoglutaric acid (aKG) (13.78 minutes).
However, both have mutually exclusive and abundant fragmentation ions, which can be
used to discern between the two and quantitate them (2HG: 129 m/z, 203 m/z, 247m/z,
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288 m/z; aKG: 198 m/z, 288 m/z).
To test whether F6P, 2AA and 2HG were truly different in at least one group, one-way
ANOVA tests was used and p-values corrected for multiple testing, by controlling the false-
discovery rate (FDR) [41]. In a few cases, when deemed necessary to justify fold changes,
a metabolite concentration between two groups was compared using a two-tailed (Welch’s)
t-test.
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III.4.3. Results and Discussion
III.4.3.1. Workflow for the GC-MS retention time alignment for TIC overlay
Make “Model Component” library
Use Library to annotate all samples
Plot Chromatograms Output datales
Retention time alignment Other software
AMDIS
R
Figure III.10.: Outline of the proposed (TIC) GC-MS alignment workflow
Figure III.10 outlines the workflow for retention time alignment of the GC-MS samples.
The first step of retention time alignment is the grouping step (see A3.1.3.1). The same
compound needs to be detected across all samples, to gauge the retention time drift from
sample to sample. For this step, the FlagMe software package [499] tries to match ev-
ery component (fragmentation pattern) that AMDIS extracts from each sample against
the ones in all other samples, to identify the same compounds. Components are often in
the order of several hundred and the algorithm does not discern between ”high quality”
and ”low quality” components. Low quality components do not represent unique fragmen-
tation patterns and therefore are often mismatched to the wrong components inside the
other samples. In the workflow proposed here, the components used for grouping and thus
retention time alignment are defined by the user. This can be done conveniently inside
AMDIS, by adding individual components of a sample to a new library. Ideally, those
components are present in the majority of the samples and have fragmentation patterns
distinct from closely eluting neighbours. A pooled QC sample is well suited for this purpose.
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Figure III.11.: TIC before and after retention time alignment:
Excerpt of the normalised total ion chromatograms (TIC) before (figure
III.11a) and after (figure III.11b) retention time alignment. Wild type is
blue, MEV-1 is red.
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In the second step, the empirically built ”model component” library is used to identify the
chosen ”model components” across all samples. Again, this can conveniently be performed
with AMDIS. A LOESS regression model, built for each sample, from the retention times
of the ”model components” is then used to align the retention times to the median re-
tention time (see A3.1.3.1). After alignment, the total ion chromatograms (TIC) can be
plotted. Alternatively, the aligned data can be output into generic mass spectral data for-
mats (netCDF), for another alignment iteration, or processing using another software suite.
Figure III.11 shows a retention time region of two sample groups, before (figure III.11a)
and after (figure III.11b) retention time alignment. Alignment clearly improves the inter-
pretability of the spectral overlay of the different samples, by removing small retention
time drifts. In fact, differences in metabolite concentrations of different sample groups can
readily be assessed, without the need of mass spectral deconvolution. This represents a
quick method for initial data exploration, without restriction to known compounds.
However, alignment procedures should be used with care. Liebeke et al. recently showed
that alignment of 1H NMR spectra may not only introduce artefacts, but can also align
the wrong peaks, particularly in cases of peaks crossing their positions [365]. Compared to
1D NMR alignment, which is simply based on the similarity of peak shapes [598, 515], the
procedure used here is based on (unique) fragmentation patterns. Thus, the chance of mis-
matches is greatly reduced. Peak crossings are not currently modelled by any GC/LCMS
alignment procedure [446], but will be far rarer for GC than NMR (where different peaks
will have individual responses to sample factors such as ionic strength). Therefore, when-
ever an alignment method is used, it is important to follow up with a subsequent deconvolu-
tion and quantification of the differential peaks, using unique quantitation ions. However,
as Liebeke et al. conclude, (1H NMR) alignment based overlay methods is still a valuable
tool for initial data exploration, particularly when unidentified metabolites are present. A
similar conclusion may be drawn in the case of TIC GC-MS alignment.
III.4.3.2. TIC alignment generates interesting hypotheses for the C. elegans
mitochondrial mutant dataset
In collaboration with the University of Cologne, metabolomics was used to analyse four C.
elegans strains with mutations in the mitochondrial respiratory chain, which either lead to
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longevity or premature ageing. To generate hypotheses about underlying mechanisms, it
was decided to use GC-MS, as evidence exists that those mutations primarily affect central
carbon metabolism, and tricarboxylic acid (TCA) cycle activity in particular [77, 483]. All
samples were analysed using the standard deconvolution based workflow, as well as the
TIC overlay based approach, proposed above.
Gauging from the aligned and normalised TIC spectra, displayed in the appendix (figure
C2.1), there are extensive differences in metabolite concentrations between the different
mutants. Using the standard workflow, many of them could be identified and shown to be
considerably different from wild type. In agreement with literature [77, 483], these included
TCA intermediates and related metabolites, such as succinate, citrate, lactate, glycerol-1-
phosphate, as well as amino acids. The dipeptide glycine-proline was found to be increased
1.8 fold (p < 0.0018) in the MEV-1 mutant compared to wild type. The same observation
was already made by Butler et al.[77], who analysed the exudate of long and short lived C.
elegans mitochondrial mutant strains. This could possible hint at a breakdown of collagen.
Many more peaks were present than identified by the standard workflow (using the Fiehn
library), and a considerable fraction of these had concentration differences between groups.
Two of the three additional metabolites that could be identified were significantly altered
in at least one strain: fructose-6-phosphate (F6P) (p < 0.651), 2-aminoadipic acid (2AA)
(p < 0.022) and 2-hydroxyglutaric acid (2HG) (p < 0003).
Even though F6P was not flagged significantly different by ANOVA, individual two-way
comparisons of mutants against wild type (t-test) indicated that GAS-1 was different
(p < 0.0038). Overall, fructose-6-phosphate showed the same concentration pattern as
glucose-6-phosphate (R2 = 0.972%). This is unsurprising, as both are in a chemical equi-
librium, linked by the phosphoglucose isomerase enzyme, and are adjacent in the same
pathway (early in glycolysis). It provides a good example of how additional metabolites
can be identified, beyond relying on a (widely-used) commercial database. Furthermore,
it is an example where both retention time and mass spectra are similar enough that it
would likely confound assignment of the library metabolite.
2-aminoadipic acid appears only as an intermediate in the lysine biosynthesis/biodegradation
pathway. 2AA is the stable oxidation product of 2-aminodipate-semialdehyde. 2-aminodipate-
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semialdehyde itself is routinely used as a biomarker for quantifying oxidative protein dam-
age, as it is a prominent carbonylated (oxidised) protein-amino acid [490, 584, 538, 161].
Recently, proteinaceous 2AA was also proposed as a biomarker for ageing of human skin,
where it was found to accumulate inside proteins with age [520]. The cuticle of C. elegans
and human skin are both comprised of collagen [114, 127, 331]. Thus, it is likely that free
2AA is a biomarker for oxidative protein damage/stress also in C. elegans with clear utility
for ageing research. In a 1H NMR profiling study, conducted in collaboration with Sukaina
Zeitoun-Ghandour and Stephen St§rzenbaum from King’s College London, 2AA was found
to be increased during exposure to the oxidative stress inducing chemical N,NÕ-dimethyl-
4,4Õ-bipyridinium dichloride (Paraquat) [660]. However, this does not match with the fact
that for the two strains in which 2AA was decreased compared to wild type (2.2 fold in
NUO-6 (p < 5×10−04); 5.7 fold in GAS-1 (p < 3×10−05)), increased protein carbonyls are
reported [483]. Clearly, 2AA has a role in C. elegans ageing and oxidative stress responses,
but its full biochemical role will require further investigation.
2-hydroxyglutaric acid is an even more intriguing assignment. Recently, 2HG was shown
to be an ”onco-metabolite”, as it is associated with various forms of cancer [96, 372, 652].
It is found in increased concentrations inside gliomas [96]. In cell models, however, its
tumour-inducing effects are reversible upon removal [372]. These effects are due to its abil-
ity to competitively inhibit multiple α-ketoglutarate-dependent dioxygenases, as recently
shown in C. elegans[646]. Some of the affected dioxygenases are histone demethylases,
through which 2HG can exert epigenetic effects [374]. It was also shown that 2HG di-
rectly affects hypoxia inducible factor HIF-1 by controlling the proline hydroxylase EGL-9
[646], required for HIF-1 hydroxylation and degradation [152]. (R)-2KG increases EGL-9
activity, and (S)-2KG decreases EGL-9 activity [333]. Unfortunately, the GC-MS method
used here cannot differentiate between the enantiomers. However, the possibility of differ-
ent HIF-1 modulation in C. elegans mitochondrial mutants is highly interesting. HIF-1
has emerged as a key player [268] and even a requirement [352] for mitochondrial medi-
ated longevity. Recently, it was shown that impaired mitochondrial function in C. elegans
neurons is enough to induce the mitochondrial unfolded protein response (UPRmt) in the
whole animal. UPRmt is required, if not the reason for the longevity mechanism [147].
Thus, a signalling molecule which cell-non-autonomously induces this response must exist
[637]. 2-HG, as a modulator of HIF-1, would be an intriguing candidate for this signal.
Even more so, as the short-lived GAS-1 mutant and the long-lived NUO-6 mutant both
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showed a 12 fold (p < 0.0005) and 9 fold (p < 0.0007) (median) decrease of 2HG compared
to wild type, respectively. Both mutants were also shown to have increased HIF-1 activ-
ity and an induced UPRmt [352, 483]. Mitochondrial longevity can also be modulated by
RNAi, rather than KO mutations (used in this study). However, silencing must occur in a
defined developmental window, between the third and fourth larval stage [137, 487, 147]:
RNAi treatment during adulthood has no effect on lifespan extension. Thus, it has been
suggested that this lifespan extension occurs via an epigenetic control mechanism [147].
Indeed, RNAi and KO induced mitochondrial longevity appear to be regulated over two
distinct mechanisms [649]. They may even lead to additive lifespan extension [649]. This is
also intriguing, considering the two proposed modes of action of 2-KG [652]: one mediated
over EGL-9 and HIF-1, the other over epigenetic mechanisms. Taken together, 2KG may
be a key molecule controlling lifespan regulation, mediated by mitochondrial function.
As well as 2AA and 2HG, several other unidentified peaks were also differentially expressed.
However, even without assigning more peaks, the current data serve as an example of how
truly untargeted approaches, such as the TIC alignment method presented, can generate
novel and interesting hypotheses, which can then be tested using standard life sciences
techniques.
III.5 Conclusion 103
III.5. Conclusion
This chapter presented three approaches to help increase metabolite coverage and ease of
annotation for NMR spectroscopy and GC-MS. All methods presented in this chapter are
readily transferable to other matrices. They may have to be adapted, however; e.g. isotope
enrichment may not be possible for matrices such as urine or plasma. Still, they can often
be obtained in larger volumes and concentrated, to improve their S/N ratio before using
the automatic database matching workflow of section III.2.
The next chapter (IV.) will develop and test a method to increase the coverage and ease
of annotation for LC-MS based metabolite profiling. This method will then be applied to
a large scale C. elegans longevity mutant screen in chapter V.
IV.. A tool for data reduction and
annotation of LC-MS features
Aims and Ojectives:
• Investigate necessary atom-count constraint for unambiguous formula
generation
• Develop an automated workflow for stable isotope labelling based data
reduction and formula generation
• Test the developed algorithm on different LC-MS datasets
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IV.1. Introduction
IV.1.1. Motivation and Background
The last chapter presented approaches to improve the metabolite coverage and ease of
annotation for NMR and GC-MS based profiling platforms. This chapter aims to do the
same for LC-MS.
As noted in chapter II., LC-MS excels by its wide coverage and high sensitivity [67]. Al-
though GC-MS displays a similar sensitivity, it requires metabolites to be volatile (after
derivatization). Therefore it can rarely be used to analyse compounds larger than 300 Da.
NMR spectroscopy, in contrast, has no restrictions on molecular weight. Indeed, the LC-
NMR experiments (in section III.3) showed lipid and steroid resonances. However, NMR’s
lack of sensitivity did not allow a detailed characterisation. LC-MS on the other hand is
a powerful tool for lipid analysis [559, 486, 396, 496]. As a large amount of the features
detected in chapter II. originate from different lipid species, and lipids are key molecular
species in (C. elegans) ageing [350, 608, 527, 438, 242, 265, 489], LC-MS is an appropriate
choice to explore metabolism and longevity. Furthermore, its sensitivity allows multiple
injections from one Petri dish worth of C. elegans biomass (3+ plates required for NMR).
This enables higher sample throughput, such as required for the longevity mutant screen
in chapter V.
IV.1.1.1. Data reduction in untargeted LC-MS profiling
The extreme sensitivity and coverage of current mass spectrometers results in a wealth
of information. As much as this opens new opportunities, it introduces major challenges.
Compared to the few thousand data points of a NMR spectrum, or the few hundred thou-
sand data points of a unit mass GC-MS run, a single, centroided, high resolution LC-MS
run (such as acquired for this study) can have up to 100 million detector count events. This
puts a heavy strain on data processing pipelines, especially considering a typical profiling
experiment can have up to hundreds of samples [245, 289, 141]. Aside from the compu-
tational requirements, efficient signal reduction methods are needed to break down the
information into a format interpretable by humans. For the first stage of post-acquisition
signal reduction, LC-MS processing tools [531, 302, 547, 482] contain sophisticated filtering
algorithms [301, 180] and methods for peak detection [123, 610, 566]. This step greatly
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reduces the amount of ”noise”, but one is still left with several tens or even hundreds of
thousands of detected peaks, usually referred to as features. ÔFeaturesÕ is an umbrella
term for chemical compounds, their isotope peaks, adducts and clusters, and the isotopes
thereof. Combinations of rule and correlation based approaches have been proposed to
further reduce this potentially redundant information [338, 64].
Afterwards, one must still differentiate between a metabolite originating from the biolog-
ical system of interest and other ”undesired” chemical entities. It is becoming more and
more apparent that unwanted contaminants, such as plasticisers or polymers [574, 216],
make up a sizeable proportion of all observable peaks [31, 196, 195, 194]. Common sources
of contamination include solvents [629, 306], storage containers [645, 663, 546], ambient
air [517] and even parts of instrumentation [597]. They may also be introduced by sample
handling procedures such as autoclaving [418] or the use of certain gloves during sample
preparation [546]. A common way for removing contaminating signal post-acquisition is the
comparison of blanks [394]. However, this is not always feasible, particularly when reten-
tion time alignment becomes necessary [531]. Another, very effective way of differentiating
between biological compound and introduced contaminant is by using stable isotopes. If
an organism can be grown on stable isotope enriched medium, a change in the isotopic
pattern in a mass spectral peak indicates it must be of biological origin. The effectiveness
of this approach to prize out genuine metabolite signals has already been demonstrated for
algae [31], bacteria [29] and Arabidopsis thaliana [196, 195, 194].
IV.1.1.2. Determination of a feature’s molecular formula
Another challenge encountered with LC-MS based profiling is compound annotation. Even
though de novo elucidation from electron impact (EI) GC-MS spectra can be challenging,
annotation of known compounds is usually straightforward. This is due to exhaustive
open source [335] and commercially available [25, 323] retention time locked fragmenta-
tion databases. Similar databases exist for LC-MS, but are still far from similar coverage
[530, 251, 630]. Furthermore, retention times are generally less reproducible than for GC,
and fragment patterns may be less characteristic of individual metabolites. However, with
recent advances in technology, accurate mass measurements close to sub-ppm accuracy
have become possible. This performance used to be the domain of (specialized and ex-
pensive) Fourier transform ion cyclotron resonance (FT-ICR) instrumentation, but is now
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more widely available for routine profiling applications through ToF-MS instrumentation.
High mass accuracy, particularly in conjunction with isotope patterns, vastly improves
database search accuracy [319]. It may even allow an ab initio molecular formula calcu-
lation for low weight molecules, especially with constraints of the expected formula space,
for example for lipids only [501]. However, these calculations generally fail to give unique
empirical formulae for larger molecules, particularly without additional constraints of the
formula space [319, 320].
Rodgers et al.[501], have proposed a method by which the theoretical possible formula space
can be constrained with the help of stable isotope labelling. They compared metabolites of
13C enriched bacterial extracts with their native 12C counterparts, which, like isotopically
labelled quantification standards [639], elute at the same retention time. If the compound
is fully labelled (and singly charged), the integer mass difference between the heavy and
light version of the metabolite equals its number of carbon atoms. Rodgers et al. hypoth-
esise that the knowledge of the exact number of carbon atoms and accurate mass at least
triples the upper mass limit for calculating the elemental composition.
Hegeman et al.[234] extended that approach, by constraining both carbon (12C/13C) and
nitrogen (14N/15N) atoms in the model plant Arabidopsis thaliana. By means of a simula-
tion, they estimated that this double constraint and 3 ppm mass accuracy can ”consistently
provide unique assignments up to 500-600 amu”. In their experiment, they were able to
generate unique assignments in 87% of the cases, compared to 20% without constraint.
Bowen et al.[58], showed that using C+N double isotope constraint was more powerful
for molecular formula calculation than the use of isotope abundance patterns [319], par-
ticularly at masses above 500 Da. Giavlisco et al. also constrained the carbon atoms of
Arabidopsis thaliana to assign metabolites with the help of databases, such as pubchem [56]
and KNApSAcK [2]. They used both direct infusion FTICR [195] and LC-FTICR [196]
for their acquisitions. In 2011 they extended their LC-MS A. thaliana constraint approach
to a 13C/15N/34S regime [194]. This allowed them to consider each peak as one of three
possible common adducts, instead of relying on it to be the H+/− adduct, like during their
previous studies. Baran et al.[31] presented a manual workflow to annotate metabolites
from the cyanobacterium Synechococcus sp. PCC 7002 by carbon constraints. They also
performed a subsequent verification of their hits by MS/MS fragmentation studies. How-
ever, a large subset of their formulae (generated by a vendor’s proprietary software tool)
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was not found in any database. Therefore, ab initio calculation of elemental composition
should be preferred over sole database matching, if possible.
However, a general theoretical analysis on the power and limitations of different atom-
count constraints is still lacking, as well as an automated workflow which can convert the
information from an LC-MS dataset. These points, which are the basis for this chapter,
are outlined in the next section.
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Figure IV.1.: Outline of the chapter
This chapter, which is outlined in figure IV.1, is divided into three major parts. 1. A
theoretical and simulation-based test; 2. the development of a processing algorithm; and
3. the testing of this algorithm on four LC-MS datasets.
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The simulation uses databases of molecular compositions. This section will investigate
what m/z instrument accuracy (ppm) is required to yield unambiguous results when a
measured mass is queried against a database, or when an ab initio molecular formula cal-
culation of this mass is performed. It will also explore the impact of different atom-count
constraints, in order to find a combination which allows unambiguous assignment of all
molecules up to 1 kDa at a typical modern ToF mass analyser instrument accuracy. The
dependency between the molecular weight of a compound and its required instrument res-
olution for unambiguous assignment will also be discussed.
In the second part of this chapter, an automated workflow that uses stable isotope enriched
samples to reduce LC-MS datasets to non-redundant, biologically relevant information will
be developed. Furthermore, the software package also generates molecular formulae based
on the exact mass and isotope shift information of biologically relevant features. To apply
this algorithm in the third section, a protocol for introducing carbon, nitrogen and sulphur
stable isotopes into E. coli and C. elegans is developed.
In a final section, this workflow is tested using LC-MS acquisitions of carbon, nitrogen and
sulphur stable isotope enriched E. coli extracts. The sample set consists of two chromatog-
raphy modes, hydrophilic liquid interaction (HILIC) and reversed phase, each in positive
and negative ionisation mode.1
1Even though the same four conditions were acquired for isotope enriched C. elegans samples, they were
not used. This was due to the use of an early stage protocol during samples preparation, which led to
incomplete isotopic labelling. As the algorithm is not ideal for working with samples of mixed isotopic
labelling levels, it was decided to refrain from an automated analysis of these samples. The problem
will be discussed in the results section. A new, fully labelled batch of isotope enriched C. elegans
samples was used for data reduction and formula annotation in chapter V.
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IV.2. Methods
IV.2.1. Sample generation and metabolite extraction
Standard worm culture protocols are not suitable for isotopic labelling experiments. As
discussed in section IV.3.2 a protocol that allows introduction of stable isotope labels had
to be developed, including determining the minimum sulphur requirement for E. coli. The
metabolite extraction was performed according to the consensus protocol, developed in the
extraction comparison chapter (II.).
IV.2.1.1. Preparation of a modular base minimal medium
Gutnick minimal medium [218] was used as a basis for labelling experiments, with the
sulphur-containing compounds (e.g. sulphate mineral salts) replaced with sulphur-free al-
ternatives. This resulted in the following modified protocol:
Salt Amount g/L mg/L
H3BO3 2.85 X
MnCl2 x 4 H2O 1.85 X
FeCl2 0.62 X
Na2 Tartrate x 2H2O 1.77 X X
CuCl2 x 2H2O 26.5 X
ZnCl2 x 2H2O 20.0 X
CoCl2 x 6H2O 46.4 X
Na2MoO4 x 2H2O 25.2 X
Na2SeO3 20.0 X
Na4 EDTA 0.5 X
Table IV.1.: Trace element solution (1000x) for modified Gutnick medium
Sterile filtered before aliquoting and storage at -40° C.
For 100 ml of medium, 20.0 ml of 5x base medium (table IV.2) and 100 µl trace element
solution (table IV.1) are combined. The remaining 80 ml can be taken from natural
abundance or stable isotope labelled glucose, ammonium chloride and sodium sulphate
stock solutions and topped up with water to 100 ml, if needed. For the NH4Cl, 10 ml of
a 100 mM (10 mM final) solution and for the glucose, 10 ml of a 4 % stock were used.
For the sulphate, 4.5 mg Na2SO4, dissolved in 10 ml was added. After sterile filtering
the base/trace element mix with the carbon/nitrogen/sulphur source, 50 ml of autoclaved
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water was added. The prepared growth media were kept at 4° C prior to use, either
in autoclaved glass bottles or sterile disposable plasticware. To minimise non-biological
contaminants, only ultra purity grade water was used.
IV.2.1.2. Determining the sulphur requirement of E. Coli on the modified minimal
medium
Salt Amount [g/L]
K2SCl2 4.3
K2HPO4 67.5
KH2PO4 23.5
MgCl2 x 6H2O 0.4
Table IV.2.: Base medium (5x):
Autoclave before
storage.
To minimise the consumption of expensive 33S, the
minimum sulphur requirement for the E. coli K-12
wild type strain NCM3722 on the modified min-
imum medium was determined. E. coli growth
curves were recorded forNa2SO4 concentrations cor-
responding to 1, 5, 20 and 185 mg/L sulphur in
the final medium. Growth was performed under the
same conditions used for actual bacterial culture for
worm labelling: 50 ml of growth medium were incu-
bated in a 250 ml flasks (325 rpm, 36° C). The flasks
were sealed with an autoclaved cotton plug to allow gas exchange. Before performing the
growth experiments, a starter culture of E. coli was grown, to allow the strain to adapt to
the minimal medium. 1 ml of the starter culture was pelleted, washed with M9 buffer to
remove all residual sulphur, and resuspended in 1 ml M9. A 100 µl aliquot was used for
inoculation. Every 30 min a 0.5 ml aliquot was taken and the OD600 measured. M9 was
used to dilute the sample if the OD was too high for the spectrophotometer.
IV.2.1.3. Generation of stable isotope labelled E. coli samples
The growth medium combinations (60 ml each) in table IV.3 were prepared, using the
base minimal medium described in section IV.2.1.1. In order to capture the most diverse
metabolome, a 25 ml sample was taken during exponential growth, and the remaining 25
ml were sampled during stationary phase. The labeled cultures were incubated as described
above. Before growing the final labeled culture, the E. coli NCM3722 strain was grown
twice in 5 ml overnight cultures of the corresponding labelled medium, to allow the strain
to adapt to the medium and to minimise carry over of unlabelled biomass. The inocula
were washed with M9 to remove any residual old medium.
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Combination 12C 14N 32S 13C 15N 33S
None X X X
C X X X
N X X X
S X X X
CN X X X
CNS X X X
Table IV.3.: Stable isotope label
combinations
Both samples (i.e. exponential and
stationary phase) were immediately
centrifuged (6,000 g, 5 min, 4 °C) and
washed with 5 ml of ice cold M9. Af-
ter resuspension in 1 ml ultra purity
water, samples were immediately snap
frozen inside 2 ml bead-beater extrac-
tion tubes, prefilled with 200 µl of 0.1
mm glass beads. Samples were stored
at -80° C until extraction.
IV.2.1.4. Generation of stable
isotope labelled C. elegans samples
A protocol for producing labelled C. elegans samples was also developed. To introduce
stable isotopes into C. elegans, its food source, E. coli, must be labelled. This was done as
described in section IV.2.1.3 above, for all possible labelling combinations. The biomass
of 100 ml stationary phase E. coli culture was sufficient to support the growth of 3-4 full
plates of worms to adulthood at 20°C incubation temperature. Before feeding the E. coli
to the worms, the pellets were washed with M9 buffer to avoid carryover of any growth
medium components. The biomass was then suspended in a small residual of M9 and
transferred onto the agar plates for C. elegans culture. In order to conserve the expensive
isotope-enriched biomass, food was not provided in excess at the beginning, but topped up
on a daily basis, ensuring worms were always fed ad libidum. Worms were sampled once
they nearly exceeded all of the bacterial lawn, to minimise bacterial contamination of the
samples. Pellets were stored at 4°C until use, but not longer than a week.
Preparation of agar plates was also modified compared to the standard protocol. First, the
1M Mg2SO4 solution (1 ml per litre of medium) was exchanged for an equimolar Mg2Cl2
solution. Molecular biology grade agarose was used rather than standard bacteriological
agar, to reduce non-biological contamination. Most importantly, when introducing the
cholesterol, ethanol must be avoided. The first batch of 13C labelled samples was contam-
inated with 12C from the ethanol. In the second batch, analysed in chapter V., cholesterol
was successfully introduced without the use of ethanol. This was done by adding the cor-
rect amount directly to the hot agar, followed by dispersion through manual shaking and
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10 min sonication inside a 50° C water bath. Plates were stored (for a maximum of two
weeks) at 4° C until use.
To ensure complete isotope labelling, the worms were grown over two generations before
sampling. An age synchronisation (bleaching) step was performed between the two genera-
tions, to ensure only second generation worms were sampled. Sampling was then performed
according to the standard protocol.
In all steps, where water was needed, ultra purity grade water was used.
IV.2.1.5. Metabolite extraction
For both E. coli and C. elegans , metabolite extraction was performed as outlined in B2,
using 80 % methanol and a bead-beater.
The growth and stationary phase E. coli samples were pooled. Three equal aliquots were
prepared of each sample.
IV.2.2. LC-MS data acquisition
Analysis of the samples was performed at Waters Corporation in Manchester, UK, with
the help of Matthew Lewis (Imperial College London), Dr Martin Palmer (Waters) and
Dr Steven Pringle (Waters). This was in order to analyse the samples on a modern (2012)
ToF instrument (Waters Synapt G2-S).
Samples were reconstituted with 250 µl water and 1:1 water:acetonitrile for reversed phase
and HILIC chromatography, respectively. The samples were solubilised by sonication for
10 min and vortexing. Insoluble debris was then removed by centrifugation (10 min, 10,000
g), and the supernatant transferred into silanized high recovery vials. Samples were kept
in a Waters Acquity sample manager at 4°C until full loop injection of 5 µl (without needle
overfill) by an I-class Acquity UPLC system.
Reversed phase chromatography was performed using a 2.1 × 150 mm Waters ACQUITY
UPLC HSS T3 column, with 1.7µm C18-alkyl functionalised particles. The column was
kept at 40° C. A gradient from solvent A (water) to B (acetonitrile), both with 0.1% formic
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added, was run (table IV.4). For both, RP and HILIC, the flow rate was 0.5 ml per min.
Time A[%] B[%]
0.00 100.0 0.0
0.10 100.0 0 .0
15.10 0.0 100.0
15.60 0.0 100.0
15.70 100.0 0.0
19.20 100.0 0.0
Table IV.4.: Gradient of reversed
phase acquisition
HILIC chromatography used a 2.1 × 150 mm
Waters ACQUITY UPLC BEH Amide column
with 1.7 µm particle size was used. Column
temperature was 50° C. The gradient, from
solvent A to B, is shown in table IV.5. Sol-
vent A was 19:1 (95 %) acetonitrile:water, and
solvent B was 1:1 acetonitrile:water. Both con-
tained 10 mM ammonium acetate and 0.04 %
NH4OH. The pH was adjusted to pH 9.0. Sol-
vent A was prepared by mixing the ammonium
salt and solution with the water. The acetoni-
trile was slowly added, while using sonication
for mixing. This was done to prevent precipitation of any salts due to the high organic
content.
Time A[%] B[%]
0.00 100.0 0.0
0.10 100.0 0.0
15.10 0.0 100.0
20.0 0.0 100.0
20.1 100.0 0.0
30.0 100.0 0.0
Table IV.5.: Gradient of HILIC
acquisition
The LC eluent was introduced into a Waters
Synapt G2-S Q-ToF mass spectrometer. The
eluent was evaporated and molecules ionised by
an electrospray source heated to 120°C, with
desolvation temperature at 550°C and a desol-
vation gas flow of 800 l/h. The capillary volt-
age was set to 0.5 kV, for both positive and
negative ionisation modes. Sample cone volt-
age was 25 V and 35 V in positive and negative
mode, respectively. 6 mass spectra per second
were acquired over a range of 50 to 1200 dal-
tons and a scan time of 0.1 s, with 0.05 interscan delay. The ToF analyser was operated
in high sensitivity mode with around 10 thousand resolution, saving the data in centroid
mode. To obtain high accurracy mass measurements, the mass spectrometer was cali-
brated to sodium formate and a lock mass was introduced into the source throughout
the run. The lock mass was 200 pg/µl Leucine-Enkephaline in a 1:1 mixture of acetoni-
trile:water. It was infused at a rate of 10 µl/min and recorded every 30 scans; averaging
four lock mass scans each time. The whole system was controlled by MassLynx version 4.1.
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IV.2.3. LC-MS data processing
After acquisition, data were converted into mzXML format and peaks detected using xcms
(version 1.33.14). Parameter settings were kept liberal, to allow for the highest coverage
possible. The ”centWave” algorithm was used with an expected chromatographic peak
width between 1 and 10 s and a signal to noise threshold of one. All other parameters were
left at default values.
IV.2.4. Programming and simulations
The simulation engine for the theoretical experiments and the algorithm for the data re-
duction and formula annotation were both implemented in R. However, all parts which
required extensive computation were outsourced into multicore C-code. Due to the sheer
amount of computational power and space required, most simulations were performed on
the Amazon EC2 cloud computing service, running Ubuntu Linux 10.04 LTE. Peak de-
tection for the workflow test datasets as well as the parameter optimisations were also
performed on the EC2 in a parallelised fashion. However, the final workflow algorithm was
developed to be run on desktop computers. The recommended specifications depend on
the number of detected peaks, and retention time and mass error windows. For a good
performance, 8 GB RAM are recommended, 16 GB ideal. The code has been tested on
Mac OS X 10.6-10.8 and Ubuntu Linux 10 with R 2.13 up to R 3.0.
The PubChem library was downloaded on the 2nd of August 2011, and the EcoCyc library
on the 8th of June 2011. Both were parsed using scripts developed in R. Only composi-
tions consisting of the elements CHNOPS with at least one carbon atom were used for the
simulations. It was decided to perform all simulations with charge neutral compounds. In
cases where a charge was present, for example an acid, the charge was in silico ”titrated”,
adding or removing protons. The mass range was limited to 1 kDa. A database of all
possible, but plausible chemical compositions, was created using the HR2 software tool by
Kind et al.[320]. It was set to generate all compositions up to 1kDa, using the chemical
rules (LEWIS and SENIOR) and probabilities (element/mass and element/element ratios)
outlined in their publication. The maximum and minimum atom-counts were: C(1-100),
H(1-150), N(0-50), O (0-50), P(0-9) and S(0-14).
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The correct function of all algorithms was always checked throughout development. All
critical computations were also repeated independently and compared to the algorithm’s
output.
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IV.3. Results & Discussion
This chapter has two aims: to provide a method to identify molecules of biological origin,
and to annotate them. By growing an organism on isotope enriched growth medium, all
synthesized metabolites will be isotopically labelled, and so distinguished from chemical
background. Furthermore, the increase in molecular weight as a result of isotope enrich-
ment is proportional to the number of labelled atoms. For example, glucose (C6H12O6) will
shift from 180 Da to 186 Da. This is very valuable for annotating an empirical formula to
unidentified peaks, as the number of atoms can be used as a search constraint in ab initio
calculations to reduce the number of possible results.
The results and discussion is divided into three major sections: 1. In silico considerations
regarding the usefulness and limitations of atom-count constrained searches and ab initio
formula calculation. 2. The development of an automated workflow to analyse isotope
labelled metabolite mixtures, acquired by LC-MS and using the gained atom-count infor-
mation for molecular formula generation. 3. Testing this workflow on an E. coli dataset.
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IV.3.1. In silico considerations for enhanced molecular formula
calculations by isotope label analysis
Before any experiments were conducted, exhaustive in silico analyses were performed, to
give a rigorous assessment of the value of atom constraints for ab initio molecular formula
calculations. The focus is on elements that have stable isotopes available and so could
readily be enriched in real systems (CHNOS). They should also be introducible into in-
vivo systems, without compromising physiological function (CNOS). Furthermore, ideally
they should be affordable in the required quantities (CNS).
IV.3.1.1. Knowing the carbon, nitrogen and sulphur atom count allows
unambiguous annotation at ToF mass accuracy
A database query or elemental composition calculation of an unknown is usually based on
its measured mass. The more accurate, the higher the chance to obtain an unambiguous
hit. Mass accuracy is expressed as a relative measure between the difference of measured
and calculated mass, according to equation IV.1. For convenience, it is expressed as parts
per million (ppm).
Errorppm =
(massmeasured −masscalculated)
masscalculated
× 106 [ppm] (IV.1)
The following simulation aims to find out how accurate a mass spectrometer would need
to be, to prevent such ambiguities, i.e. being able to differentiate a composition from its
most similar weighing neighbour. Furthermore, to what degree knowing the exact atom
count of a particular element can afford greater uncertainty of the mass measurement.
Three major databases were used: (1) The manually curated E. coli pathway database
EcoCyc [312, 313] (n = 1,188 compounds), (2) the National Institute of Health’s (NIH)
PubChem database [56] (n = 212,910) and finally (3) a database containing all plausible
molecular formulas up to 1 kDa, generated in silico by a freely available HR2 software tool
from Kind et al.[320] (n = 30,914,124). This gives three different scenarios:
(1) If a mass is matched against EcoCyc, this resembles a ”naive” database search. Only
molecules already known for an organism are expected as hits. As this is the scenario with
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the least number of possibilities out of the three, the instrument accuracy requirement to
deliver unambiguous hits should be the lowest one.
(2) A mass is matched against PubChem. In this scenario, the required accuracy is calcu-
lated to unambiguously assign a compound against all compounds ever reported.
(3) The ultimate test. Unambiguously assigning a compound against the background of
all possible elemental compositions. This scenario is effectively equivalent to an ab initio
calculation of the molecular formula.
It is important to point out that all molecules from (1) are contained in (2), and (2) is a
a subset of (3) (with a few rare exceptions).
In order to test these different scenarios, it was decided not to choose specific compounds
as models [234], but rather to perform larger-scale simulations, to deliver more generally
applicable conclusions. Therefore, all molecular formulae contained in Ecocyc were queried
against (I) itself, (II) PubChem and (III) all possible elemental compositions. The required
level of instrument accuracy (log10 ppm) for unambiguous assignment of the remaining frac-
tion of all queried compositions is shown in figure IV.2a for scenario (I), figure IV.2b for
(II) and figure IV.2c for scenario (III).
The slope may be interpreted as a cumulative probability density function for the likelihood
to resolve a compound at a given ppm accuracy, and therefore changes from scenario to
scenario. As expected, the mass accuracy required to resolve the same fraction of queried
compounds rises with the increasing number of possibilities ((I)→(II)→(III)). Even without
additional atom constraints, all compositions could be differentiated with a state-of-the-
art ToF detector (3− 5 ppm) in scenario (I). This is still true for 80 % of the compounds
in scenario (II), only around half of the formulae could be calculated ab initio at 1 ppm
(III). Clearly, constraining the atom-count during the search improves the probability of
obtaining unambiguous hits. Unfortunately, the resolution of the graphs is rather coarse.
A higher resolution would allow much clearer assessment of the impact of atom-count con-
straints.
As the graph resolution is based on matching pairs between two datasets, it can be im-
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Carbon
Nitrogen
Hydrogen
Oxygen
Phosphorus
Sulphur
Carbon + Nitrogen
Carbon + Nitrogen + Sulphur
None
(d)
Figure IV.2.: Instrument accuracy requirements impacted by various atom
count constraints I:
The fraction of unresolved unique elemental compositions is plotted against
the required instrument accuracy (in ppm) to resolve those. The ppm
domain is on a logarithmic (base 10) scale. In figure (a - c), the EcoCyc
dataset is matched against (a) itself, (b) PubChem and (c) all possible
combinations.
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(a) (b)
Figure IV.3.: Instrument accuracy requirements impacted by various atom
count constraints II:
The fraction of yet (un)resolved unique elemental compositions is plotted
against the required Instrument accuracy (in ppm).
In figure (a) the ppm domain is on a native, in figure (b) on a logarithmic
(base 10) scale. In both cases, elemental compositions from the PubChem
dataset are matched against all possible compositions. For more
information, please refer to the text.
proved by increasing the number of matching events. As the main goal is to perform ab
initio molecular formula generation it was decided to focus on scenario (III). However,
rather than just matching the small EcoCyc dataset onto all possible molecular composi-
tions, it was decided to use all chemical compositions contained in the PubChem database.
The results can be seen in figure IV.3a and IV.3b without and with a logarithmic ppm
scale, respectively. The graph with the native ppm scale displays the power of high mass
accuracy instrumentation. Above about 10 ppm resolution, it is effectively not possible
to unambiguously calculate molecular formulae. In order to determine a majority of all
compositions unambiguously, and without using any atom-count constraints, one would
require instruments at least two orders of magnitude more accurate than the current state-
of-the-art. In order to resolve all compositions, the requirement would even be extended
by 5 orders of magnitude to one part per quadrillion (ppq) accuracy. Kind et al. in 2006
[319] and Green et al.[209] also concluded that, instead of focusing on improving mass
accuracy beyond one ppm, it is more valuable to use other information, such as isotope
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patterns (although they did not provide the same exhaustive comparison to all possible
backgrounds).
Atom-counts provide additional information. Indeed, as figure IV.3b shows, certain con-
straints are very powerful when combined with high mass accuracy measurements, with
the most and least powerful being carbon/hydrogen and sulphur, respectively. This is as
expected as carbon/hydrogen display the highest diversity in the number of atom-counts,
whereas sulphur is almost always present as 0 - 2 atoms per compound. Both hydro-
gen and carbon constraints could resolve all compositions at around 0.1 ppm accuracy,
whereas sulphur has little benefit over no constraint at all. Knowing the atom-count of
multiple elements is more powerful than for single elements. Carbon/nitrogen (CN) and
carbon/nitrogen/sulphur (CNS) are of particular interest, as these isotopes can readily be
introduced into a biological system, at reasonable cost. The simulations show that CN
and CNS can unambiguously resolve all compounds below 1 kDa at 0.015 ppm and 3.7
ppm, respectively. This means that knowing the number of carbon, nitrogen and sulphur
atoms, plus molecular mass measured with a current state-of-the-art time-of-flight mass
spectrometer, it is possible to resolve all possible molecular compositions.
Graphs for all double and selected higher constraints can be found in figure C3.1 in the
appendix.
Bowen et al.[58] compared the use of atom-count constraints to the use of isotope pattern
analysis for ab initio molecular formula generation. They focused on the carbon and nitro-
gen double constraint at 5 ppm mass accuracy. They also compared the ”all compounds
formula database” generated by the HR2 software tool, used in this thesis, with a brute
force formula generator that generates every combinatorial molecular composition, even
if chemically implausible. They found that at 5 ppm and carbon/nitrogen atom-count
constraint, 55 % of PubChem’s compositions could be unambiguously calculated when
matched against the HR2 generated list. This dropped to 50 % for the all combinatorial
possible formulae. In this thesis’s simulation the same scenario yields 75 % unique solu-
tions. Even though this difference sounds large, it is in fact not that different: the CN
curve (in figure IV.3b) has its steepest slope between 10 and 4 ppm. It falls from 29 %
unique compositions at 10 ppm, to 87 % within just 6 ppm. Thus, small differences in
simulation parameters, such as their inclusion of compositions up to 1244 Da, could easily
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cause these differences. Hence, the analysis here is consistent with previous results. It also
shows that pure combinatorial molecular formula generation, i.e. without any probabilities
or chemical rules, does not result in vastly different results from the approach taken here.
Overall, Bowen et al.[58] found atom-count constraints to be superior to isotope pattern
analysis for ab initio molecular formula generation, particularly for compounds above 500
Da.
IV.3.1.2. Impact of molecular weight for unambiguous molecular formula
calculation (considering different atom-count constraints)
One would also expect a molecule’s mass to be an important factor when examining
the required instrument accuracy to calculate its molecular formula and the impact of
atom-count constraints - the lower the molecular weight of a compound, the more likely
a database query or ab initio formula calculation will deliver unambiguous hits. Indeed,
based on their experiments, Rodgers et al.[501] hypothesised that carbon-count constraints
could triple the upper mass limit for unambiguous assignment. Hegeman et al.[234] use
poly(phosphoserine) (n = 1, 2, 3, .., 10, 15) as a model for compounds that are difficult to
resolve, due to their mass being close to the the mode (top) of the mass distribution around
an integer mass bin. Using this model, they predicted that at 3 ppm instrument accuracy,
molecules can be unambiguously resolved up to a molecular weight of 186 if unconstrained,
278 with known carbon-count, 214 with nitrogen constraint and 422 if the number of car-
bon and nitrogen atoms is known.
Therefore this thesis tries to explore the general dependency between molecular weight
and unambiguous assignments, considering different atom-count constraints. Using the ab
initio calculation scenario from above, all compounds in PubChem were queried against all
possible molecular formulae, generated by a software tool from Kind et al.[320]. However,
to reduce computational requirements, only compositions that cannot be resolved at 10
ppm or less are considered, in contrast to the 100 ppm used in the simulations above. At 10
ppm accuracy, there still is no unique molecular formula for 97.9 % of all masses contained
in the PubChem dataset.
Figure IV.4 shows individual data points for each molecular composition, rather than rank-
ing them with ascending ppm accuracy requirement, as done in the section above. The
results agree with the mass limits for unambiguous assignments (at 3 ppm) proposed by
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Figure IV.4.: Required accuracy to determine molecular composition versus its
mass :
Each datapoint represents a molecular composition in the pubchem dataset.
The (log 10 ppm) instrument accuracy required to be able to unambiguously
calculate its composition from its measured mass is plotted against its mass.
Figure IV.4a: No atom-count constraint
Figure IV.4b: Carbon-count constrain
Figure IV.4c: Nitrogen-count constraint
Figure IV.4d: Sulphur-count constraint
Figure IV.4e: carbon- and nitrogen-count constraint
Figure IV.4f: Carbon- nitrogen-, and sulphur-count constraint.
The percentage below shows the percentage of all data points in the plot
from the whole PubChem dataset.
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Hegeman et al.. However, the ability to unambiguously resolve a compound’s composition
does not depend on its molecular weight as much as might be expected. Indeed, without
atom-count constraints and at ToF accuracy, many compositions with less than 200 Da
molecular weight may not be resolved, but many above 600 Da will be.
An investigation into what actually determines the required accuracy was conducted. It
was found that it depends on the atom-count ratio of the two matched compositions (for
any given element). There are certain ratios, which are much harder to resolve than others.
A more detailed investigation would exceed the scope of its thesis. It can be concluded,
however, that the required accuracy does not depend on the absolute mass per se, but also
on the exact stoichiometry of the matched molecular compositions.
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IV.3.2. A protocol for stable isotope labeling of carbon, nitrogen and
sulphur in C. elegans
Introducing atom constrains for C, N, and S means that all elemental compositions up to
at least 1 kDa can be generated ab initio. Therefore a protocol to introduce those elements
into C. elegans was developed.
In order to isotopically label C. elegans, its food source, E. coli, must be labelled. Two
protocols for stable isotope enrichment in C. elegans exist. One for 13C by An et al.[15]
and one for 15N by Krijgsveld et al.[337]. However, neither was suitable for use here (and
the second was not published at the time of this experiment). An et al. use the OP50 E.
coli strain, which is a uracil auxotroph. Full isotope enrichment would therefore require
custom synthesis of 13C/15N labelled uracil, which was not feasible. Krijgsveld et al. use
commercial 15N growth medium, which is not available for all isotope combinations in this
study. Therefore a new protocol was developed.
The metabolically ÔcleanÕ E. coli wild type strain NCM3722 was chosen, which is widely
used in metabolomics studies [29, 375]. NCM3722 grows on completely synthetic minimal
medium, for example the one developed by Gutnick et al. [218]. However, adaptation of
this protocol has previously been reported for 13C and 15N stable isotope enrichment, but
not for sulphur [375]. To this end all salts with sulphur-containing counter ions, such as
sulphates, were replaced by their chloride equivalents.
Isotope enriched sulphur can be conveniently introduced through addition of Na2SO4,
with Na233SO4 being commercially available. Due to its high price, NCM3722’s mini-
mum sulphur requirement in the used medium was determined by OD600 measured growth
curve experiments with different Na2SO4 concentrations. Results, displayed in figure IV.5
indicate, that a sulphur concentration of 10 mg per litre of medium is sufficient, to not
constrain bacterial growth. This would correspond to 45 mg per litre Na233SO4. Indeed,
this result is similar to the one determined by Cowie et al.[113] for growth of a not further
characterised E. coli strain in M9 minimal medium (equivalent to 5 mg sulphur per litre).
The protocol generates carbon, nitrogen and sulphur labelled E. coli. To feed C. elegans ,
these are pelleted and streaked onto agar plates, which are prepared without the use of
(unlabelled) peptone. Apart from E. coli as food source, C. elegans requires the addition
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Figure IV.5.: Minimum sulphur requirement for E. coli strain NCM3722:
The minimum sulphur requirement for E. coli strain NCM3722 in Gutnick
minimal medium is determined. 1 mg/L shows a serious constraint, 5 mg/L
a smaller one. 10 mg/L supports normal growth.
of cholesterol to the growth medium, as C. elegans lacks enzymes required for the biosyn-
thesis of sterols from isoprene [339]. Fully labelled 13C cholesterol is not commercially
available. As C. elegans lacks the capability to synthesise sterols, it is also not capable of
breaking down supplemented 12C cholesterol to ”contaminate” the growth medium. Thus,
natural abundance cholesterol may be used. The cholesterol is introduced by solubilisa-
tion in ethanol and addition to the agar, prior to pouring plates. Even though ethanol was
allowed to evaporate from the poured Petri dishes by leaving their lids open until solidifica-
tion [580], residual ethanol remained in the medium. Metabolism of the remaining ethanol
by the bacteria or worms led to an incomplete labelling of C. elegans biomolecules. Un-
fortunately, this rendered the first C. elegans dataset, which was intended for an in-depth
C. elegans metabolite characterisation, unusable for automated isotope assisted molecule
annotation. Figure IV.6a shows an example mass spectrum of an incompletely labelled
lipid. To avoid this problem, cholesterol was added to the agar directly (rather than as
a solution), with dispersion of the cholesterol as microcrystals by shaking and extensive
sonication. Worms were grown over several generations on ethanol-free growth medium
to ensure there were no cholesterol depletion defects, such as abnormal development or
premature death [413, 151]. Worms cultured in this manner, did show a complete 13C la-
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Figure IV.6.: Isotopic abundance pattern of (in)completely labelled lipid:
Both figures show the 13C mass spectrum of a lipid. In figure, IV.6a, the
labelling is incomplete, leading to a mixture of species with various levels of
isotope incorporation. The labelling in figure IV.6b, however, is considered
complete. It could be described as an inversion of the usual 12C abundance
pattern (1 % 13C). This is due to the 13C glucose used for enrichment was
obtained at 99 % isotope purity and therefore has 1 % 12C content.
belling of their biomolecules (considering the purity of commercially available 13C glucose),
as shown in the mass spectrum in figure IV.6b.
IV.3.3. Development of a software algorithm for automated data
reduction and molecular formula generation by stable isotopes
This section describes development of a fully automated software-engine that can extract
atom-count information from LC-MS data of a biological system that has been enriched
with stable C, N and S isotopes. It uses the extracted atom-count information to generate
molecular formulae, to accelerate assignment and help differentiate chemical contamination
from real biological information.
Preliminary experiments with just carbon and nitrogen labelling showed an abundance
of non-biological contaminants. Indeed, those signals, which are shared between different
isotope labelling regimes, were enough for xcms to perform retention time alignment. Thus
it was decided not to additionally spike samples with unlabelled extract.
E. coli data were used for developing the algorithm. Bacteria were grown according to
the protocol developed in section IV.3.2. Thus these datasets also provided a test for the
carbon, nitrogen, sulphur labelling protocol. C. elegans labelling was attempted but the
samples had to be discarded because of some metabolites being 12C ”contaminated”, due
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to the use of ethanol. Those samples can still serve as a reference for annotation, but
method development was constrained to the E. coli samples.
HILIC Reversed Phase
ESI+ HILIC+ RP+
ESI- HILIC- RP-
Table IV.6.: Dataset for algorithm
development and
validation
As shown in table IV.6, the samples were run
in four different conditions: reversed phase and
hydrophobic liquid interaction (HILIC), each in
positive and negative ionisation mode, to as-
sure the developed workflow will perform with a
range of chromatographic and electrospray condi-
tions.
The algorithm can be used with the output from any LC-MS processing software, but
was developed here on retention time aligned (retention time × mass) peak lists generated
by xcms. The algorithm requires one natural abundance sample, plus samples under 5
different stable isotope labelling conditions: singly labelled with carbon (C), nitrogen (N)
and sulphur (S), doubly labelled with nitrogen and carbon (CN), and triply labelled with
carbon, nitrogen and sulphur (CNS). The algorithm makes no prior assumptions about the
data, except an estimation of the retention time deviation (rtE) and mass errors (ppmE).
As will be shown in section IV.3.4.1, those may be optimised for best possible results. The
workflow of the algorithm itself is outlined in figure IV.9.
In the first step, peaks are queried whether they are biological in origin, and if so, their
number of carbon, nitrogen and sulphur atoms is determined (figure IV.7b). To this end, a
peak in the unlabelled sample must be matched to the corresponding peaks in the labelled
samples (figure IV.7a). This matching process equates to the grouping step of retention
time alignment. However, it is slightly more complicated, as a labelled peak will have a dif-
ferent mass. According to equation IV.2, the mass difference (∆m) between the unlabelled
and labelled mass, equals to the labelled element’s atom-count (n) times the difference
(∆u) in atomic weight between the main natural abundance atom and its stable isotopo-
logue of the element in question.
mnative −misotope = ∆m = n× (unative − uisotope) = n×∆u (IV.2)
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Figure IV.7.: Workflow of data reduction and annotation algorithm:
Details are explained in the text.
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Thus, the algorithm will flag every pair (inside a retention time window) that is n × ∆u
Dalton apart, as a potential match. ∆u is atom specific as shown in table IV.7. This is
because all atoms have a specific mass defect, i.e. the mass converted into binding energy
is different for each atom. Thus, the mass difference ∆u between 12C and 13C, for example,
is not simply a unit mass, but a very specific value, depending on the mass defects of 12C
and 13C.
Element Mass [Da] Isotope Mass[Da] Difference ∆u [Da]
Carbon 12.000 000 13.003 354 1.003 355
Nitrogen 14.003 074 15.000 108 0.997 035
Sulphur 31.972 071 32.971 458 0.999 388
Table IV.7.: Exact mass and difference (considering mass defect) of used
isotopes [132, 624]
A (reflectron) ToF mass spectrometer’s accuracy is high enough to discern these mass
differences. Thus, the algorithm can distinguish whether a shift is due to the presence
of an isotope or a coeluting molecule of higher mass value. To make the most of this
effect, the algorithm requires an estimate of the mass accuracy of the acquisition, mea-
sured in ppm (ppmE). After this step, a list of unlabelled - labelled peak pairs is outputted.
The mass defect helps to reduce possible peak pairs. Still, due to the sheer number of com-
binatorial possibilities, particularly considering the presence of natural abundance isotopes
in unlabelled samples (e.g. 13C abundance in a 12C system) or the presence of unlabelled
molecules in stable isotope enriched samples (e.g. 12C ”contamination” in a 13C system),
the number of proposed pairs is very high. The list could be drastically truncated by query-
ing the probability of those pairs. To this end, the PubChem database was used to define
confidence intervals on the basic architecture of molecules, similarly as proposed by Kind
et al.’s empirical ”7 Golden Rule” analysis [320]. As shown in figure IV.7c the molecular
weight to atom-count ratio (with carbon and hydrogen in particular) and elemental ratios
were used. In all cases, a 99.99 % confidence interval was used. Thus, a molecule would
need to have a molecular weight to atom-count ratio at least as extreme as 0.01 % of all
compounds contained in PubChem, to be discarded. Even though this algorithm’s goal is
to annotate new, non-database metabolites, it is highly unlikely for a biological metabolite
to exceed these boundaries - particularly as PubChem also contains synthetic molecules,
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such as C60. For example, to pass this rule, a molecule with a mass of 100 must contain
from one to 8 carbon atoms (8× 12 = 96!). Therefore this step just leaves pairs that may
lead to biologically plausible molecules. Atom-count to molecular weight and atom-count
to atom-count ratios can be found in the appendix, in table C3.1 and C3.2, respectively.
In the next step, the algorithm combines these pairs by comparing them to multiply labelled
samples, as shown in figure IV.7c. A carbon and a nitrogen pair, which both share the
same unlabelled counterpart, are required to have a matching carbon-nitrogen double label
in their retention time window. For example, in the case of C = 7 carbon atoms and N = 1
nitrogen atom, the carbon-nitrogen peak would be required to be CN = C+N = 7+1 = 8
Da higher than the unlabelled sample. Again, exact masses, with specific mass defects are
used. The carbon-nitrogen double pairs together with the sulphur pairs are then matched
against the carbon, nitrogen and sulphur triple labels (CNS = C + N + S). Apart from
Hegeman et al.[234], none of the other published methods use such multiple constraints,
even though they are powerful at reducing combinatorial possibilities - as will be shown in
the next section.
At this stage, it would already be possible to calculate the molecular formula of the peaks
giving rise to the None/C/N/S/CN/CNS pairs. However, the aim of the workflow is to
rigorously and accurately reduce the chemical information to biologically relevant, non-
redundant data. Thus, the operator is given the chance to check the validity of the corre-
lated pairs. To this end, check tables for each pair are generated in the PDF file format.
A check table, such as displayed in IV.8 has three major elements. It contains the over-
laid extracted ion chromatograms (EIC) of the pairs. It also displays the individual mass
spectra for each labelling regime, extracted at the apex of each EIC. Inside the mass spec-
tra, the peaks of the pairs are highlighted and the proposed atom-count displayed. Also,
the potential isotope peaks are coloured differently from the rest of the mass spectrum’s
peaks. Finally, a charge indicator indicates the charge of a (potentially) multiply charged
pair. Even though the formula generator considers multiply charged ions, there as yet is
no support to deconvolve multiple charge envelopes [665], as those play a subordinate role
in metabolite profiling.
The check tables were found to be extremely practically useful for evaluating the experi-
mental data. They allow one to spot and discard mis-matched pairs as well as those which
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Figure IV.8.: Check tables for isotope peak pairs:
The check table, consists of three elements: The overlaid EICs, the
individual mass spectra at EIC apex and a charge indicator. In this a case a
pair with 28 carbon, one nitrogen and zero sulphur atoms is proposed. As
the EICS are aligned perfectly, no multiple charge is present and the correct
peaks were detected inside the mass spectra, this assignment looks plausible
(compare to figure IV.9b). Another C, CN and CNS labelled compound
seems to be co-eluting at 570 Da. However, it is coloured green. All
isotopes which according to accurate mass measurements belong to the
proposed isotope pair, are coloured blue. This means the signal at 570 does
not belong to the proposed isotope pairs. Signals not identified as peaks by
the xcms peak detection step are coloured black.
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Figure IV.9.: Multiply charged and isotope pair mismatch:
Figure IV.9a shows an isotope pair, which is doubly charged. This is
detected by the charge indicator in the top right corner. Indeed, as shown
in magnification the peaks have a distance of around 0.5 Da, rather than 1
Da. Figure IV.9b shows a mismatched isotope pair. For the C, CN, CNS
the M-1 isotope was used, leading to an underestimation of the atom-count.
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do not meet the user’s quality criteria, such as incomplete chromatographic separation of
isomers. Figure IV.9a and IV.9b show an example of multiply charged isotope pairs and a
mismatch, respectively. Mismatches in which the M+1 or M-1 isotope was selected, were
found to be the most common mismatch by far. Thus it was started to fit isotope abun-
dance patterns [259], to recognise and remove such events. However, this is non-trivial
as often different metabolites display a different degree of isotope label incorporation.
Therefore this algorithm’s rules had to be extended to a level that it also flagged oddly la-
belled, but correct matches. To guarantee comprehensive and high quality assignment, all
algorithm predictions in this thesis were manually checked that they were not mis-matches.
After manual curation, a molecular formula is generated for each pair (figure IV.7f) under
consideration of adducts. In previous studies, Giavalisco et al.[195, 196] did not consider
any other adducts apart from M+/− and therefore are likely to have mismatched com-
pounds during their database search. In their latest study, however, they considered three
common adducts [194]. The algorithm here uses a comprehensive list of adducts [574, 44]
during formula calculation: 30 and 14 adducts for positive and negative mode, respectively,
as shown in table C3.3 in the appendix. All formula calculation is performed on the fly
and no lookup databases are required. Many of the previous studies just constrained their
searches to publicly available compound databases, not taking unknown compositions into
account [196, 194]. The generation algorithm itself is an efficient re-written implementation
of the open source HR2 formula generator [320]. This is the same formula generator which
was used to generate the ”all possible compositions” database for the simulations section.
In a final validation stage, it is checked whether the proposed molecular formula, including
adducts, holds true for all labelling regimes.
Most of the code-handling is performed inside R. However, all computationally intensive
functions, such as finding the isotope pairs, correlating them to multiple labels and the
formula generation, were implemented in optimised C functions, so that the algorithm
runs quickly. Exact timings depend on computer specifications, the number of detected
peaks and the size of retention time and mass accuracy error windows, rtE and ppmE,
respectively. However, in most cases the process was faster than the peak detection of a
single sample, as performed by xcms in the first instance.
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IV.3.4. Optimisation and testing of the data reduction and formula
generation algorithm
This section aims to asses the algorithm’s performance to reduce data and generate molec-
ular formulae.
The algorithm consists of four subunits. Peak detection (1), data reduction (2), which is
based on correlating peaks across runs (3), and the final formula generation (with consider-
ation of multiple adducts) (4). For peak detection (1), the well-tested xcms [531] software
package [566, 141, 62] can be used and therefore does not require further attention. The
data reduction algorithm will be tested for its performance in how far it picks up all bi-
ological features, but does not discard them during the data reduction. Throughout the
process (3), the algorithm aligns features from different labelling regimes, which allows for
misalignments to occur. But as the user can check potential misalignments by inspecting
the check panels produced by the algorithm, as described in the previous section, addi-
tional validation is not necessary. Correct function of the molecular formula generation
with consideration of different adducts, will however, need to be tested.
The full E. coli dataset will be used for benchmarking and validation, to show that the algo-
rithms works irrespective of chromatographic (RP/HILIC) and electrospray (+/-) modes.
IV.3.4.1. Testing and optimising the data reduction algorithm
Under ideal circumstances, the reduction algorithm strips the data of all non-biological
noise and redundancy and retains all, and only the biological information.
The performance of any algorithm depends on the correct setting of its parameters. Thus,
these should be optimized for best performance. During the design of the algorithm, care
was taken not to make assumptions about the data and its parameters. However, two
do need to be estimated; the error windows in the retention time (rtE) and m/z (ppmE)
domain, which are used when matching the peaks of the different labelling regimes. If set
too narrow, peaks that actually belong together may not be connected, leading to false
negatives. If set too wide, unrelated peaks could be matched, increasing the number of
false positives. Determining the best trade off between those two errors, for example by
receiver operating characteristic (ROC) analysis [164], would require manual consideration
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and classification of every possible peak-pair under the use of different thresholds. As this
is not feasible, a similar, but more automatable approach was taken.
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Figure IV.10.: Optimising the retention time and m/z window during matching:
Both figures display the base ion peak (BIP) chromatogram of the
negative mode HILIC dataset. All peaks, which were identified to be of
biological origin by the algorithm, are highlighted in red. Figure IV.10a
uses a very narrow matching window (rtE = 0.5s, ppmE = 1), leading to
very few assignments. The more liberal settings (rtE = 10s, ppmE = 30)
in figure IV.10b lead to a very high number of ”biological” signals. - Also
false assignments when checked with the raw-data. Figure IV.11c shows
the chromatogram of the ideal threshold for the sample set (rtE = 2s,
ppmE = 10) in.
The rtE and ppmE parameters were systematically varied between 0.25 and 10 s and 1
and 30 ppm, respectively, to observe the impact on the algorithm performance. The base
ion peak (BIP) chromatogram’s peaks were taken as performance indicators and as repre-
sentatives for the whole sample set. This was done by visually highlighting the BIP peaks
flagged as biological at a given rtE/ppmE threshold. Figure IV.10a and IV.10b show the
outcome of a low and high threshold, respectively. At low values, no peak was detected.
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At very wide rtE/ppmE settings, non-biological peaks - as confirmed by manual checks
of the raw data - were included by the algorithm. Therefore, by manually comparing the
differently thresholded BIP chromatograms with the raw data, the optimal settings for
rtE/ppmE could be selected. The corresponding chromatograms of the ideal settings for
the different chromatographic and electrospray modes are displayed in figure IV.11.
Figure IV.11 shows a high amount of non-biological signal in the BIP chromatogram, which
provides a challenge for the algorithm. It could be asked, whether the BIP generally is a
good representation of all the peaks inside the sample set, and should therefore be used
to estimate global parameters. The BIP displays the most intense m/z bin of each scan.
However, as intensity information is not considered by the algorithm in any way, BIP sig-
nals should behave like lower intensity ones. Another analysis which considers all peaks
was used to confirm that the visual BIP method yields good rtE/ppmE thresholds. In
figure IV.12 the number of total C-N-S pair combinations is plotted against the integral of
the explained BIP area, at different thresholds.
In all four cases, the plot follows a similar pattern: an initial over proportional increase
of BIP area versus peak pairs, followed by a reversal of this trend. Little gain in BIP
area, but exponential increase in peak pairs. Even at the most liberal settings (rtE = 10s,
ppmE = 30), the assigned BIP areas did not equal the full BIP area, despite the high
number of C-N-S pairs. This indicates an explosion of false positive assignments at liberal
parameter values. Also, when inspecting the plots, it becomes apparent that the ideal
rtE/ppmE thresholds should be conservative, to avoid false positives.
After determining the ideal rtE and ppmE threshold for each dataset, the performance of
the algorithm to reduce the number of signals, down to non-redundant biological informa-
tion, was benchmarked. Table IV.8 shows the number of data points, at several stages of
the algorithm.
The first thing to note is the overall 99.9 % reduction efficiency of the algorithm. Three
stages of the algorithm show a particularly high performance: the use of probability based
elemental ratios, the use of multiple labelling regimes and the semi-automated quality
checks. The semi-automatic checks mostly eliminated biological features that were multi-
ply charged. Thus, this need for manual curation does not indicate poor performance of
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Figure IV.11.: Ideal rtE and ppmE settings for the four datasets:
Figure IV.11a ESI+ HILIC (rtE = 3s, ppmE = 6.
Figure IV.11c ESI- HILIC (rtE = 2s, ppmE = 10).
Figure IV.11b ESI+ RP (rtE = 1s, ppmE = 4).
Figure IV.11d ESI- RP (rtE = 1.5s, ppmE = 8).
All peaks highlighted in red are of confirmed biological origin. The rest is
unknown contamination.
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Figure IV.12.: Different rtE and ppmE settings for the four datasets:
Figure IV.12a ESI+ HILIC (rtE = 3s, ppmE = 6.
Figure IV.12c ESI- HILIC (rtE = 2s, ppmE = 10).
Figure IV.12b ESI+ RP (rtE = 1s, ppmE = 4).
Figure IV.12d ESI- RP (rtE = 1.5s, ppmE = 8).
Explained BIP area (red signal in figure IV.11) is plotted against the total
number of C-N-S combinations at a certain threshold. The same ppmE
and rtE values share the same shape and colour, respectively. Red lines
mark the level of the as ideal determined ppmE/rtE threshold.
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Chromatography HILIC HILIC RP RP
ESI polarity + - + -
Detected peaks None 402195 321285 283172 220553
C 363811 274112 263984 194935
N 367117 254474 252549 180861
S 379594 246736 265491 177409
CN 364628 250182 251459 152268
CNS 362284 241506 250764 139291
None - X Pairs C 1661761 1367959 351962 790943
N 1627267 1311641 339283 752872
S 1870273 1308926 448623 905909
None - X Pairs C 176550 118785 47273 63290
after elemental N 147716 99156 46762 54052
ratio S 106747 65539 51721 46705
Double Constraint C+N = CN 35215 7975 24018 9411
Triple Constraint CN+S = CNS 16322 7876 10388 12408
High Quality Pairs CNS 488 421 473 268
Reduction [%] 99.879 99.869 99.834 99.878
Table IV.8.: Reduction algorithms’s performance benchmark:
This table shows the number of data points at several stages of the reduction
algorithm for the four different datasets.
the algorithm, but rather the decision to exclude multiply charged molecules, such as pro-
teins or (E. coli cell wall) carbohydrates, from the analysis. All of these multiply charged
entities were identified by the charge indicator. The efficiency of the multiple labels shows
that their use is not only necessary for constraining the total formula space, but also for
drastically cutting down random combinatorial peak pairs, when using such an automated
analysis.
It is very interesting to see that the numbers of true biological peaks are quite similar,
for two completely different chromatographic modes (RP and HILIC) and positive and
negative ionisation modes. This shows that the algorithm is highly effective, regardless of
the chosen separation stage. The small number (<< 1000) of biological peaks is perhaps
disappointing, but agrees with other studies [31].
In the final step, the remaining features are used to see how many molecular compositions,
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i.e. actual metabolites, can be generated.
IV.3.4.2. Testing the annotation by the formula generator
Before it was used to annotate the biological features, the formula generator was tested to
see whether it could generate the unambiguous formula for a compound at 3 ppm accu-
racy, as predicted by the in silico experiments in section IV.3.1. To this end, 1000 random
molecules were sampled from the PubChem database. Carbon, nitrogen and sulphur atom-
counts as well as the monoisotopic mass (as denoted in the PubChem library) were passed
onto the formula generator, to complete the hydrogen, oxygen and phosphorus counts. In
all cases, those were correct: each time one and only one formula was generated. The aver-
age error between the database mass and the one generated by the formula generator was
2.3× 10−5 ppm with a standard deviation of 7.2× 10−4 ppm. These calculations, however,
were performed without taking adducts into account, as this would require assumptions
about the adduct distributions.
Chromatography HILIC HILIC RP RP
ESI polarity + - + -
High Quality Pairs 488 421 473 268
Possible compositions 2706 2566 1432 1685
After Isotope check 895 833 491 657
After Lewis check 676 817 383 644
Table IV.9.: Number of elemental compositions calculated for the test datasets:
The total number of possible compositions, under consideration of adducts
(table C3.3), is calculated from from the reduced datasets (table IV.8). It is
then checked whether the adduct-formula combination is in agreement with
the corresponding m/z values of the different labelling regimes. All
compositions are then subject to a Lewis octet rule check [344].
Table IV.9 shows the number of elemental compositions calculated for the four datasets.
In contrast to predictions, more than one possible formula per isotope pair was initially
calculated. This is due to two reasons. The empirically determined ideal ppm thresholds
had to be chosen slightly higher than the 3.7 ppm specified in the theoretical analysis in
section IV.3.1. Indeed, the dataset with the ppm cutoff closest to 3.7 ppm (RP+ with
4ppm) actually yielded fewer compositions than initial pairs, after all checks. However,
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another, possibly more significant reason, is the inclusion of adducts- 14 adducts for neg-
ative and 31 adducts for positive ionisation mode. Thus, every isotope pair results in a
several fold higher number of adduct/formula pairs that require to be resolved - something
not taken into account during the theoretical analysis. However, two filters were used to
reduce the number of adduct/formula pairs. It proved to be very effective to compare
whether those pairs were also supported by the other isotope label regimes. This reduced
the number of possible adduct/formulae pairs by two to three fold. Another filter is the
Lewis octet rule check [344], i.e. whether the molecular compositions have no unpaired
electrons. Molecules with unpaired electrons are radicals. Compared to other ionisation
processes, such as electron impact ionisation, radicals are unlikely to be formed during the
electrospray ionisation [619].
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Figure IV.13.: Adduct distributions in the test data sets:
Adducts assigned for the four datasets. HILIC+ (IV.13a), RR+ (IV.13b),
HILIC- (IV.13c) and HILIC- (IV.13d)
Figure IV.13 shows the post-filter list of adducts assigned during the formula generation
step. Many fewer adducts than theoretically possible were assigned, demonstrating the
high specificity of the assignment and filters. Indeed, the assigned adducts are highly
plausible. As expected, the M+H and M-H ions were (nearly) always the most abundant,
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followed by alkali and modifier salt adducts. Also, the charge indicator and filters seem to
have been effective, as not a single multiply charged ion adduct was assigned. In negative
mode, the water loss (-19 m/z) was slightly more frequent than the (-1 m/z) M-H adduct,
although (when compared to related studies) it should be much more rare. In nearly all
instances, where an adduct/formula pair with water loss (M-H2O-H) was assigned, a for-
mula with M-H was also assigned, but with loss of −H2O. This makes sense but cannot be
circumvented, as the formula generator cannot discriminate between a H2O lighter formula
and a water loss. Thus, if one had to decide between the M-H adduct and H2O loss, M-H
may be a more probable choice. The same problem could apply to any adduct, which is
cause by loss or aggregation of CHNOPS elements. Even though less adducts than the-
oretically allowed were detected by the algorithm, figure IV.13d clearly shows that using
just the M+/-H adduct or only 3 different adducts per mode, as done by all other studies
[234, 196, 31, 194], is not enough and will lead to misassignments or unassigned peaks.
To examine the molecular formulae assigned to the isotope pairs, rt-mz heat maps of the
atom-counts were produced (HILIC ESI+ IV.14, reversed phase ESI+ (IV.15), HILIC ESI-
IV.16, reversed phase ESI- (IV.17)). For formulae with multiple adduct assignments, the
M+H, M-H ions were preferred. In the few cases of multiple formulae assignments, the
one with the lowest ppm values (across all labelling regimes) was chosen.
Firstly, the high efficiency of the algorithm should be noted. It identifies non-redundant
biological peaks from a huge background of potential detected peaks. Even though those
features continue beyond 1 kDa, the metabolite candidates are almost exclusively below
that value. This shows that the ”untargeted analysis of biomolecules below one kDa” [246]
is a fairly good definition of metabolomics. It can also be seen that similar atom-counts
cluster, rather than being randomly arranged across the RT × m/z domain. This is true for
the atom-counts of the directly determined elements (C/N/S), but also for the calculated
ones (H/O/P), demonstrating that the data extraction and formula generation algorithm
both deliver plausible results. Indeed, the incidents of extreme atom-counts, such as the
occurrence of 10+ phosphorus atoms per molecule are very rare - albeit not implausible,
as element probability ratios were used during molecular formula generation. The bulk of
the molecules, though, are highly plausible.
Both chromatographic modes showed their expected behaviours. HILIC had very few
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(a) (b)
(c) (d)
(e) (f)
Figure IV.14.: Molecular formulae of HILIC ESI+:
RT vz m/z plots with atom-counts for C (IV.14a), H (IV.14b), N (IV.14c),
O (IV.14d), P (IV.14f, S (IV.14e). All (non-reduced) detected peaks are in
grey.
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(a) (b)
(c) (d)
(e) (f)
Figure IV.15.: Molecular formulae of reversed phase ESI+:
RT vz m/z plots with atom-counts for C (IV.15a), H (IV.15b), N (IV.15c),
O (IV.15d), P (IV.15f, S (IV.15e). All (non-reduced) detected peaks are in
grey.
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(a) (b)
(c) (d)
(e) (f)
Figure IV.16.: Molecular formulae of HILIC ESI-:
RT vz m/z plots with atom-counts for C (IV.16a), H (IV.16b), N (IV.16c),
O (IV.16d), P (IV.16f, S (IV.16e). All (non-reduced) detected peaks are in
grey.
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(a) (b)
(c) (d)
(e) (f)
Figure IV.17.: Molecular formulae of reversed phase ESI-:
RT vz m/z plots with atom-counts for C (IV.17a), H (IV.17b), N (IV.17c),
O (IV.17d), P (IV.17f, S (IV.17e). All (non-reduced) detected peaks are in
grey.
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void volume eluting molecules, compared to reversed phase. In HILIC, small (low carbon
count) molecules eluted throughout the whole run, until late. In reversed phase, only car-
bon counts above 15 eluted after 10 min, showing many lipids, including phospholipids, as
can be clearly seen from the nitrogen and phosphorus atom-counts. In HILIC, most sul-
phur containing compounds eluted late, i.e. they were rather polar, compared to reversed
phase where they eluted early. Interestingly, the molecules eluting at the void volume in
RP are a mix of low and high molecular weight compounds. However, most of the heavier
ones also showed signs of high polarity, such as high nitrogen counts, particularly in ESI+,
thus explaining their early elution despite high molecular weight.
When comparing positive and negative modes, compounds that have the same atom-counts,
retention time and similar molecular weight, i.e. the same compound ionising in both
modes, can be found. However, plenty of compounds are unique to a single mode, high-
lighting the value of running both modes.
It is not useful to compare the number of generated formulae with those reported in other
isotope based annotation literature, as most of them use Arabidopsis thaliana samples and a
different analytical setup. Baran et al.[31] though, used carbon and nitrogen constraints to
annotate the metabolites of the cyanobacterium Synechococcus sp. PCC 7002 by reversed
phase chromatography. They were able to generate 82 unique compositions, of which they
could confirm 58 by fragmentation studies. 26 of the compositions though, were neither
contained in KEGG [450], nor the MetaCyc [476] database. Even more relevant is the
work of van der Werf et al.[588]. They tried to assign as many compounds as possible from
E. coli extracts, on GC-MS and LC-MS, using authentic standards. Overall, they were
able to assign 176 metabolites, leaving 255 unknowns. In reversed phase, they were able
to annotate 21 out of the 50 detected peaks, and in HILIC, 37 of the 87 compounds. This
is far less than the number of peaks with empirical formulae annotated in the four E. coli
datasets of this chapter.
As this thesis is more concerned with C. elegans rather than its food source, E. coli, no in-
depth analyses of the molecular compositions, e.g. database queries, were conducted. The
E. coli data were for algorithm test purposes only, as the corresponding C. elegans datasets
were of insufficient quality. Nevertheless, some ad hoc checks on individual molecular
compositions were performed. Several database matches were found to metabolites that
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are highly specific to bacteria and E. coli in particular. Those include enterobactin (RP-;
350 s; 668.14 Da) and deoxythymidine diphosphate (dTDP)-l-rhamnose (RP-; 91 s; 547.07
Da), which are E. coli iron scavengers (siderophor) [449] and precursors of E. coli virulence
factors [436, 138], respectively.
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IV.4. Conclusion
Two major current challenges of untargeted LC-MS metabolite analysis were addressed in
this chapter, both via stable isotope enrichment of the sample: reduction of large datasets
to non-redundant, biologically relevant features, and the annotation of their molecular
composition.
Simulations showed that by constraining the carbon, nitrogen and sulphur-count, unam-
biguous formulae up to 1 kDa can be calculated ab initio with current ToF mass accuracy.
The final, fully automated algorithm was able to reduce datasets by over 99.9 % and gen-
erated highly plausible molecular compositions for the remaining 0.1 % peaks.
This method can be used for many applications. An exhaustive metabolite characterisa-
tion of a new biological matrix, if it can be isotope enriched, is the most obvious example.
However, it may also be useful for samples that cannot be isotopically labelled, such as
urine or plasma. As a large subset of (central carbon and lipid) metabolites is shared be-
tween species, a characterised extract could be spiked into urine or plasma, thus providing
a cheap and comprehensive standard mixture of isotopically labelled standards for quan-
tification, including many compounds which are not commercially available. This method
is also useful for analytical method development. By determining which features are of
biological origin, a chromatographic method can be optimised to resolve these, rather than
a TIC/BIP full of unknown features, as is often the case.
The approach developed here will be used in the next chapter, the C. elegans longevity-
mutant screen. Metabolomics is usually defined as completely untargeted profiling. How-
ever, as shown, most information acquired and compared via means of multivariate anal-
yses, is redundant and not even biological. Hence, using only peaks identified to be of
biological origin should allow for better data handling and improved statistics, yielding
higher quality, and most importantly, relevant models.
V.. A metabolic model of longevity in
C. elegans
Aims and Ojectives:
• Find and annotate C. elegans metabolites using the workflow from
chapter IV.
• Match C. elegans metabolites to longevity-mutant profiling experiment
• Find a common metabolic signature of longevity
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V.1. Introduction
V.1.1. Motivation
This thesis’ aim is to develop analytical and computational approaches that help under-
stand the metabolic basis of pathways that determine life expectancy in the model organism
C. elegans.
In chapter III.4, a dataset comparing mitochondrial mutations, which lead to increased or
shorted life expectancy, was analysed using a newly-developed GC-MS workflow. However,
this dataset contained only two different life expectancy extending mutations from one sin-
gle mode of lifespan extension. So far, using whole genome RNAi screens [224, 227, 439],
over 400 [415, 651] C. elegans genes have been discovered that modulate the rate of ageing
and lead to a long-lived phenotype. These genes belong to various different signalling path-
ways, with a large proportion of the genes and pathways having human homologues [522].
Furthermore, many of these pathways are closely tied to an organism’s core metabolic
functions, such as lipogenesis or carbohydrate and amino acid metabolism. Two studies
(published while the experiments described in this thesis were ongoing) have reported dis-
tinct metabolic signatures for two of the major pathways leading to lifespan extension in C.
elegans: the insulin like signalling (ILS) pathway [183] and the mitochondrial respiration
pathway [75], which was also analysed in chapter III.4.
However, many more pathways involved in lifespan regulation remain to be investigated.
There has been surprisingly little experimental effort to compare all these different path-
ways to yield a more holistic picture - as might have been expected in the age of systems
biology, especially given that more and more evidence emerges how many of those life-
extending signalling pathways are either directly co-regulated, linked by core metabolic
processes, or share common effector mechanisms [634, 437, 524, 653, 255]. Therefore, in
this chapter, the metabolic signature of a diverse array of 24 different long-lived mutant
strains will be determined. This will allow the creation of cross-pathway models, to deter-
mine global factors related to ageing and longevity in C. elegans.
The samples will be analysed by latest generation high resolution LC-MS instrumentation.
As shown in the last chapter (IV.), the major share of peaks in LC-MS metabolomics data
may actually not be biologically relevant at all, or else redundant in some way (isotope or
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adduct peaks). Therefore, the mutant screen will be analysed in a semi-targeted manner,
with only features identified to be of biological origin used for analysis. Annotating peaks
with molecular compositions may yield chemical or even metabolic pathway information
about a feature, allowing for greater biological understanding.
V.1.2. Selection of long-lived mutant strains
Firstly, the genes to be analysed in the mutant screen need to be selected. In principle,
there are three major levers to modulate life expectancy and the ageing process in C.
elegans: genetic, pharmacological or environmental [456, 107, 210, 488]. Genetic interven-
tion can either be permanent, by introduction of a loss of function mutation in an allele,
or temporary, by silencing a gene using RNAi [294]. Environmental interventions, how-
ever, are difficult to control [385], with non-optimised conditions often yielding negative
results. Furthermore, they are rarely specific, impacting various, often unknown, physio-
logical functions, which would make comparison of different interventions difficult. Phar-
macological interventions may also give a complex response, and also depend on dose and
bioavailability is non-trivial for worms as many drugs have very poor cuticular penetration.
Gene silencing by RNAi can easily be performed by feeding bacteria which express the
required siRNA sequence. An advantage of using RNAi is that the time of silencing can be
timed. Thus, life-extending genes that are essential for development [121], such as target
of rapamycin (TOR), can be knocked down in adult worms. In order to confirm a gene’s
successful knockdown, either its expression or loss of function would have to be probed,
using molecular methods, such as gel electrophoresis and PCR, or a longevity assay, re-
spectively. However, both methods were not feasible within the scope and resources of this
project.
For those reasons, it was decided to focus on mutants. A list of all selected strains is given
in figure V.1. The criteria for inclusion were that the mutant strains had to be available
from the CGC, and must have lifespan extension documented in a peer-reviewed publica-
tion. The list contains extremely well characterized genes (e.g. daf-2 ), but also some which
have been much less investigated. This provides a chance to make use of metabolomics
as a tool for functional genomics [485] and potentially shed more light into a gene’s mode
of action. For some pathways, knockouts of different proteins of the same pathway were
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selected. The function of all the selected genes will be discussed in the next section, which
reviews the different mechanisms of genetic control of ageing in C. elegans.
V.1.3. Longevity promoting genes in C. elegans
This section discusses different mechanisms which control ageing and life expectancy in C.
elegans, with respect to the genes that will be analysed in the mutant screen. If possible,
they will be classified into categories. Also, if known, links between the regulatory gene
network and the metabolites themselves will be discussed.
V.1.3.1. Insulin like signalling (ILS)
The first discovered [182, 310] and best characterised pathway that governs lifespan in
C. elegans is the insulin like signalling (ILS) pathway, shown in figure V.1. Just like in
humans, insulin secretion is triggered upon the presence of food. Unlike humans, C. el-
egans expresses over 40 different insulin-like peptides, which may agonize or antagonize
the insulin-like growth factor 1 (IGF-1) receptor [480], more generally known as the DAF-
2 receptor in the ageing literature [317]. Upon activation, this transmembrane receptor
tyrosine kinase triggers a complex phosphorylation signalling cascade, which ultimately
inhibits DAF-16; a main hub of longevity [653]. This signalling cascade works via the
insulin receptor substrate IST-1 [635] and AGE-1, the C. elegans ortholog of a phospho-
inositide 3-kinase (PI3K) catalytic subunit [182], with AAP-1 as adaptor protein [635].
AGE-1 converts the second messenger PIP2 (phosphatidylinositol biphosphate) to PIP3
(phosphatidylinositol triphosphate) [423], which results in the activation of PDK-1, a 3-
phosphoinositide-dependent kinase [462]. The phosphatase and tensin homolog (PTEN)
catalyses the reverse reaction [452]. PDK-1 actives the serine/threonine kinases AKT-1,
AKT-2 [463] and SGK-1 [241] by phosphorylation. Each of them, independently, may
phosphorylate the forkhead box (FOXO) transcription factor, DAF-16 [368, 453], which
then becomes inactive and shuttles from the nucleus to the cytosol, with the help of 14-3-3
proteins [81].
If the activity of DAF-2 or any of the proteins in the ILS cascade is reduced, either by
KO mutation or RNAi knockdown, DAF-16 returns to the nucleus and becomes active.
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Figure V.1.: Pathways of lifespan regulation in C. elegans:
All pathway data has been collated from literature. The C. elegans protein
and the corresponding human homologue/orthologue are given
[568, 522, 654]. For details, please refer to section V.1.3
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It transcribes a whole array of genes [432, 354, 400, 519], which lead to a long-lived phe-
notype [238]. Depending on the mutated allele and severity of mutation, and therefore
residual ILS activity, the lifespan extension may be up to 100 %, effectively doubling the
worm’s lifespan. This phenotype, however, is completely suppressed by DAF-16 knock-
out, indicating that DAF-16-modulated gene expression is wholly responsible for the ILS
lifespan extension: the downstream genes of DAF-16 are key players in lifespan regulation,
development, stress resistance, reproduction, and metabolism [432, 354, 400, 519].
Like any other protein, DAF-16 undergoes proteasomal degradation. RLE-1 is an E3
ubiquitin ligase, which catalyses DAF-16 polyubiquitination and subsequent degradation.
Unsurprisingly, if RLE-1 function and therefore degradation is impaired, worms live longer
[362].
As the ILS pathway is highly conserved, genes involved in the ILS cascade, have homologues
in D. rosophila and even mammals, like mice or humans [437]. In drosophila [102, 565]
and mice [247, 53] knockout of the IGF-1 receptor or downstream components also leads
to an increased lifespan. Demographic studies in humans have connected single nucleotide
polymorphisms (SNP) in FOXO3A, the human homologue of DAF-16 [653], to human
longevity [662].
One of the DAF-16 downstream targets is the triglyceride lipase LIPL-4, which cleaves
triglycerides. It was shown that upon disruption of the ILS pathway LIPL-4 is overex-
pressed and promotes DAF-16’s longevity phenotype [608]. DAF-2 knockout worms even
showed a decreased total triglyceride content. Recently, it was discovered that lipolysis
works via mechanisms of autophagy [526], including in C. elegans[458]. Indeed, LIPL-4
based lifespan extension requires the induction of autophagy [345], which is mediated by
the TOR pathway.
V.1.3.2. Protein Turnover, autophagy and dietary restriction mediated by target of
rapamycin (TOR)
Another pathway, which is closely linked to insulin like signalling, is the Target of Ra-
pamycin (TOR) pathway [298, 348]. TOR divides into two protein complexes, with dis-
tinct functions: TOR complex 1 (TORC1) and TOR complex 2 (TORC2). TORC1 is
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a key hub for growth and nutrient sensing, integration of these signals and initiation of
many response mechanisms, centred around cell growth. For example, it can sense amino
acid concentrations via the RAG GTPase [508]. TORC2, which has been characterised to
a far lesser extent, is insensitive to nutrient status, but regulates cell shape by signalling
to the cytoskeleton. Over the last few years, TOR has also been identified as a major
determinant of ageing [398] and age related disease [286]. Even though TOR, like ILS, is
a very conserved pathway, there are species differences. Some key components of mam-
malian or even drosophila TOR do not have C. elegans homologues [286]. Thus, care must
be taken when comparing TOR-related studies performed with other species. Therefore,
mechanisms explained in this section will be restricted to the current knowledge of the C.
elegans TOR (ceTOR) signalling network.
In 2003 Vellai et al.[596] reported that reduction of ceTOR activity by post-larval RNAi
knockdown (knockout mutations lead to developmental arrest) increased lifespan. Other
studies followed [282, 228, 523, 250]. They generally knocked down LET-363, the common
protein of ceTORC1 and ceTORC2. This led to inconsistent results regarding which of the
two TOR complexes increased lifespan, and whether DAF-16 is required for this increase.
Very recently, a study [497] selectively silenced Raptor (DAF-15) and Rictor (RICT-1),
proteins specific to ceTORC1 and ceTORC2, respectively. They showed that ceTORC1
silencing leads to a DAF-16-dependent increase in longevity, by activating DAF-16 and its
downstream genes. Longevity induced by reduction of ceTORC2 activity, however, was
independent of DAF-16, but dependent on and mediated by SKN-1. SKN-1 is orthologous
to the mammalian Nrf (Nuclear factor-erythroid-related factor). Nevertheless, ceTORC2
can still undergo cross-talk with DAF-16, by activating AKT1/2 and SKG-1.
Also highly interesting is the lifespan extension associated with ceTORC downstream tar-
gets, particularly for ceTORC1. One of ceTORC1’s main effector mechanisms is modu-
lating the rate of protein biosynthesis. This is done by direct activation of RSKS-1, a
ribosomal protein S6 kinase (S6K) and IFE-2, a translation initiation factor. Knockout of
either [557, 228], leads to an increased life-span, independent of DAF-16. RSKS-1 controls
a series of downstream targets from different pathways, which also modulate ageing. By
inhibiting the insulin receptor substrate, it even interferes with ILS. RSKS-1 also inhibits
PHA-4, a FoxA transcription factor. In fact, RSKS-1 knockout dependent longevity even
requires PHA-4, but knockdown of PHA-4 itself decreases lifespan. [523]
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PHA-4 itself is also a crucial regulator of lifespan. A mutation in the EAT-2 protein,
which corresponds to a ligand gated ion channel subunit, closely related to the non-alpha-
subunits of nicotinic acetylcholine receptors, also increases lifespan [342]. This effect is
PHA-4 dependent [461], and DAF-16 independent. The EAT-2 mutation disturbs pharyn-
geal pumping and limits food intake, therefore mimicking dietary restriction (DR). The
effects of DR were first discovered in rats in the 1930s [397]: reducing caloric intake with-
out malnutrition extends lifespan and decreases age-related diseases. This effect has been
repeatedly reproduced in many organisms, such as yeast [369] and drosophila [481]. In-
creased long term survival has yet to be shown for humans. However, as very recently
reported, it has a positive effect on ageing, as tissue samples of dietary restricted patients
show transcription profiles similar to the ones of younger controls [411]. Furthermore, 6
years of DR can already significantly reduce the risk for atherosclerosis [179]. In C. elegans
DR can be induced in various ways, such as dilution of the bacterial food source [385],
intermittent feeding [250], complete removal of food [292], and drugs [478] or mutations
which mimic DR, such as EAT-2. DR regimes in C. elegans extend lifespan by increasing
autophagy [283, 225], which is mediated by downstream targets of PHA-4 [461].
Autophagy is a major catabolic mechanism, which degrades unnecessary and dysfunctional
components of a cell. During autophagy, the phagophore expands into a double-membrane
autophagosome. It surrounds cell components, such as proteins, lipid droplets [526] and
even whole organelles, such as mitochondria, which are to be degraded. After encapsula-
tion, the autophagosome fuses with a acidic lysosome filled with hydrolytic enzymes. After
the resulting autolysosome contents are degraded, the basic building blocks, such as amino
and fatty acids, are released into the cytoplasm [330, 7]. Thus, in times of scarce resources,
such as dietary restriction, autophagy provides a way of recycling basic biomolecular build-
ing blocks and also providing energetic substrates. Unsurprisingly, not only DR requires
autophagy for lifespan extension, but also longevity derived from ceTORC inhibition [225].
Interestingly, however, longevity induced by downregulation of protein biosynthesis, such
as IFE-2 or RSKS-1 knockdown, does not require autophagy [460, 225]. Even more in-
triguingly, ILS-mediated longevity and the long term diapause of the dauer larva do require
autophagy in addition to DAF-16 activation [410]. This shows that much remains to be
elucidated regarding the exact interplay of longevity pathways and effector mechanisms.
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V.1.3.3. Sirtuins (SIR)
Sirtuins are a family of highly conserved nicotinamide adenine dinucleotide (NAD+)-
dependent deacetylases [270]. They were first discovered in yeast and shown to have an
impact on ageing [291]. Shortly after, it was demonstrated that overexpression of SIR2
and SIR-2.1, in C. elegans[571] and drosophila [502], respectively, extends lifespan.
Recently, these findings have come under scrutiny. Several labs jointly showed that the
apparent longevity effects of the drosophila study were due to improper choice of controls.
The lifespan increase reported for C. elegans may be due to a second, unrelated mutation
that was accidentally induced into the C. elegans SIR-2.1 overexpression mutant, together
with the sir-2.1 vector [73]. However, the two studies have been rescued by the use of
proper controls [30] and a clean, outcrossed sir-2.1 overexpression mutant [602]. Even
though the clean strain is still long-lived, the absolute lifespan extension is less than ini-
tially reported. An eight times outcrossed sir-2.1 overexpression strain will be used for
the current study. However, rol-6, a collagen mutation that gives a dumpy phenotype, was
used as transformation marker, i.e. to select transgenic lines where sir-2.1 was successfully
inserted. Therefore a rol-6 mutant must be used as control, rather than the regular N2
wild type strain.
Recently, the mechanism by which SIR-2.1 extends lifespan in C. elegans was reported.
SIR-2.1 inhibits host cell factor HCF-1, which itself inhibits DAF-16 [495]. Thus, by in-
hibiting the inhibitor, a higher SIR-2.1 activity activates DAF-16. SIR-2.1 is activated by
a low NAD+ : NADH ratio, so it is a sensor of a cell’s redox state. It is directly linked to
citric cycle and mitochondrial (respiratory chain) activity, which also determine the rate
of ageing, as will be discussed in section V.1.3.6.
Seven different sirtuins have been described in mammals, serving different functions, cen-
tred around various core metabolic and energetic pathways [90]. Very recently, a lifespan
extension in Sirt6 overexpressing male mice was demonstrated [297]. This is exciting news,
given that sirtuins can also be activated via drugs, such as resveratrol, a natural phenol
found in red wine [257]. However, it is not yet clear whether these effects will be repro-
ducible in humans [363, 658].
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V.1.3.4. c-Jun N-terminal kinases (JNK)
c-Jun N-terminal kinases (JNK) are a highly conserved subfamily of mitogen-activated
protein (MAP) kinases. They mediate cytoprotective responses to various forms of en-
vironmental stress, such as heat, inflammation, oxidative stress, ionising radiation and
reactive oxygen species (ROS) [552, 631]. However, if overexpressed, JNK-1 increases
C. elegans[454] and drosophila [607] lifespan. In C. elegans, this is promoted by DAF-16
activation, by phosphorylation of sites different from the ILS pathway activation sites [454].
Like sir-2.1,ink-1, which will be analysed in the mutant screen, is an overexpression mu-
tant, that has the rol-6 gene as a transformation marker. Thus, it will also use the rol-6
mutant as control, rather than wild type.
No major studies on JNK lifespan extension in mammals have yet been reported.
V.1.3.5. Hypoxia-induced factor (HIF-1)
The hypoxia-induced factor HIF-1 is required for survival at hypoxic conditions. In low
oxygen conditions, C. elegans has an increased lifespan [248], which is dependent on HIF-
1 and DAF-16 [408, 357]. Until recently, the role of HIF-1 during normoxic conditions
has been unclear, with four different groups reporting either increased and or decreased
lifespan upon hif-1 knockout [92, 664, 408, 429]. Leiser et al.[356] were able to resolve
this ambiguity, by showing that C. elegans hif-1 -related lifespan depends on tempera-
ture. At low temperatures (15°C), it is short lived, but at high temperatures (25°C), it
has a significantly increased lifespan (compared to control). At the most commonly used
temperature (20°C), which will also be used to analyse HIF-1 knockout mutants in this
experiment, it is slightly long-lived. The increased lifespan is DAF-16 dependent [664, 356].
Interestingly, HIF-1 activation, for example by hif-1 overexpression, also increases lifespan;
this effect is even dose-dependent [664]. As discussed in III.4.3.2, hif-1 activity can also be
increased by deletion of the orthologue of the von Hippel-Landau tumor suppressor vhl-1,
which is responsible for HIF-1 degradation. Longevity by HIF-1 activation, however, is
DAF-16 independent. Instead, as discussed before (III.4.3.2), it seems to be mediated by
the mitochondrial unfolded protein response (UPRmt) [352] and therefore closely linked to
mitochondrial mutations which increase longevity.
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V.1.3.6. Mitochondria
Mitochondria produce a cell’s energy by ATP regeneration through the electron transfer
chain (ETC). The ETC are five protein complexes (I-V), with the first four building up a
proton gradient across the inner membrane, which is then used to power an ATP synthase
- complex V. RNAi screens have identified many ETC complex genes that increase lifespan
when knocked down [351]. In fact, silencing of subunits from all complexes can extend
lifespan, except for complex II - most probably because complex II also functions as the
succinate dehydrogenase in the TCA cycle [261]. However, there a few key genes have been
described in greater detail and will be included in the mutant screen.
clk-1 encodes a hydroxylase, required for the biosynthesis of ubiquinone (coenzyme Q, Q9)
[341].
nuo-6 encodes for a subunit of the mitochondrial NADH dehydrogenase (ubiquinone) in
complex I [649].
isp-1 expresses the Rieske iron sulphur protein (ISP), a subunit of complex III [169].
All these mutations also show slowed embryonic development and behaviour [636, 166],
potentially supporting the ”rate of living” theory of ageing [470]. This theory proposes
an indirect correlation between metabolic rate and lifespan, i.e. the higher the metabolic
rate, the lower the life expectancy. However, loss of a ctb-1 (cytochrome b protein) allele
suppresses the slow phenotype of the isp-1 mutation, without compromising its lifespan
extension. Thus, a slow metabolic rate, or reduced ATP generation, is not a necessary
requirement for lifespan extension [137]. To examine uncoupling of these two effects, an
isp-1;ctb-1 double mutation will be analysed as well as the isp-1 mutation.
There is increasing evidence that mitochondrial longevity is not mediated by simple slowing
of physiological processes, but rather controlled by a sophisticated signalling network with
different effector mechanisms. The exact mechanisms behind this, however, are far from
being understood. The mode of lifespan extension induced by mutation, is different than
the one by RNAi [649]. Mitochondrial mutations, but not RNAi, do not depend on au-
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tophagy and other dietary restriction responses. There is also evidence that mitochondrial
mutant longevity is somehow linked to ILS longevity, as the daf-16;isp-1 double knockout
is significantly shorter lived than isp-1 itself, but still much longer than wild type [169].
Also both, isp-1 [169] and clk-1 [341] can increase daf-2 KO lifespan, but this effect is not
fully additive. Thus, as there seems to be a partial ILS involvement, a daf-2;clk-1 double
mutant will be analysed.
As already discussed in III.4.3.2, mitochondrial mutants require HIF-1 for lifespan exten-
sion [352] and also the induction of the mitochondrial endoplasmatic reticulum response
[147, 92] (UPRmt). In fact, in III.4.3.2 it was argued, that both could actually be linked
via 2-hydroxyglutarate. However, Hwang et al.[268] argued that the retrograde longevity
signal from the mitochondria could be in part mediated by reactive oxygen species (ROS).
V.1.3.7. Super oxide dismutase (SOD) and reactive oxygen species (ROS)
Reactive oxygen species (ROS) were proposed to be involved in ageing as early as 1956, by
Denham Harman’s ”free radical theory of aging” [230]. Free radicals, such as superoxide
(O−2 ), and other ROS, such as H2O2, cause oxidative damage to biomolecules. They can
lead to genetic mutation by DNA cross-linking, oxidation of polyunsaturated fatty acids
in lipids (lipid peroxidation), oxidation of protein-bound amino acids (protein carbonyla-
tion) [538] and inactivation of enzymes, by coenzyme oxidation. According to this theory
oxidative damage will eventually lead to diseases, such as cancer, and macroscopic effects,
such as skin wrinkles. [174, 537]
In opposition to this, the long-lived mitochondrial mutants (clk-1, isp-1, nuo-6 ) [352, 648]
and the insulin-like-signalling mutant daf-2 [66] have increased levels of superoxide com-
pared to wild type. Furthermore, several treatments that slightly increase superoxide levels
also increase lifespan [518, 235]. In fact, increased superoxide levels are required for the
lifespan extension, as the lifespan extension can actually be abrogated by the supplemen-
tation of ROS scavenging antioxidants, such as N-acetyl-cysteine or vitamin C [518, 648].
These observations have led to a new understanding of the role of ROS and support the
theory of mitochondrial hormesis (mitohormesis) [494]. Hormesis describes the beneficial
effect of a toxin in small doses, which in high doses is detrimental. This theory goes back to
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the 19th century, to the Arndt-Schulz rule or Friedrich Nietzsche’s dictum ”That which does
not kill us makes us stronger”. Thus, small doses of ROS appear to be beneficial, whereas
high doses lead to damage, accelerated ageing and premature death [189, 494, 236]. The
molecular mechanisms, i.e. how ROS triggers signalling pathways, which lead to anti-
ageing and longevity-ensuring effector mechanisms, are yet to be elucidated [268, 28].
Physiologically, the superoxide radical (O−2 ) is recycled by superoxide dismutase (SOD)
enzymes. These metalloenzymes catalyse the reaction of superoxide (O−2 ) to molecular
oxygen (O2) and hydrogen peroxide (H2O2). The reactive peroxide is then converted
into water and oxygen by enzymes such as catalase (CAT) and glutathione reductase
(GPx). C. elegans has five SOD isoforms, with different expression levels, cytoplasmic or
mitochondrial localisation and even different metals as coenzymes. Whether sod deletion
or overexpression can lead to decreased or increased lifespan in C. elegans is still very
controversial [139, 190]. However, it was recently shown that all five SODs can be knocked
down without affecting normal lifespan, but increasing susceptibility to external stress
[591]. VanRaamsdonk et al.[589] showed that knockout mutation of the mitochondrial
manganese SOD-2, but not any other SOD, leads to increased lifespan. This result is in
contrast to Doonan et al.[139], who did not report lifespan extension by any SOD knockout.
To investigate how SOD is related to other lifespan extending genes, the sod-2 KO strain
used by VanRaamsdonk et al. will be analysed.
V.1.3.8. Fertility and germline cell signalling (GCS)
Removing C. elegans’s germ line stem cells, for example by micro laser beam surgery, in-
creases their life expectancy by 60 %. However, when the whole gonad is removed, this
effect is abolished [258]. In both cases, this leads to sterility. This is a strong argument
against ageing theories, such as the life history theory [620], which see reproduction and
lifespan as a tradeoff due to a limited amount of resources.
Germ-cell loss may also be mimicked by mutations which lead to a temperaturedependent
reduction of progeny, and result in an increased lifespan. Two different mutations that lead
to a germ-cell induced longevity, will be analysed. spe-26 encodes a Kelch motif-containing
protein, which is required for spermatogenesis [592]. Loss of function increases lifespan at
20°C [431]. Animals show a reduced fertility at 16°C, but zero fertility at 25°C. 20°C, how-
ever, as used in the current study, produced enough progeny for sample generation. glp-1
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encodes for a transmembrane protein, which acts as a receptor that is required during mi-
totic germ cell proliferation. Its loss shows a similar behaviour with regards to reproductive
capacity and lifespan as spe-26 [21]. The lifespan extension of both mutants is DAF-16
dependent. However, double mutants have normal lifespan, despite still having reduced
fecundity [431]. Again, this shows that the lifespan extension is more due to complex
molecular signalling rather than a simple resource tradeoff [358]. Indeed, additionally to
DAF-16, a whole signalling cascade centred around the steroid hormone receptor DAF-12 (a
homologue of the human vitamin D receptor) is required [647]. Similar to ILS longevity, the
expression of LIPL-4 is required for germ cell signalling (GCS) induced longevity [609, 345].
Even though it is tempting to think that ILS and GCS longevity responses simply con-
verge at the level of DAF-16, this is not the whole story. Both effects are synergistic.
DAF-2 suppressed worms which also have ablated germ cells are extremely long lived and
healthy, with a more than 5 fold increased life expectancy [22]. Therefore, there may be
a parallel mechanism which mediates longevity. Indeed, compared to ILS longevity, where
autophagy seems to be optional, it is necessary for GCS longevity [345]. Thus, PHA-
4/FOXA and possible other elements of the TOR signalling pathway are also required.
Indeed, TOR knockdown does not increase glp-1 mutant lifespan, suggesting a common
effector mechanism and a (signalling based) link between reproduction and nutrient status.
V.1.3.9. Sensory perception and neuronal control
All pathways discussed above are triggered by biomolecules, such as nutrients, or physico-
chemical conditions, like oxygen levels. Thus, they require sensory input. Over 100 years
ago, Ivan Pavlov showed [469] that sensory cues and perception may suffice to trigger
physiological mechanisms. In humans, for example, the anticipation of food, as mediated
by the taste of a non-caloric sweetener, can trigger insulin release [575]. In C. elegans the
odour of food (E. coli) can trigger ILS mechanisms and thereby influence lifespan [532].
Therefore, it is important to understand the mechanisms of how environmental cues are
perceived and neuronally integrated to affect bimolecular pathways; with respect to ageing
in particular [569].
Several genes encoding for sensory receptors [19] and neurons [8] increase lifespan when
downregulated. Generally, compared to other genes discussed above, their signalling cas-
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cades and effect on metabolism is poorly understood. No sensory mutants have yet been
analysed using metabolomic approaches. C. elegans has 302 neurons, with 60 responsible
for chemosensation and 60 for mechanosensensation. For the actual sensing, those neu-
rons express cilia, which are microtubule based subcellular organelles. They emanate from
the cell surface and may have multiple sensory receptors. It is estimated that C. elegans
has around 500 distinctive sensory receptors, most of them G protein-coupled receptors
(GPCR), that trigger ion channels, such as cGMP-gated channels [280, 271, 370].
Many of the life-extending mutations are in proteins [19], which participate in the intraflag-
ellar transport (IFT), a bisectional transport system, along microtubuli. IFT is required
for cilia formation and maintenance. The following mutations encode IFT components in
cilia of chemosensory neurons. osm-3 encodes for a kinesin motor protein. osm-5 and
osm-6 encode proteins with human orthologues, required for morphology of chemosensory
neurons and IFT. che-3 : encodes a dynein heavy chain required for IFT [654]. All these
mutants have deficient chemotaxis, and neither can they perceive odour. They also do not
show the usual carbon dioxide avoidance of C. elegans[221].
ifta-2 encodes a homologue of the mammalian Rab-like 5 protein and is involved in IFT.
However, compared to knockouts of other IFT proteins, cilia do assemble normally and
worms do not show altered chemotactic behaviour, despite being long-lived [516].
tax-4 encodes a cyclic nucleotide-gated channel subunit, expressed in sensory neurons and
is required for signal transduction. Its loss of function shows a very similar phenotype to
the OSM mutants. [19]
egl-4 expresses a cyclic GMP-dependent protein kinase [243], which appears to act through
the TGF-beta signalling pathway. Interestingly, egl-4 is downstream of many osm and che
genes and plays a role in various core physiological processes, such as dauer formation,
growth and egg laying, during dietary restriction [560].
unc-64 encodes syntaxin, which is a plasma membrane receptor for intracellular vesicles.
It is orthologous to vertebrate syntaxin and is expressed in the nervous system and se-
cretory cells of C. elegans. It is essential for synaptic vesicle fusion and therefore signal
propagation in the nervous system. unc-64 is required for normal locomotion and possibly
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also for insulin secretion [4, 654].
Interestingly, lifespan extension resulting from loss of function in all these genes is partially
reversible by daf-16 knockout. This demonstrates how tightly linked they are to common
longevity assurance pathways. However, it can be anticipated that other pathways, such
as TOR signalling, are also involved. [370]
Recently, a major C. elegans lab showed that chemosensory cilia function and and IFT
have a strong impact on lipid metabolism [386]. This is very interesting given all the re-
cent evidence for the involvement of lipid metabolism in ageing [608, 347, 640, 1] and make
RP-LC-MS metabolomics an ideal tool to gain more insights.
V.1.4. Outline of experiments
In this chapter, a large panel of long lived C. elegans mutants from various pathways/mechanisms
of lifespan extension was analysed, to find out whether there is a common metabolic de-
nominator of longevity.
Figure V.2 shows the general design of the study. In the first instance, two sample sets
are created: carbon, nitrogen and sulphur stable isotope labeled C. elegans samples, for
peak assignment, and the mutant samples. These included five biological replicates of 24
different mutants, from 11 different pathways of lifespan extension, wild-type worms had
15 replicates. All sample were extracted according to the consensus protocol from chapter
II.: 80 % methanol extraction using a bead-beater. Both sample sets, the isotope samples
and the mutant screen samples, were acquired in the same run by LC-MS, using a reversed
phase separation and positive mode electrospray ionisation (ESI+).
Using the workflow and tools developed in the previous chapter (IV.), the isotope samples
were used to identify all biologically synthesised metabolites in the C. elegans extracts
and annotate them with their molecular compositions, providing a final data matrix for
statistical analysis. The parameters for peak detection, alignment and integration were
optimised where possible.
In the final data analysis step, the metabolite × sample data matrix was analysed using
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Figure V.2.: Design of experiment:
For details please refer to the text.
univariate and multivariate methods. Univariate methods include comparison of the inten-
sity fold change to control, but also various correlation analyses. For multivariate analysis,
unsupervised and supervised methods, such as principal component analysis (PCA) and
partial least squares - discriminant analysis (PLS-DA) were used.
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V.2. Methods
V.2.1. Sample generation and metabolite extraction
For an experiment of this scale, it is important to avoid batch effects, i.e. relating to the
processing order of the samples, rather than strain specific effects. To prevent this, individ-
ual replicates and not strains were handled together for all the experimental procedures,
including sample generation, extraction and acquisition. Three evenly spaced replicates of
the wild type worms were processed within every replicate block.
V.2.1.1. Generation of longevity mutant screen samples
The long-lived C. elegans mutant strains used in this experiment are listed in table V.1.
Due to the high number of strains used, the growth and age synchronization protocols had
to be adapted from the standard protocol outlined in B1. In order to minimise the risk
of bacterial or fungal contamination, the agar plates did not contain any nutrient supple-
ments, such as peptone. Instead, OP50 was grown as an overnight culture in 25 g/l Luria
Broth medium, concentrated by centrifugation, and seeded directly onto the NGM plates
(without peptone). One plate was seeded with 250 µl of the equivalent of 25 ml LB culture
(100 x). This was enough to keep worms fed ad libidum until adulthood. Before the final
concentration and subsequent aliquoting step, all pre-concentrates were pooled to remove
batch effects. Seeded agar plates were kept refrigerated until use within a week.
Due to the variation in developmental rates of the different strains, age synchronisation
was modified in a way that allowed simultaneous growing of all strains and replicates.
Longevity mutants develop at different paces. Furthermore bleaching survival rates may
be reduced drastically by certain mutations, particularly the ones affecting mitochondrial
physiology1. Thus, to obtain a high number of synchronised worms from all strains at
the same time, plates set up at three consecutive days were pooled for synchronisation to
obtain one biological replicate. At the time of synchronisation, 2 plates had been growing
for 2.5 days, 3 plates for 3.5 days and 2 plates for 4.5 days. During synchronisation, the
1Personal communication from M. Sumakovic, University of Cologne
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pooled worms were bleached onto 8 plates.
To produce meaningful results, worms should be harvested at the same physiological time
point. In most other experiments for this thesis, the developmental point chosen was
either the L4 larval stage or early adulthood. Again, as longevity mutants develop at dif-
ferent paces and certain strains may even have a different morphological appearance during
those stages, it was decided to determine the sampling time point differently. Worms were
sampled at the first signs of the onset of egg laying, which corresponds to young adulthood.
Sampling was performed as outlined in B2 and frozen pellets (one per plate), stored at
−80°C inside bead-beater tubes, pre-filled with 200 µl of 0.1 mm SiO2 beads.
V.2.1.2. Generation of stable isotope annotation samples
All combinations of carbon, nitrogen and sulphur labelled C. elegans samples were pre-
pared according to the protocol, developed in section IV.2.1.4 (None/C/N/S/CN/CNS).
Cholesterol was added without ethanol, allowing full isotope enrichment. Three plates of
worm biomass were grown for each isotope labelling combination, to allow the preparation
of three extract aliquots. Worms were harvested in the same manner as the mutant screen
samples.
V.2.1.3. Metabolite extraction
For the mutant screen, five out of the eight frozen pellets were extracted, as outlined in B2,
using 80 % methanol and a bead-beater, yielding five replicates per strain. Three equal
aliquots were prepared for each sample, to have the option to use different types of chro-
matography (at a later stage of this project). 10 % of the whole liquid extract volume were
removed prior to aliquoting and dedicated to a pooled QC sample, which also was aliquoted.
The three replicates of stable isotope labelling samples samples were extracted the same
way as the mutant screen samples, to guarantee identical coverage. All three replicates of
the extract of a labelling regime were pooled and divided into three equal aliquots.
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V.2.2. LC-MS acquisition
LC-MS acquisition was performed with the help of Matthew Lewis (Imperial College, Lon-
don).
Samples were reconstituted with 100 µl water. To solubilise the pellet, samples were soni-
cated for 10 min and vortexed. To remove insoluble debris, samples were centrifuged for 10
min at 10k g and 4°C. 90 µl of the supernatant was transferred into flat bottom vials with
silanised high recovery insert. Samples were kept inside a Waters Acquity sample manager
at 4°C until injection by an Acquity UPLC.
Time A[%] B[%] Flow[ml min−1]
0.00 99.0 1.0 0.600
0.10 99.0 1.0 0.600
14.50 3.0 97.0 0.600
16.50 0.0 100.0 1.00
17.50 0.0 100.0 1.00
17.60 99.0 1.0 1.00
17.70 99.0 1.0 0.600
20.00 99.0 1.0 0.600
Table V.2.: LC-MS RP gradient for final
C. elegans metabolite
annotation and longevity
mutant screen
5 µl of the sample was injected onto a
Waters 2.1 × 100 mm HSS T3 column,
filled with 1.8 µm C18 linked silicon parti-
cles, that was kept at 45°C. At start, the
flow rate was at 0.6 ml per minute and
a 99 % A ( A = 100% water with 0.1
% formic acid and 1 %B (B = 100%
methanol with 0.1 % formic acid ) solvent ra-
tio. The solvent gradient is displayed in table
V.2.
The LC eluent was introduced into a Waters
Xevo G2 Q-ToF mass spectrometer. The elu-
ent was evaporated and molecules ionised by
an electrospray source heated to 120°C, with
desolvation temperature at 600°C and a desolvation gas flow of 1000 l h−1. The capillary
voltage was set to 1.5 kV in positive ionisation mode. Sample and extraction cone voltages
were 30 V and 4 V, respectively. 6 mass spectra per second were acquired over a range
of 40 to 1200 Dalton and an effective scan time of 0.15 s. To obtain high accuracy mass
measurements, the mass spectrometer was calibrated to sodium formate and a lock mass
was introduced into the source throughout the run. The lock mass was 200 pg/µl Leucine-
Enkephaline in a 1:1 mixture of methanol and water. It was infused at a rate of 10 µl/min
and recorded every 30 scans; averaging four lock mass scans each time. The whole system
was controlled by MassLynx version 4.1.
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After three blank injections, the column was conditioned, using the injection of 5 mutant
screen QC samples. First, the isotope annotation study was run. The mutant screen sam-
ples were then run in replicate blocks, with QC samples every 12 samples.
Due to a college-wide, unplanned power outage, the acquisition was interrupted within the
second replicate block of the mutant screen samples. As the power outage lead to a crash
of the LC, but not the MS system, the injection series was resumed where it stopped, after
re-conditioning the LC system with five QC samples. Thus, the acquisition was in effect a
two-batch acquisition, requiring alignment of the two batches.
V.2.3. Processing and Analysis
After acquisition, all data were converted into the CDF format, using Waters MassLynx
and peaks detected using xcms (version 1.33.14).
V.2.3.1. Processing of the isotope annotation samples
xcms parameter settings were kept liberal, to allow for the highest coverage possible. The
”centWave” algorithm was used with an expected chromatographic peak width between
1 and 10 s and a signal to noise threshold of one. All other parameters were left at
default values. The data reduction and annotation algorithm was used as described in the
previous chapter. The retention time (rtE) and ppm accuracy (ppmE) thresholds, used for
matching between the different labelling regimes were determined as described in IV.3.4.1.
A rtE = 1 and ppmE = 6 were found to detect all biological peaks, visible in the BIP, but
not detect any non-biological ones. ppmE = 6 was also used during the molecular formula
calculation. For the atom-count plots, the M+1 adduct/formula pair was preferred for
biological peaks, to which multiple adduct/formula pairs were assigned.
V.2.3.2. Database matching
The assigned adduct/formula pairs were matched to the compounds contained inside the
PubChem, LMSD, KEGG and SMID databases.
The local PubChem copy from the simulations in chapter IV. was used. PubChem [56]
contains separate entries for individual stereoisomers of a compound, such as L-alanine and
174 V.. A metabolic model of longevity in C. elegans
D-alanine, and an additional entry for the racemic form (DL-alanine). As stereoisomers
cannot be separated by achiral chromatography, alanine, for example, should only pro-
duce one hit, when queried in a database. Thus, prior to matching, the local copy of the
PubChem database had to be reduced to one entry for all stereoisomers, only. This was
done comparing the canonical and isomeric SMILES (simplified molecular-input line-entry
system) descriptors, of which the latter contains stereochemical information.
The Lipid Maps Structure Database (LMSD) [550] was downloaded on 01.05.2013 as CSV
file and parsed into R using custom scripts. All lipid classes were considered, but restricted
to CHNOPS compounds only.
A Kyoto Encyclopedia of Genes and Genomes (KEGG) [450] compound database version
from 02.12.2010 was used. It was parsed into R using custom scripts. Only non-charged,
non-salt CHNOPS compounds containing at least one carbon atom were considered.
The Small Molecule Identifier Database (SMID DB) was downloaded from smid-db.org on
the 05.05.2013 and parsed into R.
The figure produced for the results chapter, which shows the matched adduct/formula
pairs, was produced by first plotting all adduct/formula pairs as unmatched. The database
matches were then overlaid in the following order: PubChem, KEGG, LMSD and SMID.
Thus matches that were already matched by the previous database, are masked. However,
this order represents the order of metabolite specificity, with KEGG and LMSD having a
similar specificity, but different coverage.
V.2.3.3. Processing of the mutant screen samples
Before peak picking was performed, the SN , prefilter, PPM and peakwidth parameters
of the xcms ”centWave” algorithm were optimized. It was tested whether optimised pa-
rameters would reduce the number of unrelated, non-biological peaks and thus the total
amount of data. The SN and PPM parameter can be found for each peak inside the peak
list. The peakwidth may be calculated by subtracting the retention time where the ions
of a peak were first (rtmin) and last (rtmax) detected. The prefilter parameter cannot
be accessed directly. Instead, the EIC for each peak needs to be extracted. This can then
be used to calculate for how many scans k, a certain peak was above the minimum inten-
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sity I. ROC analysis was used to find whether predictive parameter settings exist, that
would allow classification of peaks as biological. The ROC analysis was performed on the
unlabelled sample from the isotope annotation workflow. Biological features were the gold
standard for true (n = 760), and all other features, the gold standard for false classifica-
tion (n = 141409). Based on this, a contingency table was calculated for each parameter
and each of the biological parameter’s settings (n = 760). From the contingency tables,
the ROC curves were drawn. Before the actual ROC analysis, it was confirmed that the
unlabelled sample from the isotope study and all samples from the longevity study could
actually be compared. To this end, quantile - quantile plots were used, to ensure a similar
parameter distribution of the peaks of those two sample(sets), when detected using the
same peak detection parameters.
A loess model was used to correct the m/z domain between the two batches (pre/post power
outage). The unlabelled sample of the isotope annotation study was also re-acquired dur-
ing the second batch, so biological features could be matched between the two samples.
All compounds that eluted within a five second window, sharing an identical carbon, nitro-
gen and sulphur count and an (unlabelled) mass within 60 ppm were considered identical
between the two samples. The 60 ppm window was chosen as a worst case scenario, after
manual comparison of several metabolites from both samples. A loess function with a
smoothing factor of 0.7 was used to model the relationship between the mass difference of
the same features from the two samples, with respect to their mass. The resulting calibra-
tion function was used to project the post-outage acquisitions onto the m/z scale of the
pre-outage acquisitions.
In the next step, the peaks identified as biological, i.e. the target peaks, had to be found
within the mutant dataset. A Monte Carlo (MC) simulation (1000 iterations) was carried
out to determine the boundaries of the retention time and mass accuracy window used to
find the targeted peaks within the samples of the longevity mutant dataset. The retention
time window was varied ±8 s around the targeted peaks’ retention time; the mass accu-
racy window by ±40 ppm. To improve simulation speed, the dataset was reduced to only
contain data points within the maximum window size (8 s with 40 ppm) (n = 216638).
The fraction of longevity mutant dataset peaks that was not yet matched by a single target
peak and the fraction that was matched by one and only one target peak (unambiguous)
was calculated for each iteration. Furthermore, the fraction of ambiguous matches, i.e. the
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cases where a target peak was matched to several mutant dataset peaks, was determined.
All simulations were performed on the Amazon EC2 cloud computing service in a paral-
lelised fashion. For visualisation, a surface was fit to the data points using the R based
”fields” package.
For retention time alignment a loess function was used as in the GC-MS alignment chapter
(III.4) or as used by xcms. The medium retention time profile was calculated from the
unambiguously matched peaks. A loess model was constructed only using the retention
time deviation to the median retention time of unambiguously matched peaks for each
sample. The model was then used to correct all retention times of the whole peak list. For
the first round of retention time alignment, a grouping window of ± 4 s and ± 10 ppm
was used, as determined by MC simulation. A smoothing parameter (”span”) of 0.65 was
used, to correct for global trends. In the second round, ± 3 s and ± 10 ppm were used
(as determined by another MC simulation, using the retention times corrected by the first
round). The span was set to 0.3, to also allow the model to compensate for local drifts.
The final grouping was performed using ± 2 s and ± 10 ppm (again determined by MC
simulation).
The data matrix was back-filled where there were gaps in the data matrix. The MZ and
RT boundaries were calculated for each sample. As all retention times were aligned to the
median retention time, the median retention time of the start and end of a target peak
was projected into the sample’s original retention time, using the generated loess models.
The MZ boundaries for the integration were the median of the target peak’s MZ value ±
10 ppm. XCMS’s getPeaks function was used to perform the integration.
After integration, the samples were normalized by probabilistic quotient normalisation, as
described in section A3.2.2, to compensate for differences in sample concentration. The
median intensity for each peak was used as a reference.
To guarantee reliable, high quality data, only metabolite candidates with coefficient of
variation (CV) of less than 26 % in their QC samples throughout the run were retained
for multivariate analyses.
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V.2.3.4. Data Analysis
The initial principal component analysis (PCA) and partial least squares - discriminant
analysis (PLS-DA) models, including all samples, were built in SIMCA P+ 13.0 (Umet-
rics, Umea, Sweden). The predictive variance, Q2, was computed by leave one out cross-
validation.
To allow the calculation of p-values for the predictive quality and sample group separation,
all subsequent PCA and PLS-DA models were built inside R [567], using the prcomp [567]
and plsreg1 [509] functions, respectively. Again, Q2 was calculated by a leave one out ap-
proach. For all control vs mutant PLS-DA models, the Q2 was associated with a p-value by
using a permutation approach, as described in the literature [622, 89, 156]. For each ”cor-
rect” model, a null hypothesis distribution was built, using 2000 models with a randomly
permuted Y-vector. Another p-value was generated to gauge the quality of separation
between control and mutant samples, using an approach recently described by Worley et
al.[638]. This was done for both the PCA and PLS-DA scores, using a software tool (”PCA
Utilities”), provided by Worley et al.. The parametric Pearson and nonparametric Spear-
man correlation between the p-values and Q2 was also supported by permutation (k = 104).
Three multivariate PLS regression models with different Y variables were built:
Y1 was the percent lifespan increase compared to control, as recorded in table V.1. Y2
was the (non-parametric) ranked version of Y1. Y3 was (non-parametric) categorical data,
partitioning all samples into three groups, according to the magnitude of their lifespan
extension (control (= 0%), moderate (< 50%), medium (< 100%), high(> 100%)). Im-
portantly, Q2 was calculated by a leave-one-group out method, rather than leaving out
individual samples.
To assess how strains compare using univariate statistics, three hierarchical clustered (Eu-
clidean distance) heat maps were drawn. First, a Welch’s two sided t-test was used to
calculate all p-values between a mutant stain and its control for each candidate metabolite.
These p-values were then used for the first heat map, to see significant, but non-directional
changes. No multiple testing correction was used as the p-values were used for visualisation
and filtering only, rather than rigorous significance testing. For the second heat map, the
fold changes between the median intensity of a metabolite candidate of each strain and its
control were calculated and clustered as log 2 fold change. To improve the dynamic range
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of the colour gradient, fold changes were limited to -8 and 8 fold. The third heat map is
a combination of both heat maps. Again, the log 2 fold change heat map was plotted, but
non-significant (p ≤ 0.05) observations were set to zero fold.
It was also tested which metabolite candidates correlate with life expectancy (table V.1).
Parametric Pearson and non-parametric Spearman rank correlation were used against the
raw, unscaled intensity data. Overexpression strains were not included. A p-value was de-
rived by permutation analysis for each correlation, on both a per sample and a per strain
basis. For the per sample basis, the life expectancy vector was randomly permuted to
assign each individual sample a life expectancy. For the strain based approach, the life ex-
pectancy was permuted on a per strain basis, i.e. all replicates of one strain always received
the same life expectancy. In order to compare the correlated metabolite candidates with
the metabolite candidates from the heat map, a custom coded heat map was plotted with
the life expectancy correlation coefficient and p-value above the corresponding metabolite
candidates.
As the most correlated metabolite candidates and the highest inter-strain fold change
metabolite candidates were found to be the same, an attempt was made to assign them.
Most of the metabolite candidates were late eluting. Thus, the remainder of the study was
focused on lipids only. The lipids were grouped into classes of common oxygen, nitrogen
and phosphorus count. By analysing in-source fragmentation (see appendix figure C4.4), it
was found that nearly all observed lipids are glycerophosphocholines (phosphatidylcholines
(PC)). By performing queries against the LipidMaps [550] and Chemspider [473] databases,
using elemental compositions and also by the inspection of other in-source fragments and
neutral losses (such as fatty acids), some of the lipid classes could be putatively assigned.
For a final analysis, it was decided to further examine the fatty acid carbon chain length
and the degree of saturation, i.e. the number of double bonds, of two lipid classes: the
diacylglycerophosphocholines (diAcGPC, positively correlated to lifespan), and the mono-
acylglycerophosphocholines (monoAcPC, negatively correlated to lifespan). The fatty acid
chain length was calculated by subtracting the number of carbon atoms (CAcPC = 9) con-
tributed by the common glycerophosphocholine backbone. To calculate the number of
double bonds, the carbon and hydrogen atom counts of the glycerophosphocholine back-
bone (CAcPC = 9;HAcPC = 18) were subtracted. Then, the number of carbon atoms from
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the fatty acid’s aldehyde groups and the additional proton from the fatty acid’s methyl
group were subtracted. For diacylglycerophosphocholines, this is CdiAcPC = 2;HdiAcPC = 2,
for monoacylglycerophosphocholines, under consideration of the non-substituted glycerol-
alcohol, it is CmonoAcPC = 2;HmonoAcPC = 2. Then the number of theoretical fully saturated
hydrogens is calculated for the given carbon count, by multiplying the carbon count by
two. The theoretical saturation hydrogen count can then be compared with the actual
hydrogen count to determine the degree of actual saturation.
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V.3. Results
The results section is divided into three main parts. The first two are methodological and
the last one focusses on the biological results. In the first section (V.3.1), the workflow
and tools developed in the last chapter were used to analyse a C. elegans extract, acquired
by reversed phase, positive ionisation LC-MS. In a second section (V.3.3), the strategy
of processing the longevity mutant dataset is presented. This section deals with optimis-
ing processing parameters, alignment and detection of biological peaks, producing a data
matrix which can be used for statistical analysis. The final section (V.3.4), is concerned
with the biological analysis of this data matrix. Univariate and multivariate approaches
were used to find a common signature across strains associated with life expectancy. This
inter-strain signature was based on concentration changes of particular lipid classes.
V.3.1. Data reduction and annotation of C. elegans features
Firstly, peaks of biological origin from a C. elegans extract were identified and annotated
with a molecular formula, allowing subsequent database matching, using the method de-
veloped in the previous chapter.
Figure V.3 shows the base ion peak (BIP) chromatogram of the C. elegans extract, with
peaks of biological origin highlighted, and an overlaid blank injection. Many high-intensity
peaks are non-biological. This was confirmed by inspecting the corresponding raw data. As
the blank demonstrates, this chemical ”noise” does not originate from the chromatographic
system, or the solvents, but from the sample itself. For worm culture and extraction, only
high purity solvents and chemicals were used. However, plasticisers or polymers can be
released from non-glass sample handling consumables, such as pipette tips, extraction and
sample tubes [574, 216], particularly as organic solvents were used during extraction. It is
not feasible to avoid all plasticware in an experiment such as this; furthermore, persistent
organic pollutants (POPs) are ubiquitous.
The optimised matching parameters (ppmE = 6, rtE = 1) for the algorithm (see chapter
IV.3.4.1) reduced the number of detected peaks by 99.3 %, leaving 931 biological features.
999 different molecular formula/adduct pairs were calculated for these, for 760 out of the
931 biological peaks. Thus, no adduct/formula pair could be generated for 171 of the
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Figure V.3.: C. elegans BIP with detected metabolite candidates highlighted:
The base ion peak (BIP) chromatogram of the C. elegans extract with
metabolite candidates of biological origin highlighted in red. A blank
(water) injection of the chromatographic system (scaled to match the same
intensity axis) is overlaid in blue.
biological peaks. This may be due to a combination of reasons. It is possible that for
some, the matching error window was too small. They may also have represented uncom-
mon adducts, which were not considered by the formula generator. Even though unlikely,
they could have exceeded the 99.99 % PubChem confidence intervals used by the formula
generator (table C3.1 and table C3.2). There is also a possibility that some compounds
contained elements other than CHNOPS. For example, selenocysteine is a known metabo-
lite in C. elegans[200]. Another reason may also be a mismatch of labelling regimes, not
immediately apparent in the check-tables.
Figure V.4 shows the different adducts assigned during molecular formula generation. As in
the previous chapter, the selection of only a few very plausible adducts, out of 31 possible,
shows the high specificity of this formula generation step. As expected, the M+H adduct
was the commonest, followed by different alkali ones [44]. It was also checked whether
metabolites had several different adducts, by finding identical molecular formulae (with
different adducts), which eluted in a one second retention time window. 45 metabolite
candidates were present with two different adducts (H/Na: 29; H/K: 10; Na/K: 6), and 27
with three different adducts (H/Na/K: 27; H/Na/2Na-H: 1). Even though Benton et al.[44]
found the M+1 adduct to be the best pick, when deciding on an ion for quantification,
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this cannot be assumed for each case. It is also possible that closely eluting isobaric com-
pounds, such as lipids with different double bond positions of the fatty acids, which ionise
as different adducts, were mistaken for different adducts of the same compound. Thus, the
redundant ”adducts” were not removed. Each adduct/metabolite pair will be quantified
inside the longevity mutant dataset. However, during model analysis, their presence will
have to be kept in mind.
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Figure V.4.: Adducts detected in the C. elegans
extract:
Adducts and their count, assigned by the
formula generator of the data reduction
and annotation algorithm.
The average ppm error for for-
mula calculation was −0.214
ppm, with a standard deviation
of 2.30 ppm, and an average er-
ror of 1.84 ppm, if absolute ppm
values were used. For none of the
biological peaks (below 1 kDa)
two different molecular formulae,
but with the same adduct, i.e.
Fx + H and Fy + H, were cal-
culated. This shows, that last
chapter’s simulation and conclu-
sions seem to be correct: It
is possible to calculate unam-
biguous molecular composition
at ToF accuracy, as soon as the carbon, nitrogen and sulphur count is known.
Figure V.5 shows the atom-counts of the molecular formulae that were assigned to the
molecular peaks. All molecular formulae are highly plausible for the elution profile of re-
versed phase chromatography. Higher carbon-counts elute at later retention times. High
molecular weight compounds eluting close to the void volume are polar, due to a high nitro-
gen count. Clusters of lipid classes, with clear presence of phospholipids, can be detected.
The next section aims at querying the generated molecular formulae against different com-
pound databases, to reveal their identity.
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Figure V.5.: Molecular formulae of reversed phase ESI+:
RT vz m/z plots with atom-counts for C (V.5a), H (V.5b), N (V.5c), O
(V.5d), P (V.5f, S (V.5e). All (non-reduced) detected peaks are in grey.
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V.3.2. Database matching of C. elegans adduct/formula pairs
The isotope labelling strategy generates molecular formulae rather than assigned metabo-
lites (i.e. metabolite candidates). Even though this often allows generalizations about the
compound class, full metabolite assignment is preferred for biological interpretation. Sev-
eral algorithms to calculate possible chemical structures from a molecular composition exist
[163, 542], but chemical structure generation is a factorial problem and a single molecular
composition can have billions of isomers [319]. Thus, an ab initio calculation approach is
not useful. Therefore, the first step is to query a metabolite database.
In this section, this was done for the molecular formulae calculated above. Each composi-
tion may be assigned to several structures and therefore require experimental validation,
according to the Metabolomics Standards Initiative’s recommendations [551]. Therefore
the focus is on what could be assigned and what is yet unknown, rather than the assign-
ments themselves. Three categories of databases will be used:
PubChem [56] is likely to contain most of the scientifically reported compounds - thus it
is used to assess whether it is likely that the compound is known.
The Kyoto Encyclopedia of Genes and Genomes (KEGG) [450] is one of the most complete
and widely used metabolic pathway databases. Due to its wider coverage [14], it was pre-
ferred over MetaCyc [476]. As KEGG has a relatively poor coverage of lipid compounds,
the Lipid Maps Structure Database (LMSD) [550] was additionally used to compensate
for this. If a molecular formula can be matched to any of the two, it is likely to exist in a
biological context, possibly with an associated metabolic pathway.
C. elegans also has some very organism specific metabolites. Ascarosides are sugar-based
metabolites which act as important signalling molecules, particularly in the context of
ageing and development [74, 536, 603, 276]. A large amount of different permutations of
ascarosides with different functions exist [603]. They are deposited in the Small Molecule
Identifier Database (SMID DB), which was therefore used to assign C. elegans specific
molecules.
Figure V.6 and table V.3 summarise the database matching results. Even though the
majority of formula/adduct pairs could be matched to at least one known (PubChem)
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Figure V.6.: Database matches for generated formula/adduct pairs:
The C. elegans features, for which a molecular formula was generated, were
queried against different databases. Details are given in the text.
compound, nearly a third (321) remained unannotated. Half (163) are from biological fea-
tures, for which no formula/adduct pair has been matched yet. Thus, they are most likely
undescribed compounds. As shown by the figure, most of them are of higher molecular
weight, which may complicate elucidation. Lipid maps (LMSD) yielded the second most
matches, unsurprisingly, as a major share of the detected features are lipids. Most of them
are phospholipids, as confirmed by the LMSD metadata, but already known based on their
molecular profile in figure V.5. On average, only KEGG and SMID delivered unambiguous
matches. This may be mostly be due to the lower number of entries. For the SMID, it is
also due to its high specificity, as it only matches C. elegans specific molecules. Four as-
caroside molecules were matched, which corresponds well with expectations from previous
studies [603], including retention times: they elute in a medium-polarity window where few
other metabolites are present. The identification of these secondary metabolites confirms
that the pipeline works well.
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Database Entries [n] matched ”overmatch” [fold]
PubChem 16 594 399 678 18
LMSD 35 828 357 4
KEGG 13 592 145 1
SMID 164 5 1
Table V.3.: Database matches for generated formula/adduct pairs:
For each database, that the molecular formula/adduct pairs (n=999) were
matched to, the total number of compound entries and number of matched
compounds is given. Also the median of how many different database entries
could be matched to a single formula/adduct pair (”overmatch”).
The annotated peaks must then be extracted from the longevity mutant dataset. This is
discussed in the next section.
V.3.3. Processing and matching of the mutant dataset
This section discusses the processing of the longevity mutant dataset, which ultimately
leads to a metabolite candidate × sample matrix, which is then analysed in the next sec-
tion.
V.3.3.1. Optimising the peak detection parameters
In order to reduce the total amount of data, it was investigated whether xcms peak de-
tection parameters could be optimised (see section A3.1.3.1). Using the stable isotope
reduction workflow, biological features were identified against a complex background. It is
a plausible assumption, that biological features may have different analytical properties to
other peaks. If this is the case, it may be possible to find specific peak-picking parameters
which are selective towards biological features. The signal-to-noise ratio (SN), the mini-
mum intensity threshold (prefilter), the ppm deviation between consecutive scans (PPM)
and the peak width (peakwidth) can be adjusted for peak detection and may potentially
help discern between biological and abiotic features. Receiver operating characteristics
(ROC) analysis [164] was used. ROC analysis is used to select an optimal threshold for a
binary classification algorithm (True, False). This is done by plotting the true positive rate
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(TPR) against the false positive rate (FPR). The TPR, also referred to as sensitivity, is the
probability of a classification as true, given that the questioned case is true. The FPR is the
probability of classifying a case as true, even though it actually is false. For peak picking
optimisation, true would be the classification ”of biological origin”, false ”of other origin”.
The ROC plots are displayed in figure C4.2, in the appendix. The prefilter, the PPM ,
and the SN parameters were all of predictive value, when deciding between biological and
not. They were all far away from the diagonal (TPR = FPR), which would indicate
a random classification. The ROC curves are also coloured based on the percentage of
expected data reduction a certain threshold could achieve. None of the parameters could
allow for a reduction of more than 20 %, without at least risking a 20 % false positive rate.
Thus, the benefits do not outweigh the risk of losing relevant information. Particularly
as this experiment is semi-targeted, and so it was decided, to process the whole longevity
mutant dataset with the liberal parameter settings, also used for the isotope annotation
samples. This resulted in close to 16 million features in the whole dataset.
V.3.3.2. Alignment of the m/z domain
During acquisition, the injection series was interrupted by an unplanned power outage.
This effectively led to a two batch sample acquisition. Even though the mass spectrometer
did not reset, unlike the LC system, its absolute mass calibration was offset. As the lock-
spray for the continuous mass correction assumed its proper function, the m/z domain of
the second batch was still on a correct relative, but a wrong absolute scale. A loess (locally
weighted scatterplot smoothing) regression function was used to model the difference be-
tween the absolute mass scales of the two batches. The regression function (shown in the
appendix in figure C4.1), which is nearly linear between 200 and 1000 Da (R2 = 0.998),
was then used to post-acquisition correct the m/z values of all affected samples.
V.3.3.3. Dataset matching and retention time alignment
The next step was to find the metabolite candidates, i.e. the peaks of biological ori-
gin annotated with a molecular formula in section V.3.1, within the main dataset. This
procedure corresponds to the grouping step in a peak alignment algorithm, such as pro-
vided by xcms. The use of xcms grouping function failed: the algorithm (density) did
not find enough ”well behaved peak groups” (see section A3.1.3.1), and the alternative
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Figure V.7.: Determining the matching window for the target peaks within the
longevity mutant sample set I:
The figure shows the simulation results, evaluating different retention time
and mass accuracy window boundaries, to find the best thresholds to match
the targeted metabolite candidates within all samples of the longevity
mutant dataset (”grouping”). Figure V.7a displays the percentage of yet
unmatched peaks. Figure V.7b shows the percentage of matches where a
target peak matches one and only one dataset peak. Figure V.7c shows the
percentage of peaks, which has already more than one peak that it could
match to within the specified search window; i.e. its match is ambiguous.
algorithm (nearest) was aborted as only two of the 200 samples had been processed after
two days. Thus, the off-the-shelf algorithms failed as a consequence of the sheer number
of detected peaks. Therefore, custom functions were used to locate and group only the
targeted metabolite candidates. In the first stage, the retention time and mass accuracy
boundaries (”grouping window”) were determined. This was done by performing a Monte
Carlo simulation, evaluating different search window sizes, as done for the NMR database
search in chapter III.2.3.3.
Figure V.7 displays the results of the simulation, used to determine the ideal retention
time and mass accuracy boundaries for finding the target metabolite candidates. Figure
V.7a shows the minimum boundaries required, by displaying the fraction of targeted peaks
which do not yet have a match (from the sample set’s peaks). Ideally, this number is very
small. The minimum threshold is surprisingly clear cut for both dimensions. ±3 ppm and
±1.5 s would only leave 40 % of all (possibly matchable) sample set peaks unassigned.
The thresholds at which peaks are found increase perpendicular to each other. This means
they are independent and without major interaction. Figure V.7b shows the percentage
of sample set peaks which has one and only one match from target peaks. This would be
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the ideal case. Thus, a high percentage is desirable. Plot V.7c shows the percentage of
ambiguous matches. These are those sample set peaks, which could be matched to more
than one target peak. Thus, a low number can be considered as ideal. All three plots
must be considered to select a threshold. Generally, it seems that the choice of the ppm
threshold has a smaller influence on the result, than the retention time threshold. For the
first round of grouping, before the retention time correction, it was decided to keep the
settings more liberal. At 4 s and 10 ppm half of all peaks are unambiguously matched.
Beyond that threshold, there is also little decrease of unmatched peaks and the percentage
of ambiguous peaks is still rather low < 10%.
Retention time correction for the grouped target peaks was also performed using custom
written code. The algorithm is the same as the one used by xcms and in the GC-MS
alignment chapter (III.4): a loess (locally weighted scatterplot smoothing) regression func-
tion to model each sample’s retention time deviation from a median retention time across
the whole run. Only unambiguous peaks were included. In figure V.8a, the proposed loess
function for the retention time alignment to the median retention time can be seen for each
sample. There are clear batch effects between the pre- and post-power outage samples and
the unlabelled sample from the isotope study. Following the first round of RT correction,
regrouping was performed (using a ±10 ppm and ±3 second window). A second round of
retention time correction was conducted.
As shown by the MC simulation for the final grouping step, the retention time window
can be reduced down to ± 2 s. Indeed, as shown by histograms, the distribution of reten-
tion time deviations from the median retention time profile has much improved from the
first round of grouping (figure V.8b) to the one after the second round of retention time
alignment (figure V.8d). Also, as figure V.8c shows, after the second round of retention
time correction, barely any visible RT batch effects remain. Most of the individual peaks
cluster close to the median retention time.
After the successful alignment of retention time profiles of the different samples, the full
target peak by sample matrix was constructed. The gaps need to be filled, i.e. where a
peak was not found in a particular sample. All gaps were filled using xcms functions, to
make integration comparable to the one during xcms peak detection.
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Figure V.8.: Retention time alignment based on grouped, target peaks:
Figure V.8a and V.8c show the loess regression models used for the first and
(not actually applied) third round of retention time alignment, respectively.
The models describe the deviation from the median retention time profile
across the whole run length. The individual dots are the peaks, used to
build the regression models. Peaks and models of the longevity mutant
screen samples acquired before the power outage are coloured in black, the
ones after the power outage in red. Blue is used for the unlabelled sample of
the isotope annotation study, which was used to identify the target
metabolite candidates. Histogram V.8b and V.8d show the distribution of
deviations from the median retention time profiles before and after two
rounds of retention time alignment, respectively.
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Figure V.9.: Determining the matching window for the target peaks within the
longevity mutant sample set II:
The figure shows the simulation results for selecting the final retention time
and mass accuracy grouping window (after the second round of retention
time alignment). Figure V.7a displays the percentage of yet unmatched
peaks. Figure V.7b shows the percentage of matches where a target peaks
matches one and only one dataset peak. Figure V.7c shows which percentage
of peaks has already more than one peak that it could match within the
specified search window, i.e. its match is ambiguous.
V.3.3.4. Preparing the data matrix for analysis
Probabilistic quotient normalisation (PQN) was used to compensate for differences in sam-
ple concentration (see section A3.2.2). Figure V.10a and V.10b show box plots of the log10
intensity distribution before and after PQN, respectively. A clear improvement in intensity
homogeneity can be observed. Indeed, the median coefficient of variation (CV) of all QC
sample metabolite candidates throughout the run improved from 36 % to 26 %.
As already discussed in chapter II.4.5, injection to injection intensity variation of the same
sample during runtime cannot be totally avoided. Some metabolites ionise more reliably
through the course of an acquisition than others. Thus, in large profiling studies it has
become good practice to exclude those metabolites from (multivariate) analysis which can-
not be measured reproducibly [141]. To do so, metabolite candidates which exceed a set
CV threshold within their QC samples, are discarded [199]. For bioanalytical method val-
idation, the Food and Drug Administration (FDA) recommends a cutoff at 15% and 20%
if the analyte is close to the limit of quantification [165]. Here, the median QC CV (26 %)
was selected as cut-off. Even though this value exceeds FDA recommendations, up to 30
% is considered acceptable for biomarker discovery studies [199, 296, 613].
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Figure V.10.: Intensity distribution before and after intensity normalisation:
The box plots show the log10 intensity distribution for each sample before
(figure V.10a) and after (figure V.10b) the probabilistic quotient
normalisation. As reference, the median intensity for each metabolite
candidate was used. Samples are not in runtime, but alphabetical order
(with all replicates of a group next to each other).
Even though highly variable metabolite candidates have been removed, analysis may still
be impacted by a runtime bias, such as a signal drift through the acquisition. To gauge the
impact of unwanted, systematic bias, in relation to the samples, the clustering of the QC
samples should be checked using unsupervised multivariate methods [511, 199, 296, 613].
Figure C4.3 shows a hierarchical clustered heat map of all samples. All QC samples clus-
ter together, indicating a robust acquisition. No batch effects (pre/post power outage) are
visible.
In LC-MS metabolite profiling, absolute signal intensity does not correspond directly to
absolute concentration. Thus, absolute intensity information of individual peaks may bias
a multivariate model. Therefore, it was decided to use unit variance scaling (see section
A3.2.2) for all multivariate analyses. This gives all variables the same weight, regardless of
their absolute intensity. It can be problematic with profiling data, as it may increase the
contribution of (generally less intense) noise and artefact variables. However, as for the
current study, all peaks are (mostly non-redundant) biological signals only, unit variance
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scaling is appropriate.
V.3.4. Data analysis - the role of metabolism in C. elegans longevity
V.3.4.1. A single, all strain model, is not the best data analysis strategy
Could a single (multivariate) model be built for all long-lived strains to identify a common
metabolic signature of longevity? To this end, an unsupervised (PCA) and a supervised
model (PLS-DA) were built, combining all life-extending mutations, including their respec-
tive controls.
The resulting models can be seen in figure V.11. When inspecting the first two components
of both models (figure V.11a and V.11b), a highly complex pattern of overlapping strains
can be seen; in contrast to the desired clear separation between sample groups. One may
even think that the two modelling techniques failed to reduce the dimensionality, i.e. com-
plexity of the data, or that there is no metabolic difference between sample groups. This,
however, is not the case. There are differences between strains, hidden inside the data
matrix. When inspecting higher dimensional components (figure V.11c and V.11d), sepa-
ration and clustering of individual strains is observed. The complexity of the models may
simply be a consequence of the high number of individual sample groups (25). Both mod-
elling techniques aim at reducing the dimensionality of the variables, by linearly combining
them to ”meta-variables” of maximum discriminatory power [579]. However, they do not
summarise the dimensionality of the observations, for example by combining all replicates
of one sample group. If the model complexity really is caused by the high number of sample
groups, one would expect the number of latent variables required to sufficiently model the
data, also to be high. For both the PCA and PLS-DA models, the cumulative explained
variance (R2) and the predictive value of this variance (Q2) increases for more than the
first 20 latent variables (figure V.11e and V.11f). After that, their predictive value stalls or
even decreases, indicating overfitting [622, 61]. That the number of optimal components
to describe the data is in a similar range to the number of sample groups, may not be
a complete coincidence. Such a high number of latent variables, however, does not allow
for straightforward model interpretation. Thus, this data set illustrates the limitations of
those two powerful techniques. It also requires a different strategy for data analysis. It
may be appropriate to analyse smaller models, which describe parts of the problem and can
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(a) (b)
(c) (d)
(e) (f)
Figure V.11.: PCA and PLS-DA models including all samples:
Figure V.11a, V.11c and V.11e are from the PCA model. Figure V.11b,
V.11d and V.11f are from the PLS-DA model. In figure V.11a and V.11b
the first two components of each model are shown. V.11c and V.11d display
higher components, in which several strains form distinguished clusters. In
figure V.11e and V.11f the cumulative explained variance (R2) and cross
validated (predictive) variance (Q2) can be seen for each of the fitted
components (latent variables) of the two models.
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then be summarised to gain a holistic picture, rather than creating a model of all strains.
V.3.4.2. Most mutant’s metabolic phenotype differs from the control
The hypothesis is that individual mutants have significantly different metabolite concen-
trations, compared to the control. To test this, two-group models comparing all replicates
(n = 5) of a knockout mutant strain to wild type (n = 15) were evaluated. For the
Sir2.1 and cJNK overexpression mutants, the appropriate control (n = 5), different from
wild type, was used. Again, PCA and PLS-DA were used as unsupervised and supervised
models. PCA separates samples based on maximum variance. Thus, a separation between
control and long-lived strain (within the first two principal components) indicates that
there is more in-between than within group variation. PLS-DA can answer whether sam-
ple group membership can be predicted, based on the metabolite profiles. The predictive
value of a model is expressed by Q2, a cross validated version of the R2 score. The closer it
is to one, the more predictive the model. Thus, a positive Q2 value only tells how much of
a model’s variance is predictive. It does not make any statement about the likelihood of a
possible mis-classification event. Therefore, the Q2 value of each model was converted to a
p-value, using a permutation approach (n = 2000); a strategy described, and recommended
in the literature [622, 89, 156]. Furthermore, a p-value based method, recently described
by Worley et al.[638], was used to determine, whether the separation of two sample groups
is statistically significant.
Table V.4 summarises all multivariate models, comparing the individual strains of this
study to control. Overexpression strains LG394 and HT941 were compared to the genetic
background matching control strain LG398, whereas all others used wild type as control.
This was necessary as N2 and L398 have a very distinct baseline metabolome, as their
PCA separation indicates (p <= 6.21 × 10−08). As expected, PLS-DA, as a supervised
method, had greater separation of the sample groups. The predictive power of each model
was tested, using a permutation derived p-value. All models did pass with a significance
level of at least p ≤ 0.05, and frequently much better. Thus, as hypothesised in V.3.4.1, the
dataset contains a wealth of information, which simply cannot be captured inside a single
model and expressed in two/three dimensional projections. Individual models, however,
may reveal this information.
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gene (allele) PCA p PLSDA p PLSDA Q2cum PLSDA Q2 p LSE [%]
spe-26 (it118) 6.1E-01 2.4E-13 0.88 ≤5.0E-04 45
akt-1 (mg306) 3.7E-01 7.3E-08 0.52 5.0E-03 48
daf-2 (e1370) 2.0E-07 1.8E-12 0.91 ≤5.0E-04 100
unc-64 (e246) 5.5E-01 1.4E-09 0.76 ≤5.0E-04 35
glp-1 (e2141) 3.3E-03 2.0E-10 0.76 ≤5.0E-04 75
clk-1 (e2519) 1.1E-03 2.4E-10 0.83 ≤5.0E-04 40
eat-2 (ad1116) 1.3E-01 2.2E-07 0.64 ≤5.0E-04 40
egl-4 (ks61) 5.6E-01 2.5E-09 0.82 ≤5.0E-04 25
jnk-1 (+) 7.6E-01 3.9E-05 0.37 4.00E-02 25
rle-1 (tm2447) 2.0E-04 2.0E-11 0.87 ≤5.0E-04 25
ife-2 (ok306) 2.6E-02 5.6E-10 0.82 ≤5.0E-04 25
sir-2.1 (+) 3.6E-01 1.3E-04 0.58 1.8E-02 15
nuo-6 (qm200) 3.8E-01 7.4E-10 0.83 ≤5.0E-04 70
daf-2 (e1370); clk-1 (e2519) 1.1E-05 2.8E-13 0.92 ≤5.0E-04 400
isp-1 (qm150) 1.9E-02 1.9E-13 0.89 ≤5.0E-04 65
isp-1 (qm150); ctb-1 (qm189) 9.4E-03 3.4E-14 0.88 ≤5.0E-04 60
tax-4 (p678) 7.4E-03 5.2E-10 0.84 ≤5.0E-04 90
che-3 (p801) 1.7E-01 3.4E-07 0.62 ≤5.0E-04 100
osm-3 (p802) 4.4E-03 1.2E-11 0.90 ≤5.0E-04 65
osm-6 (p811) 9.5E-01 7.1E-09 0.55 ≤5.0E-04 60
osm-5 (p813) 4.2E-02 1.3E-12 0.79 ≤5.0E-04 120
sod-2 (ok1030) 4.2E-03 5.5E-10 0.81 ≤5.0E-04 50
rsks-1 (sv31) 2.4E-03 1.8E-10 0.77 ≤5.0E-04 25
age-1 (hx546) 7.0E-01 3.5E-08 0.26 4.3E-02 100
ifta-2 (tm1724) 4.4E-01 2.5E-07 0.55 1.5E-03 30
hif-1 (ia4) 4.3E-01 4.5E-11 0.78 ≤5.0E-04 25
Table V.4.: PCA and PLS-DA models of mutant versus control:
This table summarises the performance of all PCA and PLS-DA models. For
each model two components were fitted and each strain was compared to a
control strain (such as wild type). P-values describing the model’s confidence
for the separation [638] of the two strains are given for PCA and PLS-DA.
For the PLS-DA model, the predictive variance (Q2) and associated p-value is
also listed. Furthermore, the lifespan extension for each strain is given. For
the convenience of interpretation, cells have been coloured. Significant
p-values are highlighted in red with p <= 0.05 , p <= 0.01 and p <= 0.001 .
Q2 is on a continuous blue colour scale from 0 to 1 . The lifespan extension
is on a continuous green colour scale, ranging from 0% to 100% .
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PCA p PLSDA p PLSDA Q2cum PLSDA p(Q2)
parametric R -0.21 -0.14 0.18 -0.03
parametric p-value 0.12 0.10 0.14 0.44
nonparametric ρ -0.17 -0.26 0.30 -0.11
nonparametric p-value 0.18 0.08 0.05 0.29
Table V.5.: Correlating the model quality and lifespan extension:
Parametric (Pearson) and nonparametric (Spearman) correlation of the
model parameters and % lifespan extension, of the values from table V.4.
It was also tested whether any of the parameters describing a model’s performance, such as
the Q2 or p-values, correlated with the % lifespan extension. The results are summarised
in table V.5. On average, the nonparametric correlations were better than the parametric
correlation. Still, nearly all correlations were very weak and non-significant, as determined
by permutation tests (n = 10k). The nonparametric correlation of the PLS-DA Q2cum,
however, appears to be significant at p <= 0.05 and positively correlated, with a Spear-
man’s rank correlation coefficient of ρ = 0.30. This would mean that a more predictive
metabolic phenotype at youth is connected to a longer lifespan extension. Even though
the weak correlation precludes any strong conclusions, the potential correlation of lifespan
extension to the metabolic phenotypes deserves further attention.
V.3.4.3. The multivariate link between life expectancy and metabolism
The major goals of this chapter is to evaluate whether there is a global signature or even
a single biomarker for life expectancy.
The weak, but significant nonparametric correlation analysis between the predictive quality
(Q2cum) of the individual PLS-DA models and life expectancy should be further investigated.
To this end, a PLS regression against the lifespan extension for each mutant was performed.
The overexpression mutants were not included, as they would require a separate control,
which was shown to be metabolically distinct from the regular control. Three regression
models were built. The first one aims to model the absolute lifespan extension (figure
V.12a), expressed in percent from wild type. The second model is non-parametric, as it
regresses to the ranked lifespan extension (figure V.12b). For the third model, the strain’s
life expectancy was divided into an ordinal variable with four ranks: control (= 0%), mod-
erate (< 50%), medium (< 100%), high(> 100%).
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Figure V.12.: PLS regression models of life expectancy:
PLS regression of absolute (figure V.12a) and ranked (figure V.12b) lifespan
extension. Each strain is marked in a different colour; black is wild type. In
figure V.12c, the life expectancy is partitioned into three groups (control
(= 0%), moderate (< 50%), medium (< 100%), high(> 100%)), to
qualitatively model the magnitude of life span extension.
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Figure V.13.: Predicted versus actual lifespan extension:
The predicted (y-axis), versus the actual lifespan (x-axis) is plotted. The
first column is from the absolute lifespan extension model, the second from
the ranked and the third from the group one. Row one is component one,
row two, component two and row three is component three. The last row of
plots shows the R2 and Q2 values for each of the model’s components.
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All three models, in particular the two rank models, show a clear trend (along their di-
agonal). As expected, not all of the 25 included long-lived strains follow this trend; also
some (2-3) replicates of the wild type control strain show outlying behaviour. To further
investigate this trend, the predicted, versus the actual life expectancy was plotted for each
of the three models for component 1 to 3 (figure V.13). Indeed, the life expectancy is
predicted reasonably well. As can be seen in figures V.13j, V.13k and V.13l, all models
explain ≥ 40 % of the variance (R2cum) across the first two components. However, none of
the models passed the cross validation step, with their Q2 close to zero or even being neg-
ative. This means the lifespan extension can be modelled, but the models are not robust
and should therefore not be consulted for biological interpretation [622]. As all data for
lifespan extension was taken from literature and therefore not acquired under standardised
conditions, it is hardly surprising that a model using absolute numbers may not be robust.
Thus, the two PLS against rank models were built, in which the leverage of some extremely
long-lived mutants, such as the daf-2 ; clk-1 double mutant, is reduced. These models were
expected to be more robust, as they should help compensate for problems arising from the
comparison of absolute lifespan extension data across different labs, as such data tend to
be variable [108].
Thus, it may be concluded, that no robust, multivariate metabolic predictor of longevity
can be found using the employed method. It is very likely, however, that removing sample
groups from this model will increase its predictive abilities and lead to such a signature
for certain subgroups, as already demonstrated for insulin like signalling [183, 392] and
mitochondrial [77, 75] mutants. The global PLS models are trying to model too many
different factors. The next obvious step is to consider univariate methods. As individual
biomarkers may even be preferred over multivariate signatures for biological interpretation,
it was decided to find lifespan-correlated metabolite candidates.
V.3.4.4. Inter-strain comparison shows a distinct, systematic metabolite signature
The most basic univariate method may be a simple significance test, such as a t-test. These
are often used as an initial filter for omic data, to reduce the number of variables to only
statistically relevant ones [582, 435, 120]. During a first, coarse filtering step, type one er-
rors, arising from multiple testing may be accepted in order to avoid type two errors. This
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is perfectly justifiable, if any hits will be subject to rigorous statistical follow up testing.
Figure V.14a shows a strain versus variable (metabolite) heat map. The colour corresponds
to the (log 10) p-value of a t-test between the mutant and its corresponding control, for any
given variable. Clearly, as already gauged from the individual PCA and PLS-DA models,
certain strains are more distinct from wild type than others. Any clusters in this heat
map are non-directional, i.e. they are grouped by affected metabolite candidates, rather
than by clusters of up or down regulation. Figure V.14b shows the (log 2) fold change of
each mutant’s variables versus control. Some systematic metabolite patterns across most
strains can be seen. Several metabolite candidates are increased or decreased by over 8
fold. However, not all strains seem to be subject to these systematic concentration changes
to the same degree. In fact, when only fold changes which are significant (t-test p < 0.05)
are considered, some of the strains appear to be fairly unaffected. This can be seen in figure
V.14c, which is a combination of figure V.14a and V.14b and assigns all non-significant
(t-test p > 0.05) comparisons a zero fold change.
Overall, there appears to be no pattern correlated to DAF-16 dependence, nor clear func-
tional clustering of genes acting by the same mechanism/pathway of lifespan extension.
However, some do cluster, such as the mitochondrial (MIT) mutants. Surprisingly, the
insulin like signalling (ILS) mutants do not. The ILS; MIT (daf-2; clk-1 ) double mutant
and the daf-2 mutant itself show the most consistent and distinct signature. The clk-1 sig-
nature itself is far away, indicating a dominating contribution of the ILS pathway to this
extremely long-lived double mutant. Generally, mitochondrial and ILS mutants appear to
be very similar in their metabolic response, which is intriguing, given their assumed inde-
pendence. The lifespan of the SOD mutant has also been challenged. However, it shows
a distinct metabolic response, similar to the one of many other lifespan extending muta-
tions, such as ILS and MIT. Also the TOR-dependent translation mutants, particularly
the rsks-1 mutant, have distinct patterns. It shares parts of the common signature, but it
also has unique features, which is in agreement with its independence of most other known
life-extending mechanisms. Many of the less well-characterised sensory mutants produced
a signature which aligns with the overall pattern, confirming that they eventually feed
into classic downstream longevity mechanisms. Knockout of rle-1, which degrades the key
longevity regulator DAF-16, leads to a very similar pattern as knockout of the DAF-16
suppressor daf-2 itself. Still, it is not clear why other members of the ILS cascade (such
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(a)
(b)
(c)
Figure V.14.: Clustered heat maps of (significant) fold changes:
Figure V.14a: All metabolite candidates significantly different from control
(t-test p < 0.05); figure V.14b: Fold changes of all metabolite candidates
(mutant vs control); figure V.14c: Combination of both figures: Only
significant (t-test p < 0.05) fold changes are considered. For details, please
refer to the text.
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as age-1 or akt-1 ) failed to reproduce the daf-2 signature. However, some other mutants
also had little to no significant metabolite changes, e.g. the overexpression mutants jnk-
1 and sir-2.1. Also the fertility (FERT) and dietary restriction (DR) mutation did not
show a strong phenotype, but still had some metabolites which followed the overall pattern.
Overall, however, there certainly appears to be structure in the dataset, with commonly
up and down regulated metabolite candidates. But what is its cause? One property all
mutants have in common is modulation of life expectancy. Thus, in the next step, it
was tested whether some metabolite candidates had a direct correlation with mutant life
expectancy.
V.3.4.5. The inter-strain metabolite signature is correlated to life expectancy
In the above analysis, a common pattern of co-regulated metabolite candidates across
many of the strains was detected. It was hypothesised that this could represent a global
signature, correlated to life expectancy. Hence, all individual metabolite candidates were
correlated to life expectancy. Figure V.15 shows the results. (The overexpression mutants
were excluded.)
Both, parametric Pearson correlation (figure V.15a and V.15b) and the more conservative
non-parametric Spearman rank (figure V.15c and V.15d) correlation were used. All cor-
relations were also validated by assigning permutation (k = 104) derived p-values to each
correlation. Two permutation approaches were used. Individual sample (figure V.15a and
V.15c) and group-wise (figure V.15b and V.15d) permutation. For the individual sample
permutation, the lifespan extension vector was permuted randomly. When group labels
were permuted, all replicates of one strain received the same lifespan extension. Thus,
the most liberal and conservative scenarios are displayed in figure V.15a and V.15d, re-
spectively. Many metabolite candidates show a clear and statistical significant correlation
with life expectancy. Both positive (direct) and negative (indirect) correlations can be seen.
Figure V.16 shows the heat map, but also gives the correlation coefficient and p-value of
the correlation for each metabolite. It also indicates whether the metabolite is a lipid.
It can be seen that metabolite candidates subject to the global fold change pattern also
have significant correlation to lifespan. This confirms the hypothesis that the inter-strain
pattern, which dominates the dataset, describes the link between metabolite concentra-
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Figure V.15.: Univariate intensity - lifespan correlation for each metabolite:
The correlation coefficient between intensity and lifespan extension was
calculated for each metabolite individually. In figure V.15a and V.15b the
Pearson correlation coefficient (R) was used. The nonparametric Spearman
rank correlation coefficient (ρ) was used in figure V.15c and V.15d. The
colour scale corresponds to the correlation coefficient’s magnitude and
direction. The size of each scatter point increases with the correlation’s
significance, expressed by its p-value. To calculate the p-value, the
individual label (V.15a and V.15c) and group (V.15b and V.15d)
permutation approach, described in the last section, were used. All grey
data points did not reach a significant p-value (p ≤ 0.05).
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Figure V.16.: Intensity fold change and life expectancy correlation:
This figure combines the information from figure V.14b and V.15d. Next to
the log 2 fold change heat map (vs control), it plots the correlation
coefficient for each metabolite with life expectancy and the significance
level of the associated p-value. It can be seen that metabolite candidates,
which are associated with the inter-strain metabolite pattern also
significantly correlate with life expectancy. Many are lipids.
tions and life expectancy. Furthermore, most of the metabolite candidates significantly
correlated with life expectancy are lipids.
V.3.4.6. Particular phospholipid classes correlate with life expectancy
As shown above, many different metabolite classes are directly correlated to longevity.
As the molecular compositions for all of the metabolite candidates are known, database
searches can provide putative assignments for each correlation readily. However, as each of
those correlations could tell its own story and generate hypotheses, looking at individual
metabolite candidates would exceed the scope of this thesis. Thus, it was decided to con-
tinue with ”big picture” analyses, focusing on metabolite classes, rather than individual
206 V.. A metabolic model of longevity in C. elegans
compounds.
Lipids were clearly the most significant metabolite class. Even in the most conservative
scenario (figure V.15d), many late retention time features have significant correlation co-
efficients. Within those, two main clusters exist. At around 800 seconds, there are several
features, which are negatively correlated. At around 900 seconds, however, many features
have a positive coefficient of correlation of up to R ≈ ρ = 0.45. When comparing the two
correlation clusters with the atom-count plots from figure V.5, various sub clusters can be
seen with different nitrogen, oxygen and phosphorus counts in particular. This is not sur-
prising, as those elements differentiate between different lipid classes, for example between
phospholipids and triglycerides. To find out more about the nature of those correlated
clusters, an attempt was made to visualise the different lipid classes.
Figure V.17a shows a 2-D chromatogram of the lipid region, with different lipid groups
highlighted. A lipid group was defined as metabolites with equal oxygen, nitrogen and
phosphorus atom counts (table V.17b). These groups do not unambiguously correspond to
biological lipid classes, such as those defined by LipidMaps [550], but are a good estimation.
Some of the lipid classes were putatively assigned. The early retention time cluster consists
of lipids carrying one fatty acid (FA), and the late retention time cluster are lipids with
two fatty acids. In the second cluster, many lipids are subject to in-source fragmentation:
the loss of the phosphocholine head group or one fatty acid can be observed. Thus, these
signals are in the same mass range as the mono-fatty acid cluster, but may be discarded
from further analysis. Figure V.17a also shows how the two correlation clusters (and some
surrounding lipids) themselves readily divide into different subgroups. Those subgroups
are lipid clusters of the same lipid class, but with different carbon and hydrogen counts,
i.e. different FA chain lengths and degrees of saturation. Figure V.17c and V.17d show
the positively and negatively correlated lipids, respectively.
All of the correlated lipid classes are glycerophosphocholines, also referred to as phos-
phatidylcholines (PC), as the loss of specific in-source fragments shows (see appendix
figure C4.4). Those decreased in long-lived mutants have one FA conjugated to their
glycerol backbone (monoacylglycerophosphocholines, monoAcPC), and the ones increased
carry two FAs (diacylglycerophosphocholines, diAcPC). monoAcPC and diAcPC are both
phosphatidylcholines, which have their FAs linked to the glycerol backbone via ester bonds.
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Figure V.17.: Different lipid classes determine life expectancy:
Figure V.17a groups all lipids in groups of of common oxygen, nitrogen and
phosphorous count (legend in figure V.17b). Major upregulated and
downregulated lipid classes, together with their putative assignments, are
shown in figure V.17c and figure V.17d, respectively.
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Another upregulated group were 1-alkyl,2-acylglycerophosphocholines, which have one FA
linked as an ester, the other one as an ether. In the second cluster, there are also a few
dialkylglycerophosphocholines and sphingomyelins, which are lipids with their FAs linked
via two ether bonds or via an amide bond, respectively. However, as the mono- and di-
acylglycerophosphocholines represent the lion’s share of all correlated lipids (nmono = 119,
ndi = 125), only those were considered further.
(a) (b)
Figure V.18.: Chain length, degree of saturation and correlation with life
expectancy of mono- and diacylglycerophosphocholines:
The degree of saturation, i.e. the average number of double bonds per fatty
acid (FA) and the average carbon chain length is plotted for all
monoacylglycerophosphocholines (monoAcPC) (figure V.18a) and
diacylglycerophosphocholines (diAcPC) (figure V.18b). For better
comparison, for the diAcPC, the number of double bonds and chain length
is scaled to a per fatty acid, rather than per molecule basis. For the diAcPC
a red median regression line (Tukey’s median median) [581] is drawn
between the significantly (p ≤ 0.05) correlated metabolite candidates.
The oppositely correlated lipid classes were primarily differentiated with regards to the
number of fatty acid tails per glycerophosphocholine backbone. However, they may also
differ by the nature of the coupled FAs. Two main properties that characterise a FA are
their carbon chain length and their degree of saturation. (The position of the double bonds
may also be of interest, but was not considered here as it would require a different exper-
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imental approach, such as MS-MS fragmentation studies or lipid fractionation, hydrolysis
and subsequent GC-MS analysis.) Those two properties and the correlation coefficient and
p-value from last chapter’s correlation analysis (figure V.15d) are displayed in figure V.18.
Figure V.18a shows that all significantly (p ≤ 0.05) decreased monoacylglycerophospho-
cholines carry saturated or monounsaturated fatty acids (MUFA). As seen in figure V.18b,
the significantly (p ≤ 0.05) increased diacylglycerophosphocholines are linked to fatty
acids of various degrees of saturation. Their fatty acids can be polyunsaturated fatty acids
(PUFA) with up to 5 double bonds. On average, the monoAcPC had higher fatty acid
chain lengths than diAcPC lipids. For the significantly changed diAcPC, a direct corre-
lation between chain length and number of double bonds is visible. Indeed, both values
correlate (ρ = 0.80) significantly (p < 0.0001), according to a Spearman rank correlation
test.
210 V.. A metabolic model of longevity in C. elegans
V.4. Discussion
V.4.1. A fair compromise between targeted and untargeted
Metabolomics [171] and metabonomics [444] were introduced as completely untargeted
approaches, aiming to assess concentrations of all metabolites within a given matrix.
Metabolomics was soon recognized as a powerful tool for hypothesis generation, and for
functional genomic annotation [485, 440, 211]. However, a completely untargeted strategy
also has drawbacks. Modern instruments produce so many data, it becomes impossible to
annotate every molecule or even assess whether a peak is an actual metabolite. As shown,
the vast majority of peaks are real signals, but are not biologically relevant. The risk of
misleading findings increases with the number of detected signals.
For those reasons, targeted approaches, which try to assess a limited, but known subset
of metabolites have become more popular. For LC-MS, two groups have developed this in
particular: the Sauer [68] and Rabinowitz [29, 375] group from ETH and Princeton, respec-
tively. Targeted methods are particularly powerful for hypothesis testing, as the activity
of whole biological pathways [457, 168] can be reconstructed. This allows for more direct
biochemical modelling approaches, rather than purely statistical ones. Targeted analysis
requires some a priori decisions with regards to the metabolites. This, however, may miss
biological information.
Here, an approach is demonstrated to annotate all biological peaks within a matrix and
target them in the dataset. This method removes non-biological signals, and also removes
redundancy within the biological signals; M +n isotope peaks for example. Adducts could
also potentially be removed, although this was not done here. Fragments, however, were
annotated and removed from the data analysis. Removing redundancy not only reduces
the risk of false positive assignments, it also improves the quality of multivariate mod-
els, by giving equal weight to each metabolite - rather than each signal. Thus, more
liberal and potentially revealing modelling approaches may be used. After modelling rel-
evant metabolites may even be identified more rapidly, as the molecular composition is
already known. Unfortunately, one molecular composition may represent several metabo-
lites. Thus, pathway based modelling approaches may not be feasible, without further
identification. However, as demonstrated, metabolite subclasses, such as lipids, including
their properties, such as number of carbon chain length or degree of saturation, can readily
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be assessed and compared.
Despite all those benefits, the strategy also has certain drawbacks. Firstly, it requires the
sample to be stable isotope enriched, which may exclude some common samples, such as
biofluids. However, it may be possible to use an E. coli or yeast extract to assign common
metabolites, within those matrices. Another potential problem is that only metabolites
which were assigned in the first instance can be found in the dataset. Thus, if labelling
is performed using the control samples, but a certain biomarker is only visible within one
treatment condition, this molecule may be missed. However, it is questionable whether
this risk outweighs the risk of a false assignment in an untargeted study or justifies the
resources to produce a stable isotope version for each experimental condition, such as
required by IROA (isotope ratio outlier analysis) [131, 69]. However, if an additional un-
targeted analysis of the data is performed, the true biological peaks may help with feature
alignment or even improving the peak detection parameters in the first place. It may also
be possible to predict the retention time [419, 117] and m/z of missing metabolites of a
certain group. For example, the position of undetected members of a lipid class may be
inferred by interpolating between the chain lengths and degree of saturation of annotated
members of this class.
In the end, the choice of a method will depend on the application. The method described
here is a good compromise between targeted and untargeted approaches. Ultimately, there
can never be a truly untargeted method, as every analytical platform is selective towards
certain compound classes [98].
V.4.2. An increased phospholipid pool links C. elegans longevity
pathways
In this project, a large array of C. elegans mutants, which are long-lived due to modulation
of various (independent) mechanisms of lifespan extension, were queried for their common
metabolic changes. There was a clear set of commonly up and down regulated metabo-
lite candidates with respect to controls, and most of those up/down regulated metabolite
candidates had a significant correlation with life expectancy. The bulk of those potential
longevity biomarkers are phospholipids. This is exciting, as recently research has found
that many different core longevity mechanisms are tightly linked and dependent on lipid
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metabolism itself [1, 346, 226]. In this study, two main lipid clusters could be identified.
Glycerophosphocholine lipids linked to one fatty acid showed a negative correlation with
longevity, and lipids with two fatty acids, showed a positive correlation. The downregulated
lipids were monoglycerophosphocholines (lysophosphatidylcholines), but several different
classes of 2 fatty acid lipids were upregulated. However, the majority of those were diacyl-
glycerophosphocholines (phosphatidylcholines).
How are these lipid classes connected? Diacylglycerophosphocholines are a major con-
stituent of the phospholipid bilayer and a hub of lipid synthesis pathways [158]. However,
monoglycerophosphocholines (monoAcPC) and diacylglycerophosphocholines (diAcPC) can
be converted into each other by fatty acid cleavage or transfer through phospholipase A
and acylglycerophosphate acyltransferase, respectively. Thus, the simplest explanation
for the observed strong increase of diAcPC and generally much less severe decrease of
monoAcPC would be an increase of the diAcPC pool, depleting the monoAcPC reservoirs.
This would also explain why in several independent studies [126, 183, 15] some long-lived
mutants had a significant decrease of free glycerophosphocholine base - the precursor for
monoAcPC. Indeed, Perez et al.[474] found that daf-2 mutants, which had the most severe
diAcPC/monoAcPC in-/decrease in this study, have an increased overall phospholipid pool
(compared to wild type), with a significant contribution from de-novo synthesis. Thus, it
seems that all mechanisms of lifespan extension share an elevated pool of phospholipids,
and phosphatidylcholines in particular. But what is the mechanism behind this link?
Lipids are an organism’s major long-term energy store. However, in C. elegans, there is
no general correlation with total lipid storage and longevity. Germline as well as insulin-
like signalling mutants have elevated fat stores [608, 474]. Dietary restricted mutants,
which show the same general pattern in this study, are lean. Lipids, including certain
phospholipids, act as specific signalling (second messenger) molecules [642]. However, in
this study a non-specific increase of whole lipid classes, rather than individual (signalling)
molecules, was observed. As phosphatidylcholines are the main constituent of biological
membranes, maybe an increase in phospholipids coupled to specific fatty acids, i.e. the
change of certain biophysical membrane properties, may prolong lifespan. Recently, Reis
et al.[489] suggested that some of the longest lived ILS mutants, such as certain daf-2
alleles, show an increase of more saturated fatty acids, and therefore are less prone to
peroxidation. However, there is an agreement that the radical oxygen (ROS) theory is too
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simplistic and fails to explain many mechanisms of lifespan extension [139], particularly as
several modes of lifespan extension seem to depend on ROS or are even mediated by ROS
[26, 268, 648]. Also, the superoxide dismutase mutant, which was analysed showed the
general longevity pattern [589]. In this study, the degree of saturation of the significantly
increased diacylglycerophosphocholines was analysed. There was no selectivity; saturated,
mono saturated and even many polyunsaturated fatty acids were found to be conjugated.
There was a correlation between the number of double bonds and fatty acid chain length,
but this, however, is a known biochemical mechanism [563, 433] to maintain the physico-
chemical properties of the lipid membrane: decreased membrane fluidity due to increased
fatty acid chain length can be offset by introducing more double bonds. Thus, overall,
there seem to be no longevity effects due to changes in the physicochemical properties of
the phospholipid bilayer itself. However, the phospholipid bilayer does not only make up
the cell membrane. In fact, the cell membrane only constitutes two percent of a cell’s
phospholipid bilayer [7]. Phospholipids provide all means for compartmentalisation to the
cell. Thus, more phospholipids will provide more compartmentalisation.
What does increased compartmentalisation have to do with longevity? Potentially, a lot.
A third and nearly half of a cell’s total phospholipid bilayer is used to form the cell’s mito-
chondria and the Golgi apparatus plus endoplasmic reticulum, respectively. There is ever
increasing evidence that these two organelles act downstream of many classical longevity
(signalling) pathways to provide two key longevity effector mechanisms [371]: improved
bioenergetic competency and mitochondrial biogenesis [66, 493, 26, 28], and an increased
recycling of unused or damaged cell organelles and biomolecules by means of vesicular
autophagy [383, 505]. Both processes require an increased amount of compartmentali-
sation and therefore phospholipids, as summarised by figure V.19. As recently shown,
lipolysis also works by autophagy. Thus, the joint process of lipolysis and autophagy has
been termed lipophagy [526]. Indeed, in most long-lived mutants, next to autophagy, a
large scale remodelling of lipid pools, mainly a lipolysis of triglyceride stores, can be ob-
served [458]. Dietary restriction [283, 576, 425], sirtuins [425, 426], insulin-like-signalling
[576, 232, 608] (and therefore sensory mutations and DAF-16 degradation machinery),
TOR [576], germline signalling [608, 345], decreased mitochondrial respiration [576, 649]
and possible SOD downregulation all implicate or even depend on lipophagy for lifespan
extension. The translation mutants, particularly rsks-1 showed a metabolic phenotype
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Figure V.19.: Proposed model of longevity through increased
compartmentalisation:
Longevity pathways, which in literature have been shown to act through
the corresponding effector mechanism are coloured in blue. This diagram is
an over-simplification of the actual pathways themselves. Please also refer
to the introductory figure V.1 and the referenced literature.
which was distinct, but slightly different from the common pattern. This confirms that
they can perform lipophagy, but do not depend on it and there are additional effector
mechanisms this model cannot account for. Autolipophagy is also a major survival mech-
anism, which is required for the extreme longevity of the dauer larval stage [410]. Thus,
increased compartmentalisation may simply provide means to an organism, to utilise its
resources more efficiently and renew its organelles, which effectively eliminates damage and
leads to a ”younger” phenotype. Decreased ageing and longevity would be the consequence.
V.4.3. The next steps
A simple model was proposed, which explains this experiment’s results and is in agree-
ment with all major lifespan extension pathways. However, a few mutants, such as the
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hif-1 mutant, failed to show the common pattern. Perhaps this mutant simply did not
extend longevity under the experimental conditions used. Indeed, for hif-1, which is tem-
perature sensitive, 20°C leads to a modest increase in lifespan, if any [356]. Thus, while
it was not feasible to perform longevity assays for all of the mutant strains in this thesis,
ideally they would be repeated rather than relying on literature data. This would almost
certainly improve the statistical relationships found, as exact lifespan extension values are
notorious for varying slightly between labs.
In this thesis, only positively ionised metabolites which retained on reversed phase were
analysed. For more comprehensive coverage, however, both ESI modes and different modes
of chromatography should be used [588, 67]. This could easily be done in the future. It
would be interesting to look at central carbon metabolism, and energy, redox and lipid
biosynthesis precursors particularly. Energy and redox equivalents are the triggers for the
AMP-kinase (AMPK) [20] and Sirtuin [270] lifespan extension mechanism, respectively.
daf-2 was shown to have an altered carbohydrate and amino acid metabolism [183] and
mitochondrial mutants modulate small organic acid metabolism [75]. More detailed lipid
analysis could also be performed. Unfortunately, due to the chosen extraction method
[187, 186], triglycerides were not extracted. However, methods for C. elegans lipidomic
analysis have been published [396], and again could easily be adopted in the future.
The workflow needs further development in general. For now, only molecular compositions
are generated. Using MS/MS fragmentation, those compositions could be converted to
actual metabolite (names). It would be easy to implement, to have automatically gen-
erated MS/MS target lists for all peaks identified as being of biological interest. The
resulting fragment spectra could be matched against fragmentation databases [530, 251].
If a metabolite could not be matched within such a database, in silico fragmentation tools
[632, 193] may be used. A new tool, LipidBlast, recently developed by Kind et al.[322]
may be helpful to assign the fatty acids conjugated to lipids. In any case, putting actual
names to metabolite candidates would enable a whole new dimension of analyses, such as
pathway based modelling approaches.
Finally, the proposed model will require some biological validation. It would be interesting
to see how lipids change over time. The challenges of such time-course ageing experiments
will be discussed in the next chapter. Molecular methods may be used for hypothesis
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testing. Particularly imaging approaches, like mass spectrometry based imaging [545], also
discussed in the final chapter, may help to determine whether the compartmentalisation
hypothesis is correct.
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V.5. Conclusion
This chapter applied the method developed in the previous chapter to annotate C. elegans
metabolites in a panel of long-lived mutant strains to find a common metabolic signature
of longevity.
760 biological peaks were detected and assigned with molecular compositions. This equated
to a data reduction of over 99.5 %. However, as shown later, this still includes (lipid) frag-
ments and adducts. Those metabolite candidates were detected in a dataset of 24 long
lived C. elegans mutants with various mechanistic bases for lifespan extension. It was
shown that metabolite candidates can be used to align all samples of the dataset; at a
step where standard algorithms failed. Also, this chapter provided a good example of how
processing parameters can be chosen on a rational, experimental basis, rather than by best
guess or relying on default values only. Univariate and multivariate models were built to
find a common signature of longevity: lipids were a key metabolite group, with a sharp
increase in phosphatidylcholine concentrations across all strains. This led to the formula-
tion of a model, in which increased phospholipids provide the cell with additional means
of compartmentalisation. This compartmentalisation is used to invoke a common effector
mechanism of many of the longevity pathways - lipophagy. Also, it allows for increased
mitochondrial biogenesis. It may be concluded, that by providing the structural means to
perform recycling of old, unused and damaged cellular material, an increase of the phos-
phatidylcholine pool enables an organism to rejuvenate itself and become long-lived.
VI.. General discussion, future
technologies and perspectives
The overall aim of this PhD was to develop methods for metabolomic analysis of the model
organism Caenorhabditis elegans, that could then be applied to questions of ageing. A spe-
cific focus was to combine state-of-the-art analytical chemistry and computational data-
processing approaches. Ultimately, several software tools and workflows were developed
which could be useful not only for C. elegans ageing research, but the wider metabolomics
community, particularly for work with model organisms. The final two experimental chap-
ters showed how powerful the combination of analytical and computational approaches can
be, when applied to important biological questions.
In this chapter, an overview of the major findings will be given, and two new approaches
presented, which have a high future potential in this area. The relevance of this thesis to
the current state of metabolomics and ageing research will be discussed.
VI.1. Summary of the key results
The first results chapter laid the basis of this PhD by developing an extraction proto-
col which maximises coverage, yield and reproducibility, and is compatible with multiple
analytical platforms. As well as deciding on a final optimized method, 80 % methanol
extraction using a bead-beater, this chapter also provided a first snapshot of the C. ele-
gans metabolome on these three platforms. The chapter focussed on the (often neglected)
tissue disruption requirement for metabolite extraction, and also found that the solvent
system used had a large impact on the final result. A generally applicable key finding
was that certain extraction protocols may appear to work well on one, but not on another
analytical platform. Thus, it was recommended to, ideally, always benchmark protocols
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across multiple analytical platforms. Finally, it also identified limits and shortcomings of
the three analytical platforms for C. elegans metabolomics, which were addressed in the
next two chapters by extensive method development.
In the second results chapter, simple improvements to methods were tested, which aimed
to address limitations of the the used workflow or NMR and GC-MS metabolite profiling,
with a particular focus on improving metabolite annotation and assignment.
A method to automatically annotate HSQC spectra was developed. For sensitivity im-
provement, the C. elegans, worms were fully 13C enriched. Adoption of a new heteronu-
clear 2D pulse sequence, widely used in structural biology for labeled proteins, yet untested
for small molecule analysis of stable isotope enriched samples (ct-HSQC), reduced carbon-
carbon splitting. Removal of this ”artefact” meant that it was feasible to use the labeled
samples to improve sensitivity, yet still peak pick the spectra and to match against the
online databases. This gave quick and comprehensive automatic assignment of many of
the small molecules of this extract. These were ”pre-validated” in the sense that many of
them had already been assigned manually in the first chapter, but it demonstrates proof-
of-principle that the approach worked, while giving greater coverage of the C. elegans
metabolome.
Next, a LC-NMR ion-pairing strategy was developed. It was found that deuteration of
the ion pairing reagent does not negatively impact separation performance, but improved
spectral quality by silencing of its otherwise NMR visible protons. In general, ion-pair chro-
matography separated several compounds from the NMR visible C. elegans metabolome
and revealed metabolites obscured in conventional 1-D tube-based NMR. It was also shown
that ion-pairing LC-MS is useful to annotate compounds which are difficult to assign in a
1-D or even 2-D spectrum, such as ATP, ADP and AMP.
The final method described in the second results chapter, was a approach to complement
the current library-based GC-MS workflow with an untargeted approach. It was shown that
alignment and overlay of the total ion chromatograms (TIC) of different sample groups is
an effective way to determine differences in metabolite concentration without any a priori
knowledge about the identity of the metabolites. Two additional metabolites were detected
that weren’t identified by the standard workflow, and were significantly different between
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short-lived and long-lived C. elegans mutants. Interestingly, these two metabolites, 2-
aminoadipic acid and 2-hydroxyglutaric acid, have already received significant attention
in the (ageing) literature. The new data could be used to generate hypotheses for future
validation.
In the third results chapter, an isotopic labelling method was developed, which addresses
two current major problems of LC-MS metabolomics: data reduction and compound an-
notation. Complete ab initio molecular formula generation based on accurate mass only is
unrealistic with current technology. However, it was demonstrated that determining the
carbon, nitrogen and sulphur atom-count by isotopic labelling means that all molecular
composition up to 1000 Da can be resolved unambiguously. This led to the formulation of
a triple stable isotope labelling protocol in E. coli, and also C. elegans; the first example
of triple labelling in an animal, although plants have previously been triply labelled. A
software package was developed to analyse the data resulting from LC-MS runs of triply
labelled samples, to detect all peaks of biological origin, and annotate them with their
molecular composition (formula). Using E. coli extracts, it was shown that this software
algorithm works for different chromatographic conditions and for both positive and nega-
tive electrospray ionisation. Most surprisingly, more than 99.9 % of all LC-MS detected
peaks turned out to be non-biological, and hence not metabolites.
The final results chapter used this isotopic labelling method to analyse a set of 24 long-
lived C. elegans mutant strains. First, all biological peaks were annotated with molecular
compositions. In a second step, those target peaks were detected, aligned and integrated
in the mutant dataset. It was shown, that those target peaks can be used to rationally
optimise the algorithm’s parameters and also help to retention time align the samples; a
procedure which did not succeed using other contemporary software packages. Finally,
there was a metabolic signature of long life, i.e. a set of metabolites which were associated
with longevity across the set of mutants analysed. The main metabolites correlated with
longevity were lipids. The calculated molecular compositions could not only be used to
readily annotate different lipid classes, but also to calculate their properties, such as length
and degree of saturation of their fatty acid chains. The long-life signature turned out to
be because of a general increase of the glycerophosphocholines lipid pool. This was used
to propose the ”compartmentalisation hypothesis”. More glycerophosphocholine lipids are
present because they are needed to build sub-cellular membranes for compartmentalisa-
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tion, which form the basis of several recently described longevity effector mechanisms: mi-
tochondrial biogenesis, lipid hydrolysis and autophagy. Thus, it seems that most longevity
pathways share common effector mechanisms, which are linked by a increased requirement
for compartmentalisation and therefore glycerophospholipids.
VI.2. Two key problems and and two promising key
technologies
This thesis provides solutions to several problems encountered in metabolomics. However,
there still remain many questions that require further investigation or improvements in
methodology. Throughout this thesis, suggestions for improvements of the proposed meth-
ods or comments on required biological follow up experiments were made. Rather than
providing another list of hypothetical issues that should be tackled, two promising new
tools that emerged from this work, and their potential to help answer two key questions,
will be discussed. Development of both methods started during this PhD and the proof of
concepts were published [84, 185]. Even though they still require a substantial development
and testing to become routine tools, they both have high potential to help elucidate the
metabolic factors that affect ageing and longevity in C. elegans.
VI.2.1. The problem of measuring ageing: ”The worm sorter”
This thesis’s title is ”Analytical and computational methods towards a metabolic model
of ageing in Caenorhabditis elegans”. The first 3 results chapters were concerned with
developing those methods. The last chapter then used those methods to propose a model
for the metabolic basis of longevity in C. elegans. Whereas longevity is tightly connected
to ageing, metabolic changes throughout the ageing process itself must also be investi-
gated. However, during this PhD it became apparent that several problems would have
to be solved in order to obtain the highest quality data. A key problem is the mixing
of generations. After 3.5 days of development, an adult hermaphrodite worm lays up to
300 eggs, and after another 3.5 days these will produce offspring themselves. By then, the
number of offspring will have superseded the starting generation by more than two orders
of magnitude. This means that it is necessary to separate adults from offspring, otherwise
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synchronized populations rapidly become a mix of adults and juvenile worms.
What alternatives are there to a ”worm sorter”. Worms can be manipulated on a individual
basis and separated from their offspring by transferring them to new agar plates. However,
as this requires daily ”picking” of worms, it is not a viable option for the thousands of
worms required for a single metabolomics sample, with the current analytical workflow.
Another method maintains a large population of age synchronised worms by using mutants
which are sterile when maintained at higher temperatures [287, 377, 432, 227], similar to
the fertility mutants used in the longevity mutant screen. However, as such a condition is
far from normal physiology, impacts life expectancy itself, and as shown in the last chapter
produces a distinct metabolic phenotype, this is not an option either. Another common
method is the addition of FUdR (5-fluoro-2-deoxyuridine) to the medium [224, 353, 340].
FUdR is a mitosis inhibitor. As C. elegans cells stop dividing after the larval stage, FUdR
will arrest all progeny at larval stage but keep their parents alive. Until recently, FUdR
was thought to be rather inert with regards to adult worm physiology. However, it can
significantly extend the lifespan of certain mutant strains [5, 590]. For example, life ex-
pectancy of the gas-1 mutant, analysed in the GC-MS alignment chapter, can nearly be
doubled by the use of FUdR. This effect is even dose dependant [590]. Davies et al.[125] also
showed that FUdR has a significant impact on the metabolic phenotype. It was even able
to suppress metabolic longevity responses of daf-2 mutants; the mutation which showed
the strongest metabolic phenotype in the mutant screen. For those reasons FUdR cannot
serve as a solution to the ”offspring problem”.
Therefore, a microfluidics based solution - ”The worm sorter” - was developed in col-
laboration with Xavier Casadevall i Solvas from the deMello lab [84]. This is a small
microfluidics based device to separate adult worms from their offspring. Microfluidics is
an emerging technology, aiming to produce low-cost [399] devices which can manipulate
fluids on a nanoscale, with applications in chemical synthesis, biological analysis, diag-
nostics and many more fields [623]. It has already been used to to study live animals
like C. elegans[343, 104, 381, 266]. Even some worm sorting systems had been developed.
However, they all rely on high tech instrumentation, involving image acquisition of indi-
vidual worms, computational classification and the actuation of micro-valves to sort them
[503, 100, 267, 116, 507]. In this project, a small, low-cost device was developed (over
several generations), which allows to separate adult C. elegans from their offspring - by a
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Figure VI.1.: The ”Worm sorter” may solve the ”offspring problem”:
The microfluidic device (figure VI.1c) can sort adult worms from eggs, small
and medium worms. It only requires a syringe pump to apply a flow
gradient and another syringe pump (or Eppendorf tubes) to collect the
sorted fractions (figure VI.1a). The sorting is performed by a smart maze,
which redirects adult worms to take a different path than smaller
individuals, which a are simply flushed out through another exit by the
applied flow gradient (figure VI.1b). The ROC curve in figure VI.1d shows
that a high selectivity can be achieved, depending from which output the
worms are sampled.
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passive mechanism. Figure VI.1 shows the setup of this device. It only requires a syringe
pump, but a microscope is useful during the setup phase (figure VI.1a). The chip (figure
VI.1c) contains a smart maze of small channels with six outlets. The syringe pump creates
a flow velocity gradient across the chip. When a mixed population is introduced into the
chip, large worms are redirected by the maze to swim to the opposite side of the chip,
whereas small worms and eggs are directly washed out by the flow(figure VI.1c). Thus,
adult worms can be collected from outlet five and six, offspring (larvae and eggs) from
outlet one and two. As the ROC (figure VI.1d) curve shows, the sorting is highly specific.
In the latest generation devices, 94 % of all adults could be recovered with only 0.2% of
larval contamination and a throughput of 200 worms per minute and chip. However, this
approach is fully scalable by using chips in parallel or series to improve throughput or
separation efficiency, respectively.
Unfortunately, this device is still in an experimental phase, and its operation and setup is
still not straightforward. However, as the development is being continued by the deMello
lab, one day, it will hopefully provide a superior alternative to all other solution’s of the
”offspring problem”. This would allow time course experiments to analyse the impact of
metabolism throughout the actual ageing process of a synchronous C. elegans population.
VI.2.2. Biology is spatial: TOF-SIMS
Paradoxically, a model of increased compartmentalisation was proposed on the basis of an
extract, generated from thousands of worms, each with a thousand cells, which may have
thousands and millions of compartments themselves. Averaging over thousands of individ-
ual systems, to provide an integrated phenotype is both a strength and the weakness of
metabolomics [441]. However, validation of this hypothesis may require more specific tech-
niques, which are able to show an increase in compartmentalisation, such as an increased
autophagy and mitochondrial biogenesis.
As those processes are all at an upper nanometre scale [650], this stretches the limits of
classic light microscopic techniques and confocal or even electron microscopy would be
the preferred method [222]. Microscopy in general, however, does not provide chemical
information. Thus, mass spectrometry based imaging is becoming an increasingly popu-
lar technique [545, 233, 447, 466]. Many different techniques exist, with matrix-assisted
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laser desorption ionisation (MALDI) probably being the most prominent. MALDI, how-
ever, works on a scale of several tens of micrometers [13, 112, 448] and therefore is not
able to obtain cellular or sub cellular information from C. elegans[318]. Another tech-
nique, secondary ion mass spectrometry (SIMS) can be considered a cross between a mass
spectrometer and an electron microscope [393], even with high mass accuracy capabilities
(ToF-SIMS) [209]. Therefore SIMS should operate at the right length scales to visualise
an increase in compartmentalisation. Indeed, ToF-SIMS was shown to be able to image
a phospholipid bilayer with a lateral resolution of 100 nm or less [215]. In fact, lipids,
with cholesterol and phospholipids in particular, are a molecular class which allows for
very sensitive ToF-SIMS analyses [528, 406, 178]; even quantitatively [459]. It was even
demonstrated that different lipid chain lengths can be discriminated [491]. Also, not possi-
ble with any of the other methods, ToF-SIMS can perform depth profiling. By abrogating
the specimen’s upper layer with the ion gun and subsequent imaging, ToF-SIMS can even
produce 3D chemical images of single cells [177, 59]. Also, by using stable isotope labels
the spatial dynamic of biomolecules inside single cells can be studied [543].
To evaluate the opportunity of using ToF-SIMS for spatial C. elegans metabolomics, a
pilot project, together with Sarah Fearn and David McPhail from the department of ma-
terials science at Imperial College was initiated. Some of the already published results
[185] are shown in figure VI.2. As figure VI.2a shows, ToF-SIMS imaging of worms, fixed
by freeze-drying [389], was able to prize out morphological structures, which otherwise are
only visible by electron microscopy. Unsupervised principal component analysis was also
able to discriminate between the extracts of a wild type and daf-2 mutant (figure VI.2b).
In another experiment, it was possible to discriminate between different lipid classes (not
shown).
However, in order to be able to use ToF-SIMS to answer biological questions, it is nec-
essary to optimise sample preparation, in order to be certain that observations are not
due to sample preparation artefacts [389]. Classic techniques for producing thin sections
for EM involve resin embedding, which preserves macromolecular ultrastructure but com-
pletely destroys metabolic information. Cryosectioning approaches are challenging, even
simply being to locate an individual worm at the correct orientation. However, ToF-SIMS
promises to be a promising tool of great value to bring a spatial component to C. ele-
gans metabolomics. Some of the key biochemical phenomena underlying ageing, such as
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Figure VI.2.: ToF-SIMS imaging mass spectrometry:
ToF-SIMS can perform mass spectrometry based imaging, but at a electron
microscopy like resolution. Figure VI.2a shows an imaged C. elegans larva,
with sections of the head magnified. Morphological structures are clearly
visible. However, these are false colour images of the total ion count. In
fact, each pixel contains a complete high resolution mass spectrum. Figure
VI.2b shows that a principal component analysis can discriminate between
a ToF-SIMS acquired extract of a daf-2 mutant and wild type. All data
were acquired using a Bi3+ cluster liquid metal beam [577]
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autophagy, cannot be fully understood without the spatial component [346, 458]. Indeed,
not only for ageing but for many other kinds of biological phenomena that could be studied
by metabolomics in C. elegans , imaging mass spectrometry, and other approaches such as
Raman microscopy, can provide information not available any other way.
VI.3. Current issues
This section puts some of the key contributions of this PhD into the wider context of
metabolomics and (C. elegans) ageing research.
VI.3.1. Metabolomics
In a comprehensive review, Dunn et al.[143] discuss ”growing pains” in the field of metabolomics.
The number one pain is ”Chemical identification of metabolites”; methods are needed to
automatically assign all metabolites contained inside a sample, rather than manually iden-
tifying metabolites of biological interest. Exactly this issue has been addressed by some
methods proposed in this thesis. The 13C ct-HSQC annotation workflow provides such a
tool for NMR, albeit limited to metabolites present in the spectral database; which in this
thesis was a fair amount of all resonances. Putative assignments will obviously require
manual validation to cut down false positives. The other method, which works without
any a priori metabolite information, is the isotope annotation workflow. This method has
many applications, as shown in the last chapter. Unfortunately, this algorithm cannot
deliver metabolite IDs. However, given the recent progress in in silico fragmentation tools
[632, 193, 322], reliable automatic generation of metabolite IDs may not be far off. The
analysis of the lipid classes in the longevity mutants was a demonstration of the type of
analyses that could be performed, if all metabolites were annotated in each single study.
Another issue, albeit rarely mentioned, is the correct choice of parameters. Metabolomics
is very dependent on computational tools, and correct parameter settings are crucial to its
output and therefore success [142, 62]. Whereas this goes without saying for many wet lab
procedures, such as actual sample acquisition, it often seems to be ignored at the sample
processing stage. There are many possible reasons: not understanding the importance of
parameter settings; uncertainty about how to optimise them; or even lack of access to
these parameters, particularly with modern ”push button” solutions on the rise. While
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such solutions may outperform inexperienced users, they cannot outperform experienced
operators and also bear a risk of producing subptimal output. In this thesis, no parameter
was left at default value. An attempt was made, to rationally find the optimum for each
processing parameter. For example, it was found that certain peak detection parameters
are even selective towards biological peaks. Even though those optimisations were facil-
itated by the fact that all code was developed or optimised by the user, such a rational
search for the best variables should be encouraged within the community. People must
realise, that correct parameter choices may contribute towards the quality of the result
on a similar scale, as good practice sample quality control measures [511] and rigorous
statistical data handling [61].
VI.3.2. (C. elegans) ageing research
Over the last two decades, much work has been done to elucidate pathways that affect
lifespan. Major labs have worked on different parts of those different signalling network.
Also, more work has been done on the signal transduction, rather than the downstream
effector mechanisms, which ultimately lead to the lifespan extension. However, in the last
few years, there has been a push to identify these mechanisms, such as the unfolded pro-
tein response [147], lipophagy [345] or mitochondrial biogenesis [26]. Unsurprisingly, most
of the major longevity signalling cascades, often studied in isolation, ultimately feed into
these few effector mechanisms. A common endpoint, downstream of various (independent)
pathways, can be observed in the form of a common metabolic signature of the longevity
mutants. This demonstrates that metabolomics, as the most downstream and integrated
endpoing of an organism’s gene, transcript, protein, metabolite cascade, was an appropri-
ate tool to identify a common signature. Providing this integrated phenotype, is a key
strength of metabolomics, and perhaps the more upstream or more specific ”omics”, such
as transcriptomics or proteomics, may have not succeeded.
But, as metabolomics is unspecific, those other, more specific ”omics” will be required
to validate the proposed compartmentalisation model. Obviously, as worms are a simple
model organism, this hypothesis must also be validated in other, more complex mammalian
model systems, such as mice. Ultimately, it also has to be tested in humans, which for
any scientific model is the most challenging task. However, very recently a clinical study
on long-term dietary restriction in humans showed an up regulation of autophagic activity
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and mitochondrial biogenesis and generally ”younger” transcription profiles [411]. This is
in absolute agreement with the model proposed here, which therefore may be applicable to
human longevity and ageing; particularly as the molecular mechanisms this model relies
on are very conserved.
Some of the mutations studied were in genes which, under physiological conditions, are
modulated by the environment, such as the sensory mutants, the dietary restriction mutant
and even the insulin like signalling mutants. This implies that genetic and environmental
influences jointly affect the level of effector mechanisms. Thus, the same lifespan extension
may be reached by environmental intervention or genetic predisposition. If this was also
true for humans, the presence of common gene-environment longevity effector mechanisms
could provide a molecular explanation, for the increase of life expectancy, observed in de-
veloped countries. It would also mean, that longevity may be modulated by conscious
lifestyle decisions.
VI.4. Conclusion
In summary, combining methods from different fields, such as chemistry, biology and com-
puting, can address questions that are difficult to answer within a single discipline.
The methods developed in this PhD thesis have addressed current needs for metabolomics
in C. elegans and have also provided new insights into how different mechanisms of lifespan
modulation may be linked on a molecular level.
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Appendices
Theory and methods
This chapter aims to revise and summarise the basic concepts behind the science[173, 561,
479] and methods used in this thesis and may be referred to, when trying to understand
the exact methodologies of the experimental chapters. Particularly as methods are a ma-
jor emphasis of this work. Even though this chapter is very detailed and concepts are
supported by illustrations, whenever possible, it is far from comprehensive. Therefore, the
reader is advised to refer to the cited literature.
A1. The basic constituents of matter
All matter is composed of atoms [33, 412], mostly in the form of molecules. Atoms them-
selves are made up of an atomic nucleus and the negatively charged electrons surrounding
it. The nuclei itself is a mixture of the positively charged protons and the non-charge
carrying neutrons. A charged atom, i.e. where the proton and electron count differ, is
also called ion. The charge is written as superscript behind the elemental symbol, such
as H+ for a proton. The number of protons is expressed by its proton number. Each
proton number corresponds to a different element, which is written as subscript in front
of its elemental symbol, such as 1H, 7N or 26Fe. The proton number defines an element’s
place in the periodic table and therefore its unique properties. An element, however, with
its constant proton count, may exist with several different numbers of neutrons. Those
variations of an element are called its isotopes, denoted by the neutron count written as
superscript in front of the elemental symbol, such as 1H for the protium and 2H for the
deuterium and 3H for the tritium isotope of hydrogen. Isotopes can be stable or subject
to radioactive decay with an associated half-life time. In nature many element are present
as several isotopes, distributed at a certain ratio. For example, on earth carbon is present
as 12C and 13C, in a ratio of 98.9% to 1.1%. (14C is only available in trace amounts). This
isotope ratio, is also referred to as the natural abundance of an element. When referring
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to the molar weight of a molecule, it is important to know, whether it is the mono isotopic
weight, i.e. the molecule just consists of one specific isotope, or the average molecular
weight, which is a weighted average, according to the natural abundance. For example,
the average weight of glucose at natural abundance is 180.1559 g/mol, whereas the one of
12C glucose is 180.0633 g/mol. [24]
A2. Analytical chemistry
Precise
X = mean of the individual
X
X
X
X
Accurate
Figure A2.1.: Precision and accuracy:
Quantifying a compound in
a matrix may be compared
to hitting a target.
Analytical chemistry is divided into separa-
tion science, qualitative analysis and quantita-
tive analysis. Whereas separation science deals
with the separation of mixtures with more than
one analyte, the other two refer to the mode
of detection. Qualitative analysis is concerned
with identifying the analyte, quantitative anal-
ysis with determining its concentration within
a matrix. Most detection methods of mod-
ern analytical chemistry, such as mass spec-
trometry (MS) or nuclear resonance (NMR)
spectroscopy can perform both, qualitative and
quantitative analysis. However, they usually
have a different concentration threshold. The
limit of detection (LOD) is the concentration
that is required to be certain about the pres-
ence of the specific analyte in the sample. It
usually is lower than the limit of quantification
(LOQ); the minimum concentration that can be determined reliably with the given method.
Both limits, which are very specific for the analytic method, instrument setup and analyte,
depend on the signal to noise ratio (SNR). Albeit there are several ways to express the
SNR, they all set the analyte signal in reference to the background signal level. The back-
ground usually being a mixture of co-detected undesired chemical entities of the matrix
and the electronic noise from the detector. [231]
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Additional parameters besides LOD and LOQ, which characterise an analytical method
are accuracy, precision, selectivity and robustness. Accuracy measures the proximity of
a measurement to the actual (true) value and precision the reproducibility of a measure-
ment, i.e. in how far repeated measurements vary. The exact relationship is illustrated in
figure A2.1. Selectivity describes in how far a particular analyte inside a matrix or complex
mixture can be determined, without any other component’s interference [600]. A method’s
robustness measures its ability to remain unaffected by small deliberate changes to any of
its parameters. It is used to characterise its reliability during normal use.
Metabolomics has high requirements for all of these parameters, as it tries to reliably
measure as many as possible components of very complex mixtures in a high number of
samples. Therefore method development and characterisation should be an integral part
of any major metabolomics study.
For more detailed information on definitions and explanations, please refer to the In-
ternational Union of Pure and Applied Chemistry’s (IUPAC) Compendium of Chemical
Terminology (”The Gold Book”) [405].
A2.1. Separation science
Separation science encompasses all the different methods that are used to convert a complex
mixture into two or more products, in or order to reduce its complexity prior to detection
or isolate and purify any of its components. Those range from crude separation princi-
ples, like sieving, distillation, filtration, crystallisation or centrifugation to sophisticated
methods such as modern electrophoresis or chromatography. Column chromatography is
the only separation method used in this thesis. Its principles will be outlined in this section.
A2.1.1. Basic principles of chromatography
All types of chromatography rely on the interaction of analytes, dissolved in a mobile phase,
with a stationary phase. As mobile phase, liquid and gas are used for liquid chromatogra-
phy and gas chromatography, respectively. The stationary phase is usually bonded with or
packed with small particles bonded with functional groups that determine the selectivity
of the interaction with the analytes. The more interaction with the stationary phase, the
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higher an analyte’s retention and therefore the time required to elute. This time, which
is very specific (and reproducible) for each analyte on a given system is defined as its re-
tention time (RT). If an analyte is not retained whatsoever, it elutes at the solvent front,
also referred to dead time, as it is the minimum time for any molecule required to travel
through the void volume of the chromatographic system.
However, retention alone does not yet guarantee a successful chromatographic separation.
To separate compounds of very similar retention behaviour, a certain resolving power is re-
quired. Resolving power is measured in the number of theoretical plates, a concept loaned
from distillation columns. The number of theoretical plates and therefore resolving power
is directly proportional to the column length. However, column length is usually limited
by the increase in pressure, particularly as modern columns are packed with small func-
tionalised particles. The exact relationship between all these parameters can be modelled
using an equation A1, introduced by VanDeemter et al.[586].
HEPT = A+ A
u
+ C × u (A1)
The resolving power of a column, the height equivalent to a theoretical plate (HEPPT),
depends on three terms. A, the Eddy-difussion, which is diffusion that occurs due to
non-ideal packing of the column. The second term is the fraction between a coefficient B,
describing the diffusion of the analytes in longitudinal direction and the linear velocity of
the mobile phase u. This means the higher the flow rate, the lower the impact of diffusion.
The third term is the product between the linear velocity and C, the resistance to mass
transfer coefficient. As B and C are fixed, a HEPT versus u curve can be calculated to
find the optimal flow rate for a given chromatographic setup.
A2.1.2. Liquid chromatography
A2.1.2.1. Instrumentation .
The C-term of the VanDeemter curve depends on the particle size the column is packed
with. The smaller the particles, the better the separation efficiency (HEPT). However, the
smaller the particles, the higher the back pressure of the system. For the 5µm diameter
particle size of a modern high performance liquid chromatography (HPLC) system, hydro-
static pressure is not sufficient. A pump, generating pressures up to 400 bar is used to
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perform the separation. Figure A2.2 illustrates the basic assembly of such a HPLC system.
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Figure A2.2.: Liquid chromatography (LC) system:
Assembly of a typical binary (two different solvents) LC system, such as
used for experiments in this thesis.
First, the solvent is degassed to avoid bubbles interfering with the separation. The pumps
deliver solvent A and B to the gradient mixer in the user defined ratio and build up the
system’s operating pressure. The injection system contains an injection loop with defined
volume. During an injection, the loop is (fully) filled with the sample, delivered by the
needle of a sample manager. Then the solvent flow is diverted through the injection loop
and the sample carried onto the column inside the solvent stream. On the column, which
is heated to a defined temperature, separation is performed prior to detection (by UV, MS,
NMR or a combination thereof).
Recently, a new generation of LC systems has started to replace HPLC systems. By further
decreasing the particle size down to < 2µm diameter, ultra performance liquid chromatog-
raphy (UPLC) systems are able to significantly improves chromatographic resolution and
therefore LOD/LOQ and analysis times [555]. According to the vanDeemter curve, this
requires a further increase in pressure. Indeed, UPLC system, such as the one that will
be used for the LC-MS experiments in this thesis, operate at pressures up to 1000 bar. [101]
A2.1.2.2. Common modes of liquid chromatography .
Depending on the column’s packing material (stationary phase), the mobile phase and vari-
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ous modifiers, many different types of chromatography, each based on a different separation
principle and therefor selectivity, can be performed with a single LC setup. Reversed phase
(RP), hydrophobic liquid interaction (HILIC) and ion pairing (IP), are the most common
chromatography modes for metabolite profiling. As they all are used within this thesis,
they will be discussed briefly. However, other important types of chromatography include
normal phase, ion exchange, affinity and size exclusion chromatography. [373]
Separations can be isocratic, i.e. with no change in the mobile phase composition, or a
changing gradient of two (binary) or more mobile phases may be used. The later makes
particular sense if throughout one analysis analytes with highly diverging affinities to the
stationary phase have to be separated. The solvent with the weakest eluting power for the
given stationary phase is gradually exchanged for a stronger one. If all solvent are ordered
by their elution strength, they are arranged in the elutropic series.
Reversed phase chromatography separates analytes based on their lipophilicity. The hy-
drophobic stationary phase is usually composed of alkanes bonded onto silica beads, with
C18 being the most prominent chain length. The elutropic series usually ranges from polar
solvents like acetic acid, pyridine, water over alcohols like methanol, ethanol to very apolar
solvents, such as chloroform, with hexane being the strongest. However, for the majority
of all reversed phase applications a gradient from water to methanol or acetonitrile is used.
Therefore apolar analytes, such as lipids are well retained, but polar ones, such as small
organic acids or sugars elute at the very beginning of a run. It is therefore well suited for
the separation of semipolar and apolar molecules, such as encompassed in blood, tissue
extracts or urine. Another benefit of this selectivity is that inorganic salts, such as NaCl
elute with the void volume and not cause undesired interferences if mass spectrometry is
used for detection. [613]
HILIC has been developed by Andrew Alpert [12] to allow the analysis very polar molecules.
The selectivity of HILIC is roughly inverse to RP, with the most polar molecules being re-
tained the longest. Its separation mechanism is not fully understood yet, but is likely to be
a combination of different mobile and stationary phase interactions, with liquid/liquid par-
titioning being the most prominent [237]. Typical stationary phases packing for HILIC in-
clude plain silica (SiO2) beads, or functionalisation with aminopropyl (NH2), cyanopropyl
(CN), carbamoyl (Amide) or even some zwitter-ionic groups [295]. In contrast to a re-
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versed phase system, HILIC starts at high organic solvent (A) and gradually changes to
aqueous conditions (B). Therefore the sample requires to be reconstituted in at least 50:50
water:organic, unlike for reversed phase, where only water is used. Solvent A is usually
a > 90% acetonitrile buffer and B an aqueous buffer. The most common buffer systems
are ammonium formate or ammonium acetate. HILIC is also well suited for LC-MS as the
high organic at start allows for good electrospray performance [29, 534]. [237]
Ion pair chromatography is based on a reversed phase system, but allows for the separa-
tion of (very polar,) charged molecules. Additionally to a classical reversed phase method,
the solvents are supplemented with an ion pair reagent. Those are amphiphilic molecules,
such as tetrabutylamine for anionic separations or heptafluorobutyric acid for cationic sep-
arations. The hydrophobic chain(s) are to retain the molecule on a C18 phase, the ionic
group to interact with the charge of the (oppositely) charged analyte. After the neutral
charge complex has bonded to the stationary phase, it can be eluted like a regular reversed
phase retained analyte. However, as the retention of the complex is due to the ion pair’s
hydrophic group, rather than the compound itself, those complexes usually have very sim-
ilar retention characteristics. Therefore a gradient of several isocratic regions, specifically
tailored for the used ion pair, is preferred over a linear reversed phase gradient. Using ion
pair chromatography and mass spectrometric detection can yield very powerful methods
[378, 68, 375]. However, it is important to ensure that sensitivity is not compromised by
ion suppression by the desired ion pair [217]. [87].
A2.1.3. Gas chromatography
Gas-chromatography is a very established and efficient separation technique [278], suited
for small molecules that are volatile or can be made volatile by means of derivatisation. The
mobile phase is an inert carrier gas, such as helium or hydrogen. As stationary phase either
packed or capillary columns are used. In the second case the stationary phase is a liquid,
absorbed to a carrier material. As capillary columns achieve much higher chromatographic
resolution, they will be used for experiments in this thesis.
A2.1.3.1. Instrumentation .
Figure A2.3 outlines the principal assembly of a gas chromatograph.
A defined amount of the sample is injected into an inert glass liner by the injection syringe
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Figure A2.3.: Gas chromatography (GC) system:
Assembly of a typical gas chromatography system, such as used for
experiments in this thesis.
of the sample manager. A septum ensures air-tightness after the needle is withdrawn. As
the glass liner is heated, the sample is evaporated instantly. The steady stream of carrier
gas sweeps the volatile sample into the capillary column, where analytes start to interact
with the stationary phase.
For experiments in this thesis, a 30 m long, 0.25µm inner diameter, silicon oil film coated
(95% dimethyl/ 5% diphenyl polysiloxane) capillary column was used as stationary phase.
On this column, molecules are retained based on their polarity; the less polar, the higher
the retention time. In contrast to (RP) LC, where elution is performed by changing the
mobile phase polarity, in GC a temperature gradient, controlled by the programmable GC-
oven is used for elution. A higher temperature will lead to less interaction between analytes
and stationary phase and therefore a shorter retention time. Finally, once a compound is
eluted it can be detected. In this thesis, a mass spectrometer was used as detector, as
described in section A2.3.3.
A2.1.3.2. Derivatisation .
In order to be passed onto the column and separated, GC requires an analyte to be volatile.
Some small molecules don’t fulfil this prerequisite, due the polarity of their functional
groups. However, by converting polar functional groups into less polar ones, derivati-
sation can make those molecules GC compatible. In this thesis, a two-step derivati-
sation procedure, consisting of methoximation followed by silylation, is used, as it was
shown to be reproducible and have a broad coverage [171, 214, 67]. In the first, the
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methoximation step, carbonyls are converted into a Schiff base, by methoxyamine. This
prevents sugars from cyclysation (and forces them into open-ring formation) and sta-
bilises α-ketoacids. In the second step, in all functional groups with acidic protons,
such as alcohols, amines, carboxyls and thiols, the acidic proton is replaced by a silyl
group. Two silylation reagents are particularly common in metabolomic studies. MSTFA
(N-methyl-trimethylsilyltrifluoroacetamide), as used in this thesis, and t-BDMS (tert-
butyldimethylsilylation), as it reduces fragmentation and often showing the analyte’s molec-
ular ion peak [67]. Care must be taken, when annotating derivatised peaks as chemical
side reactions, such as the conversion from arginine to ornithine, are possible [220].
A2.1.3.3. Retention time indices and retention time locking .
In GC, the retention time is often expressed as a relative measure, a retention index, instead
of absolute time. The retention index, first described by Ervin Kovats [336], is independent
of the used GC system and therefore allows easy method transfers and database matching
[27]. A retention index sets a compound’s retention time in relation to the the two alkanes
in-between it elutes, when injected together with a series of gradually in chain length
and therefore retention time increasing n-alkanes. According to equation A2 the Kovats
retention index I depends on the retention time tr and carbon chain length of the smaller
(n) and larger (N) n-alkane.
Iunknown = 100× [n+ (N − n)tr(unknown) − tr(n)
tr(N) − tr(n) ] (A2)
However, as shown by Stein et al.[541], a retention index, similar to the Kovats retention
index can also be calculated, based on the analyte’s molecular properties, such as its func-
tional groups, avoiding the use of n-alkanes as internal standards.
Another technique, recently developed and used in this thesis, to compensate for retention
time deviations between different runs, batches or even systems is outlined by Blumberg
et al.[54]. Retention time locking (RTL). Conveniently, in RTL only one internal standard
is used for the global alignment of retention times and calculation of retention indices.
This is done by calibrating the system’s head pressure against the retention time of the
internal standard. This enables a constant flow-rate, eve though the gas expands during
the temperature gradient [154].
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A2.2. Analyte detection
Many mechanisms to detect analytes (after chromatographic separation) exist. One distin-
guishes between classical methods, such as titration or flame tests, and instrumental meth-
ods. Instrumental methods divide into spectroscopy, mass spectrometry, electrochemical
methods and thermal methods. As the major focus of this PhD is on NMR spectroscopy
and mass spectrometry only these two will be described in the following sections.
A2.2.1. Nuclear magnetic resonance (NMR) spectroscopy
Nuclear magnetic resonance (NMR) spectroscopy relies on an atomic nucleus absorbing
electromagnetic energy through excitation and re-emitting it at a specific, diagnostic fre-
quency.
A2.2.1.1. The quantum physics behind NMR .
In order for a nucleus to do so, it requires it to have a magnetic and angular momentum,
which gives rise to its spin. A spin only exists if a an isotope has a spin number other than
zero, i.e. an odd and/or even number of neutrons and protons. Some of the most frequent
studied NMR active nuclei are for example 1H, 14N,15N,17O,19F or 31P. However, this sec-
tion will only deal with nuclei with a spin number of I = 1/2; 1H and 13C in particular.
According to quantum mechanics, a nucleus with a spin number of I = 1/2 can only have
2I + 1 = 2 orientations. Once a nucleus is put into an external magnetic field B0, it
either aligns with the field or against it, giving rise to a lower and higher energy level,
respectively. This behaviour is displayed in figure A2.4. ∆E is the energy difference
between those two spin states. According to the fundamental equation of spectroscopy
(A3), a photon, matching this exact energy difference can excite the system by leveraging
it from the lower to the higher state.
∆E = hv (A3)
With h being Planck’s constant (h = 6.626 × 10−34Js) and v the nucleus resonance fre-
quency. This frequency, also called Larmor frequency, is the frequency with which the
individual nuclei rotate around their axis. This rotating motion is described by their spin.
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Figure A2.4.: Spin physics of NMR spectroscopy :
Upon applying a magnetic field B0 the 1H nuclei’s spins align with the
field, and precess around the B0 axis, rather than random angles.
Furthermore they divide into a lower (N+) and higher (N−),energy state,
which can be reached via excitation with a photon of ∆E energy. Mz is the
resulting net magnetisation vector between upper and lower spin state,
which itself processes with the resonance frequency parallel to B0.
In the case of the external magnetic field B0, the rotation axis is aligned with B0. B0 does
have a linear relationship with the Larnor frequency, expressed in equation A4.
v = 12piγB0 (A4)
Therefore the Larmor frequency can simply be expressed as:
∆E = hγB02pi (A5)
γ is the gyromagnetic ratio. It is a specific constant for each nucleus, such as 42.58 MHz/T
and 10.71 MHz/T for 1H and 13C, respectively.
There are slightly more spins in the lower energy level (N+), than the higher energy (N−)
level, giving the nuclei the net magnetisation vector Mz. The exact ratio is defined by
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a Boltzmann statistic, according to equation A6, with k being the Boltzmann constant
(k = 1.3805× 10−23J/K) and T the energy in Kelvin.
N−
N+
= e−∆E/kT (A6)
The ratio of the number of nuclei between the higher and lower excitation state directly
defines the LOD of NMR spectroscopy. As both, the magnetic field strength and the gy-
romagnetic ratio are directly proportional to the excitation and therefore emitted energy
∆E, they both impact the LOD. Thus, some nuclei, despite equal isotopic abundance,
are more sensitive then others. Also, stronger magnets will lead to higher sensitivity and
improved resolution.
A2.2.1.2. The vector model of NMR spectroscopy .
During every NMR experiment, the nuclei are excited into the higher state and the energy
emitted upon relaxation is recorded. To excite the nucleus a 90°pulse is used. This is a
high frequency electromagnetic pulse perpendicular to the net magnetisation vector MZ ,
which drags it down from the Z into the X-Y plane (figure A2.5a). The net magnetisation
is then allowed to rotate inside the X-Y plane at approximately the Larmor frequency. For
convenience, another coordinate system, the rotating frame of reference system is used.
The new coordinate system(X’-Y’), rotates inside the X-Y plane at the Larmor frequency,
as shown in figure A2.5c. Any magnetisation vector that travels faster than the resonance
frequency, travels clockwise about the Z-axis. Magnetisation vectors slower than the Lar-
mor frequency move counter-clockwise (figure A2.5d).
When rotating inside the X-Y plane, the net magnetisation vectors induce a current into
the detector coil, which gives rise to a signal, displayed in figure A2.5e. This signal, fol-
lowing a sinc-function, i.e. a (co)sine wave exponentially decaying to zero, is called free
induction decay (FID). It is due to the relaxation of the excited nuclei. As the net magneti-
sation vector’s magnitude rebuilds along its Z-axis, the current induced into the detector
coil cedes. The magnetisation vector’s relaxation from zero magnitude in the Z-direction to
its original (unexcited) Mz value is called the spin-lattice relaxation (T1). The reduction of
the vector’s XY magnitude is referred to as spin-spin relaxation (T2) and is always less or
equal the time required for the spin-lattice relaxation. The magnetisation decay is greatly
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Figure A2.5.: Vector model of NMR spectroscopy:
The Mz net magnetisation vector is tilted into the X-Y plane by a 90°pulse
(figure A2.5a), inside which it keeps processing at the resonance frequency
(figure A2.5b). A X’-Y’, rotating frame coordinate system is defined,
rotating at the resonance frequency(figure A2.5c). In this new coordinate
system, spin from nuclei precessing faster than the resonance frequency
travel clockwise (blue), the ones slower, counter-clockwise (green) (figure
A2.5d). The precession is detected before relaxation into the unexcited
state. The decaying signal is called free induction decay (FID)(figure
A2.5e). After Fourier transform, a frequency spectrum is yielded, showing
the resonance frequency of the two different nuclei populations. [57]
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governed by two factors; molecular interactions and inhomogenities in B0.
Figure A2.5e also shows that the two different net magnetisation vectors having a differ-
ent frequency during their decay. This is due to their slight deviation from the resonance
frequency. When the FID is converted from the time to the frequency domain, using a
Fourier transform, a frequency spectrum, displayed in figure A2.5f is yielded. [103, 360]
A2.2.1.3. The chemical shift .
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Figure A2.6.: 1H NMR chemical shift range of different functional groups:
The chemical proton shifts from various functional groups are given on the
ppm scale.
These small deviations from the resonance frequency are referred to as chemical shift.
They provide diagnostic information on the chemical environment of the nucleus. Each
nucleus does not directly experience the native B0 field, as the atom’s circulating electrons
generate a small magnetic field themselves, which shields the nucleus from B0. According
to equation A5 a small change in B0 does directly affect ∆E and therefore the precision
frequency, leading to the chemical shift. The electrons and therefore the chemical shift is
influenced by the type of bond and neighbouring chemical groups of different electroneg-
ativity. Most chemical functional groups have specific shift ranges [442]. Figure A2.6
shows some common examples. As the spectrometer’s resonance frequency depends on
its magnetic field strength, using a Herz scale would make it difficult to compare between
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spectrometers. To this end, a relative scale is used. Each resonance is scaled relative to
a chemical standard, according to equation A7, to yield the chemical shift σ, expressed
as ppm. As chemical standards, tetramethylsilane (TMS) and its organic acid derivates
such as trimethylsilyl-2,2,3,3-tetradeuteropropionic acid (TSP) are used for organic and
aqueous solvents, respectively. [252]
σ = (vSample − vReference)× 10
6
vReference
(A7)
A2.2.1.4. Spin-Spin coupling .
Another NMR specific phenomenon is spin-spin coupling. [360] Not only do close func-
tional groups impact the magnetic micro-environment of a proton, but also its closest
proton neighbours, i.e. those connected over 2 to 3 bonds. The interaction of two neigh-
bouring protons, that are in different chemical environments, i.e. have different chemical
shift, leads to signal splitting. Signal splitting leads to multiplets, such as doublets, triplets,
quartets, etc. In a simple spin system, i.e. when a proton only couples with one chem-
ically different group, it has a multiplicity of n + 1 with n being the coupling partner’s
proton count. The intensity distribution of the multiplet’s peaks follows Pascal’s triangle,
according to the number of possible quantum states. Figure A2.7 illustrates this principle
by using ethanol (C2H5OH) as an example.
If a proton can see two ore more protons of different chemical environments or stereochem-
istry, which also introduces non-equivalence, higher order splitting patterns result. For
example the ethyl group in the middle of 3-Amino-1-propanol (NH2−CH2−CH2−CH2−
OH) has two chemically different methyl groups to either side. It will therefore see two
triplets, which results in a triplet of a triplet multiplicity, with a complex intensity pattern.
Due to the ppm scale, a multiplet’s chemical shift, which is located at the symmetry axis of
the multiplet is independent of an NMR’s field strength. The coupling constant J , however,
is not. J is the difference between the individual maxima of the multiplet. It is measured in
Hz and is a measure of the magnetic interaction between the coupling nuclei. Figure A2.8
explains the coupling constant and multiplicity (doublet, triplet, quartet) from a vector
model perspective. In the previous ethanol example, both, the triplet and the quartet have
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Figure A2.7.: NMR spectrum of ethanol and the corresponding spin
populations:
Ethanol’s methyl group (CH3) can ”see” three different spin orientations
when coupling with it’s neighbouring ethyl group (CH2). As two of the
spin states are effectively the same (up/down), those have twice the
intensity as the other two, resulting in a 1:2:1 signal intensity. The methyl
group, however, can see its ethyl partner in four different spin states, with
the intensity ratio of 1:3:3:1 according to Pascal’s triangle. The CH3
protons of the spiked in chemical shift reference TMS, however, have no
coupling partner and therefore appear as singlet. Even though the alcohol’s
acidic proton was illustrated in this spectrum, it usually is not visible, if
the used solvent, e.g. D2O allows for proton/deuterium exchange.
Furthermore, the methyl group and acidic proton do not produce a
multiplicity as there is no coupling across heteroatoms such as O, N or S.
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Figure A2.8.: Chemical shift and coupling in the NMR vector model
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a coupling constant of J = 7 Hz. The coupling constant can also be used as diagnostic
criterion, as just like the chemical shift, it is specific for different chemical groups. It even
allows statements about the conformational interaction between two protons, such as the
dihedral angle.
Chapter III. builds on a 2D NMR sequence in which carbon-carbon couplings are ”removed”
from the spectral area, by collapsing their coupling constants. This can be achieved by a
180° pulse, as shown in figure A2.9.
The 180° is also a vital part of other pulse sequences, as it allows to refocus the spins. This
is important as due to inhomogenous magnetic fields, the spin isochromats may dephase
and lead to undesired line broadening. A 180° refocusing pulse can reverse this.
A2.2.1.5. NMR for quantification .
NMR is a quantitative detection technique. The integral of a multiplet is proportional
to the number of its underlying protons in a given molecule and sample. The multiplet
integral ratio of the methyl:ethyl in ethanol should therefore be 3:2. If an internal standard
of known concentration and proton number is used, its integral can be used to calculate
the absolute concentration of any other analyte in the solution. However, for precise, fully
quantitative work, several parameters require careful consideration [506, 212].
A2.2.1.6. NMR instrumentation .
To perform NMR experiments, an NMR instrument, comprising of the superconducting
magnet, the probe and various electronic systems, is needed. The principal assembly of a
magnet and detector probe is illustrated in figure A2.10.
To achieve field strengths of several hundred MHz, extremely high magnetic field strengths
are needed. For example 14.1 Tesla are required for 600 MHz 1H observation frequency.
Such magnetic fields can only be supplied by superconducting solenoid magnets. For the
super conduction effect cryogenic temperatures are required. Therefore, the magnet is
chilled by liquid helium (4.2 °K), which itself is cooled by liquid nitrogen (77 °K), sepa-
rated from the atmosphere by a vacuum dewar. Both cryogenics require regular top-ups.
A sample tube is introduced into the magnet via a sample port and kept spinning around
its axis by a temperature controlled stream of air, inside the probe. Spinning the sam-
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Figure A2.9.: The 180° refocusing pulse:
A 180° pulse is an important building block in the design of pulse
sequences, as it allows to refocus the couplings. After a 90° pulse excites
the spins into the X’Y’ plane (figure A2.9a), they start to precess (and
dephase). After a defined time t, a 180° pulse along Y’ is applied (figure
A2.9b). They individual spins are mirrored with respect to the Y’ axis, but
proceed precessing with their initial direction and speed (figure A2.9c).
After the time t, all spins will be refocussed 180° from their starting
position (figure A2.9d).
A2 Analytical chemistry 307
Helium Fill Port
Nitrogen Fill Port
N2(l)
He(l)
Vacuum
M
ag
ne
t
Probe
Sample Port
Spinning 
Sample Tube
RF transmitter
RF receiver & amp
(a)
Figure A2.10.: Assembly of a NMR magnet and probe:
Assembly of the liquid helium and liquid nitrogen chilled superconducting
magnet on the left. The probe is magnified on the right. For explanations
refer to the text.
ple averages out minor field inhomogeneities and allows for a narrower line width. The
specifics of the probe determine the bore of the NMR tubes (5 mm in this thesis) and
the observable nuclei. Inside the probe, there is an radio-frequency (RF) coil to irradiate
the sample with the pulse sequence and a RF detector coil, to sample the FID. Both are
controlled by electronics. The detector coil feeds the signal through various filters into
an amplifier which passes the signal on to an analogue-to-digital converter (ADC), that is
connected to a computer.
NMR spectroscopy has a relatively high LOD. One method to improve the signal to noise
ratio (SNR) and therefore LOD of acquisitions is to maintain the receiver RF coils and
preamplifier at very low temperatures. This reduces the noise contribution from the random
thermal motion of electrons inside the conductors (Johnson-Nyquist noise) and therefore
improves the SNR up to five fold. Some experiments in this thesis were performed using
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low concentration samples and were therefore acquired with such a ”cryo-probe”. [549]
Metabolomics sample sets often consist of several tens of samples. Therefore automatic
sample handlers are frequently used. In order to reduce effort and ensure consistency, an
automatic sample manager was used for certain experiments in this thesis. The sample
manager changes samples and automatically performs the shimming and receiver gain
adjustment, as outlined in the next section.
A2.2.1.7. NMR sample set acquisitions .
The standard procedure of an NMR sample (set) acquisition is outlined in this section.
Figure A2.11 outlines all major steps.
Sample preparation
Acquisition
Shimming Receiver gain adjustment
Each sample
Probe Tuning & Matching
90º Pulse determination Adjust water suppresion 
Each sample set
Figure A2.11.: Standard procedure of a NMR sample acquisition :
Flow chart of a standard procedure for a NMR acquisition [36] of a sample
set, used in this thesis. For details please refer to the text.
An NMR experiments starts with sample preparation. Dried samples have to be resus-
pended in appropriate solvents. For two reasons, those solvents are usually deuterated.
First, the NMR uses deuterium as a ”lock”, in order to correct for frequency drifts and
temporary magnetic field inhomogeneities. Secondly, the solvent’s protons would be NMR
visible themselves. As compared to the analyte, the solvent is very highly concentrated, the
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dynamic range of the ADC would not be able to grasp a reasonable signal of the analyte.
Therefore a 100 % D2O pH 7 phosphate buffer with 0.5 mM TSP as shift reference will be
used for all NMR experiments in this thesis.
Before starting a series of acquisitions (particularly after using a different solvent), the
magnets resonance frequency requires to be tuned and matched. Matching and tuning
change the impedance of the probe and adjust the resonance frequency of the RF coil,
respectively. Both parameters depend on the polarity and dielectric constant of the used
solvent composition and are essential to minimise the power needed for a 90° pulse. After
the sample has been introduced and allowed to equilibrate to the set temperature, the 90°
pulse for the given matrix can be ”found”. This involves finding a RF pulse length (at a
set pulse power), that flips the majority of the nuclei by 90°, (into the XY plane) to reach
the maximum signal amplitude. In practice, the 360°pulse, i.e. the pulse at which the net
magnetisation vector is back at the starting position, orthogonal to the detector coil, with
therefore no visible signal, is determined and divided by 4. Finally, the water suppression
must be adjusted. Suppressing the a residual water peak is particularly important when
analysing low concentration samples, as is the case within the aims of this thesis. The used
pre saturation water suppression sequence used in this thesis irradiates a RF signal prior
to the acquisition to saturate and silence all H2O and HDO protons [529]. In order to
suppress the water peak effectively and not affect neighbouring regions, the RF frequency
has to be adjusted to the apex of the residual solvent peak.
Once all the parameters have been found, the desired pulse sequence can be set up and
specific parameters adjusted as desired. An important parameter is the number of scans.
An NMR experiment, consisting of the pulse train and FID acquisition, is usually con-
ducted several times and the individual spectra averaged to improve the signal to noise
ratio (SNR). According to equation A8, the SNR is proportional to the square root of the
number of individual acquisitions (scans). This means doubling the number of scans will
double acquisition time, but only improve the SNR by 1.4 fold. Therefore a reasonable
tradeoff is required. For pulse sequence specific reasons (phase recycling) it often is rec-
ommended to set the number of scans to the multiple of a certain factor, such as 4.
SNR ∝ √nScans (A8)
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The next two steps prior to acquisition, the shimming and receiver gain adjustment, need
to be performed with each individual sample. During the shimming the field strength of
small magnets inside the superconductor’s B0 field are (manually) adjusted to even out
field inhomogeneities. Low field homogeneity leads to asymmetric or too wide peak line
widths, reducing resolution. As each sample disturbs the B0 homogeneity it is essential
to shim and check the line width prior to each acquisition. During the receiver gain ad-
justment, the optimal gain for the amplifier, to use the full dynamic range of the ADC, is
determined. Too low receiver gains compromise the SNR, too high receiver gains lead to
signal distortions and artefacts.
After all these steps, the acquisition can be started. After the acquisition, the next sample
is inserted, shimmed, receiver gain adjusted and acquired. Details on the subsequent
processing of NMR spectra is discussed in section A3.1.1. [36, 57]
A2.2.1.8. Two dimensional NMR spectroscopy .
Although most NMR based metabolite profiling approaches use one dimensional 1H pulse
sequences, a few examples of two dimensional NMR based profiling have been published
[376, 15]. However, two dimensional (2D) NMR is widely used for assignment purposes.
The sequences used for metabolite annotation in this thesis will be described briefly. Two
major types of experiments were used; 1H-1H homonuclear and 1H-13C heteronuclear ex-
periments.
1H,1H - Correlation Spectroscopy (COSY) was the predominant used homonuclear pulse
sequence. COSY maps an 1H on its X and Y axis. The cross peaks correlate the neigh-
bouring protons. In the case of ethanol, the triplet and quartet of the ethyl and methyl
would be connected via a cross peak. This is very useful to assign spin systems that could
not be correlated just from a one dimensional spectrum. A COSY works by transferring
magnetisation from one spin to its coupling partner (coherence transfer), yielding a spec-
trum which is symmetric with regards to its diagonal.
Heteronuclear Single Quantum Coherence (HSQC) spectroscopy is the most frequently
used heteronuclear pulse sequence. It allows to correlate 1H signals to the ones of 13C
or other heteroatoms, such as 15N. Therefore its cross peaks indicate the heteroatom to
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which a proton is attached. This is not only helpful for de-novo elucidation, but also for
assignment as it introduces a second, (independent) variable, the carbon ppm shift. As the
carbon shift range ranges from 0 up to over 200 ppm it can be deciding for ambiguous 1H
shifts. Also, as it spans from 0 - 10 × 0 - 200, spectral overlaps occurring in the 1H domain
can often be resolved. However, it has a major draw back. Its long acquisition times and
low inherent sensitivity, due to the lower gyromagnetic ratio of carbon and the only 1 %
natural abundance of 13C. Chapter III. aims at addressing this issue by using performing
acquisitions with 13C enriched samples.
Heteronuclear multiple-bond correlation spectroscopy (HMBC) extends HSQC to long
range couplings, in the order of 2 - 4 bonds. It is mainly useful for structure elucida-
tion as it allows to connect several spin systems.
There are several other two dimensional established pulse sequences, such as total corre-
lation spectroscopy (TOCSY) or J-resolved spectroscopy (JRES). TOCSY extends COSY
up to 5 bonds, whereas JRES directly measures coupling constants and correlates these
to the multiplets from the one dimensional NMR spectrum. However, neither of these
techniques were used in this thesis.
A2.2.2. Mass spectrometry
Mass spectrometry detected the charge to mass ratio (m/z) of ions. Figure A2.12 shows a
mass spectrum of ethanol.
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Figure A2.12.: Mass spectrum of ethanol:
Mass spectrum of ethanol. The negatively ionised M− molecule has a m/z
of 45, followed by its M + 1 and M + 2 isotope peaks.
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All mass spectrometers consist of three basic units, outlined in figure A2.13.
Source Analyser Detector Electronics
Gas phase transformation
and Ionisation
Vacuum
m/z based separation Ion counting Signal processing
Figure A2.13.: Basic assembly of a mass spectrometer:
The basic units of a mass spectrometer will be described in the text.
First, inside the source, the sample is transferred into the gas phase and analytes are
ionised. Secondly, ions are separated according to their mass to charge ratio (m/z) inside
a mass analyser. Finally, the ions are counted by a detector unit. Althought rarely men-
tioned, depending on the instrument type there is a fourth unit, consisting of sophisticated
signal processing modules. Furthermore, as starting at the source, most of these units
require a (ultrahigh) vacuum to avoid collisions of the ions with gas atoms and remove
non-ionised matter. The vacuum, down to 10−10 Torr is often built up over several stages
using rotary and (turbo)molecular pumps.
A2.2.2.1. Types of ionisation sources .
A plethora of different ionisation techniques have been invented and are available for mass
spectrometers. The choice of source depends on the type of analytes and matrix to be
analysed [504, 262]. Even though not clear cut, ionisation techniques may be classified
into several categories. Electron impact and chemical ionisation, gas discharge ion sources,
desorption ionisation, spray ionisation and ambient ionisation.
EI (Electron Impact ionisation) [134] and CI (Chemical Ionisation) [430] are predominantly
used for GC-MS analysis and will be discussed in section A2.3.3. ICP (Inductively Cou-
pled Plasma) [253] may be the most widely used gas discharge ion sources, particularly as
ICP-MS is the method of choice for trace metal analysis. Desorption ionisation techniques
include LMIS (Liquid Metal Ion Source) [554] mostly used by SIMS (Secondary Ion Mass
Spectrometry) and FAB (Fast Atom Bombardment), pioneered by Barber and Morris [420].
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Remarkably, due to its soft ionisation characteristics, FAB was the first technique to allow
the analysis of whole biomolecules such as insulin [32]. The spray ionisation technique used
for the LC-MS experiments in this thesis was ESI (Electrospray Ionisation), pioneered by
Fenn et al.[170]. It will be described in detail in the LC-MS section (A2.3.2. The other no-
table spray ionisation source is APCI (Atmospheric Pressure Chemical Ionisation). Among
the ambient ionisation techniques MADLI (Matrix-Assisted Laser Desorption Ionisation),
simultaneously developed by Tanaka et al.[562] and Hillenkamp et al.[300] is very promi-
nent in the field of protein and (bio)polymer analysis. More frequent developments include
DESI (Desorption Electrospray Ionization) and DART (Direct Analysis in Real Time).
Recently, ambient ionisation techniques have gained particular popularity, as those enable
mass spectrometry imaging (MSI) approaches. MSI rasters the surface of a sample and
produces an image; however, instead of colour, like in microscopy, each pixel is associated
with a mass spectrum and therefore chemical information [545].
Most of these techniques are able to produce positively (cations) and negatively (anions)
charged ions, respectively.
A2.2.2.2. Types of mass analysers .
Once all ions have been transferred to the gas phase, they need to be separated based on
their mass to charge ratio, prior to detection. As for ionisation sources, several different
types of mass analysers, based on different separation principles, exist. Each with their
own unique properties and therefore areas of application. This section discusses the basic
properties of mass analysers, before listing them. The ones used in this thesis, the time-
of-flight (ToF) and quadrupole (Q) analyser will be discussed in more detail.
Mass accuracy is a mass analyser’s ability to deliver accurate and precise measurements.
Most mass analysers default into two categories. Low and high mass resolution.
Low mass resolution instruments can only discriminate between integer differences
in molecular mass. High mass resolution instruments can differentiate between sig-
nificantly closer related masses. Their accuracy is measured as the relative measure-
ment error, in relation to the measured mass, expressed as parts per million (ppm).
Equation A9 defines the ppm error.
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Errorppm =
(massmeasured −masscalculated)
masscalculated
× 106 [ppm] (A9)
High mass accuracy usually requires the continuous infusion of a reference standard
of known m/z ratio, to correct for subtle drifts throughout the run. For this purpose,
a Leucine-Enkephaline solution will be used as lock spray in this thesis.
Resolution or resolving power is the mass analyser’s ability to distinguish two closely
related m/z peaks. According to equation A10 it is defined as the fraction between a
measured m/z value and ∆m, which usually is the full with half maximum (FWHM),
i.e. the peak’s width at half its height.
R = m∆m (A10)
Mass Range determines the m/z range within peaks can be measured. This value is more
likely to have an upper, rather than a lower limit.
Dynamic Range is the order of magnitude in difference between the largest and smallest
quantity that can simultaneously be determined.
Scan rate is the rate at which mass spectra are acquired. This value is of particular im-
portance if the changing sample composition throughout the acquisition is of interest;
as in the case of an online-coupled separation step (LC-MS; GC-MS).
Table A2.1 outlines the most common mass analysers and some of their basic properties,
that will be discussed in the following text.
Analyser Resolution [m/∆m @ FWHM] Mass accuracy [ppm] Scan rate [scans/s]
Sector 3 000 - 80 000 ≤ 5 0.1 - 0.5
Quadrupole ≤3 000 low 0.5 - 4
Ion trap ≤4 000 low 5 - 10
Time-of-flight 8 000 - 40 000 1 - 10 20
Orbitrap ≤ 100 000 ≤ 1 0.5 - 2
FT-ICR ≤ 1000 000 ≤ 1 0.3 - 1
Table A2.1.: Basic properties of different mass analysers. [619, 130] Exact values depend
on the instrumental setup and vary between instrument manufacturers.
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(Electro/Magnetic) sector instruments were the first type of mass spectrometers [395, 284]
and are well suited to demonstrate the general separation principle of a mass spectrometer.
When moving inside a electric or magnetic field, charged particles experience a Lorentz
force F . According to equation A11 this force depends on the ion’s charge z, the electric
field E and the cross product of the ion’s velocity v and the magnetic field B.
F = z(E + v ×B) (A11)
According to Newton’s second law (equation A12) the force F is required to accelerate a
particle of the mass m, with an acceleration of a.
F = ma (A12)
Combining both equation, one yields equation A13
m = z(E + v ×B)
a
(A13)
Considering the elementary charge of an electron (z = e = 1.602× 10−19C), a differential
equation A14 is yielded, that is fundamental to any mass analyser. It sets an ion’s m/z in
relation to space and time, the two domains all mass analysers use to perform separations.
m/z = (E + v ×B)
a
(A14)
Sector instruments have a fixed magnetic and/or electric field of known strength. If only
one, a magnetic or an electric field is used, the above equation can be simplified by omitting
the corresponding term; E for magnetic sector and v × B for electric sector instruments).
Following from the equation and the right-hand rule, the ion is deflected on a path with
a radius proportional to its m/z. A detector can scan the path and determine a parti-
cle’s m/z. Albeit doubly focused instruments (an electrostatic analyser is added) achieve
good accuracy and resolution, their slow scanning speeds, large footprint and high cost has
widely led them to be replaced with other mass analysers.
Quadrupole mass analysers [468] consist of four circular, parallel arranged rods, as dis-
played in figure A2.14. A RF alternating current (AC) voltage, with a direct current (DC)
offset is applied to the four rods. The same ACDC voltage is always applied to the two
opposing rods. The AC proportional for the non-oppositely situated rods is 180°phase
shifted and therefore having an opposing charge. Ions in-between the four rods will expe-
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Figure A2.14.: Quadrupole mass analyser:
Ions of different m/z ratios from the source, focused by ion optics, are
accelerated into four parallel rods. By applying a complex voltage pattern
and therefore generating a quadrupolar electric field in-between the rods,
ions are kept in this field, moving towards the detector in a spiral motion.
By controlling the generated field, ions of particular a m/z ratio can be
filtered out prior to reaching the detector.
rience a quadrupolar electromagnetic field. Any ion accelerated to travel parallel to the
rods, in the gap between the rods will travel along those in a spiral motion. By varying
the AC to DC ratio, the acceleration and speed of the ions along the spiral path can be
controlled. According to the differential equation derived above, this allows masses with
certain m/z to be selected. Indeed, as illustrated in figure A2.14, the quad operates like a
m/z filter, only allowing a selected range of ions to reach the detector stage. Other ions,
with unstable trajectory will collide with the rods and are therefore be removed [130, 10].
During regular operation the quadrupole ”scans” along the m/z range during each scan to
yield a mass spectrum. Therefore, if used as a ”detector” for a large range of masses, it
has a non-optimal LOD as the dwell time, i.e. the time spent to allow ions to pass the
quad must be shared between all the m/z bins in every scan. Also the mass accuracy and
resolution and scan rate are the lower end of mass analysers. However, if used as a filter
or to monitor very few ions at a time, like in Q-ToF or triple-quad instrumentation, it can
achieve a very low LOD/LOQ. Those hybrid instruments are discussed in section A2.2.2.4.
As it is a very inexpensive and robust mass analyser, it is also the most used mass analyser
for GC-MS.
Ion trap analysers [467], were invented by Wolfgang Paul, just like the quadrupole mass
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analyser, which it shares most features with. An ion trap usees the quadrupole field to
store ions of selected masses, by keeping them on a stable trajectory. Masses can be ejected
selectively for detection or fragmentation. It is possible to collect the fragments and re-
peat the process of selected precursor fragmentation (MSn). This technique has become
essential in the mass spectrometric analysis of proteins.
Orbitrap mass analysers are a very new, but already important type of trap [387]. Ions
are trapped by the balance of the attracting electrostatic field around a spindle-shaped
electrode and their experienced centrifugal forces. They orbit this spindle in elliptical
trajectories, with an angular frequency ω according to equation A15, with k as a force
constant. The harmonic oscillation around the spindle shaped electrode induces a current
into a detector, which can be converted into a m/z spectrum.
ω =
√
1
k
× (m/z) (A15)
A particular advantage of this trap over a quadrupole trap is its FTICR like performance
with regards to mass accuracy, resolution and sensitivity [260].
FTICR (Fourier Transform Ion Cyclotron Resonance) [109] mass analysers are considered
the most accurate and highest resolution mass analysers. Ions are trapped in a Penning
trap, i.e. inside a magnetic field created by a strong NMR-like superconducting magnet.
The circularly rotating ions are excited by an orthogonal electric field (at their cyclotron
resonance frequencies) to rotate in a larger cyclotron radius. After removing the electric
field, the ions rotate at their cyclotron resonance frequency f , according to equation A16.
Upon passing the detector electrodes, they produce a free induction decay (FID), which
can be Fourier transformed into a mass spectrum. Like for the Orbitrap, mass resolution
and accuracy is inversely proportional to scan rate, requiring a trade-off setting if coupled
to an LC system [196].
f = Bz2pim (A16)
Time-of-flight (ToF) [82, 633] mass analysers achieve a mass accuracy rivalling the one
of the orbitrap and FTICR analysers. However, the scan rate is significantly better, and
instrument costs lower, making it an attractive choice for metabolite profiling applications.
Indeed, ToF based instruments will be used for detection in the LC-MS experiments of this
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Figure A2.15.: Time-of-flight (ToF) mass analyser:
Ions of different m/z ratios from the source, focused by ion optics, are
accelerated into the ToF tube by an ion-pusher. Throughout the
flightpath, the lower speed of ions with a higher m/z ratio causes them to
fall behind the ones with a smaller m/z ratio. The detector registers the
time an ion needed to complete the flight path, which is proportional to
its m/z. An ion-mirror like reflectron doubles the flight path.
thesis. Figure A2.15 shows the fundamental principle of a ToF analyser. An electric field
with the (voltage) potential U , is generated by an ion-pusher, to accelerate a particle into
the ToF-tube. According to equation A17, a particle of the charge z, experiences the
potential energy Ep, when passing through the (voltage) potential U .
Ep = zU (A17)
The whole potential energy Ep acquired through the field, leads to an acceleration of the
particle and will be completely converted into kinetic energy along the way (equation A18).
Ek = Ep (A18)
According to equation A19, the kinetic energy Ek depends on the mass m and speed v of
A2 Analytical chemistry 319
an object.
Ek =
1
2mv
2 (A19)
Therefore, after the field, the ion will have a kinetic energy according to equation A20. As
the provided energy is the same, ions with higher mass will have gained less speed.
zU = 12mv
2 (A20)
Considering that after the acceleration through the potential the ion’s speed remains con-
stant and that according to equation A21 speed is the time t an object needs to travel the
distance d, equation A20 can be substituted to yield equation A22.
v = d
t
(A21)
t2 = d
2
2U
√
m
z
(A22)
Equation A22 establishes a relationship between the ion’s flight path length d and its m/z
ratio. After taking the square root and considering that according to equation A23, the
constant potential U and flight path length d can be summarised in the constant k, one
yields a final equation A24.
k = d√
2U
(A23)
t = k
√
m
z
(A24)
Equation A24 displays a simple relationship between the flight time t and the square root
of the m/z ratio. In other words, by registering the time an ion took to travel along the
ToF tube, its m/z ratio can be calculated. This is easily possible. At t = 0 the pusher (,
displayed in figure A2.15) accelerates an ion package onto the flight path. The detector
registers at which time how many ions arrive. This count versus time distribution can then
be converted into a count versus m/z distribution - a mass spectrum.
The ToF analyser in figure A2.15) has a reflectron [9, 390], instead of having a linear flight
path from pusher to detector. A reflectron acts as an ion mirror and is used to adjust for
the kinetic energy dispersion of the ions. Furthermore, doubling the flight path improves
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mass resolution as ions have more time to separate. However, it inversely affects sensitivity,
as ions may get lost on the way. The illustrated reflectron is operated in ”V-mode”. Mod-
ern mass spectrometers can also operate in ”W-mode”, using a second reflectron to even
further increase the path length. This leaves the operator the choice between resolution
and sensitivity.
It is also possible to combine mass analysers by operating them in series. Two very common
examples are the triple quad (QQQ) and the Q-ToF. The former is a linear combination of
three quadrupole mass analysers, the second a combination of a quadrupole and a time-of-
flight analyser. Both of them have major importance for molecule fragmentation studies,
as explained in section A2.2.2.4.
A2.2.2.3. The Detector .
After all ions have been separated according to their m/z, they require to be registered by
a detector, before a mass spectrum can be output.
Upon reaching the detector, the ion current is usually amplified and then converted into
a digital signal. Most mass spectrometers use electron multipliers as detectors. For the
digitisation analogue to digital (ADC) converters and in rare cases, such as in some Waters
instruments time to digital converters (TDC) are used. The electronics then convert the
continuous ion count into discrete mass spectra for each scan.
A2.2.2.4. Fragmentation and hybrid instruments: The QQQ and Q-ToF .
When trying to annotate or even elucidate molecules by means of mass spectrometry, high
resolution m/z ratios and isotope pattern provide a good starting point - at least for the
determination of the molecular composition [320]. However, to obtain structural infor-
mation, fragmentation studies are needed. When a molecule breaks up into its part, the
resulting fragmentation pattern can be used to match against a database, or confirm the
presence/absence of particular chemical groups and their connection. Fragmentation of
molecules can occur in various ways; unintended or planned. Unintended fragmentation,
for example the dissociation of labile molecules in the source may yield structural infor-
mation, but is mostly undesired - particularly in metabolite profiling studies. Intended
fragmentation can be achieved by the source design, for example by electron impact ioni-
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sation in GC-MS, or by collision-induced dissociation (CID) in LC-MS. CID fragments by
accelerating ions to provide them with kinetic energy and then collide them with neutral
molecules, such as helium, nitrogen or argon gas. The kinetic energy, adjustable by the
accelerating voltage allows to control the intensity of the collision and therefore breakage
of particular bonds. Different voltages will result in different fragmentation patterns of the
same molecule.
CID is mostly performed on two types of instruments. The triple quad (QQQ) and the
Q-ToF.
The triple quadrupole, first proposed by Yost et al.[656], holds three quadrupole mass
analysers in series, with the middle, quadrupole either operating as regular ion guide or
collision cell (filled with collision gas). When the second quadrupole (Q2) is operated as
collision cell, four basic types of fragmentation experiments can be performed [129]. A
product ion scan (Q1 selects m/z, Q3 scans all m/z), a precursor ion scan (Q1 scans all
m/z, Q3 selects m/z), neutral loss scans (Q1 and Q3 scan all m/z with constant offset)
and selected reaction monitoring (SRM) (Q1 and Q3 select single m/z). Particularly SRM,
or its extension to multiple masses at a time, multiple reaction monitoring (MRM), has
become indispensable for targeted LC-MS profiling methods [29, 68]. This is, because com-
pared to untargeted profiling by a quadrupole mass analyser, SRM methods have a very
low LOD, as the mass analyser can dwell only on one or few ions at a time. QQQ methods
are also the method of choice for quantification by mass spectrometry.
A major disadvantage of QQQ however is their inability to perform high mass accuracy
measurements - a particular drawback for untargeted profiling. The Q-ToF, however, is
a high mass resolution instrument, with CID capabilities. It has a quadrupole for mass
selection, a CID chamber and an orthogonal ToF for detection, as first proposed by Morris
et al.[421, 422] and illustrated in figure A2.16. As it allows for ToF-like high mass accuracy
untargeted profiling, but also for targeted MRM-like methods, it has become one of the
most adopted instruments in the metabolomics community. Many LC-MS experiments of
this thesis will be performed by Q-ToF mass spectrometers.
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Figure A2.16.: Q-ToF (quadrupole time-of-flight) mass analyser:
The Q-ToF combines the quadrupole unit from figure A2.14 and the time
of flight module from figure A2.15, separated by a collision cell. The
quadrupole allows to select a m/z and fragment it by collision with inert
gas in the collision cell. Diagnostic fragments can then be detected using
the ToF mass analyser.
A2.3. Hyphenated approaches
Even though NMR spectroscopy and mass spectrometry are very powerful analytical meth-
ods in their own right, their full potential may be unleashed when online-coupled to a
prior separation stage; particularly for complex mixture analysis, such as performed dur-
ing metabolomics experiments. However, coupling analytical methods may create technical
problems and also make it necessary to constrain the individual parts.
The following sections will discuss the fundamental principles, potential, limitations and
the general workflow for LC-NMR (A2.3.1), LC-MS (A2.3.2) and GC-MS (A2.3.3).
A2.3.1. LC-NMR
Pioneered in the 1970s using low field strength iron magnets, LC-NMR has become a
mature laboratory technique. It is primarily used for complex mixture analysis, such as
pharmacokinetic or natural product studies, when structural information, for subsequent
structural elucidation is desired [157].
LC-NMR can be performed in various modes. On-flow, stop-flow and with solid phase
extraction SPE (cartridges). On-flow NMR online-couples the eluent flow of a HPLC sepa-
ration to a NMR magnet, as illustrated in figure A2.17. A major disadvantage, is the short
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Figure A2.17.: On-flow LC-NMR system:
An HPLC system is coupled on-line to a NMR magnet. Fraction collection
after NMR acquisition is optional. The right side shows a magnification of
the flow-probe. The eluent with the analytes is continuously pumped
through a flow cell, instead of a regular 5 mm tube. [6].
residence time of a peak inside the flow-cell, which results in a only low number of scans to
be averaged, and therefore a bad SNR. Stop-flow uses the same setup. However, as soon
as a peak of interest reaches the flow-cell, the flow is stopped and an arbitrary number of
scans and experiments can be performed on the trapped peak. If the flow is stopped for too
long, diffusion will compromise the chromatographic performance. In the SPE cartridge
approach an oﬄine separation is performed and the individual fractions dried. The individ-
ual fractions are then subsequently eluted into the flow-cell using deuterated solvents. The
other two approaches require expensive deuterium oxide and deuterated d3-acetonitrile as
solvents.
Even though solvents are usually deuterated, solvent suppression for the residual water and
H3-acetonitrile is required. However, as the water resonance frequency depends on other
solvents in the mixture (acetonitrile), it will shift throughout the HPLC gradient [305] and
suppression of a single frequency is of little use. Thus, a modern LC-NMR spectrometer ex-
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ecutes a survey scan prior to the acquisition scan. The survey scan registers the new solvent
resonance frequency, which can then be suppressed during the subsequent acquisition scan.
For the separation in LC-NMR a reversed phase gradient of D2O to d3-acetonitrile is typi-
cally used [535, 207]. However, a few other types of chromatography, such as HILIC [201],
ion exchange [133] or ion pairing [525] have been reported.
Chapter III.3 will use a LC-NMR system, to compare the performance of a reversed phase
and an ion pairing method, particularly adapted for LC-NMR. The on-flow results are then
compared to a manual HPLC fractionation, analysed by conventional tube NMR.
LC-NMR is also frequently coupled to a mass spectrometer, to record m/z and even frag-
ment information, to aid the structure annotation/elucidation process. LC-NMR-MS anal-
ysis splits the flow in a split ratio of 90 % to 10 % for NMR and MS, respectively. The
MS eluent may be supplemented with a small amount of organic solvent to aid ionisation
[111].
A2.3.2. Liquid chromatography coupled to mass spectrometry (LC-MS)
A liquid chromatography system, as described in section A2.1.2.1 can be coupled online
to a mass spectrometer (section A2.2.2), by infusing the chromatographic eluent into the
source of the mass spectrometer. The source is needed to evaporate the solvent and ionise
the analytes. There are different types of source that would be compatible with a LC-MS
system. However, the most prominent LC-MS source by far is the electrospray ionisation
(ESI) interface, developed by John Fenn [170].
A2.3.2.1. Electrospray ionisation .
Electrospray is an atmospheric pressure ionisation mechanism. Atmospheric pressure ion-
isation mechanisms are very sensitive [65], soft (little in-source fragmentation), and allow
simple sample introduction and coupling of an online separation stage. Their technical
challenge relies in gradually increasing vacuum conditions, up to 10−8 mbar at the detec-
tor, whilst still allowing sufficient ions to pass into the instrument. Figure A2.18 shows
the assembly of an ESI source and the ESI mechanism. The vacuum is built up over three
stages, the ionisation, the focusing and the detector stage, with the first served by a rotary
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Figure A2.18.: Electrospray ionisation (ESI) mechanism:
The illustration shows the working mechanism of an electrospray
ionisation source, operated in positive ionisation mode. The size of the
individual components, particularly the source to droplet ratios are not
authentic, as this drawing is for illustration purposes of the mechanism
only [88].
pump and the last two by turbo molecular pumps. In the first step of the ESI mecha-
nism, the LC eluent is dispersed into small droplets by passing through a charged steel
capillary. All droplets are accelerated towards the first vacuum stage by a high electric
field, applied between the capillary and the sampling cone (3-6 kV). The direction of the
field determines whether the sources operates in positive (ESI+) or negative (ESI-) mode
to generate cations or anions, respectively. Before entering the first vacuum stage, the
droplets need to pass a curtain of hot, inert gas (N2), which causes them to evaporate -
aided by the vacuum. This causes causes the solvent droplet, with the dissolved analytes,
to shrink. The charges, created by removing or adding electrons through the capillary volt-
age, sit on the surface of the droplet. However, with a shrinking diameter, but constant
electron excess/shortage, those charges move closer together. At a certain droplet size, the
repelling forces between the opposing forces become to high and the droplet is torn into
pieces. This process, called Coulomb explosion, disperses the droplet into smaller droplets,
which are subject to further evaporation. This whole process repeats until all solvent has
been removed by the vacuum and the ”naked ions” remain. Another voltage accelerates
the ions of the desired charge into the second vacuum change. All non-charged particles
are removed by the vacuum. At the second stage, the vacuum increases and a RF lens
focuses the ions into a tight beam, which is passed into the third stage - the detector stage.
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At this stage only ions of the desired charge are left [49, 88, 445, 304, 334].
In the simplest case, the ion of a neutral molecules (M) is formed by adding or sub-
tracting a proton (M+;M−) in positive and negative mode, respectively. Therefore the
peak in the mass spectrum will be increased or decreased by the weight of one proton
(M+ = M + 1.00727;M− = M − 1.00727). The molecule hydrogen pair is called adduct.
In a LC-MS run, many other adducts, apart from the (M+;M−) are likely to be found
[574]. In positive mode, sodium (M+ + Na) and potassium (M+ + K) are frequently ob-
served. In negative mode, the formation of formic acid adducts (M−+FA) are common, if
formic acid was added to aid ionisation [641] or improve chromatography. It is also possible
for molecules to cluster during adduct formation (2M+ + H). Electrospray is also known
for producing multiply charged ions, particularly for molecules above 1 kDa. This is very
helpful for protein analysis as the m/z ratio of multiply charged molecules, that otherwise
would exceed the range of the detector, can easily be measured. Adducts and multiple
charges need to be taken into account when performing database searches.
Coupling two analytical methods, may also lead to constraints of the individual ones. So
is the case in LC-ESI-MS. Buffered solvents, such as phosphate buffers, are commonly
used for LC-UV applications. However, the ESI interface is incompatible with high salt
concentrations. In the simplest case, those may lead to heavy buffer-adduct formation.
Furthermore, they will contaminate the source, by building up salt crystals around the
cones, compromising their diameter and leading to a sensitivity drop throughout the run.
It may also happen, that high salt concentrations suppress the signal completely, in a pro-
cess called ion suppression. An exception are volatile buffers, such as formic acid, which
are often aided to ensure chromatographic reproducibility and aid ionisation [641].
Ion suppression is the suppression of an analyte signal by another compound inside the
system [18]. Research suggest that less volatile molecules aversely affect droplet formation
and solvent evaporation, when in high concentration [17]. Those non volatile molecules
may be salts, ion pairing agents, but also highly concentrated endogenous compounds.
They lead to reduced sensitivity for other analytes or even quantification errors. As one of
the dogmas of metabolomics is that a single compound’s signal intensity is proportional to
its concentration, when compared across several samples, ion suppression can be a major
pitfall. Thus it is to be avoided as much as possible. In order to reduce ion suppression
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the use of high quality solvents is essential. Sample cleanup, often as part of the sample
extraction, may help [388]. However, most importantly, a good chromatographic separa-
tion, minimising the number of analytes eluting at the same time, is mission critical.
A2.3.2.2. LC-MS sample set acquisitions .
This section describes how a typical LC-MS profiling experiment, such as performed for
the mutant screen in chapter V. is set up.
As for each platform, the first step is sample preparation. Modern LC systems do not tol-
erate any non-soluble particles. Therefore those need to be removed by cold centrifugation,
after reconstitution with the starting condition solvent. Supernatants can be transferred
into a 96 well plate as was the case for the extraction comparison study in chapter II..
Individual high recovery vials, such as for the mutant screen and isotope labelling exper-
iments in chapters V. and IV., respectively, may also be used. Another important step
is checking the condition of the LC-MS system. Particularly as the used UPLC systems
operates at pressures up to 1000 bar, it is important to check for improperly mounted
fittings or leakages. It is also important to clean the electrospray source prior to use.
As mentioned above, salts and molecules can deposit onto the surfaces, particularly onto
the cones close to the orifice and compromise the overall LOD. After the source has been
resembled, the mass spectrometer’s mass accuracy may be calibrated to achieve as low
as possible ppm errors. This is usually performed by infusing a mixture of compounds
with known m/z ratios. In this thesis sodium-formate, which forms specific clusters across
the whole m/z range, is used. Furthermore all voltages, such as capillary, extraction or
detector voltage are adjusted to achieve maximum sensitivity. At this stage, the latest, the
solvents may be topped up or swapped. Before starting the actual experiments, several
blanks and quality control (QC) samples may be injected. Blanks are helpful to estimate
background arising from the system or solvents. High background signal may not only
lead to false positively detected peaks, but is also a major risk factor for ion suppression
[17]. QC samples, which are a representative pooled mix of sample aliquots, are used to
monitor the system’s stability throughout the run [511]. However, they are also well suited
to condition the chromatography system. During the conditioning phase, the QC mix is
injected repeatedly, until the chromatographic system is stable, i.e. the retention time drift
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between injections has become negligible and chromatograms overlay nicely. It is also rec-
ommended to check the correct operation of the lock spray, to ensure high mass accuracy.
If the whole system performance lies within the expected quality standards, acquisition
of the sample set may commence [616, 141, 613]. However, it may be necessary to use
intensity correction models for high sample number acquisitions, as described by Dunn et
al.[141].
A2.3.2.3. Different types of chromatograms: TIC, BIP, EIC .
After, or also throughout acquisition, data must be analysed. As LC-MS data is three
dimensional, visualisation is not straightforward. Even though data can be plotted three
dimensionally, for example by using coloured heat maps, this is not often done. Most
times, the 3D LC-MS data is plotted as a 2D projection, with the m/z domain collapsed.
This yields a relative intensity versus retention time plots. However, as abolishing the m/z
dimension leads to a loss in information, three types of chromatograms, collapsing the m/z
domain in different ways, exist. Figure A2.19 shows examples of those.
Total ion chromatogram (TIC): The TIC sums all m/z intensity values of a scan. It
therefore corresponds the total ion current of a scan. As can be seen in figure A2.19a,
the baseline drift is clearly visible. Thus a TIC is useful to check peaks with respect
to background (noise).
Base ion peak chromatogram (BIP): The BIP only displays the intensity of the most
intense peak at each scan. Therefore the BIP is dominated by the most intense
peaks (figure A2.19b). Compared to a TIC, the baseline is not considered. A BIP
can be useful to find peaks, that can be further isolated in an EIC.
Extracted ion chromatogram (EIC): The EIC is the chromatogram of a single m/z slice
of defined width, such as all ions between 338.2 and 338.4 Da in figure A2.19c. Only
one peak seems to lie between those two masses. Therefore it is well suited to display
(the chromatographic profile of) individual peaks. Figure A2.20 shows the mass
spectrum of the peak at 15 min.
A2.3.3. Gas chromatography coupled to mass spectrometry (GC-MS)
Gas chromatographs were first coupled to mass spectrometers, decades before LC-MS was
invented. McLafferty [402] and Gohlke [202] were the first to couple a quadrupole and a
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Figure A2.19.: Different types of chromatograms (TIC,BIP,EIC):
Total ion (TIC) (figure A2.19a), Base ion peak (BIP) (figure A2.19b) and
a m/z = 338.3 Da extracted ion (EIC) (figure A2.19c) chromatogram of a
C. elegans extract acquired in positive ESI mode.
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Figure A2.20.: Mass spectrum of peak apex from EIC in figure A2.19c:
ToF mass analyser, respectively, to a gas chromatograph. This has become possible after
the invention of the electron impact ionisation source, by J. Benyon [46], who realised the
potential of fragmentation patterns to aid the identification of chemical compounds. The
combination of machine independent retention indices and diagnostic fragmentation pat-
terns, generated by each molecule, make GC-MS one of today’s most important analytical
platforms.
A2.3.3.1. Electron impact ionisation (EI) .
Electron impact ionisation (EI) is a ”hard” ionisation technique, breaking up the molecule
into diagnostic fragment ions. A typical EI source is illustrated in figure A2.21.
In the EI source, the non-charged molecules, arriving from the GC-column are bombarded
with a stream of electrons. Those are generated by a light bulb like cathode - the filament,
and accelerated towards the anode. The electrons do not impact the molecule, but rather
interact with its molecular bonds, which leads to excitation and breakup of the bond [42].
By convention, an electron collision energy of 70 eV is used, to make spectra comparable
across different machines. Indeed, EI spectra are very reproducible, allowing database
matching (section A3.1.4.1). After fragmentation, the ions are then accelerated between
the electric field of the repeller and extractions lens, and separated by they m/z ratio prior
to detection.
Figure A2.22 shows the EI spectra of caffeine (figure A2.22a) and malic acid (figure A2.22c),
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Figure A2.21.: Electron impact ionisation (EI) source:
Molecules are fragmented and ionised by electron bombardment.
together with a fragmentation tree for caffeine (figure A2.22a).1
For caffeine, all major fragment ion can be explained by specific fragments. This shows the
strength of EI-GC and fragmentation studies in general, to assign and elucidate molecules.
Fragmentation occurs according to complex rules, such as rearrangements [403]. Fragments
may not only be detectable ions, as figure A2.22a shows. Also radicals, such as ·CH3, or
neutral, gaseous molecules , such as CO, referred to as neutral losses, are common frag-
mentation products.
When using derivatisation agents, it is possible, that the major fragments are due to
fragmentation of the groups added by the derivatisation agent. The MSTFA derivative of
malic acids displays such a case (figure A2.22c). Still, some diagnostic fragments may be
found in lower abundance. However, if those, in conjunction with retention time, do not
1All fragment ions are putative, but can then be tested by accurate mass measurement and isotopic
labelling studies.
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Figure A2.22.: GC-EI-MS fragementation:
Figure A2.22a illustrates the electron impact ionisation (EI) spectrum of
caffeine. Major fragment ions are explained by the fragmentation tree in
figure A2.22b. A molecule can fragment in different ways, by either a
radical or neutral loss. The two most abundant fragments of the EI
spectrum of malic acid (figure A2.22c) originate from the MSTFA
derivatisation agent, rather than the compound itself.
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allow unambiguous assignment of the molecule, the projects in this thesis will refrain from
doing so.
A2.3.3.2. GC-MS sample set acquisitions .
This section outlines the analytical workflow of a typical GC-MS experiment setup and
acquisition, as already done in sections A2.2.1.7 and A2.3.2.2 for NMR and LC-MS, re-
spectively. Figure A2.23 outlines all necessary steps.
Injection
Methoximation
Derivatisation
Silylation
Gas leak check
Liner & septum change
Instrument tuning
Instrument preparation
Add internal standards 
Sample preparation
Figure A2.23.: Standard procedure of a GC-MS sample acquisition:
Flow chart of a standard procedure for preparation and acquisition of a
GC-MS sample set, such as used in this thesis. For details please refer to
the text.
In GC-MS the experimental setup divides into instrument and sample preparation, which
out of the used analytical methods is the most time-consuming for GC-MS. To the dried
samples, the retention time lock standard, d27-myristic acid in this thesis, and quanti-
tation standards, such as U-13C-glucose and 2,3,3-d3-leucine are added. As reproducible
derivatisation requires anhydrous conditions, the sample must be thoroughly dried, before
incubation with the methoximation solution. After silylation with MSTFA, an injection
standard, 2-flourobiphenyl, is added to correct for small variations in injection volume.
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The samples, if not already done so, are transferred into glass vials with inert, silanised
inserts.
To prepare the instrument, the liner and septum are changed for each new sample set,
as those become contaminated throughout injections. After changing them, it is essential
to check for gas leaks. This can be done by checking that the water and oxygen peaks,
introduced by ambient air, are below a manufacturer defined threshold. Gas leaks would
lead to uncontrollable retention time drifts and oxygen might even damage the stationary
phase at high temperatures. When an air-tight system is guaranteed, the instruments can
be tuned, i.e. lens and detector voltages optimised. Usually performed automatically, the
system uses an internal standard to optimise sensitivity, isotope ratios and mass resolution.
If all checks are passed and samples are finished derivatising, injections may commence. It
is recommended to start of with blank injections and then QC samples to check the system
cleanliness and performance, such as retention time reproducibility, sensitivity and peak
widths, respectively. [323, 186]
A2.4. How to choose an analytical platform
After all analytical platforms (NMR, LC-MS and GC-MS) used in this thesis have been
discussed, an important question emerges: Which platform should be chosen for which
application.
Figure A2.24 tries to outline considerations that must be taken into account when choosing
the analytical platform for a metabolite profiling experiment.
Nuclear magnetic resonance (NMR) spectroscopy is relatively insensitive and therefore re-
stricted to the analysis of high concentration compounds. Primarily, those are molecules
from the central carbon metabolism, such as glucose, amino acids and nucleotides. As it
only requires compounds to have protons in order to be visible and does not perform any
prior separation, it has no bias towards specific compound classes, as LC-MS and GC-MS
would have. However, the lack of a prior separation stage also leads to signal overlap and
potential masking of smaller concentrated or similar compounds. Chapter III.3 aims at
addressing this problem, by performing a LC-MS analysis of a C. elegans extract. De-
spite the sensitivity and overlap drawbacks, NMR, particularly as assignment is straight
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Figure A2.24.: Choosing an appropriate analytical platform:
Considerations regarding choice of the analytical platform. Details are
discussed in the text.
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forward, is well suited for an initial survey.
Mass spectrometry is a very sensitive technique; down to femtomolar concentrations. How-
ever, as figure A2.24b and A2.24c show, different types of chromatography and the choice of
a certain ionisation interface make it selective towards specific compound classes. GC-MS
is very well suited for small and apolar molecules, as it requires them to be volatile, which
is inversely correlated with molecular weight and polarity. As the electron impact (EI)
source creates ions by fragmentation, the compounds, compared to electrospray, may even
be completely apolar, without any ionisable functional groups. GC-MS coverage may be
increased by means of derivatisation, i.e. the conversion of polar functional groups into ap-
olar ones. However, derivatisation is not an necessarily option for larger polar molecules,
as the derivatisation agent (used in this thesis) ads significant weight to the compound
and therefore increases its volatility. Electrospray (ESI) is well suited for polar and ionic
compounds. It is compatible with a large range of molecular weight. Very low weight
molecules, such as small alcohols and acids, may be subject to evaporation and removal
by the vacuum pump. On the other end, the formation of multiply charged ions, allows
very large compounds to be detected in the m/z (mass to charge ratio) operation range
of common mass analysers, such as ToF instruments. Two major drawbacks of LC-ESI-
MS are potential problems with ion suppression and difficulty with compound annotation.
However, the later will be addressed in chapter IV..
When deciding to use ESI, the selectivity is already determined by the used chromato-
graphic mode, as figure A2.24b shows. Reversed phase is well suited for apolar and medium
polarity, such as lipids or vitamins. The more ionic or ionisable groups, the better it is re-
tained by ion pair chromatography. Ion pairs can separate extremely polar molecules, such
as multiply charged, highly phosphorylated nucleotides [366]. HILIC is very well suited for
polar molecules, but may be extended to cover certain lipid classes [666]. In the case of
ion pairing and HILIC, different solvents and modifiers are needed to analyse cationic and
anionic ions.
It becomes apparent that there is no analytical platform, which may cover all metabolites,
but rather that different analytical platforms compliment each other; particularly if true
untargeted profiling is desired. Therefore, the metabolomics community has started to
move towards multiple analytical platforms studies. [628, 23, 67, 48, 414, 187, 39, 513].
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However, such cross-platform approaches bring challenges on the levels of sample prepa-
ration, analysis and data processing and integration. The next section will discuss data
processing workflows for the different platforms. The first experimental chapter of this
thesis, chapter II., will investigate tissue extraction methods, compatible with all three
major platforms; NMR, GC-MS and LC-MS.
A3. Informatics
After all data has been collected, it must be processed and analysed. Particularly for
metabolite profiling studies, which accumulate a wealth of analytical data to prise out sub-
tle changes in metabolite concentrations between different samples, computational methods
have become indispensable. This section will present the data processing and reduction
workflow used in this thesis for each platform. A short introduction into common data
analysis, such as data pretreatment methods, univariate and multivariate statistics will
conclude this methods chapter.
A3.1. Data processing
Table A3.1 lists the number of data points and resulting file size for individual files, that
have resulted from experiments in this thesis.
Data type Data point / file File size
1-D NMR 16k - 64k < 1 MB
2-D NMR x k by x k (mostly empty) x - xx MB
GC-EI-MS (low res.) few ten k 1− 20 MB
LC-ESI-MS (high res.) up to 100 M up to 1 GB
Table A3.1.: Typical number of data points and file size of different
experiments:
x and xx are undetermined numbers of one and two digits length,
respectively; k and M are the SI prefixes for thousand and million,
respectively.
It immediately becomes apparent, that prior to any data analysis and irrespective of the
analytical platform, data processing methods need reduce the total amount of informa-
tion to a few relevant data points (variables). Ideally, they will also remove duplicate
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information, such as several spectral variables expressing the concentration of the same
metabolite. Furthermore, this condensed information requires alignment across multiple
samples, so that the concentration of a particular compound can be compared across all
samples. This section discusses the details of these two major steps for NMR (A3.1.1),
LC-NMR (A3.1.2), GC-MS (A3.1.4) and LC-MS (A3.1.3).
A3.1.1. Processing of NMR spectra
In a modern NMR instrument, the (90°) excitation pulse consists of a broad range of fre-
quencies, to excite all nuclei of slightly different frequency (different chemical shift) at once.
The detected response of such a multi frequency pulse is a complex mixture of decaying
harmonic oscillations, of different frequencies, called the free induction decay (FID). In or-
der to yield a frequency spectrum of this time domain signal, fast Fourier transform (FFT)
algorithms can be used [110, 153]. However, data processing in NMR may already begin
before the FFT. Figure A3.1 outlines all necessary steps from the FID, to an analysable
spectrum.
A3.1.1.1. Window functions, phase and baseline correction and shift referencing .
Before FFT, the FID may be multiplied by a window function, to modulate the peak shape
in the frequency spectrum. For one dimensional 1H spectra, the most common window
function is an exponential decay function, which is multiplied with the FID, as displayed
in figure A3.1a. An exponentially decaying function in time domain, corresponds to a
Lorentzian filter kernel in the frequency domain. Therefore it is aimed to reduce the noise
in the spectrum. The amount of smoothing is determined by the line broadening factor,
measured in Hz. If set to high, it may remove diagnostic fine structure of the peaks.
Another disadvantage is that with a higher line broadening factor peaks become broader.
After FFT, the peaks must be ”phased”. Usually, the FID oscillation, detected in the Mx
axis is not a perfect cosine wave, i.e. it’s maximum is not at 0 (cos(0) = 1), but rather
starts later, i.e. it has a phase shift. Therefore after FFT its frequency spectrum is dis-
torted as shown in figure A3.1b. However, by adjusting the phase angle to transform the
FID into a ”perfect” cosine wave, an aesthetically pleasing, interpretable NMR spectrum
is yielded. The next steps are baseline correction (figure A3.1c) and referencing the ppm
scale (figure A3.1d). For baseline corrections different methods exist [644]. In most cases
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Figure A3.1.: NMR spectra processing workflow:
Figure A3.1a shows an exponentially decaying window function, to be
multiplied with the FID prior to FFT to smooth the peaks. The next
inevitable step, is to correct the phase angles of the frequency spectrum
(figure A3.1b). If desired, the baseline (figure A3.1c) and chemical shift
(figure A3.1d) offset can be corrected. For detailed explanations, please
refer to the text.
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a polynomial or spline function are fitted. For the referencing, either the added internal
chemical shift reference, such as TSP or a metabolite of know shift, that is unaffected by
pH variation, are used.
A3.1.1.2. Alignment versus fitting or binning .
After the individual spectra have been processed, they can be be compared. In the easiest
case by spectral overlay as done in figure A3.1b. To automatically compare and analyse
spectra, for example by multivariate models, they require further processing, due to small
variations in chemical shift. Those small variations are introduced by difference in pH,
or concentrations in electrolytes, metabolites or proteins. The easiest way to overcome
this problem is binning. Binning reduces the spectral resolution by dividing it into evenly
spaced, user defined or via means of an algorithm calculated intervals [16]. The used inter-
vals should be wide enough to overcome the small variations in peak positions. However,
in samples with a different baseline, wide shifts or even peak overlaps, binning is not very
reliable and discouraged [115]. Another method is to align the peaks to a prior defined
consensus spectrum. Different algorithms are available. In this thesis a recursive segment-
wise peak alignment algorithm proposed by Veselkov et al.[598] will be used to align the
raw data. Recently, peak alignment procedures have also been put under scrutiny, as they,
themselves may introduce artefacts. They also fail in the rare case of two peaks crossing
their position. In such cases, peak fitting is the best choice. Liebeke et al.[365] discuss
this problem. Peak fitting tries to quantify a peak by fitting a peak shaped model to its
area. This can be done with manual guidance, for example with the Chenomx software
suite [617]. Chenomx will be used to quantify the metabolites in the extraction comparison
chapter (II.) of this thesis. Recently, Hao et al.[229] have released a completely automated
peak fitting suite, which has been shown to also work well in the case of large pH shifts,
overlapping and crossing peaks [364]. A major advantage of fitting, regardless of manual or
automatic execution, is that it ends up with one numeric value for each peak or even com-
pound. This reduces the amount of data, and also removes correlated, redundant variables,
which may be advantageous in subsequent modelling procedures. If appropriate internal
standards are used, fitted data can also be transformed into fully quantitative data, which
is particularly interesting for quantitative pathway modelling tools.
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A3.1.1.3. Processing of 2D NMR spectra .
The processing of 2D NMR spectra follows the one of 1D spectra. However, depending
on the pulse sequence (HSQC, COSY, HMBC, JRES,..) different window functions can
improve the results, in particularly the SNR. In most cases the FFT will also need to be
performed in the second dimension. For phasing and baseline correction, specific peaks
across the whole spectrum are chosen. After performing the phasing and baseline correc-
tions on their 1D projections, their consensus correction models are applied to the whole
spectrum. Spectra also need to be referenced in both dimensions.
As a COSY spectrum is symmetric with respect to its diagonal, its mirror image can be
added to improve the SNR.
A3.1.2. Processing of LC-NMR spectra
LC-NMR spectra may be processed like a stack of 1D spectra. If other detectors are used
in parallel or series, retention time alignment between those may become necessary.
A3.1.3. Processing of LC-MS data
As table A3.1 shows, LC-MS acquisitions carry by far the largest amount of recorded in-
formation. Also, compared to two dimensional (ppm × intensity) NMR data, LC-MS files
have a three dimensional structure. Each datapoint has an associated retention time (RT),
mass to charge ratio (m/z) and intensity value. Also, after reduction, it is required to
align the variables of several data files in two, independent (RT×m/z) dimensions, rather
than one like NMR (ppm). Thus, they require more sophisticated processing algorithms,
to reduce the information. Several software packages and tools are available, which incor-
porate such algorithms. Most vendors sell their own software suites, for example Water’s
MassLynx. Those commercial solutions are usually easy to use black box systems, which
are convenient for application focused endusers. However, for explicit method develop-
ment, also on the data processing side, those are less suited. Therefore, for this thesis,
open source software packages were used.
Although many free open source software solutions have been published [604, 547, 277,
618, 409, 315], mzmine [302, 482] and xcms [531, 45] are the most widely used in the
metabolomics community. However, all of those work in the same fashion: Peak detection,
alignment across files and finding the peaks that were not detected in certain samples in
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the first place, to yield a peak versus sample intensity matrix. Usually one package offers
a set of different algorithms for the same step. Not rarely do different software packages
adopt each other’s methods, if they were found to perform well. Compared to mzmine,
which requires its modules to be written in C, xcms is implemented inside the open source
statistical programming suite R, with the option to write and use C libraries. As R is
much better suited for code prototyping, it was decided to base this thesis’s experiments
and tool development on the xcms software package
A3.1.3.1. The LC-MS deconvolution and alignment workflow: XCMS .
Out of the four experimental chapters of this thesis three apply xcms, optimise its param-
eters or even build tools onto its existing algorithms. Therefore this section describes its
workflow and important parameter settings in more detail. Parameters are highlighted in
italics.
Before data can be loaded into R, it must be converted, from the vendor’s proprietary file
format, to an open source format, such as mzXML [472]. Furthermore profile mode data,
i.e. mass spectrometry data which also records the peak variance in the m/z domain,
could be reduced to centroided data, i.e. peaks that are only described by their apex m/z
value. After those steps, xcms can be launched inside an R session. The first processing
step is peak detection, to identify chromatographic peaks within an abundance of noise.
Peak detection for high mass resolution data (”centWave” algorithm [566]) is performed in
two steps, illustrated by figure A3.2.
At first regions of interest (ROI) are defined. ROI are traces in the chromatogram, where
a signal, above a certain intensity can be seen for a minimum number of consecutive scans,
with minimal m/z variation in-between those scans. The number of consecutive scans and
minimum intensity are specified by the prefilter parameter. The minimum ppm deviation
in the m/z domain is defined by the ppm parameter. Figure A3.2a gives a graphical rep-
resentation of this procedure and its parameters. As not all ROI are peaks necessarily, a
second, step checks whether the ROI has the typically expected shape of a LC-MS peak.
A wavelet (”mexican hat”) filter kernel, which corresponds to the second derivative of a
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Figure A3.2.: Wavelet peak detection in xcms:
First, the regions of interest (ROI) are found (figure A3.2a), which are then
fitted with a wavelet filter kernel (figure A3.2b). All peaks which fit the
wavelet well are identified as peaks (figure A3.2c).
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Gaussian function, is used as model peak shape. The model’s width, its wavelet coef-
ficients, are determined automatically. However, it is recommended to use the peakwidth
parameter to specify the expected minimum and maximum width of a peak expected under
the chromatographic conditions. This parameter is particularly important, when UPLC
systems are used, as the default parameters are set for the much wider HPLC peaks. The
wavelet also determines the peak’s apex and integrated intensity, and its retention time
and m/z boundaries, as illustrated in figure A3.2b. By knowing a peak’s apex intensity,
its signal to noise ratio (SNR) can be calculated, by relating it to its chromatographic
neighbourhood. Using the snthresh parameter, a minimum SNR, below which peaks are
discarded, can be set. However, as noted by Dunn et al.[142], this SNR cannot necessarily
be compared with classical SNR values and therefore settings as low as 1 may yield repro-
ducible peaks. An extra parameter requires to be set, when using Waters instrumentation
with lock mass corrections. During acquisition of the mass correction lock spray every few
seconds, the eluent spray is interrupted for two scans, leaving gaps in the chromatogram.
An algorithm, developed by Benton et al.[43] can fill those gaps by interpolation, when the
lockMassFreq parameter is set to ”TRUE”. At the end of the peak detection procedure,
all chromatographic peaks are identified (figure A3.2c) and their intensity and position is
recorded inside a table.
In LC-MS detected peaks are often referred to as ”feature”. This acknowledges that the
origin of the peak is not yet known. The term metabolite or compound would be mislead-
ing, as it could also be an isotope peak, adduct or cluster. Thus, the term feature will be
used throughout the thesis.
The next step of the xcms workflow is to align the features, which originate from the same
compound, across multiple files. In xcms, this is performed in two steps, which can be
repeated iteratively until a satisfactory result is reached. In a first step, coarse RT and
m/z windows are spanned to ”group” features with a very similar mass and retention time
across different samples. The RT and m/z boundaries of these windows can be defined
by the bw and the mzwid parameter of the grouping function, respectively. In the ideal
case, the windows are large enough to allow for mass inaccuracies and naturally occur-
ring retention time deviation, but small enough to not pool features of different origin. If
for a certain group one and only one feature was assigned from a datafile, this groups is
regarded as ”well behaved” and most likely to originate from the same compound. In a
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second step, those well behaved peak groups are used to estimate the local retention time
deviation (induced by variations in RT), for each file. This is done by calculating the RT
deviation of each feature from its group’s median RT. This RT deviation from a group’s
median is used on a per file basis to build a model of each file’s RT deviation across the
whole retention time range, by fitting a LOESS (locally weighted scatterplot smoothing)
regression model [105]. This procedure is illustrated by figure A3.3.
Figure A3.3.: Retention time alignment in xcms:
The retention time deviation from the median RT of the ”well behaved”
peak groups (dots) is modelled across the whole RT range using LOESS
regression (solid line). Individual colours correspond to different sample
files (acquisitions).
Using this model, all features are aligned to the median RT. In fact, also the times of the in-
dividual scans are aligned, allowing to predict the expected RT position of a feature, which
was not found in a particular sample. Thus, the correct area (where the feature should
have appeared) can be calculated in the final step. For the alignment step, the most im-
portant parameter is the span parameter. It defines the degree of polynomial smoothing,
i.e. whether individual input data points may affect the curvature of the resulting model
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or the model is more representative for the average of data points. Finding a satisfying
span parameter requires the user to estimate whether the retention time model, as shown
in figure A3.3 is realistic. The grouping and alignment step should be repeated iteratively,
to refine the group’s window size, which in return will allow a more precise retention time
deviation model. It is reasonable to aim at a maximum retention time deviation of less
than one second, after correction [44].
At this stage, one already has a feature (variable) by sample (observation) intensity ma-
trix. However, this matrix may still contain missing values, in case a feature was not found
during the initial peak detection step. As leaving zeroes would negatively impact any sub-
sequent statistical analysis, those missing values require to be filled. The retention time
deviation model can predict the expected position of the missing feature from the not well
behaved groups (i.e. those features not found in each sample). Thus, in order to complete
the intensity matrix, xcms integrates the mass spectra at the missing features’ expected
positions.
Finally, a complete feature by sample matrix can be exported fur subsequent data analysis.
A3.1.4. Processing of GC-MS data
Even though compared to LC-ESI-MS, GC-EI-MS files contain far less data points and
are recorded in low mass resolution (in this thesis), they are of similar complexity. As
illustrated in figure A3.4, a GC-EI-MS data file structure can be viewed as sparsely pop-
ulated retention time × integer m/z matrix, with several fragmentation patterns. Even
though fragmentation patterns are complex, they are very diagnostic and allow to identify
a compound, as discussed in section A2.3.3.1.
A3.1.4.1. Fragmentation patterns and database matching .
Indeed, initiated by McLafferty in the 1970ies, extensive fragmentation and retention in-
dex databases for GC-EI-MS have been curated over the last few decades [335]. The most
comprehensive current library may be the NIST/EPA/NIH Mass Spectral Library [25],
with over 200 thousand entries. As it would be impractical to manually compare recorded
fragmentation patterns with the database’s for identification purposes, efficient matching
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Figure A3.4.: GC-MS spectrum:
2D heat map of a GC-MS acquisition of a C. elegans extract with the
corresponding TIC on top. Underneath intense TIC peaks, their
fragmentation pattern is visible in the heat map.
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algorithms have been developed. Even though some of these are very complex, involving
probability calculations and using meta information [404], the simple dot product matching
algorithm, performs unchallenged in routine matching applications [540]. The dot prod-
uct matching algorithm simply calculates the dot product between two unit norm scaled
intensity vectors of an unknown (VUnknown) and a library (VLibrary) spectrum, according to
equation A25.
(∑ |VLibraryVUnknown|)2∑
V 2ULibrary
∑
V 2Unknown
(A25)
In case both vectors matche perfectly, i.e. the vector is identical, the dot product becomes
one. If both vectors contain no intensity at a single, common m/z value, the dot product
will be zero. Partial matches will therefore yield scores between 0 and 1, depending on the
two vector’s similarity. When performing a database query for a fragmentation pattern,
the software would compute the dot product between the queried vector and all database
fragmentation patterns and rank them according to their similarity. If the match score
exceeds a prior set threshold (and the retention time index is also within a set confidence
interval), the fragmentation pattern may be assigned as the best matching compound. As
the dot product is a simple arithmetic procedure, the algorithm is very fast and allows
large databases to be queried quickly.
The most widespread used matching software was also developed by NIST: AMIDS, the
Automated Mass Spectral Deconvolution and Identification System, developed by Stein
and coworkers [539] is actually much more than a simple fragmentation pattern matching
software. It allows to find the fragmentation patterns in the first place, i.e. it determines
which fragments belong together and are likely to originate from a single compound. Those
extracted m/z clusters are called components, which then can be matched to a database.
Not only is it highly sensitive, but AMDIS is also able to deconvolve overlapping fragmen-
tation patterns, which originate from compounds, that were not completely separated by
the gas chromatograph. AMDIS will process a sample set on a file-to-file basis, outputting
the detected components, their intensity and their database annotations, in case a com-
pound could be matched. However, when used for metabolomics experiments with multiple
sample sets, the AMDIS workflow has two shortcomings, compared to the xcms software
package used for LC-MS processing (A3.1.3.1). It does not align the components across
multiple files. Neither does it allow to re-integrate the area, in cases where a component
was not detected in a particular sample.
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For this reason, post processing workflows are required. The standard (post processing)
workflow used for processing the GC-MS data sets in this thesis is presented in the next
section.
A3.1.4.2. GC-MS processing workflow .
First, the acquired data files are converted into the open source netCDF (Network Com-
mon Data Form) format, using the vendors software. Prior to its use, AMDIS requires ad-
justments to its parameters in order to deliver the best possible results. In particular, the
average peak width (scans per component), minimum intensity threshold and the threshold
for the fragmentation pattern and retention index matching require to be optimised. This
is best done by using a QC sample as a representative example and varying the parameters
until a satisfactory performance is yielded. Satisfactory would be identifying and match-
ing a high number of peaks, which can be assumed to be matched correctly. After those
settings are found, AMDIS is executed on all files. To align the annotated components
across multiple samples and re-integrate peaks that were missed by AMDIS, a software
complement, in-house developed by Volker Behhrends et al.[38] was used. The Matlab
based software called GAVIN, steps through each metabolite individually, visualising the
AMDIS integration boundaries and allowing to adjust them manually. Furthermore, it
allows checking of the assigned mass spectra to the spectral database in order to exclude
potential miss-matches. It is also possible to select the quantification ion - the ion of the
component (fragmentation pattern) which is used as the representative intensity for this
component. In case of overlapping components, the fragmentation ion must be chosen
to be unique to the desired component. GAVIN outputs an intensity metabolite × sam-
ple matrix, which can be used for subsequent data analysis, as described in the next section.
Even though this workflow has proven to work well, it has a major drawback. Only com-
ponents, that were identified as a metabolite (by the database matching), are considered.
Components that are not contained in the database or can not bet matched with sufficient
confidence are discarded. Numerous other GC-MS data processing workflows have been
reported [144, 172, 570, 63, 548, 83, 95], that (partially) address this problem.
Chapter III.4 will develop a GC-MS workflow, which works irrespective of database match-
ing and is a TIC alignment WYSIWYG (what you see is what you get) approach to GC-MS
metabolomics.
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A3.2. Data analysis and statistics
After peaks have been extracted from the raw data, they may be analysed using classical
univariate statistics or multivariate pattern recognition techniques, described in section
A3.2.1 and A3.2.3, respectively. Section A3.2.2 gives a short overview over data prepro-
cessing methods, such as normalisation and scaling, which are of particular importance,
when multivariate models are used.
A3.2.1. Univariate statistics
This thesis will not only use statistics to analyse the results and test upcoming hypothe-
sis, but also the methods, with computational algorithms that are used or developed, in
particular, rely on key statistical concepts [70]. Therefore important statistical concepts
will be revised briefly in this section.
After a short revision of important parameters of descriptive statistics, inference statistics,
with confidence intervals and statistical testing will be discussed.
A3.2.1.1. Distributions and descriptive statistics .
Any event in the universe has a certain likelihood for it to occur - its probability. It may
not ever occur, and thus its probability will be infinitely close to 0 (0%) or inevitable, with
a probability of 1 (100%). Probabilities are sampled from their underlying probability
distributions. Even though a probability distribution can have any possible shape, there
are a few model distributions, that most processes can be assigned to. Those model distri-
butions, either discrete or continuous, can be described by mathematical functions. Their
probability density functions (PDF). Import distributions include the Binomial, Boltz-
mann, Chi-squared and Poisson distribution. The distribution mostly used in this thesis
and maybe science in general, is the normal distribution, as shown in figure A3.5.
If however, the type distribution cannot be determined to make inferences about its param-
eters, nonparametric methods, such as those that rely on ranks, rather than a continuous
scale, may be used [188]. A very important non-parametric way of describing a distribution
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is the median or any other percentile. If ranked, the median is the numerical value at half
of the data sample. The median is the 50th percentile. The 95th percentile, would be the
numerical value of the 95th of 100 ranked values.
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Figure A3.5.: The normal distribution:
The probability density function of a standard normal distribution, i.e. a
normal distribution with a mean µ of zero and a standard deviation σ of
one. Also, in a non-skewed (normal) distribution, the mean equals the
median and has the highest density. The often used 95 % and 99 %
confidence intervals are also shown.
According to its PDF, given by equation A26, the normal distribution, can be characterised
by additional parameters, also illustrated in figure A3.5. Its mean µ and variance σ2, which
often is expressed as the standard deviation
√
σ2 = σ. Most parametric statistical tests
build on the normal distribution and therefore these two parameters.
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f(x) = 1
σ
√
2pi
e−(x−µ)
2/2σ2 (A26)
For a set of n values x1, x2, ..., xi, the sample mean x can be calculated according to equa-
tion A27.
x = 1
n
n∑
i=1
xi (A27)
For the same set, the sample standard deviation (SD) can be computed according to equa-
tion A28.
SD =
√√√√ 1
n− 1
n∑
i=1
(xi − x)2 (A28)
In non skewed normal distributions, the mean equals the median and maximum of the
PDF, specifying the most likely value from this distribution. The standard deviation de-
scribes the amount of variation inside a distribution, in other terms the dispersion from
the mean. The larger, the further away individual samples can be found away from the
mean. Thus, it can be used to build confidence intervals, as will be explained in the next
section.
Another measure that will be used frequently throughout the thesis, to describe the re-
producibility of an analytical measurement is the relative standard deviation (RSD), also
referred to as coefficient of variation (CV). According to equation A29, it is the ratio be-
tween the standard deviation SD and the mean x.
CV = SD
x
(A29)
A way to express the strength of the correlation between two vectors, is to calculate their
covariance, according to equation A30.
cov(X, Y ) =
N∑
i=i
(xi − x)(yi − y)
N
(A30)
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If the covariance is normalised by the standard deviations of both vectors, the Pearson’s
correlation coefficient R is yielded (equation A31).
R = cov(X, Y )
σxσy
(A31)
|R| describes the magnitude of the two correlating vectors, with 1 being co-linear and 0
being orthogonal. If R is positive and negative, the correlation is direct and indirect, re-
spectively.
A3.2.1.2. Statistical inference .
Statistical inference encompasses all the methods and concepts, that can be used to draw
conclusions from data that is influenced by random variation and therefore an integral
part of science. In order to choose the right tool of statistical inference, it is important to
know the underlying structure of the data, such as from which probability distribution it
is derived or whether it has be treated as non-parametric. Statistical inference concepts
divide into Bayesian inference and frequentist inference. Only the later will be discussed in
the scope of this section as it is the one immediately relevant. Furthermore, unless noted
otherwise, a normal distribution is assumed for all further considerations.
When during an experiment a reading is performed, a sample (values) from the underlying
population distribution is taken, and used to build up a sampling distribution. Ideally
the population and sampling distribution are the same. However, in reality this largely
depends on how many random samples (n) are taken. The more - the more the sampling
distribution’s mean and standard deviation will converge to the ones of the population.
Figure A3.6 illustrates this.
If sampling from the population’s distribution is repeated, each time, the sampling distri-
bution’s mean and standard deviation will be different, varying around the true values. The
extent to which repeated samples vary around the true value (i.e. the standard deviation),
can be estimated using the standard error of the mean (SEM). According to equation A32,
the SEM depends on the population distribution’s standard deviation s and the number of
samples n taken in during the sampling procedure. Those concepts show the importance
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Figure A3.6.: Probability and its distribution:
During an experiment 100 samples were taken from a normally distributed
population distribution (figure A3.6a). The results can be summarised in a
histogram - bucketing the outcomes and the frequency of those outcomes
(figure A3.6b). A histogram is a discrete, empirical probability distribution.
It is also possible to fit a continuous probability density function to the
sampled values (figure A3.6c). Figure A3.6c shows the histograms and
fitted pdf in for four different sample sizes. It is obvious that the more
samples, the closer the empirical pdf resembles the pdf of a normal
distribution, with sampling distribution’s parameters (SD as dashed line; x
as solid line) approaching the population distribution’s parameters.
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of having replicates, i.e. a certain sampling size, in any scientific experiment.
SEx =
σ√
n
(A32)
In a normal distribution, the SEM can be used to estimate confidence intervals. If multi-
plied with 1.96, then added and subtracted from the sample mean, the upper and lower
95% confidence interval are obtained, respectively. Confidence intervals are an important
aspect of inference statistics, as they give an estimated range, where the unknown popula-
tion distribution’s parameters are expected. For example, when a sampling procedure, of
several samples each, is repeated 100 times, 95 of the 100 different sampling distribution’s
parameters should lie within a prior defined 95 % confidence interval. Thus, a confidence
interval allows to estimate whether it is likely to have obtained a realistic estimate of the
population parameters during a sampling event. This is the basis for statistical hypothesis
testing [176].
In statistical hypothesis testing a decision is made, whether a result could have occurred
by chance alone, i.e. whether it is or is not from a certain population distribution, defined
by a confidence interval. The general procedure is as follows:
A certain hypothesis, for example, whether a biomarker is associated with a disease is put
forward. The null hypothesis H0 would state that there is no association, whereas the
alternative hypothesis H1 claims there is. A significance test aims to test whether H0 can
be rejected with a certain confidence, in favour of H1. It is essential to know the structure
of the data, such as underlying type of distribution or statistical independence, in order to
choose the correct test, when making the inference. In this thesis, only two major groups
of tests will be used. T-tests and F-tests (ANOVA). (Exact details about the testing pro-
cedures, such as used test and significance levels will be given in the method section of
the corresponding results chapter.) T-tests are a group of significance tests that use the
mean, whereas F-tests use the variance to judge whether H0 may be rejected. Both work
by calculating a T-statistic and F-statistic, that are compared with a T-distribution and
F-distribution, respectively, using lookup tables to yield a p-value.
P-values are the probability of obtaining a test statistic at least as extreme as the calculated
one. The lower, i.e. the closer to the tail of a distribution, the less likely. Geometrically,
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a p-value is the integral of the probability density functions tail, starting at the observed
data point and ending at infinity. If a p-value is smaller than the prior agreed significance
level α, H0 is rejected in favour to H1. A common significance level is 5 %, which would
correspond to a 2σ event in a normal distribution (compare figure A3.5).
According to contingency table A3.2 four scenarios are possible, but only two of them
desired; accepting H0 when H0 is actually true, or rejecting it when it is actually false.
H0 is true H1 is true
Accept H0 Right decision Wrong decision (Type 2 error)
True positive False negative
Accept H1 Wrong decision (Type 1 error) Right decision
False positive True negative
Table A3.2.: Contingency table of statistical hypothesis testing outcomes
A type 1 error, also referred to as false positive, is when H0 is incorrectly rejected. A
relationship is falsely assumed. In the prior example, the biomarker would be associated
with the disease, albeit in reality it isn’t. In fact, the probability of committing a type
1 error, equals the significance level α. Type 2 errors, false negatives, accept H0, even
though H1 is true. The test failed to reveal an actually correct relationship. For example,
the biomarker would not be associated with the disease, even though it is. The probability
β of committing a type 2 error is unknown. However, 1 − β is the power of a hypothesis
test, i.e. its probability of not committing a type 2 error.
In hypothesis testing, it is important to find the right trade of between these two errors.
Thus, choosing an appropriate significance level is important in order to neither miss, nor
state incorrect relationships.
In metabolomics, more than one compound are measured and evaluated for their prob-
ability of being a (bio)marker, associated with a certain condition, such as disease or
manipulation. This would require the calculation of multiple statistical hypothesis tests.
But if one were to perform 100 tests with a significance level of α = 5%, on average, one
will commit five type 1 errors - without knowing which in which instances these errors
occurred. To avoid this, one can acknowledge this problem and adjust the p-values by
multiple testing procedures [40], such as Bonferoni [3] or Benjamini-Hochberg correction
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[41]. Bonferroni is the more conservative method and tries to control the family-wise error
rate (FWER), i.e. the probability of committing one or more type 1 errors. This can be
done by dividing the initial significance level, e.g. α = 5% by the number of performed tests
n. In case three performed tests, 5%/n = 5%/3 = 1.7% would be the new α. Benjamini-
Hochberg correction controls the false discovery rate (FDR), i.e. the expected proportion
of type 1 errors among all significance tests. It is less conservative as it tolerates more
false positives, but reduces the number of false negatives (increased power). To perform it,
p-values are sorted from the largest to the smallest. The largest p-value remains the same,
but the second largest is adjusted by multiplication with n/(n−1), the second largest with
n/(n− 2), and so on.
Another strategy to minimise type 1 errors in multiple testing scenarios would be by min-
imising the number of necessary comparisons in the first place. For example, by using
multivariate data exploration tools or multiple group statistical testing procedures, such
as ANOVA, the total number of useful tests may be constrained to the most promising
candidates only, rather than testing every possible combination.
ANOVA is a collection of linear statistical models, that compare the total variance to the
one of individual groups to derive a F-statistic and p-value. If the p-value is significant one
of the groups is significantly different. The different group can be found using post-hoc
testing procedures.
Multivariate models, such as principal component analysis, will be discussed in section
A3.2.3. However, multivariate methods often require the prior use of normalisation, cen-
tring and scaling procedures discussed in the next section.
A3.2.2. Data preprocessing: Normalisation, centering and scaling
Irrespective of subsequent analysis, data should be normalised [599]. Normalisation is usu-
ally the first step of data pretreatment. It aims at reducing concentration effects that arise
from a bias in sampling, such as different concentration in extracted biomass or dilution
effects (cell media, urine) [115]. Ideally, after normalisation, only differential metabolites
would differentiate two samples, rather than one’s overall higher concentration (intensity).
Three different approaches for normalisation are typically used. Scaling to external stan-
dards, scaling to internal standards and empirical approaches. An example for scaling to
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an external standard would be using another, from the profiling method independent assay,
such as a spectroscopic Bradford protein determination to compensate for differences in
sampled biomass. As internal standard, a metabolite that is known to be contained in a
constant concentration inside a given matrix, could be used - analogously to the ”house-
keeping genes” used for the normalisation of microarray expression data. An example for
an internal standard scaling factor is creatinine in urine samples, as its excretion can be
assumed as constant [281]. Alternatively, if normalisation is only desired to compensate
for distortions occurred during the sample preparation, such as incomplete recovery during
extraction or pipetting inaccuracies, spiked in (stable isotope labelled) standards could be
considered. Two main empirical approaches have been used; total integral normalisation
and probabilistic quotient normalisation (PQN) [136]. Whereas the first has come under
scrutiny and should be avoided, particularly for MS detected datasets, the second one will
be used in this project. PQN works under the assumption that the median fold change
of all variables equals zero. Unless in the rare hypothetical case that the vast majority of
signals displays a fold change in one particular direction (most metabolites are either up-
or downregulated), it is very robust. Therefore it has become the default normalisation
method for metabolic profiling studies.
Mean centering and scaling are the two next pretreatment steps, which are very common,
particularly when multivariate analyses are used. Their equations are given in table A3.3.
Mean centering sets the mean of each variable across all samples to zero, by subtract-
ing the mean. Therefore all changes are centred around zero, rather than the mean of a
metabolite. Thus if a variable wouldn’t change across any of the samples, it is set to zero
and therefore ”removed” from the analysis. Also, the offset between high and low intense
features is removed. Thus, only relevant concentration changes are left for analysis. Figure
A3.7 illustrates its effect on variables.
Scaling divides all variables by a number - the scaling factor. Its goal is to reduce large
differences in fold changes across the different variables. Otherwise, inside a multivariate
model, a very high fold change of one variable could outweigh several smaller, but equally
important fold changes of other variables. However, this may also result in the danger
of allowing small, random, noise derived variables to have a higher weight in the analysis
and lead to misinterpretation. Therefore it is particularly important to follow up with
(unscaled) univariate statistical testing, when scaling methods were used.
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Figure A3.7.: Effect of mean centering and scaling on data:
Boxplots of metabolites of a typical metabolomics experiment are used to
visualise the effect of mean centring, unit variance and log scaling. The
right column is the mean centered version of the left one. Figure A3.7a
shows the raw data, figure A3.7c the unit variance scaled and figure A3.7e
the log scaled (base 10).
The two most common scaling methods are unit variance scaling and pareto scaling. Unit
variance scaling uses mean centred data and divides it by its standard deviation. This
results in a standard deviation of one for all data, and therefore gives all variables equal
importance (figureA3.7c). Also, it allows data to be analysed as correlations, rather than
covariance. Pareto scaling is slightly more conservative. It divides by the square root of
the standard deviation. Thus large fold changes are scaled more, relative to smaller ones.
Therefore, compared to unit variance scaling the data stays closer to its original structure.
Albeit often referred to as a scaling method (”log scaling”), a logarithmic transform is
technically no scaling method, as it does not divide by a scaling factor. However, it usually
is used with the same intention as the methods mentioned above (figure A3.7e). Care must
be taken when the standard deviations are high as log is a logarithmic transform thereby
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Operation Type Formula Unit
Centering Centering xˆij = xij − xi original
Unit variance Scaling xˆij = xij−xisi dimensionless
Pareto Scaling xˆij = xij−xi√si original
Log Transform xˆij = log10 xij log original
started Log Transform xˆij = log10(xij+min(abs(x))) log original
gerneralised log Transform xˆij = ln(xij +
√
x2ij + λ) dimensionless
Table A3.3.: Data preprocessing methods:
Formulae for the various data preprocessing methods explained in the text
[587]. i and j are the sample and variable index, respectively. xˆ denotes the
data after transformation. The transform parameter λ is discussed in the
text.
giving different scaling weights to different numbers. Log transformation is also useful to
reduce heteroscedasticity and transform multiplicative interactions to additive relations. A
major disadvantage of log transform is that it is not defined for negative numbers. There-
fore mean centering has to be performed after the transformation. Furthermore, if there
are any negative values in the dataset, it is not applicable. However, for this case two
closely related alternatives have been formulated. The started log transform [500] and
the generalised log transform [146, 145, 464]. For the started log transform a small offset,
usually the absolute value of the smallest (negative) value, is added. Then a regular log
transform can be performed. As the generalised log transform yields similar results, but
requires a complex calibration of a sample set specific parameter (λ) [464], the started log
transform is used in this thesis.
A3.2.3. Multivariate statistics and pattern recognition
Multivariate techniques are useful, when a system has more than one outcome variable.
For example, if a cohort of patients should be compared with regards to their blood glucose
levels, univariate methods are appropriate. If, however, the patients should be compared,
based on the measurement of their 22 amino acids, multivariate methods should be used,
instead of performing 22 univariate tests; one for each amino acid. This is because 22 T-
tests, for example, would drastically increase the likelihood for a type one error or otherwise
require very stringent multiple testing correction. A multivariate technique would already
hint at the relevant variable, which could be followed up with univariate post-hoc tests.
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Particularly in metabolomics experiments, where the number of variables may be as high
as a few ten thousand or more, this is an important consideration. The most classic
multivariate method is a generalised version of the univariate ANOVA, the multivariate
analysis of variance (MANOVA) [533]. However, like for ANOVA, it performs inference
testing based on probability distributions and therefore has certain prerequisites to its
input data quality. In metabolomics datasets, those prerequisites are not always met.
Furthermore, a MANOVA is very powerful for analysing factorial designs, but less suited
for the initial exploratory analysis of a large dataset [285]. Therefore the metabolomics
community usually defaults to multivariate pattern recognition techniques for the initial
analysis. [521, 275]
Pattern recognition techniques are used to classify data and reduce the number of its di-
mensions. The number of dimensions can be reduced by expressing the data through latent
variables. Latent variables are weighted linear combinations of the original variables. In
the simplest case, if a variable (dimension) does not discriminate between any data points,
it may as well be discarded. Particularly in metabolomics experiments, data often dis-
plays high redundancy and multicollinearity, such as one compound described by multiple
resonances in NMR or one compound giving rise to multiple isotope and adduct peaks in
MS. This redundant information can be summarised by the use of latent variables and the
number of variables (dimensionality) reduced. [579]
Pattern recognition techniques divide into two categories - supervised and unsupervised
methods. Supervised methods, have a priori information about the data’s metadata, such
as the sample’s group membership. Unsupervised methods do not have any information
about the system whatsoever. They entirely rely on a the data’s internal structure, such as
its variation, distance or correlation, when analysing the relationship between individual
observations (samples). The most common supervised method in metabolomics are deriva-
tives of partial least squares regression (PLS). Used unsupervised methods are hierarchical
cluster analysis (HCA) and the metabolomics workhorse - principal component analysis
(PCA). [384]
A3.2.3.1. Principal component analysis (PCA) .
Principal component analysis (PCA) [471] is a projection technique, that allows to visualise
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the maximum variance, encountered in the data.
First, the data matrix X requires to be mean centred [416], i.e. its variable means must
be zero, as described in section A3.2.2.
The m by n data matrix X, has m number of observations (samples) and n number of
variables (metabolites, peaks or spectral bins). PCA will transform this data into a new
coordinate system. The principal component space. Thereby, the original matrix X is de-
composed into a scores matrix T and a component matrix P , according to equation A33. E
is the error term, summarising all residuals. The scores matrix T contains the orthogonal
latent variables (principal components), with most of the variance described by principal
component one (t1pT1 ), then two (t2pT2 ), and so on. P , the loadings matrix, describes the
influence (weight), of the original X-variables inside the principal component space.
X = TP T + E = t1pT1 + t2pT2 + ...+ E (A33)
The transformation into the principal component space can be best explained in a geo-
metric representation. Each observation of the original matrix X, can be considered as a
datapoint inside a n-dimensional hyperspace (n-dimensional coordinate system), spanned
by the variables of X. This as illustrated by figure A3.8a for a n = 3 scenario.
PCA transforms all these data points into a new coordinate system, spanned by latent
variables, the principal components. The first principal component t1 lies in the direction
of the largest variation. t2 explains as much possible variation, that has not already been
accounted for accounted for by t1, i.e. it is orthogonal to t1. This continues until all vari-
ation of the system has been explained by principal components. Figure A3.8 illustrates
this procedure.
Compared to the interpretation of a high dimensional data matrix, interpretation of the
principal components, particularly if plotted, is straight forward. As the principal compo-
nents were defined along the paths of largest variation, when plotted against each other
(in the ”scores plot”), the principal components display the largest variation. In the sim-
plest case, the largest variation within a dataset is between two distinguishable groups,
such as diseased and healthy, or wild type and mutant. In such a case, the groups are
expected to separate along one or a combination of the principal components. Principal
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Figure A3.8.: Principal component analysis (PCA):
Each observation is a data point inside a n-dimensional hyperspace. In this
case a data matrix with n=3 different variables (such as metabolites). The
principal components are spanned in the direction of the highest variation
and are orthogonal to each other. Transformed data points plotted inside
the principal component space are called scores plot (figure A3.8b).
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Figure A3.9.: PCA scores and loadings plot interpretation:
This is a fictional example explaining the interpretation of the scores and
loadings plot, yielded by a principal component analysis. Consider a blood
test being performed on a cohort of healthy and a cohort of diabetic
patients. Five compounds are measured: Glucose, cholesterol, sodium
chloride, a yet unidentified metabolite X, and the ethanol levels, to check
the patient’s compliance. After principal component analysis, the scores
plot, displayed in figure A3.9a, shows that the largest variation in the
dataset lies between the diabetic (green) and healthy (blue) individuals.
Those clearly separate in direction of t1, with a group of three healthy, as
outliers on t2. Consulting the loadings plot, in figure A3.9b, the variables
driving the separation can be identified. As expected, the diabetic patients
are characterised by higher glucose levels. Cholesterol and sodium chloride
seem to be irrelevant, when discriminating between diabetic and healthy.
Metabolite X however, is of higher concentration in the healthy population
and it would be interesting to annotate it. Also, the three outliers show
bad compliance to the study design, as they seem to have consumed
ethanol and may therefore be excluded from subsequent statistical analyses.
Next to elucidating biomarker X, univariate methods, for example a t-test,
should be used to assess, whether it is significantly associated with the
healthy individuals.
In this example, the five measurement dimensions were reduced to three
relevant ones, and if outliers are removed, to two. This illustrates the power
of PCA for high dimensional metabolomics data. There is also a general
spread in t2, even though, despite the three outliers, the other study
participants may be sober. PC are latent variables. Glucose and metabolite
X mainly separate on t1, but also have a small impact on t2, thereby giving
all observation a spread and partial diagonal character, rather than making
them a singular line on p1.
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components are latent variables, i.e. composed out of the weighted original variables. To
find out, which original variable is discriminating between the two groups (visible in the
scores plot), these weights, contained in the loadings matrix can be plotted. The resulting
”loadings plot” contains all original variables, with their positions arranged according to
the weight they have for the principal components in the scores plot. Thus, if a variable in
the loadings plot is spatially aligned with a separated group in the scores plot, this variable
causes the separation. If a variable is close to the centre of the loadings plot, its impact
on the plotted principal component is negligible. In this manner trends, trajectories and
(dis)similarity between the sample groups can be explored. Figure A3.9 illustrates this by
a giving a fictional example.
It is important to note, that when explaining the loadings from a t1 versus t2 scores plot,
the associated p1 versus p2 loadings plot must be used. Similarly, the question, how many
principal components should be interpreted, emerges. In theory, there is no limit, except,
that at most, there are as many principal components as initial variables. However, the
information content (with regards to variation) drops as with each PC. The percentual
amount of the system’s variation explained by a single PC is often given as its R2 value.
As the amount of explained variation decreases with higher principal components, the R2
does so as well (R21 > R22 > ... > R2n). In most cases, most of a system’s variation can be
explained within the first few PC (R21−3 = R21 +R22 +R23). In this thesis, only the first two
PC will be used.
R2 = 1−
∑
E2∑
X2
(A34)
R2 is calculated according to equation A34.
Finally, it is important to keep in mind, that ordinary principal components or R2 values
are not associated with significance values [89], as they only are projection techniques.
In scenarios like the example from figure A3.9, they should always be followed up using
inference statistics.
A3.2.3.2. Partial least squares regression (PLS) .
Partial least squares regression (PLS) is a supervised modelling technique. It expresses the
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common structure between the X and Y matrix, by maximises their covariance and can
therefore be used for prediction. PLS decomposes those matrices according to equation
A35 and A36, with T and U as score matrices, P and C as loadings matrices. E and F
contain the unmodelled residuals. [579]
X = TP T + E (A35)
Y = UCT + F (A36)
In this thesis, Y is not a matrix, but a vector, such as life expectancy for the observations
in the data matrix X. The scores plots (usually only U is used) can be interpreted similar to
the one’s of PCA. However, it must be kept in mind that it is not variation, but covariance
that the separation is based on. Also, as it has a priori information, i.e. is a supervised
method, it is important to validate the model and make sure it is actually predictive and
not over fitted [622]. To this end, several methods for validation are available (reviewed by
Szymanska et al.[156]). The most commonly and also the approach used in this thesis, is
Q2 cross validation. Q2 is the cross-validated version of R2, and therefore tells how much
of the covariance can actually be predicted by the model. If a model has a high R2 and
low Q2 value, it fits the data, but is not predictive, i.e. over fitted. Q2 can be derived
via leave-one out methods. One sample (group) is excluded from building the model, but
used during prediction of Yˆcv. After every sample (group) has been left out once, Q2 can
be calculated according to equationA37.
Q2Y = 1−
∑(Yˆcv − Y )2∑
Y 2
(A37)
A3.2.3.3. Partial least squares - discriminant analysis (PLS-DA) .
PLS regression can also be used for discriminating between different sample groups, i.e.
force the separation between those in a supervised manner. In this case, Y is used as
a dummy variable, corresponding to the sample classes, for example Yi = 0 for control,
Yi = 1 for wild type. Again, cross-validation determines if the model is actually useful.
[579]
Protocols
B1. Wormculture
All protocols were executed, according to the Wormbook - a peer reviewed online resource
of the C. elegans community [544]. When necessary, deviations from the standard pro-
tocols were made. Chemicals and consumables for the worm culture were obtained from
VWR (Lutterworth, UK). Exceptions are stated. All worms were grown at 20°C inside a
cooled incubator.
B1.1. Growth medium
Worms are cultured on nematode growth medium (NGM) plates. Those are prepared by
dissolving 3 g NaCl, 17 g Agar and 2.5 g bacterial peptone in 0.975 L of water, purified by
a millipore system (Millipore, Watford, UK). After autoclaving and letting cool to ≈ 60°C
the following autoclaved solutions are added: 1ml 1M CaCl2, 1ml 1M MgSO4 and 25 ml
1M phosphate buffer (108.3gKH2PO4, 35.6gK2HPO4, H2O to 1 litre) adjusted to pH 6.
Finally 1 ml of a 5 mg/ml cholesterol in ethanol solution subject to sterile filtering through
a 0.22µm PTFE filter are added, prior to pouring into 90 mm petri dishes (≈ 20ml per
plate).
Plates are left at room temperature for two days to allow inspection for possible contam-
ination. Then, they are either stored at 4°C for later use (up to a maximum of 4 weeks)
or seeded with 200 µl of an overnight culture of E. coli strain OP50, grown in 25 g/l luria
broth medium in H2O. Seeding is done using a l-shaped spreader to create a lawn of uni-
form thickness, staying clear of the edges of the petri dish. Plates are incubated overnight
at 36°C to allow for a bacterial lawn to grow.
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B1.2. Age synchronisation
In some experiments, a mixed-age population was used to maximise metabolic diversity.
However, to obtain a clear snapshot of a metabolic phenotype, age synchronisation is re-
quired. This can be achieved by a wormbook[544] procedure called ”bleaching”. Gravid
worms are subject to an alkaline bleach solution to ”dissolve” them and release their eggs
which hatch at the same time ± 4 hours.
The worms of an agar plate, containing several gravid hermaphrodites, are washed into a 15
ml conical tube, using 2 x 3 ml aliquots of sterile M9 buffer (3 g KH2PO4 , 6 g Na2HPO4
, 5 g NaCl, 1 ml 1 M MgCl2 , H2O to 1 litre). 1 ml of 10 M NaOH and 3 ml of 10 % NaOCl
solution are added and topped up to 10 ml with ddH2O. After shaking for 5 minutes the
tube is centrifuged for 2 minutes at 2000 g. The supernatant discarded, and the pellet
washed twice with 10 ml of M9. Before the pellet is transferred to the edge of a newly
seeded NGM plate, the pH of the last washing supernatant is checked to ensure it is at pH 6.
B2. Default sampling and extraction protocol
Ahead of any profiling experiments, an extraction method evaluation, outlined in chapter
II., was performed. The consensus from these experiments, led to a standard sampling and
extraction protocol used for all subsequent analyses.
To prevent degradation, all samples were kept on dry ice as much as possible throughout
extraction. Ice cold only solvents were used. All solvent and materials used for the extrac-
tion were obtained in highest available purity.
Based on the results from the extraction method comparison, the following standard pro-
tocol for all future extractions was derived:
For harvesting worms of a single agar plate (corresponding to one biological replicate),
those were washed into a 15 ml conical tube, using 2 x 3 ml aliquots of sterile M9 buffer.
After 5 minutes, all worms will have settled as a pellet on the bottom of the tube. At this
stage a washing step could be performed by letting the pellet settle inside a fresh tube filled
with 10 ml of M9 buffer. The necessity of a washing step is discussed in II.5.1. However,
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in most experiments no washing steps were performed, but deviations will be mentioned.
The (washed) pellet of 300µl was transferred into a 2 ml bead-beater tube. This was done
using a glass pipette, to minimise the loss of biomass, due to an observed static adhesion
of the worms to plastic pipette tips. The pellet was snap frozen immediately and stored
at -80°C until extraction.
On dry ice, the bead-beater tube was filled with 200 µl of 0.1 mm glass beads and 1.2 ml
of cold methanol were added. The sample was immediately extracted using a Precellys 24
bead-beater (Bertin Technologies, Montigny-le-Bretonneux, France), operated for two 20
second cycles at 6.5×103 rpm, with 20 seconds pause inbetween. Samples were centrifuged
(5 min, at 16× 103 g, 4°C), the supernatant transferred into a 15 ml centrifuge tube and
the pellet re-extracted with 1.5 ml of 80% methanol. The obtained supernatant was pooled
with the first and the total volume topped up to 3 ml - where necessary. This volume was
aliquoted into three 1 ml technical replicates, which were then dried down in a vacuum
concentrator at room temperature and store at -80°C until analysis. Aliquots designated
for GC-MS analysis were dried directly inside silanised GC-MS glass vials (Agilent), rather
than 1.5 ml sample tubes.
B3. NMR spectroscopy
B3.1. Preparation
Dried samples were reconstituted with 650 µl 0.1M 2H2O based phosphate buffer, pH 7,
containing 0.5 mM 3-(trimethylsilyl)-2,2’,3,3’-tetradeuteropropionic acid (TSP) and 1 g/l
NaN3. To guarantee solubilisation of the pellet the samples were sonicated for 5 minutes
and vortexed. Samples were centrifuged for 5 minutes at 13,000 g to separate insoluble
debris from the supernatant, of which 600 µl were transferred into a 5 mm NMR tube.
B3.2. Acquisition
NMR acquisition was performed as described previously [37].
As most experiments were conducted on different magnets and probes, using different pulse
sequences, the exact protocols will be described in the corresponding method section of
each chapter.
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B3.3. Processing and analysis
Also the NMR processing regime was dependant on the experiment and can be found in
each experiment’s methods section.
B4. Gas Chromatography - Mass Spectrometry
All GC-MS acquisitions were performed according to a standardised protocol by Kind et
al.(”The Fiehn Method”) [323], in order to use their retention time locked fragmentation
library for identification. Their derivatisation procedure consists of a two step protocol
with methoximation, followed by silylation.
B4.1. Preparation
10 µl of 1.5 mg/ml 27-d-myristic acid (in methanol) were added to the sample for re-
tention time locking. Samples must then be dried thoroughly in a vacuum concentrator
prior to derivatisation. In the first step, samples were incubated with 20 µl of 20 mg/ml
methoxyamine hydrochloride in anhydrous pyridine for 90 minutes at 30°C. For the second
step, samples were silylated with 90 µl of N-Methyl-N-(trimethylsilyl) trifluoroacetamide
(MSTFA) for 30 minutes at 37°C. During both incubation steps, vials were briefly agitated
every 15 minutes to ensure mixing of sample and the derivatisation reagents. Finally, 10
µl of 1mM 2-fluorobiphenyl in anhydrous pyridine was added as injection standard. Using
a glass pipette, the derivatised sample was transferred into silanised high recovery vial
inserts (Agilent), which itself was placed back into the original vials.
B4.2. Acquisition
For the acquisition an Agilent 6890 (Wokingham, UK) gas chromatograph with split/splitless
injector was used. 1 µl was injected into a glass-wool split liner at 250°C and a split ratio
of 1:5-1:10, with a 3-10 ml/min helium gas flow. A DB5-MS column ( 30 m length, 0.25
mm inner diameter, 0.25 µm film, 95% dimethyl 5% diphenyl polysiloxane) was used. The
oven was operated at a 1 ml/min constant flow of helium, with a tenperature ramp from
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60°C (one minute hold) to 325°C at 10°C/min. A 10 minute hold was performed before
cool down to 70°C, leading to a 37.5 min total runtime per sample.
As detector, an Agilent 5973 MSD single quadrupole mass spectrometer with electron im-
pact ionisation (EI) at 70 eV was used. The transfer line was kept at 290°C, the filament
source at 290°C and the quadrupole at 250°C, whilst scanning over a range of 50-600 u at
2 spectra/s. Fragmentation and acquisition started after a 5.90 min solvent delay.
Samples were handled by an Agilent 7693 autosampler. The whole setup was controlled
by Agilent’s Chemstation software.
B4.3. Processing
Acquired spectra were converted into the netCDF format before using the Automated
Mass Spectral Deconvolution and Identification System (AMDIS) [539], available free of
charge from the National Institute of Standards and Technology (NIST) (Gaithersburg,
MD, USA) for deconvolution. Settings for peak detection and matching to the Fiehn
retention time locked fragmentation database [323] or authentic standards were optimised
for each sample set. However, those were kept conservative with high retention time and
fragmentation deviation bias in order to minimise false positives [540]. As AMDIS does
not integrate the baseline if a fragmentation component was not detected inside a sample,
baseline re-integration for each metabolite was performed using the Matlab based software
add-on GAVIN [38]. This led to a sample × metabolite intensity matrix.
B4.4. Analysis
The GC-MS data analysis is described in each experiment’s method section.
B5. Liquid Chromatography - Mass Spectrometry
As all LC-MS experiments were performed using different instrumentation, parameter sets
and processing workflows, experimental details will be discussed in each chapter’s method
section.
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Name PubChem Key GC-MS NMR Class
Betaine 247 x Biogenic amine
Choline 305 x Biogenic amine
O-phosphocolamine 1015 x Biogenic amine
Phosphocholine 1014 x Biogenic amine
putrescine 1045 x Biogenic amine
3-aminoisobutyric acid 64956 x Amino acid
Alanine 602 x Amino acid
Arginine 232 x Amino acid
Asparagine 236 x Amino acid
Aspartate 424 x Amino acid
Glutamate 611 x Amino acid
Glutamine 738 x Amino acid
Glycine 750 x x Amino acid
Isoleucine 791 x x Amino acid
Leucine 857 x Amino acid
Lysine 866 x Amino acid
Methionine 876 x Amino acid
Phenylalanine 994 x x Amino acid
Proline 614 x Amino acid
Pyroglutamic acid 7405 x Amino acid
Serine 617 x x Amino acid
Threonine 205 x Amino acid
Threonine 205 x Amino acid
Tyrosine 1153 x Amino acid
Valine 1182 x x Amino acid
Beta- alanine 239 x Amino acid Derivative/Precursor
Cystathionine 834 x Amino acid Derivative/Precursor
D-Ala-D-Ala 601 x Amino acid Derivative/Precursor
Homoserine 779 x Amino acid Derivative/Precursor
Hydroxy-proline 5810 x Amino acid Derivative/Precursor
Ornithine 389 x Amino acid Derivative/Precursor
D-(+)-Trehalose 1143 x x Carbohydrate
Glucose 5793 x Carbohydrate
3-Glycerophosphate 754 x Carbohydrate Derivative/Precursor
3-Phosphoglycerate 724 x Carbohydrate Derivative/Precursor
D-glucose-6-phosphate 5958 x Carbohydrate Derivative/Precursor
Gluconic acid 604 x Carbohydrate Derivative/Precursor
Glycerol 753 x x Carbohydrate Derivative/Precursor
myo-Inositol 892 x Carbohydrate Derivative/Precursor
sn-Glycero-3-phosphocholine 71920 x Carbohydrate Derivative/Precursor
Sucrose 5988 x Carbohydrate Derivative/Precursor
Acetate 175 x Carboxylic acid
Citramalic acid 1081 x Carboxylic acid
Citric acid 311 x Carboxylic acid
Formate 283 x Carboxylic acid
Fumarate 723 x x Carboxylic acid
Lactate 612 x x Carboxylic acid
Malate 525 x Carboxylic acid
Phosphoenolpyruvic acid 1005 x Carboxylic acid
Phosphoglycolic acid 529 x Carboxylic acid
Propionate 1032 x Carboxylic acid
Succinate 1110 x x Carboxylic acid
Heptadecanoic acid 10456 x Fatty acid
Linoleic acid 3931 x Fatty acid
Palmitic acid 985 x Fatty acid
Stearic acid 5281 x Fatty acid
Adenosine 191 x Nucleoside
Guanosine 765 x Nucleoside
Xanthosine 1189 x Nucleoside
Adenine 190 x Nucleoside base
Thymine 1135 x Nucleoside base
Uracil 1174 x Nucleoside base
Xanthine 1188 x Nucleoside base
AMP 224 x x Nucleotide
ATP 238 x Nucleotide
GTP 762 x Nucleotide
Inosine 5-monophosphate 8582 x Nucleotide
UMP 6030 x Nucleotide
Pyrophosphate 1023 x Phospate
Nicotinic acid 938 x Vitamin or derivative
Pantothenic acid 988 x Vitamin or derivative
Cholesterol 304 x Steroid
Methoxytryptamine 1833 x Biogenic amine
Phenylethanolamine 1000 x Biogenic amine
Table C1.1.: C. eleganscompounds detected via GC-MS and NMR:
Pubchem identifier and compound class is also given.
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Table C2.1.: HMDB metabolites matched with 12C and 13C HSQC cross peaks:
Metabolites returned by searching the 12C and 13C HSQC cross peaks
against the HMDB HSQC reference spectra. Table contains name,
HMDB[630] and PubChem[56] identifier, the number of cross peaks for each
metabolite and the % fraction which of those were detected in the 12C and
13C HSQC spectrum. If no number is given, no peak was detected.
No Metabolite Name HMDB id PubChem id Peaks % 13C % 12C
1 Citicoline HMDB01413 13804 11 100 55
2 D-Glucose HMDB00122 5793 10 100 30
3 Glycogen HMDB00757 439177 10 100 25
5 Trehalose HMDB00975 7427 8 100 100
4 Glycerophosphocholine HMDB00086 71920 8 100
6 Cytidine triphosphate HMDB00082 6176 7 100 43
7 Spermidine HMDB01257 1102 7 100 29
8 Guanosine diphosphate HMDB01201 8977 6 100 67
10 Glycerol 3-phosphate HMDB00126 439162 5 100 100
16 D-Arginine HMDB03416 71070 5 100 60
12 Ornithine HMDB00214 6262 5 100 60
9 L-Cystathionine HMDB00099 439258 5 100 40
15 Spermine HMDB01256 1103 5 100 40
11 L-Lysine HMDB00182 5962 5 100 20
13 Glycyl-L-leucine HMDB00759 92843 5 100
14 N-Acetylglutamic acid HMDB01138 185 5 100
22 D-Xylitol HMDB02917 6912 4 100 100
18 L-Arginine HMDB00517 6322 4 100 75
21 Threonic acid HMDB00943 151152 4 100 75
17 Ribitol HMDB00508 6912 4 100 50
19 L-2-Hydroxyglutaric acid HMDB00694 439939 4 100 25
20 L-Valine HMDB00883 6287 4 100 25
24 L-Glutamic acid HMDB00148 33032 3 100 100
29 3-Phosphoglyceric acid HMDB00807 724 3 100 67
23 Glycerol HMDB00131 753 3 100 67
25 L-Alanine HMDB00161 5950 3 100 67
27 L-Glutamine HMDB00641 5961 3 100 67
31 D-Glutamine HMDB03423 145815 3 100 33
32 D-Leucine HMDB13773 6106 3 100
26 L-Asparagine HMDB00168 6267 3 100
28 L-Leucine HMDB00687 6106 3 100
Continued on next page
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30 N-Acetyl-L-aspartic acid HMDB00812 65065 3 100
40 Acetylglycine HMDB00532 10972 2 100 50
44 D-Lactic acid HMDB01311 61503 2 100 50
37 L-Lactic acid HMDB00190 107689 2 100 50
36 L-Serine HMDB00187 5951 2 100 50
45 Putrescine HMDB01414 1045 2 100 50
46 Acetylphosphate HMDB01494 186 2 100
33 Beta-Alanine HMDB00056 239 2 100
34 Citric acid HMDB00094 311 2 100
43 D-Alanine HMDB01310 71080 2 100
35 Ethanolamine HMDB00149 700 2 100
41 Glutaric acid HMDB00661 743 2 100
42 Hydroxypropionic acid HMDB00700 68152 2 100
38 Oxoglutaric acid HMDB00208 51 2 100
47 Pectin HMDB03402 441476 2 100
39 Phosphoenolpyruvic acid HMDB00263 1005 2 100
50 Glycine HMDB00123 750 1 100 100
52 Succinic acid HMDB00254 1110 1 100 100
54 Tartaric acid HMDB00956 444305 1 100 100
48 Acetic acid HMDB00042 176 1 100
55 Dihydroxyacetone HMDB01882 670 1 100
57 Dimethyl sulfone HMDB04983 6213 1 100
49 Dimethylamine HMDB00087 674 1 100
56 Dimethylmalonic acid HMDB02001 11686 1 100
53 Malonic acid HMDB00691 867 1 100
51 Orotic acid HMDB00226 967 1 100
58 Uridine diphosphate-N-acetylglucosamine HMDB00290 445675 15 93 73
59 Maltotetraose HMDB01296 439639 18 89 39
60 D-Glucuronic acid HMDB00127 444791 9 89 33
61 D-Maltose HMDB00163 10991489 17 88 35
63 Adenosine triphosphate HMDB00538 5957 8 88 75
62 Allocystathionine HMDB00455 10104953 8 88 25
65 Adenosine 3’,5’-diphosphate HMDB00061 159296 7 86 71
70 Adenosine phosphosulfate HMDB01003 10238 7 86 71
71 Guanosine triphosphate HMDB01273 6830 7 86 71
64 Adenosine monophosphate HMDB00045 6083 7 86 57
68 Uridine 5’-diphosphate HMDB00295 6031 7 86 57
66 L-Aspartic acid HMDB00191 5960 7 86
69 N-Alpha-acetyllysine HMDB00446 192590 7 86
Continued on next page
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No Metabolite Name HMDB id PubChem id Peaks % 13C % 12C
67 Pantothenic acid HMDB00210 988 7 86
72 Alpha-D-Glucose HMDB03345 79025 13 85 46
75 Guanosine monophosphate HMDB01397 6804 6 83 50
74 L-Isoleucine HMDB00172 6306 6 83
73 L-Phenylalanine HMDB00159 6140 6 83
76 Uridine diphosphate glucose HMDB00286 53477679 17 82 65
81 D-Lysine HMDB03405 57449 5 80 40
78 Gamma-Glutamylcysteine HMDB01049 123938 5 80 40
77 Homo-L-arginine HMDB00670 9085 5 80 20
79 Aminocaproic acid HMDB01901 564 5 80
80 Erythrose HMDB02649 439574 5 80
82 Maltitol HMDB02928 493591 14 79 57
83 N1-Acetylspermine HMDB01186 916 9 78 22
84 Uridine diphosphategalactose HMDB00302 18068 13 77 54
85 Inosinic acid HMDB00175 8582 8 75 63
86 Sorbitol HMDB00247 5780 8 75 63
87 1-Methylguanosine HMDB01563 96373 8 75
88 Alpha-Aspartyl-lysine HMDB04987 6427003 8 75
92 L-Iditol HMDB11632 5460044 4 75 75
89 (R)-3-Hydroxyisobutyric acid HMDB00336 11217234 4 75
91 3-Aminoisobutanoic acid HMDB03911 64956 4 75
90 Citrulline HMDB00904 9750 4 75
94 Beta-N-Acetylglucosamine HMDB00803 24139 15 73 60
93 N-Acetyl-D-glucosamine HMDB00215 11861101 15 73 60
95 Maltotriose HMDB01262 439586 18 72 39
97 Glucose 1-phosphate HMDB01586 439165 7 71 43
96 Isovalerylglutamic acid HMDB00726 133383 7 71
98 NAD HMDB00902 5893 19 68 32
99 D-Xylose HMDB00098 135191 18 67 22
100 7-Methylguanosine HMDB01107 445404 9 67 22
102 Glutathione HMDB00125 124886 6 67 50
106 Gluconic acid HMDB00625 10690 6 67 17
104 Gluconolactone HMDB00150 7027 6 67 17
105 N6-Acetyl-L-lysine HMDB00206 92832 6 67 17
103 Guanosine HMDB00133 6802 6 67
101 Iodotyrosine HMDB00021 439744 6 67
107 N-Acetyl-L-tyrosine HMDB00866 68310 6 67
121 Phosphorylcholine HMDB01565 1014 3 67 100
128 D-Threitol HMDB04136 169019 3 67 67
Continued on next page
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108 L-Carnitine HMDB00062 2724480 3 67 67
110 L-Threonine HMDB00167 6288 3 67 67
125 Canavanine HMDB02706 439202 3 67 33
119 Diaminopimelic acid HMDB01370 439283 3 67 33
117 Homocysteine HMDB00742 778 3 67 33
118 Propionylglycine HMDB00783 98681 3 67 33
131 3-Dechloroethylifosfamide HMDB13858 1983 3 67
120 3-Hydroxyanthranilic acid HMDB01476 86 3 67
127 4-Guanidinobutanoic acid HMDB03464 500 3 67
129 4-Heptanone HMDB04814 31246 3 67
115 4-Hydroxyphenylpyruvic acid HMDB00707 979 3 67
123 Acetaminophen HMDB01859 1983 3 67
124 Acetylcysteine HMDB01890 12035 3 67
113 D-Alpha-aminobutyric acid HMDB00650 439691 3 67
122 DL-O-Phosphoserine HMDB01721 106 3 67
109 Gamma-Aminobutyric acid HMDB00112 119 3 67
114 Ketoleucine HMDB00695 70 3 67
112 L-Alpha-aminobutyric acid HMDB00452 80283 3 67
126 L-Dihydroorotic acid HMDB03349 439216 3 67
116 Levulinic acid HMDB00720 11579 3 67
111 Phenol HMDB00228 996 3 67
130 Sulfamethoxazole N1-glucuronide HMDB13855 996 3 67
134 Glucose 6-phosphate HMDB01401 5958 11 64 36
133 N-Acetylmannosamine HMDB01129 11096158 11 64 36
132 NADP HMDB00217 5886 11 64 27
139 Uridine 5’-monophosphate HMDB00288 6030 8 63 63
137 D-Mannose HMDB00169 18950 8 63 50
135 Argininosuccinic acid HMDB00052 16950 8 63 38
138 Saccharopine HMDB00279 160556 8 63 38
136 Cytidine monophosphate HMDB00095 6131 8 63 25
140 Cysteineglutathione disulfide HMDB00656 53477713 10 60 30
146 Hydroxyphenyllactic acid HMDB00755 9378 5 60 40
149 L-Arabitol HMDB01851 439255 5 60 40
143 2-Hydroxyadipic acid HMDB00321 193530 5 60 20
151 3-Phenoxypropionic acid HMDB02229 81596 5 60 20
148 6-Phosphogluconic acid HMDB01316 91493 5 60 20
145 Homocitrulline HMDB00679 65072 5 60 20
142 L-Tyrosine HMDB00158 6057 5 60 20
150 N-Acetylputrescine HMDB02064 122356 5 60 20
Continued on next page
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141 (S)-3-Hydroxyisobutyric acid HMDB00023 440873 5 60
144 Leucinic acid HMDB00665 92779 5 60
147 Ureidosuccinic acid HMDB00828 93072 5 60
152 N-Acetylgalactosamine 4-sulphate HMDB00781 446101 12 58 33
153 Allose HMDB01151 12285879 7 57 29
154 5-Phenylvaleric acid HMDB02043 16757 7 57
155 Coenzyme A HMDB01423 6816 16 56 25
156 Inosine triphosphate HMDB00189 8583 9 56 56
159 Mannose 6-phosphate HMDB01078 439198 9 56 33
157 Aminoadipic acid HMDB00510 469 9 56 11
160 D-Pantethine HMDB03828 452306 9 56
158 L-Aspartyl-L-phenylalanine HMDB00706 93078 9 56
161 Cellobiose HMDB00055 10712 20 55 45
162 Alpha-Lactose HMDB00186 84571 20 55 30
164 Furan HMDB13785 5988 11 55 27
163 Sucrose HMDB00258 5988 11 55 27
165 L-Arabinose HMDB00646 439195 12 50 25
166 Homocarnosine HMDB00745 10243361 8 50 13
167 5-Methoxydimethyltryptamine HMDB02004 1832 8 50
177 D-Xylulose HMDB01644 5289590 6 50 50
170 L-Acetylcarnitine HMDB00201 1 6 50 17
171 2-Methyl-3-ketovaleric acid HMDB00408 189028 6 50
168 3-Methoxytyramine HMDB00022 1669 6 50
173 3-Methyl-2-oxovaleric acid HMDB00491 47 6 50
172 3,4-Dihydroxyhydrocinnamic acid HMDB00423 348154 6 50
174 DL-Dopa HMDB00609 836 6 50
169 L-Dopa HMDB00181 6047 6 50
176 N-Formyl-L-methionine HMDB01015 6995182 6 50
175 Valerylglycine HMDB00927 4737557 6 50
195 2,3-Butanediol HMDB03156 262 4 50 25
181 Glutarylglycine HMDB00590 23592950 4 50 25
183 Isovalerylglycine HMDB00678 546304 4 50 25
185 L-Homoserine HMDB00719 12647 4 50 25
184 L-Methionine HMDB00696 6137 4 50 25
192 Methionine sulfoxide HMDB02005 847 4 50 25
193 N-Methyl-D-aspartic acid HMDB02393 22880 4 50 25
187 Neopterin HMDB00845 4455 4 50 25
186 Pyrrolidonecarboxylic acid HMDB00805 499 4 50 25
179 Tyramine HMDB00306 5610 4 50 25
Continued on next page
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190 2-Ketohexanoic acid HMDB01864 159664 4 50
180 4,5-Dihydroorotic acid HMDB00528 648 4 50
196 5-Aminopentanoic acid HMDB03355 138 4 50
191 D-threo-Isocitric acid HMDB01874 5318532 4 50
188 Histamine HMDB00870 774 4 50
194 Methylimidazoleacetic acid HMDB02820 75810 4 50
178 Phenylacetic acid HMDB00209 999 4 50
182 Succinylacetone HMDB00635 5312 4 50
189 trans-Cinnamic acid HMDB00930 444539 4 50
200 Betaine HMDB00043 247 2 50 100
202 Creatine HMDB00064 586 2 50 50
219 N-Methyl-a-aminoisobutyric acid HMDB02141 6951124 2 50 50
214 Phosphocreatine HMDB01511 587 2 50 50
197 1,3-Diaminopropane HMDB00002 428 2 50
198 2-Ketobutyric acid HMDB00005 58 2 50
217 2,2-Dimethylsuccinic acid HMDB02074 11701 2 50
209 5-Hydroxymethyluracil HMDB00469 78168 2 50
220 A-Ketoglutaric acid oxime HMDB02467 13012726 2 50
201 Acetoacetic acid HMDB00060 96 2 50
215 Acetone HMDB01659 180 2 50
208 Adipic acid HMDB00448 196 2 50
222 Diethanolamine HMDB04437 8113 2 50
203 Dihydrouracil HMDB00076 649 2 50
204 Dimethylglycine HMDB00092 673 2 50
211 Galactaric acid HMDB00639 3037582 2 50
216 Isobutyric acid HMDB01873 6590 2 50
212 Isopropyl alcohol HMDB00863 3776 2 50
210 L-Cysteine HMDB00574 5862 2 50
221 Phosphonoacetate HMDB04110 546 2 50
205 Propionic acid HMDB00237 1032 2 50
213 Pyrocatechol HMDB00957 289 2 50
207 Sarcosine HMDB00271 1088 2 50
218 Syringic acid HMDB02085 10742 2 50
206 Taurine HMDB00251 1123 2 50
199 Ureidopropionic acid HMDB00026 111 2 50
223 5-Hydroxylysine HMDB00450 3032849 9 44 33
224 dATP HMDB01532 15993 9 44 22
232 D-Tagatose HMDB03418 92092 7 43 43
233 5-Methoxytryptamine HMDB04095 1833 7 43 14
Continued on next page
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225 Carnosine HMDB00033 439224 7 43 14
227 Glucosan HMDB00640 2724705 7 43 14
228 Suberylglycine HMDB00953 6453952 7 43 14
229 2’-Deoxyguanosine 5’-monophosphate HMDB01044 65059 7 43
230 dGTP HMDB01440 65103 7 43
231 Diphenhydramine HMDB01927 3100 7 43
234 o-Tyrosine HMDB06050 91482 7 43
226 Xanthosine HMDB00299 64959 7 43
236 Glucosamine HMDB01514 45933887 12 42 25
235 2-Methylbutyroylcarnitine HMDB00378 6426901 12 42 17
237 Lactulose HMDB00740 11024312 22 41 14
239 3,4-Dihydroxyphenylglycol HMDB00318 91528 5 40 20
241 D-Arabitol HMDB00568 827 5 40 20
247 L-Norleucine HMDB01645 21236 5 40 20
242 Ortho-Hydroxyphenylacetic acid HMDB00669 11970 5 40 20
245 Phenylacetylglycine HMDB00821 68144 5 40 20
240 2-Hydroxy-3-methylbutyric acid HMDB00407 99823 5 40
238 Dopamine HMDB00073 681 5 40
244 Hydrocinnamic acid HMDB00764 107 5 40
243 Hydroxyisocaproic acid HMDB00746 83697 5 40
246 trans-Ferulic acid HMDB00954 445858 5 40
248 Stachyose HMDB03553 439531 23 39 22
249 NADH HMDB01487 928 18 39 28
253 Ribothymidine HMDB00884 445408 8 38 38
251 Uridine HMDB00296 6029 8 38 38
255 5-Methylcytidine HMDB00982 92918 8 38 25
250 Cytidine HMDB00089 6175 8 38 25
256 dCMP HMDB01202 13945 8 38 13
252 Isobutyryl-L-carnitine HMDB00736 10177002 8 38
254 L-Tryptophan HMDB00929 6305 8 38
257 D-Galactose HMDB00143 439357 11 36 9
258 L(-)-Nicotine pestanal HMDB01934 89594 11 36
259 1-Methyladenosine HMDB03331 27476 17 35 12
260 Pteroyltriglutamic acid HMDB01902 6968 15 33
261 Metoprolol HMDB01932 4171 12 33 8
262 Fructose 6-phosphate HMDB00124 69507 9 33 22
263 Inosine HMDB00195 6021 9 33 11
267 3-Methylhistidine HMDB00479 64969 6 33 17
265 L-Histidine HMDB00177 6274 6 33 17
Continued on next page
C2 Supplementary tables and figures for chapter III 381
Table C2.1 – Continued from previous page
No Metabolite Name HMDB id PubChem id Peaks % 13C % 12C
266 Serotonin HMDB00259 5202 6 33 17
271 3-Chlorotyrosine HMDB01885 119226 6 33
272 3-Phenylbutyric acid HMDB01955 20724 6 33
264 Epinephrine HMDB00068 5816 6 33
269 L-3-Phenyllactic acid HMDB00748 643327 6 33
268 L-Kynurenine HMDB00684 161166 6 33
270 Phenyllactic acid HMDB00779 3848 6 33
288 2,3-Diaminopropionic acid HMDB02006 97328 3 33 67
278 6-Dimethylaminopurine HMDB00473 3134 3 33 33
274 Choline HMDB00097 305 3 33 33
294 Erythritol HMDB02994 222285 3 33 33
275 Galactitol HMDB00107 11850 3 33 33
273 p-Hydroxyphenylacetic acid HMDB00020 127 3 33 33
292 1,11-Undecanedicarboxylic acid HMDB02327 10458 3 33
289 2-Pyrrolidinone HMDB02039 12025 3 33
293 2,4-Diaminobutyric acid HMDB02362 470 3 33
301 2,4-Dichlorophenol HMDB04811 8449 3 33
286 5-Aminolevulinic acid HMDB01149 137 3 33
296 Acetoin HMDB03243 179 3 33
291 Cadaverine HMDB02322 273 3 33
302 cis-4-Octenedioic acid HMDB04982 11805205 3 33
297 Cyclohexanone HMDB03315 7967 3 33
281 Cysteine-S-sulfate HMDB00731 115015 3 33
298 D-Cysteine HMDB03417 92851 3 33
279 Gamma-Butyrolactone HMDB00549 7302 3 33
295 Guanidinosuccinic acid HMDB03157 439918 3 33
280 Isovaleric acid HMDB00718 10430 3 33
290 Itaconic acid HMDB02092 811 3 33
299 L-Allothreonine HMDB04041 99289 3 33
277 L-Cystine HMDB00192 67678 3 33
276 L-Malic acid HMDB00156 222656 3 33
282 Malic acid HMDB00744 525 3 33
283 Pimelic acid HMDB00857 385 3 33
300 Selenocystine HMDB04122 15104 3 33
285 Suberic acid HMDB00893 10457 3 33
287 Theophylline HMDB01889 2153 3 33
284 Undecanedioic acid HMDB00888 15816 3 33
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Wild type
ISP-1
GAS-1
MEV-1
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NUO-6
Figure C2.1.: Aligned spectra of the mitochondrial mutant dataset:
The normalised total ion chromatograms show clear differences in
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C3. Supplementary tables and figures for chapter IV
Element minimum [# Atoms/Da] maximum[#ÊAtoms/Da]
Carbon 0.011 0.080
Nitrogen 0 0.040
Sulphur 0 0.018
Table C3.1.: Minimum and maximum atom-count to m/z ratios:
Determined as 0.01% and 99.99% PubChem confidence intervals
Element minimum [#ÊCarbon/ # Element] maximum[# Carbon/ # Element]
Hydrogen 0.08 7.00
Nitrogen 0 5.00
Oxygen 0 6.00
Phosphorous 0 3.00
Sulphur 0 2.5
Table C3.2.: Minimum and maximum elemental ratios:
Determined as 0.01% and 99.99% PubChem confidence intervals. Carbon is
used as the reference, as any molecule is required to have at least one carbon
atom.
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Adduct Charge/Mode
M-H 1-
M-H2O-H 1-
M+Na-2H 1-
M+Cl 1-
M+K-2H 1-
M+FA-H 1-
M+Hac-H 1-
M+Br 1-
2M-H 1-
2M+FA-H 1-
2M+Hac-H 1-
3M-H 1-
M-2H 2-
M-3H 3-
M+H 1+
M+NH4 1+
M+Na 1+
M+CH3OH+H 1+
M+K 1+
M+ACN+H 1+
M+2Na-H 1+
M+ACN+Na 1+
M+2K+H 1+
M+2ACN+H 1+
2M+H 1+
2M+NH4 1+
2M+Na 1+
2M+K 1+
2M+ACN+H 1+
2M+ACN+Na 1+
M+ 1+
M+2H 2+
M+H+NH4 2+
M+H+Na 2+
M+H+K 2+
M+ACN+2H 2+
M+2Na 2+
M+2ACN+2H 2+
M+3ACN+2H 2+
2M+3H2O+2H 2+
M+3H 3+
M+2H+Na 3+
M+H+2Na 3+
M+3Na 3+
Table C3.3.: Adducts used during molecular formula calculation.
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Figure C3.1.: Accuracy requirement for ab initio formula calculation, impacted
by various atom-count constraints:
x-axis is log10(ppm), y-axis is yet unresolved fraction of metabolites. Refer
to chapter IV.3.1 for more information.
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Figure C4.1.: LOESS function to correct post-acquisition calibrate m/z domain:
The individual data points are the difference (in measured mass) of the
same compound before and after the power outage. All measurements
across the whole mass range show a clear trend and therefore allowing
post-acquisition correction of the m/z domain (for the post power outage
samples). In red, a LOESS (locally weighted scatterplot smoothing)
regression function is fitted through the data points. This function can then
be used as a calibration curve, allowing to correct the masses of the affected
samples.
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(a) (b)
(c) (d)
Figure C4.2.: ROC curves for optimising xcms peak detection parameters:
Receiver operating characteristics (ROC) analysis was used to try optimise
xcms peak detection parameters, to potentially cut the numbers of detected
features. For more details, please refer to the appropriate methods or
results section V.2.3.3 and V.3.3, respectively. Figure C4.2a shows the ROC
curve for the SN , figure C4.2b for the prefilter, figure C4.2c for the PPM
and figure C4.2d the peakwidth parameter. The colour indicates by how
much a certain parameter threshold would reduce the number of detected
data points.
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Figure C4.3.: Hierarchical clustered heat map of all samples:
All samples are unit variance scaled. The cluster of QC samples is
highlighted by a black square. Within all samples, patterns are visible.
However, the data structure appears to be highly complex.
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Figure C4.4.: Glycerophosphocholines versus glycerophosphoethanolamines:
This figure shows the base ion peak (BPI) chromatogram and several
extracted ion chromatograms (EIC) of the lipid region of a QC sample. It
can be seen, that there is little evidence for ethanolamine or aminoethane,
which would indicate the presence of glycerophosphoethanolamines.
Instead, choline and glycerophosphocholine fragments, hinting at
glycerophosphocholines can be seen. The earlier eluting
monoacylglycerophosphocholines seem to preferentially loose
phosphocholine, whereas the later eluting diacylglycerophosphocholines are
more likely to only split of choline.
